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 1 Introduction 
The central subject of this thesis is to derive clinically applicable methods to measure and 
improve the reproducibility of treatment delivery in radiotherapy by means of portal 
imaging. The most important criteria that such methods should meet, apart from being 
effective, is that (1) they are relatively simple to implement and (2) the additional workload 
required in daily practice is small. This approach was inspired by the observation that 
routine application of portal imaging in clinical practice, according to well-defined 
protocols, remains relatively rare.  
Below, we first sketch the general aims and practice of radiotherapy. From this brief 
overview, a number of aspects become apparent that are essential to the work described in 
the following chapters. In particular, the meaning of systematic and random geometrical 
errors in radiotherapy is emphasised. 
1.1 Radiotherapy  
Surgery, radiotherapy and chemotherapy are currently the three predominant therapies in 
the treatment of cancer. Although a combination of these treatment modalities is often used 
to provide optimal treatment, here we will concentrate solely on the role of radiotherapy. In 
radiotherapy, high energy particles  ('ionising radiation') are used to deliver damage to 
tumour cells by interaction of these particles with the cellular matter. Irreparable damage to 
the nuclear DNA may lead to direct cell kill through loss of vital cell functions or can 
induce cellular suicide ('apoptosis'). High energy particles may penetrate deeply into tissue. 
This property is exploited in external beam therapy, where beams of photons, electrons or 
other particles of MeV energies are generated outside the patient (usually by linear 
accelerators) and collimated into beams that enter the patient (Fig. 1.1). This approach 
introduces a number of fundamental problems, which not only generate most of present 
radiotherapy physics research but also constrain the way radiotherapy treatment can be 
delivered in practice.  
Each clonogenic tumour cell should be killed by the delivered radiation dose to 
definitely eradicate malignant growth. However, tumours are usually detected only after 
they have reached macroscopic dimensions (10-100 grams). This implies that lethal 
radiation doses must be delivered to relatively large volumes of tissue. The external 
radiation beams, however, will deposit energy in normal tissue both before and beyond the 
target tumour volume, which may induce substantial cell kill in tissues vital to either life 
itself or the quality of life. The present approach to simultaneous minimisation of dose in 
these 'critical organs' and maximisation of dose in the target volume of tumour cells is by 
calculating optimal radiation beam entrance directions and energy fluence distributions 
within these beams. Taking such complex dose delivery techniques to the limit may in 
theory provide distributions of high dose confined almost exactly to the target volume, 
thereby enabling a high degree of normal tissue sparing at a large tumour dose. However, 
practical issues in the execution of radiotherapy treatment may introduce a significant 
difference between the calculated ('planned') distribution of dose and the actual distribution 
achieved. This thesis deals with a number of inaccuracies introduced by the use of a static 
geometrical model of the patient anatomy. 
2 
1.2 Radiotherapy treatment chain 
We will limit our discussion to patients treated on the basis of 3-dimensional (3D) anatomic 
information obtained from a computed tomography (CT) scan acquired with the patient in 
treatment position, but most of the important aspects are also valid when treatment planning 
is based on other diagnostic modalities. The volumes of the tumour to be treated and the 
critical organs are defined within the 3D CT dataset. The tumour volume is then usually 
extended by a geometrical margin to define the actual volume to be irradiated to a certain 
prescribed dose level. This margin must account for the geometrical uncertainty involved in 
the definition of the tumour as well as for the inaccuracies introduced in subsequent steps of 
the treatment chain. Next, the treatment planning system allows for the calculation and 
optimisation of the (3D) dose distribution achieved with a specific treatment technique. In 
so-called 'conformal radiotherapy,' the aim is to conform this planned dose distribution as 
closely as possible to the patient specific anatomy, using all practically available irradiation 
techniques. Conventionally, the patient is then positioned on a simulator to mimic the actual 
treatment on a linear accelerator. Using geometical information from the treatment plan 
established previously, reference marks are tattooed or drawn on the patient skin or on 
specific fixation devices (e.g. a head mask) based on the co-ordinate system in the 
simulator room. This co-ordinate system is usually defined by a set of laser beams 
generated by wall-mounted lasers in the latter room. Because a similar set of lasers is 
present in the treatment room, the reference marks enable a quick set-up of the patient at the 
treatment unit. Once the set-up at the simulator is considered satisfactory, reference 
radiographs are acquired which prescribe the daily set-up of the bony anatomy of the 
Accelerator gantry
CCD camera
Radiation beam
Fluorescent screen
Electronic portal image
EPID
Figure 1.1 External beam radiotherapy configuration with EPID 
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patient in the treatment beams. With the advent of CT-simulators, this separate simulator 
step can be omitted by marking the patient directly after the planning CT scan has been 
obtained. From the CT data, so-called digitally reconstructed radiographs (DRRs) are 
calculated which can replace the simulator radiographs as reference images.  
 The prescribed radiation dose is usually not delivered in one session but instead divided 
into a number of fractions, with intervals of typically one day. There are various 
radiobiological reasons for such a fractionated dose delivery. For instance, normal tissues 
often exhibit more effective DNA damage repair than tumours. Hence, normal tissues may 
partly recover from such damage in the intervals between fractions, allowing for a larger 
total tumour dose.  
The treatment chain sketched above introduces many possibilities for inaccuracies. 
Because we will concentrate on geometrical inaccuracies, we give an example of how small 
errors related to skin marks might emerge at the CT scanner, simulator and during 
treatment. On the CT scanner, temporary marks are placed on the patient's skin to define the 
co-ordinates of the patient in the planning CT scan using the laser system of the scanner. If 
these skin-marks are later used to position the patient on the simulator to mark the 
definitive patient set-up, inaccuracies occur because 
(1) The co-ordinate system of the CT scanner and simulator may not exactly coincide 
(2) The skin generally is a flexible structure, allowing for motion relative to the internal 
anatomy of interest 
(3) Judgement of the alignment of skin marks on the lasers is usually by eye. Because 
multiple skin marks are involved, a 'reasonable fit' must be sought. However, as deviations 
of the posture of the patient relative to that during the CT scan may not always be uniquely 
identifiable, such a fit represents a compromise of unpredictable quality. 
If, in the above, we replace simulator by treatment unit and (if a simulator is used) CT 
scanner by simulator, it is obvious that these three causes of inaccuracy are equally 
applicable at the treatment unit during each of the treatment fractions. Apart from the errors 
related to the use of skin marks, there exist many other sources of geometrical inaccuracy 
between treatment preparation and execution. For instance, due to dynamic processes such 
as breathing, both the treated tumour and normal tissues may exhibit their own specific 
motion on various time scales. Irrespective of the source of the geometrical deviations 
between planned and delivered treatment, a separation can be made into 'systematic' and 
'random' inaccuracies. Because such a separation turns out to be crucial for treatment 
planning and optimisation purposes, we describe its application in patient set-up in the next 
section. 
1.3 Systematic and random set-up errors 
As in most patient set-up studies, below we will sometimes refer to the geometrical 
inaccuracies as errors, although strictly speaking this may not always be the most 
appropriate terminology. To understand the concept of systematic and random errors as 
applied in this thesis, it is sufficient to consider the simple situation in which the treatment 
simulation can be skipped, i.e. reference marks suited for patient set-up at the treatment unit 
are placed at the CT scanner (see section 1.2). Each set-up is executed with a finite 
accuracy, hence a displacement of the patient relative to the intended set-up used in the 
treatment planning occurs during each treatment day.  In Fig. 1.2(a) these displacements are 
given for 2 directions for a treatment of 20 fractions. The mean displacement over all 
fractions, represented by the arrow 's' in Figure 1.2(a), is referred to as the systematic set-up 
error. The systematic set-up error represents the recurring difference between intended and 
4 
actual set-up. However, patient set-up is slightly different during each fraction and so the 
total set-up error in a given fraction is the sum of the systematic set-up error and an 
additional, fraction specific error (represented by the arrow 'r' in Fig. 1.2(a)). The latter 
error is referred to as random set-up error, because it represents the fluctuating, stochastic 
component of the set-up error during treatment. In Fig. 1.2(b), we present the frequency 
distribution of random set-up errors in the anterior-posterior (AP) direction, as measured in 
600 patients treated for prostate cancer (containing data of over 6000 fractions). As shown 
in Fig. 1.2(b), this distribution is described well by a normal distribution. Hence, the 
random set-up errors are often characterised by the standard deviation (SD) of their 
frequency distribution. This SD is usually denoted by σ (see Fig. 1.2(b)). 
The matter gets slightly confusing when we consider more than one patient. Then, the 
systematic set-up error also becomes a fluctuating quantity, but now the fluctuations are 
between patients and not between fractions. This is illustrated in Fig. 1.3(a), where 
systematic set-up errors for 10 patients are drawn as solid arrows. The stochastic nature of 
the systematic error roots in the fact that many of the processes that contribute to the net 
observed systematic error, such as the skin marking described in section 1.2, are non-
reproducible. Hence, the systematic error observed for a patient would be different if the 
entire treatment chain was repeated. Consequently, one can also interpret the arrows in Fig. 
t 
s 
r X
Y
σ
0
250
500
750
-10 -5 0 5 10
AP random error (mm)
N
Figure 1.2. (a) Measured set-up errors for 20 fractions of a specific patient, in two 
directions (X,Y). Each square represents the set-up error of a particular fraction. The 
solid circle indicates the mean of these errors and the corresponding displacement 
(arrow 's') is the systematic set-up error of this patient. The total set-up error of any 
fraction (e.g. the greyed square and corresponding arrow 't') is the sum of the systematic 
error and the random set-up error (arrow 'r') of that fraction.  
(b) Frequency distribution of random set-up errors as measured in 600 prostate ca. 
patients in the anterior-posterior direction (solid line), and a fitted normal distribution 
(dashed line). The SD (σ) is indicated, as well as the mean of the distribution (vertical 
line), which by definition equals 0. 
(a) (b) 
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1.3(a) as the systematic errors that could occur if the patient of Fig. 1.3(a) would complete 
the treatment chain 10 times, neglecting that some systematic errors may be patient 
specific. Note that certain components that make up the systematic set-up error are 
completely patient independent. For instance, if the lasers in the treatment room are mis-
aligned by a constant amount from those used for placing skin marks, this constant 
deviation will be present in the systematic set-up error for each patient. The frequency 
distribution of the systematic errors in the AP direction, obtained for the same patient group 
as in Fig. 1.2(b), is depicted in Fig. 1.3(b). Again, the distribution is nearly normal, and is 
usually characterised by the mean systematic error µ and the standard deviation Σ (both 
indicated in Fig. 1.3(b)).  
The description of set-up errors in terms of systematic and random errors turns out to be 
particularly useful when patient populations are studied. Appropriate pre-treatment quality 
assurance can render µ small, and so usually the important quantities are Σ and σ. Both 
SD's measure the spread of set-up errors around the ideal value 0 and margins used in 
treatment planning to cover for uncertainties in set-up accuracy (section 1.2) can therefore 
be expressed in these quantities. Note that the illustration of set-up errors given above 
pertains to translations, which is sufficient if one considers a single point is space. 
However, in realistic anatomy, rotations can also be of importance. In principle, these 
rotations can be described similar to translations, i.e. by the values (µ, Σ, σ). In practice, 
rotations are more problematic as they complicate the 2D analysis of images described 
below and furthermore the translations measured in various directions become mutually 
dependent in the presence of rotations. If these effects are neglected, one must make sure 
that rotations can be kept sufficiently small. 
Figure 1.3.(a) Systematic set-up errors for 10 patients, represented by arrows. An asterisk 
marks the systematic error of the patient in Fig. 1.2 (a). (b) Frequency distribution of 
systematic set-up errors (solid line), measured in the patient group of Fig. 1.2(b), and a 
fitted normal distribution (dashed line). The mean of this distribution is indicated by the 
vertical line, which is displaced by an amount µ from 0, the SD equals Σ. 
0
20
40
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N
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1 *
(a) (b) 
Σ
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1.4 Portal imaging and its role in advanced radiotherapy treatment 
All research presented below is related to the use of Electronic Portal Imaging Devices 
(EPIDs) in radiotherapy. An EPID utilises the radiation exiting the patient during treatment 
to create an image of the patient anatomy crossed by the radiation beam (Fig. 1.1). These 
electronic portal images (EPIs) are similar to X-ray radiographs, but because the photons in 
the treatment beam are of a much higher energy (typically a factor 100) and the source of 
the treatment beam is not specifically designed for imaging, portal images suffer from less 
contrast, signal to noise ratio and spatial resolution. Therefore, creating high quality EPIs 
remains a technological challenge and EPIDs are under continuing technological 
development. The EPIDs described in this work were developed in our clinic and are CCD 
camera based. This type of EPID uses a fluorescent screen similar to those used in 
combination with X-ray films, to convert the high-energy photons of the treatment beam 
into visible light. The light is captured by a (non-standard, high sensitivity) CCD camera 
and the ensuing images are processed and analysed by dedicated software. Based on the 
excellent performance of our original prototype (Rotterdam Advanced Portal Imaging 
Device or RAPID), a collaboration with Cablon Medical (Leusden, the Netherlands) was 
started in 1999 to develop the Theraview New Technology (TNT) system. Both prototype 
and commercial TNT systems were used in the studies comprising this thesis. 
EPIs can be used to measure set-up errors relative to the intended set-up and hence 
improve the accuracy of that set-up. There are two different approaches to calculate and 
correct for measured set-up errors, i.e. off-line and on-line. In the on-line approach, an EPI 
is obtained using a small part of the fraction dose at the beginning of each fraction, the set-
up deviation is measured (while the patient remains on the treatment couch) and corrected 
for immediately, after which the remaining dose is delivered. In the off-line approach, 
measured deviations are not used to correct the set-up immediately but instead an estimate 
of the systematic error is calculated from EPIs of various fractions and used for correction 
in subsequent fractions. The above definition implies that on-line corrections can reduce 
both random and systematic set-up errors whereas off-line corrections reduce only 
systematic errors. 
Next to set-up corrections, EPIs can be used in transit dosimetry. This application 
requires that the intensities measured in the EPI can be translated to the radiation dose 
impingent on the detector with a high accuracy (~1 %).  The CCD camera's we apply in our 
EPIDs are well suited for this task. The resultant portal dose images (PDIs) can be used to 
verify the dose delivered to the patient. 
 EPIs thus combine information on geometry and dosimetry during the actual treatment 
and therefore yield an ideal tool for quality assurance and improvement of treatment 
delivery. Particularly in conformal radiotherapy, where the demands on the set-up accuracy 
are high and the technique of dose delivery may involve complex dynamic processes, 
EPIDs have become a prerequisite for treatment verification. 
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1.5 Subjects treated in this thesis 
The main aim of this thesis was to derive practical and effective methods to reduce set-up 
and dosimetric errors using portal imaging. Below, we outline the contents of the following 
chapters. 
Chapter 2. Introduction to the TNT EPID and dosimetry applications 
In this chapter, a technical description of our EPID is given and its suitability for dosimetry 
measurements is investigated. The advantage of the applied 'high elbow', in which the 
distance between the fluorescent screen and the mirror that directs the light towards the 
camera is larger than in conventional EPIDs, is described. A practical algorithm to translate 
EPIs into accurate PDIs is developed.  
Chapter 3. Relation between geometrical uncertainties and treatment planning margins 
 In section 1.2, we mentioned that in treatment planning, margins are used to account for 
geometrical uncertainties such as set-up errors. In Chapter 3, the coverage probability (CP) 
model is developed to quantitatively investigate the consequences of geometrical 
uncertainties on the tumour dose distribution and to derive appropriate planning margins. If 
the statistical distribution of systematic and random set-up errors is known for a specific 
patient population, this model can be used to calculate the probability of under-dosage of a 
tumour treated with a certain planning margin. By constraining this probability, appropriate 
margins may be derived. These margins may be assessed in a patient specific manner, 
taking into account the exact dose distribution and patient anatomy. As an alternative, a rule 
of thumb can be formulated which expresses margins that are approximately correct for an 
entire patient population.  
Chapters 4 and 5 Investigation of the systematic and random set-up errors in lung 
cancer patients 
If the skin marks that are used for patient positioning at the treatment unit are placed on a 
simulator (section 1.2), the set-up error during the simulation session (relative to the 
intended set-up in the treatment plan), will be present in all subsequent treatment fractions. 
Hence simulator set-up errors are systematic errors. Furthermore, set-up corrections at the 
treatment unit are based on comparing portal images with reference images that should 
reflect the correct position of the patient anatomy with respect to the treatment field. 
Consequently, if the reference images are simulator radiographs, such set-up corrections 
cannot reduce the systematic errors introduced during simulation. In chapter 4, the 
magnitude of the simulator set-up errors was investigated by comparing simulator films 
with digitally reconstructed radiographs (DRRs). DRRs are calculated directly from the CT 
scan used in treatment planning and therefore represent the intended set-up exactly.  
In chapter 5, we describe the application of a procedure to omit the simulation session, 
and mark patients only during the CT scan procedure. Together with the use of DRRs as 
reference images, this enables a true reduction of systematic set-up errors by use of EPI. 
Chapters 6 and 7. A low workload method for accurate correction of systematic set-up 
errors.  
In chapter 6 we describe a new (off-line) protocol to reduce systematic errors (i.e., reduce 
the width Σ of the distribution in Fig. 1.3(b)).  This No Action Level (NAL) protocol 
presents a straightforward approach to executing set-up corrections, and aims at a major 
reduction in systematic errors at a minimal imaging and image analysis workload. A 
theoretical description is developed to calculate the impact of this protocol on systematic 
errors, which is validated with retrospective analyses of measured set-up data and Monte 
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Carlo simulations. All obtained results are compared to those achieved with the Shrinking 
Action Level (SAL) set-up protocol, as this is the most frequently applied protocol to date. 
An extension of the NAL protocol, the so-called correction verification stage or COVER 
is introduced in chapter 7. COVER was designed to prevent the systematically erroneous 
execution of set-up corrections determined with the NAL protocol (e.g, a correction of 1 cm 
to the left is prescribed for a specific patient, but is consequently executed as a 1 cm shift to 
the right). Similar to the NAL approach, we investigated how the impact of wrongly 
executed set-up corrections could be maintained sufficiently small at a minimum workload. 
To do this, a detailed risk analysis was performed, based on both Monte Carlo simulations 
and analytical calculations to derive a general recipe for COVER measurements and 
analysis. 
Chapter 8: Set-up accuracy improvement by portal imaging in head-and-neck cancer 
patients 
Here, we describe a clinical study on the set-up accuracy of head-and-neck cancer patients. 
An off-line correction protocol (SAL) was applied to reduce the systematic set-up errors. In 
addition, the possible impact of time trends and results achievable with a NAL protocol in 
this population were investigated in detail. 
Chapter 9: Problems in set-up analysis introduced by non-rigid body anatomy 
Most of the work introduced above deals with correcting patient set-up based on 
translations of the patient using the treatment couch. This usually works fine because 
rotations in the volume of interest can be kept small. However, for larger treatment 
volumes, such rotations and in general changes in posture of the patient may become 
important. Most models that describe the impact of rotations on the translations observed in 
a 2D EPI projection are based on a rigid patient anatomy. However, the occurrence of 
rotations may be inconsistent with such a rigid anatomy. This problem is illustrated in 
Chapter 9 for cervix cancer patients treated with fields of up to 40 cm length.  
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Abstract 
 
Purpose: The application of a newly developed fluoroscopic (CCD-camera based) 
Electronic Portal Imaging Device (EPID) in portal dosimetry is investigated. A description 
of the EPID response to dose is presented in terms of stability, linearity and optical cross 
talk inside the mechanical structure.  
Methods and Materials: The EPID has a relatively large distance (41 cm on-axis) between 
the fluorescent screen and the mirror (high elbow), which results in cross talk with 
properties quite different from that of the low elbow fluoroscopic EPIDs that have been 
studied in the literature. In contrast with low elbow systems, the maximum cross talk is 
observed for points of the fluorescent screen that have the largest distance to the mirror, 
which is explained from the geometry of the system. An algorithm to convert the images of 
the EPID into portal dose images (PDIs) is presented.  
Results: The correction applied for cross talk is a position dependent additive operation on 
the EPID image pixel values, with a magnitude that depends on a calculated effective field 
width. Deconvolution with a point spread function, as applied for low elbow systems, is not 
required. For a 25 MV beam, EPID PDIs and ionisation chamber measurements in the 
EPID detector plane were obtained behind an anthropomorphic phantom and a 
homogeneous absorber for various field shapes. The difference in absolute dose between 
the EPID- and ionisation chamber measurements, averaged over the four test fields 
presented in this paper, was 0.1 ± 0.5% (1 SD) over the entire irradiation field, with no 
deviation larger than 2%. 
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2.1 Introduction 
 
Accurate dosimetric treatment verification (within 1 standard deviation (SD) ~ 2%) with 
Electronic Portal Imaging Devices (EPIDs) has developed rapidly over the past years, and 
the first detailed patient studies now become available [30, 69, 100]. Recent studies 
combine the 2D dosimetric information present in EPID images with 3D CT data to derive 
information about deviations in patient anatomy from the transmission dose [69, 129]. 
Since EPID images can be used simultaneously for verification and improvement of patient 
set-up accuracy as well as dosimetric quality assurance [69, 142], their value in the safe 
delivery of complex conformal radiotherapy plans, particularly if dose escalation is 
involved, is obvious [43, 146].  
Two approaches to dosimetric quality control during patient treatment (in vivo 
dosimetry) with EPIDs can be identified. The first approach, proposed by Leong [74] and 
Wong et al [142], rests on the prediction of a portal dose image (PDI) in the EPID detector 
plane, based on CT and photon beam data, which can be compared to the PDI derived from 
the EPID image [84, 98]. The potential advantage of the comparison of portal dose in the 
detector plane is that not only errors in the magnitude and distribution of the dose may be 
detected, but significant deviations between the patient anatomy during the planning CT 
scan and during the treatment may also become apparent  [69]. The second approach 
involves back-projection of the EPID PDI to estimate the dose at a dosimetrically relevant 
point or plane in the patient [30, 100] or even the 3D dose distribution [50, 83, 148], 
generally assuming that the planning CT scan is consistent with the patient anatomy during 
treatment. The back-projected dose may then be compared to the dose predicted by the 
treatment planning system. 
Any method of absolute dosimetric verification with EPIDs rests on the availability of 
reproducibly measurable PDIs. The two commercially available EPIDs which are 
considered suited to render such PDIs are the CCD-camera based fluoroscopic Philips SRI-
100 EPID [52, 68, 99] and the Varian Portal Vision liquid-filled matrix ionisation chamber 
[42, 147]. The SRI-100 system was developed in collaboration with our institute and its 
dosimetric properties were characterised in detail by Heijmen et al [52] and Pasma et al 
[99]. They showed that EPID images can be converted into PDIs with an accuracy of 1 SD 
= 1% with respect to ionisation chamber measurements for clinically applied fields, 
including wedged and dynamic multileaf collimated fields. The use of a CCD camera (as 
opposed to a tube camera), although not favorable in terms of signal-to-noise ratio (SNR) 
due to its small optical coupling factor and relatively low quantum efficiency [2], is 
appropriate since it yields a long term response stability that meets the requirements of 
portal dosimetry [38, 43, 52].  
Based on the experience with the SRI-100, we developed a new EPID equipped with up-
to-date (commercially available and unmodified) components. Special care was taken in the 
selection of the CCD camera and its electronics, as these were the limiting factors for image 
SNR in the SRI-100 [2]. The EPID, to which the acronym RAPID (Rotterdam Advanced 
Portal Imaging Device) was assigned, currently employs a commercially available 
mechanical structure (TheraView Technology by Cablon Medical BV). This structure is 
available in a “low elbow” (on-axis distance of 23 cm between fluorescent screen and 
mirror) and in a “high elbow” version (corresponding distance of 41 cm).  
The aim of this paper is twofold: first, we establish that the RAPID detector has the 
proper characteristics for practical portal dose measurements, i.e. (i) there exists a unique 
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relation between image pixel value and portal dose measured with an ionisation chamber 
which is independent of absorber thickness or distance from the EPID, and (ii) this relation 
is reproducible over both short (minutes to hours) and long (weeks to months) time scales.  
These investigations were performed with a high elbow system, but apply equally well to 
the low elbow version of the RAPID. Next, we propose and experimentally verify a method 
for conversion of EPID images to PDIs which deals specifically with the optical cross talk 
in the structure of a high elbow EPID. Due to the relatively large distance between screen 
and mirror, the cross talk of a high elbow system is expected to differ significantly from 
that measured by Pasma et al [99] for the (low elbow) SRI-100 EPID. 
 
2.2 Methods and materials 
All references below to position (x,y), pixel size and field size are in a plane parallel to the 
EPID fluorescent screen which contains the isocentre. The position coordinates x and y are 
measured in a right-handed system where the positive y direction points towards the gantry 
and the origin (0,0) coincides with the isocentre. For clarity, we shall sometimes measure 
distances in the plane of the fluorescent screen and use the coordinates  (xFS, yFS) which are 
equal to 1.5 × (x,y) (see section 2.2.1.1).  
2.2.1  Description of the EPID 
2.2.1.1 EPID hardware 
The RAPID detector consists of a fluorescent screen (FS), a front-surface mirror, a CCD 
camera, and a PC with a frame grabber. The FS, which is a layer of 150 mg/cm2 Gd2O2S:Tb 
(Kodak Lanex Fast-B) coated onto a 2 mm thick brass build-up plate, and the  mirror (tilted 
at an angle of 45° relative to the FS) are part of the standard TheraView structure [89]. We 
increased the build-up of the FS with a 1 mm thick stainless steel plate to bring the 
fluorescent layer near the depth of the maximum dose at 25 MV (see section 2.2.3). The on-
axis distance between the fluorescent screen and the mirror for the high elbow version of 
the structure investigated in this paper is 41 cm, with a minimum separation of 22 cm near 
the edge (∆z in figure 2.1(a)).  
The CCD camera (Adimec MX12)  is placed in a horizontal position directed towards 
the mirror (figure 2.1(a)). It is shielded from photo-neutrons by 5 cm thick blocks of Boron-
doped polyethylene above and beside the camera. A similar 15 cm thick block, which has a 
conically shaped opening for the lens, is placed in front of the camera. Inside this neutron 
shield is a photon shield consisting of a 2 cm thick lead plate above, and a plate of equal 
thickness but with a circular opening for the lens, in front  of the camera. 
The CCD contains 1024 × 512 active pixels of 7.5 × 15 µm2 each. The quantum 
efficiency of the CCD peaks near the central wavelength of the FS  (545 nm) at 30% 
(manufacturer specification). A Navitar High Speed lens with a focal length of 25 mm was 
selected  (stopped at f/1.1) to ensure that the image of the FS area of 38 × 38 cm2 (∆yFS × 
∆yFS, ∆yFS as in figure 2.1(a)) just covers the entire CCD area.  
The CCD has frame transfer read-out with a transfer time of 5 µs to the storage part of 
the chip, implying that, in principle, measurements with virtually no dead-time can be 
performed since the camera electronics allow a new acquisition to be started during the 
read-out of the storage part (which takes less time than the minimum frame integration time 
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of 40 ms). The camera is used in so-called ‘trigger mode’, in which the camera requires a 
trigger pulse to initiate a frame acquisition. In this mode, the integration time on the CCD 
can be selected from 40 to 1280 ms (in steps of 40 ms) by the RAPID software via a serial 
link to the PC. A printed circuit board (PCB) was developed to generate these trigger pulses 
in response to a signal from the camera which indicates that a frame has been completely 
acquired. The analog video signal of the camera is digitized by a 10 bit frame grabber 
(Matrox Pulsar), yielding images with a pixel value range of 0-1023 ADC units.  
The vertical position of the detector, i.e. the source to detector distance (SDD), can be 
selected via a manual control over a range of ~ 40 cm, but for general clinical use it is kept 
fixed at 150 cm. All measurements described below were performed at SDD = 150 cm 
(maximum field size: 25 × 25 cm2 at isocentre level) with the 25 MV scanning photon 
beam of a MM50 Racetrack Microtron (Scanditronix Medical AB) at a nominal dose 
rate rD of 300 MU/min. 
 
2.2.1.2 EPID software and image acquisition procedure 
The host PC runs a dedicated windows application, which was developed in our hospital. 
The program supports a patient database, configurable image acquisition procedures, 
display enhancement and quantitative image analysis tools, EPID performance quality 
assurance procedures and fully integrated decision protocols for off-line and on-line patient 
set up corrections [116]. The image processing functions make use of the library of routines 
(Matrox Imaging Library) that comes with the frame grabber.  
 Before a new image acquisition is started, the CCD frame integration time (Tint) which 
yields an expected signal of 700 ADC units is calculated. The expected signal is predicted 
according to the model described by Althof et al [2]. The calculation aims at a maximum 
frame integration time while avoiding saturation of the signal. This approach minimises the 
contribution of the camera read-out noise on the final image [107]. In practice, signal levels 
are usually such that Tint is between 0.5 and 1.0 s. The total number of frames (nf) to be 
acquired to obtain an EPID image for a selected exposure X (MU) is calculated from 
)]T(/[ int drf TDXn += , where Td is the dead-time per frame (48 ms) introduced by the 
PCB described in the previous section. For patient set-up verification, X can be much 
smaller than the total MU delivered in the treatment field. However, for in-vivo dosimetry, 
the X selected in the software is always 25% larger than the total MU to be delivered. As a 
result, the total image acquisition time becomes 25% larger than what would be required to 
integrate the delivered exposure at the nominal dose rate and so drops in effective dose rate 
of up to 25% (e.g. due to beam start up effects) will not lead to a stop of acquisition before 
the irradiation has stopped. 
 The frame integration time of the camera is set to the calculated Tint and a pre-exposure 
‘dark current’ image is obtained with a number of frames equal to  nf  or, if the exposure 
time nf (Tint + Td) exceeds 5 s, the number of frames corresponding to an acquisition time ≤  
5 s. The frames are added real-time in a 32 bit deep frame buffer allocated in host RAM. 
The dark current image measures signal offsets that are mainly due to thermally generated 
charge on the CCD [2]. Next, the exposed image is obtained in a similar fashion. The 
addition of frames for the exposed image is started as soon as the average signal level in a 
frame increases by a software configurable amount (typically 5%). Given the 10 bit ADC 
resolution, the 32 bit frame buffer can store over 4 × 106 frames without saturation which 
allows for a maximum exposure of ~107 MU. The dark current image, scaled according to 
 13
the ratio of the acquisition times of the exposed and the dark current image, is subtracted 
from the exposed image.  
To improve SNR, the contents of adjacent pairs of pixels in the horizontal direction are 
added, effectively yielding 512 × 512 pixels. For the SDD of 150 cm, this yields an 
effective pixel size of 0.46 × 0.46 mm2 at isocentre level. The image is divided by nf and 
stored to disk with 16 bit precision and an image header from which the acquisition settings 
can be retrieved. This ‘raw’ image can be used for portal dosimetry. 
Generally, for patient set-up verification, the raw image is divided by an open field 
‘calibration image’ (with floating point precision) to correct for fixed pattern noise due to 
position dependent EPID sensitivity variations [2, 67]. The resultant image is processed for 
optimal contrast resolution on the monitor and displayed. This processed image is also 
stored and may be used for off-line set-up analysis. 
The EPID images that were used in this study were obtained with 150 monitor units 
(MU) exposure, unless mentioned otherwise. This is slightly larger than the exposures 
usually encountered in clinical practice (typically 50-100 MU) but ensures a highly 
reproducible accelerator output (1 SD < 0.2%) which is convenient for measurements (the 
dose measurements with the ionization chamber described below are not performed 
simultaneously with the EPID acquisition but a short time after).  
 
2.2.2  Response stability and linearity 
If a pixel value in the stored raw image is Gs, then the quantity of interest to dosimetry is  
intdint
s
f TTTGnG /)( +≡  
 which is the accumulated signal over all frames corrected for the dead time of the detector 
(48 ms, see previous section). The EPID response (G/Dp, where Dp is the portal dose) must 
meet a number of requirements to be suited for (high precision) in vivo dosimetry. Firstly, 
G/Dp must be sufficiently constant (1 SD ≈ 0.5%), both on a short time scale (seconds to 
minutes) and a long time scale (months), to permit a reliable detection of discrepancies in 
portal dose of ~ 2%.  Secondly, the dependency of the response on the frame integration 
time must be known so that the response can be predicted for any Tint value encountered in 
clinical practice. Images obtained with a Tint that optimises the SNR for set-up verification, 
may then be converted to PDIs. Finally, G/Dp should be independent of the actually 
delivered exposure, as verification of this exposure is one of the major goals of in-vivo 
dosimetry.  
The on-axis pixel value Gc considered below is the average of G(x,y) over a central 
region of 1.5 × 1.5 cm2, which renders the impact of random image noise negligible: a 
typical clinical RAPID image obtained with a few MU exposure already has a SNR ~ 100 
(pixel value divided by random noise on that value, see Althof et al, [2]). Since the average 
is calculated over ~ 900 pixels, the relative error on Gc due to random noise processes is < 
0.05% at even the lowest exposures (1-2 MU).  
 
2.2.2.1 Response Stability 
The short term response stability was assessed by sequential acquisition of ten images with 
an interval shorter than one minute between acquisitions. This procedure was performed 3 
times with a separation of approximately one month. Since the accelerator output is very 
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stable over the short measurement period of a single acquisition session (1 SD ≈ 0.2% 
[38]), the SD of Gc is a measure of the short term response variation.  
The long term stability has been derived from results of the beam output quality 
assurance (QA) procedure which was described by Dirkx et al [38]. The QA procedure 
involves the daily acquisition of portal images of open 17 × 17 cm2 fields for the gantry 
angles  0, 90, 180 and 270°. The exposure for each field is 150 MU. For each gantry angle, 
the day-to-day variation of Gc was assessed. The values of Gc reflect both accelerator 
output fluctuations and EPID sensitivity variations. Therefore, the variation in Gc presents 
an upper limit on the EPID long term sensitivity variations.  In addition to the on-axis 
region, eight 1.5 × 1.5 cm2 regions that were centred on the corners and midpoints of the 
sides of a central square of 12 × 12 cm2 were analysed. The average pixel value in these 
eight regions reflects position dependent changes in the detector sensitivity as well as field 
flatness variations. For each day, the average pixel values in the off-axis regions were 
divided by the on-axis Gc value to correct for overall output or response variations. The SD 
of the day-to-day variation of this ratio was determined in all regions.  
 
2.2.2.2 Response variation with CCD frame integration time Tint 
We have investigated how Gc varies with Tint for fixed exposures of 50 MU. Images were 
acquired with a Tint that ranged from 280 to 1280 ms for a 10 × 10 cm2 open field behind a 
15 cm thick flat polystyrene absorber. This range of Tint encompasses the frame integration 
times encountered in clinical practice. A dedicated acquisition procedure, in which the user 
can select Tint, was applied. The exposure X set in the software was 70 MU, to ensure that 
the delivered 50 MU exposure would be acquired entirely. If the camera output is linear in 
the amount of optical photons received by the CCD for all Tint, and the input stages and 
ADC of the frame grabber are linear as well, then Gc should be independent of Tint.  
 
2.2.2.3 Linearity of pixel value with exposure 
We verified the linearity of the system with exposure as follows: images were obtained 
with fixed acquisition settings and a number of frames nf  sufficient to capture 200 MU at 
the nominal dose rate. The images were acquired for 20, 40, 60, 90, 120, and 150 MU. The 
lower bound of 20 MU was based on measurements of the Racetrack Microtron cGy/MU 
value, which showed that the SD on this value is < 0.2% for exposures > 20 MU (Maarten 
Dirkx, priv. comm.) Due to the frame transfer read-out of the CCD (section 2.2.1.1), the 
RAPID is an integrating detector (in contrast to a scanning system), and should not be 
sensitive to beam start-up effects or dose rate variations in general. In the above described 
measurement situation, one therefore expects that Gc is linear in the delivered MU, which 
implies constancy of Gc/Dp for a given absorber and treatment beam. We tested this linear 
relationship by calculating the SD of Gc/MU with respect to the mean value of Gc/MU. 
 
2.2.3 Ionisation chamber measurements and the water equivalent EPID 
thickness 
Ionisation chamber (IC) measurements were adopted as the standard for the assessment of 
the accuracy of PDIs derived from EPID images. Absolute portal dose measurements were 
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obtained with a PTW ionisation chamber (N31002) which was placed in the polystyrene 
miniphantom described by Pasma et al [99]. The IC was placed with its centre at a depth of 
5 mm in the miniphantom (150.5 cm from the focus).  On top of this 5 mm, the build-up 
could be varied using 5 mm thick polystyrene plates which had the same cross-section as 
the miniphantom. The phantom was scanned in the FS plane using an empty RFA-300 
water phantom (Scanditronix Medical AB). Corresponding EPID images were converted to 
the same resolution by averaging pixel values in 0.5 × 0.5 cm2 regions centred on the IC 
scan grid. 
In general, a signal from the IC in the miniphantom will differ from the corresponding 
EPID signal due to the fact that (i) the EPID FS is made of non-water equivalent material, 
(ii) the geometry of the EPID FS is different from that of the miniphantom and (iii) the 
conversion of deposited energy to a measurable signal is different for the two systems. It is 
therefore essential that, for the range of clinically encountered patient thicknesses, air gaps 
between patient and EPID, and field sizes, the ionisation chamber signal is matched to the 
EPID signal as closely as possible. To achieve this, we follow the method applied by Pasma 
et al [99]  which relies on the existence of an optimal build-up thickness of the IC. This 
optimal build-up yields the most accurate proportionality between EPID signals and 
absolute IC doses. 
The optimal IC build-up thickness, ICd
)
, which is effectively the water-equivalent 
thickness of the FS, is measured as follows. For a set of fields (Ω) and IC build-up 
thicknesses ( ICd ) the on-axis response is measured for a set of homogeneous water-
equivalent absorbers of thickness t with air-gap L to the EPID [98]. The variation in the 
response for a given field and build-up thickness is defined by 
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where <A>B denotes the average of A over the range of B and Nt,L is the number of (t,L) 
combinations for which measurements were performed. We define ICd
)
 to be the value of 
ICd  at which ΩΩσσ ),( ICT d= is minimal. To derive ICd
)
, EPID images and IC 
measurements for various ICd  were obtained for t = 10, 25, 40 cm, L = 25, 37.5, 50 cm and 
square fields Ω with a field side of 5, 10 and 18 cm.  As mentioned in section 2.2.1.1, the 
build-up of the EPID FS is close to the depth of maximum dose at 25 MV so that (i) the 
impact of electrons generated in the patient on the EPID signal is small and (ii) ICd
)
 is well 
defined since the EPID signal will be a weak function of variations in the spectrum of the 
incident photon beam. 
We derive in the Appendix that if ICd
)
 renders Tσ suitably small, then under reasonable 
assumptions the image pixel value G at position (x,y) can be expressed by 
)',';,()','()','(''),( yxyxKyxSyxDdydx
D
GyxG
FS
p
refp
∫= .  (2.2) 
The subscript ref refers to values measured in the reference situation, defined by: (x, y) = 
(0,0),  t = 25 cm, L = 37.5 cm and Ω a 10 × 10 cm2 symmetrical field. S(x,y) is the relative 
sensitivity of the EPID at (x,y) and K(x,y;x’,y' ) is the optical cross talk kernel (more details 
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are in the Appendix). Note that G in equation (2.2) depends solely on Dp, and not explicitly 
on patient anatomy or set-up. 
 
2.2.4 Effect of extra build-up layer on EPID spatial resolution  
The thickness of the fluorescent screen build-up was increased by 1 mm of stainless steel. 
The effect this might have on the spatial resolution was investigated with the QC-3 line bar 
pattern phantom [118] which contains line pairs (lp) at spatial frequencies of 0.1, 0.2, 0.25, 
0.45 and 0.75 lp/mm. The phantom was placed on top of the FS and images were obtained 
with and without the steel plate. The relative (square wave) modulation transfer function 
(RMTF) and its half value spatial frequency, f50, were obtained according to the method 
described by Rajapakshe et al [106]. To estimate the accuracy of the f50  determination, the 
regions of interest (ROI) were shifted by ± 2 pixels (in steps of 1 pixel) in the x and y 
direction, the size of the ROI was varied by ± 20% in steps of 10%, and f50 was calculated 
for each case. 
 
2.2.5 An algorithm to convert high elbow EPID images into PDIs 
Pasma et al [99] have published an algorithm to calculate PDIs from images obtained with 
the SRI-100 system. They assumed an approximately shift invariant kernel to cast equation 
(2.2) into the form  
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In their description, the function S becomes slightly field size dependent (S → Sw) to 
compensate for the fact that K (which is measured only on-axis) is not completely shift 
invariant. It therefore no longer represents the true local EPID sensitivity, since it also 
includes a contribution from optical cross talk.  
For a high elbow EPID, the situation is quite different, as becomes apparent from figure 
2.1. The EPID image may be decomposed into two components. The first component is the 
primary contribution, which consists of photons that are reflected once off the mirror and 
then reach the camera lens (the solid arrows, labelled 'p' in figure 2.1). For a point source in 
the FS plane, the primary contribution is made up by photons emitted within the solid angle 
subtended by the camera lens aperture as seen from that point source (~ 3 × 10-4 sr). The 
secondary contribution, or cross talk, stems from photons reaching the lens after multiple 
reflections on the mirror and reflection or scatter from the (nearly white) fluorescent screen. 
We assume the inside of the EPID structure to be perfectly black and hereafter indicate by 
cross talk the light which is reflected from the mirror back to the FS and re-emitted from 
the screen to the mirror. Based on this assumption, and the fact that the plane x = 0 is 
perpendicular to the mirror, we can find the regions of the FS which may potentially yield 
cross talk by considering the projection of pathways of light onto the plane x = 0.  
As figure 2.1(a) reveals, for a source point at y = - 6 cm ( yFS = - 9 cm) only a primary 
contribution exists. Since we are interested in dosimetric information on a scale of ~ 0.5 × 
0.5 cm2, this implies )'6,'()',';6,( yxxyxyxK −−−∝−= δ with δ the Dirac delta 
distribution. However, for a source point at y = 0, cross talk may occur at y > 0, as indicated 
by figure 2.1(b).  
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The dotted line arrows in figure 2.1(b) are the rays that enclose the beam of emission (of 
opening angle θs) which could generate such cross talk. Note that the region in which cross 
talk is manifested is rather extended in the y direction (in this case, from y = 3.3 cm to y = 
12.7 cm or equivalently  yFS = 5 cm to 19 cm).  
Figure 2.1(c) reveals that for a source point at y > 0, similar cross talk is generated for an 
even larger range, namely all positive y and also at slightly negative y. Figure 2.1(d) depicts 
what happens when the x direction is entered into the problem. We have drawn the 
projection onto the x-z plane of a number of rays which originate at x = y = + 6 cm and 
yFS = -9 cm
towards
camera
∆z
y
z
∆yFS
p
mirror
FS
yFS = 0
p
θss s
yFS = 9 cm
p
θs
ss0
xFS = yFS = 9 cm
mirror
x
z
Figure 2.1. Schematic view of light propagation inside the high elbow structure. The 
drawings in (a)-(c) depict a (to scale) cross-section at constant x, and the optical photon 
paths (indicated with arrows) are perpendicular projections onto this plane. Solid lines 
represent the pathways that give a primary contribution to the image signal (indicated 
by 'p'), dashed lines represent secondary pathways. Secondary pathways that may give 
rise to cross talk in the image are indicated by 's'. The secondary pathways indicated in 
(b) and (c) are the extremes of the range that could possibly contribute to cross talk for a 
source point at the indicated y-position. In (d), a projection onto a y = constant plane is 
given of rays which project in (c) as the line indicated by s0. 
 
(c) (d) 
(a) (b) 
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which would all occur like the ray indicated by the label 's0' in figure 2.1(c) when projected 
onto the y-z plane. From this figure, and the symmetry of the EPID, it is evident that if a 
source point at a certain position (x,y) generates a cross talk contribution at a point (x',y'), it 
will do so for all x and x'; in fact, all x are optically coupled to all x’ for such a pair (y,y’). 
Therefore, the cross talk contribution will be a broad function in x’ too.  
From the geometry depicted in figure 2.1(a) one can easily derive that the FS region As,FS 
that may generate cross talk is the area within ∆yFS/2 < xFS < ∆yFS/2 (in fact, all x in the FS) 
and ymin,FS < yFS < ∆yFS/2 with ymin,FS = -∆yFS/2 +(∆z)2/∆yFS as long as ∆yFS > ∆z (the 
secondary contribution would completely vanish if ∆yFS < ∆z). Note that, due to the fact 
that the direction of each ray in figure 2.1 which adds to the cross talk may be reversed, the 
cross talk in the image can only appear in As,FS.  
Similarly, we may calculate the source region As,FS(yFS) specific to cross talk at yFS. For 
yFS > ymin,FS, As,FS(yFS) has a finite area, given by ∆yFS/2 < xFS < ∆yFS/2 and ymin,FS(yFS) < yFS 
< ∆yFS/2 with ymin,FS(yFS) = -∆yFS/2 +(∆z)2/(yFS + ∆yFS/2). Again, because ray directions can 
be reversed, a source point at yFS may contribute to the cross talk in, and only in, As,FS(yFS), 
which implies that As,FS(yFS) is also the source region for all multiple reflections between 
the mirror and the fluorescent screen that may contribute to cross talk at yFS. By substition 
of (x,y) = (xFS,yFS)/1.5 in the above expressions, it is straightforward to obtain the source 
region in the (x,y)-coordinate system. Hereafter, we will only refer to (x,y) and source 
region As(y) in the development of the algorithm. 
The amplitude of the secondary contribution is expected to be small relative to the 
primary contribution, due to (i) the (relatively) large distance between screen and mirror, 
(ii) the forwardly peaked light distribution of the primary emission [143], (iii) the small 
solid angle in which the emission relevant to cross talk occurs (see θs in figure 2.1) and (iv) 
the small fraction of light re-emitted from the FS which will actually contribute to the 
observed cross talk (light which reflects from the FS will never reach the lens, so only the 
fraction which is re-emitted by the FS into the same small solid angle as the primary 
emission can be detected in the EPID image).  
Based on this smallness of the cross talk we develop equation (2.2) to first order in K. 
The kernel may be separated into )',';,()','()',';,( yxyxyyxxyxyxK εδ +−−= , where 
the δ-function is due to the primary contribution, and ε describes the cross talk contribution. 
Since +


=
ref
p
p G
D
S
GD  higher order terms in ε , the first order expansion of equation 
(2.2)  becomes  
∫+=
)(
)','()',';,(''),(),(),(
ysA
p
refp
yxGyxyxdydxyxDyxS
D
GyxG ε  (2.4) 
where the integral has now been confined to the source region As(y) discussed above (the 
integral vanishes for y < ymin, yielding 
ref
p
p G
D
S
GD 


= for this region). 
Suppose that the field width (the extent in the x-direction) at y', w(y') is constant for the 
source region of y: w(y') = w0 for y' ∈ As(y). The number of source points which contribute 
to the cross talk at y is then proportional to the product of w0 and the length of As(y), ls(y) = 
[∆yFS -(∆z)2/(1.5y+∆yFS/2)]/1.5. Since all points in As(y) contribute to the cross talk  (albeit 
in slowly varying degrees, e.g. due to the emission profile, the optical pathlength and the 
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angle of incidence after reflection off the mirror), we assume that the amount of cross talk 
at y scales with the average pixel value <G>(y) in As(y): 
);()()','()',';,('' 0
)(
wyfyGyxGyxyxdydx
ysA
>=<∫ ε   (2.5) 
with the cross talk distribution function f << 1. We expect that f increases with increasing y 
because ls(y) increases monotonically with y (> ymin). The quantity <G>(y) is defined by 
)(
)','(''
)(
0
)(
ylw
yxGdydx
yG
s
ysA
∫
=>< .     (2.6) 
 
For an arbitrary field shape, we assume that equation (2.5) still holds if we replace w0 in 
equations (2.5) and (2.6) by 
∫
∫
=>< 2/
)(min
2/
)(min
))'(('
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y
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ywHdy
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yw ∆
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     (2.7) 
 
where H is the step function (H(x) = 0 if x ≤ 0, H(x) = 1 if x > 0). Using this approximation, 
we assume that the cross talk generated by the pixel value distribution G(x',y') for (x',y') ∈ 
As(y) is equal to the cross talk generated by homogeneous pixel value <G>(y) in a 
rectangular "equivalent" field of width <w>(y) and length ls(y). The definition of <G>(y) 
(equation (2.6)) assures that the amount of detected light generated in the equivalent field is 
equal to that in the source region: 
∫ )( )','(''ysA yxGdydx = <w>(y) ls(y) <G>(y).   
With the aid of the expression in equation (2.5), we can now derive Dp from equation (2.4) 
by 
),(
))(;()(),(),(
yxS
ywyfyGyxG
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D
yxD
ref
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
= .   (2.8) 
 
To calculate Dp from G we must obtain the sensitivity array S and the cross talk distribution 
functions f. We define Sw×20= (G/Dp )/(G/Dp)ref for a field of constant width w(y) ≡ w and 
length of 20 cm, for t = 25 cm and L = 37.5 cm and measure the array S20×20 (x,y) ∀ (x,y) 
and the profiles Sw×20 (0,y) ∀ y  and  w = 4, 8, 10, 12, 14, 16 and 18 cm. To determine Sw×20, 
G is obtained from EPID images and Dp from  IC measurements of the w × 20 fields. Note 
that, with the field length of 20 cm at isocentre level used in these measurements, the 
effective ∆yFS = 30 cm (instead of 38 cm) yielding a value of ymin  = –4.5 cm.  
From equation (2.8) it is easy to derive that, to first order in f,  

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where Gw×20 is the pixel value distribution for the w × 20 field and <Gw×20> is calculated 
according to equation (2.6). Since, in our first order model, the cross talk will vanish for 
<w> = 0,  we derive S and f from 
)(
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1
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The limit w → 0 is obtained from linear extrapolation to w = 0 of S w×20 (0,y) for each y. 
Finally, the local sensitivity array S(x,y) may be calculated using equations (2.9) and (2.10): 
1
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An arbitrary EPID image, G(x,y), can now be converted into a PDI with the aid of equations 
(2.6-8). The function ))(;( ywyf >< to be applied in equation (2.8) is found from linear 
interpolation of );( wyf  in w between the two measured field widths that enclose <w>(y). 
 
2.3 Results 
2.3.1 Response Stability 
Regarding the short term stability, the SD of Gc was 0.2% with respect to its mean for all 3 
measurement sessions, comparable to the short term output fluctuations of the accelerator 
and sufficiently small for in vivo dosimetry. 
The beam output QA measurements showed a long term variation of Gc over a period of 
306 days of 0.5% (1 SD), independent of gantry angle. This variation includes the (long 
term) output fluctuations of the accelerator. Ionisation chamber output measurements over 
the same period indicate a similar fluctuation (1 SD ≈ 0.5%). In all 8 off-axis regions, the 
variation of G/Gc in the 306 day period was 0.2% (1 SD), and again no dependency on 
gantry angle was observed. These results are similar to those found by Dirkx et al [38] for 
the SRI-100 EPID. We conclude that the RAPID is sufficiently stable to perform in-vivo 
portal dose measurements without frequent recalibration. 
 
2.3.2 Linearity with frame integration time 
The results of the linearity measurements are displayed in figure 2.2. The reproducibility of 
the measurements was better than 0.2% (1 SD) for all 9 studied Tint, consistent with the 
reproducibility found in section 2.3.1. The value of Gc showed little variation with Tint : the 
SD of Gc was 0.16% with respect to the average (note that the value of Gcs, which is a 
measure for the charge accumulated by the CCD per image frame, varied by over a factor 
4). Therefore, the EPID response is independent of Tint. 
 
2.3.3 Linearity with exposure 
The value of Gc turned out to be perfectly linear in the delivered exposure over the entire 
exposure range 20-150 MU : 1SD = 0.17%, which is equal to the short term reproducibility 
of the accelerator output. Therefore, within the measurement accuracy, Gc/Dp is constant for 
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a given treatment situation. The smallness of the SD confirms that the SNR of Gc (which 
was obtained from a single image), is sufficiently large, even at small exposures, to render 
the random noise on Gc negligible (see section 2.2.2). To obtain clinically relevant 
information from PDIs, a pixel size of 0.5 cm at isocenter in both directions yields 
sufficient spatial resolution [69]. With the numbers quoted in section 2.2.2, we find that the 
random noise on pixel values G(x,y) obtained at such a resolution ~ 0.1% in a clinical 
image of only 2 MU exposure. Combined with the above results on the linearity of Gc in the 
delivered exposure, we conclude that the number of MU used to generate a PDI presents no 
relevant limitation on its accuracy.  
 
2.3.4 Ionisation chamber build-up 
The optimal thickness 
)
d IC  of the IC build-up was found to be 3 cm of polystyrene, for 
which σ T  = 0.5% and all the measured residual errors (the term in brackets in the right-
hand side of equation (2.1)) are less than 1%. The on-axis G/Dp ratios obtained for the 3 
studied field sizes and for “isocentric” irradiation (L + t/2 = 50 cm) are depicted in figure 
2.3. We conclude that the use of 
)
d IC  renders G/Dp  sufficiently constant to be applicable to 
in vivo dosimetry. The extra 1 mm thick stainless steel plate mounted on top of the FS did 
not appreciably reduce f50. From the QC-3 measurements we obtained f50 = 0.217 ± 0.002 (1 
SD) lp/mm for the standard screen, and  f50 = 0.213 mm ± 0.002 lp/mm with the added steel 
0.98
0.99
1.00
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1.02
5 15 25 35 45
t (cm)
G
c/D
p 
[ ]
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Figure 2.3. The ratio Gc /Dp for isocentric irradiation of absorbers of thickness t per 
field size. The curves are normalized to the mean per field size. The 2 SD wide error 
bars at the top of the graph were estimated from repeated Gc and Dp measurements.  
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plate. The actual reduction of f50 of 2% is therefore within the estimated accuracy of the 
experiment. The value of f50 is estimated from two sample points of the RMTF at relatively 
low spatial frequencies [106]. However, also at the higher frequencies 0.25 and 0.45 lp/mm 
the value of the RMTF measured with the extra steel plate was identical to the value 
measured with the standard screen. This finding is consistent with the fact that we could not 
separate by eye the corresponding QC-3 phantom images. Therefore, the expected impact 
of the steel plate on the quality of clinical images is negligible. 
2.3.5 The EPID sensitivity array and the cross talk distribution functions 
The profile S(0,y), as derived from equation (2.10), is shown in figure 2.4(a). We found that 
to derive the limit w → 0 of Sw×20(0,y) a linear extrapolation to w = 0 is appropriate since the 
change in Sw,20(0,y) with w is to a high accuracy linear in w for all y: we fitted a first order 
polynomial in w to Sw,20(0,y) for each y, and found that the deviation over the full range of 
w between this fit and the measured values, averaged over y, had 1 SD = 0.2%. 
In figure 2.4(a) we also show profiles of Sw×20 at  x = -8, 0 and 8 cm. For comparison 
purposes, the S20×20-profiles at x = -8 and 8 cm were normalized to have the same average 
as the x = 0 profile, as indicated by the prime in the figure legends. The small scale noise on 
the profiles is due to inhomogeneities in the light output of the FS, which are different for 
each x. The profile indicated by the crosses in figure 2.4(a), was obtained by fitting a 
second order polynomial to the average profile of S20×20 for the 3 displayed x values. From 
the difference of the latter profile with S(0,y) we find that the cross talk manifests itself 
increasingly at positive y, as expected from the fact that ls(y) increases with y.  We also see 
that the S20×20-profiles at x = -8 cm and +8 cm have the same large scale structure as the 
profile at x = 0. In fact, the SD of the S20×20-profiles with respect to the polynomial fit is 
0.8%, 0.9% and 0.8% respectively for x = -8, 0 and 8 cm, reflecting that the effect of cross 
talk is hardly dependent on x, as was made plausible in section 2.2.5.  
The above results indicate that the approximation expressed by equation (2.5) is valid, 
and so we applied equation (2.10) to derive the cross talk distribution 
Figure 2.4. (a) Profiles along the y-axis of the sensitivity S and the array S20×20. Details 
are in the text. (b) The cross talk distribution functions );( wyf . The vertical lines 
connect the actually measured points to the corresponding fitted curves. 
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functions );( wyf displayed in figure 2.4(b). The cross talk is indeed of small amplitude 
(always less than 6%), and so the first order approach developed in section 2.2.5 is 
appropriate. As predicted, there is negligible cross talk for y < -4.5 cm and in fact we put 
0≡);( wyf  for this range of y. For the other y-values, the solid curves in figure 2.4(b) 
were determined as follows. First, we observe that );( wyf  is almost perfectly linear in w 
for all y, as expected from section 2.2.5 and the linearity in w of Sw×20 described above. This 
implies that );( wyf may be separated into variables according to )();( yfwwyf 0×= , 
which defines the ‘shape function’ )(yf0 . Inserting this result into equation (2.10), and 
taking the first derivative with respect to w we obtain 
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The limit at the right-hand side of equation (2.12) was obtained by linear extrapolation to w 
= 0 of the term in square brackets (which is virtually constant in w). The solid lines in 
Figure 2.5. (a) Outlines of the 10 × 14 cm2 fields used to assess the accuracy of the 
proposed method for conversion of EPID images into PDIs, projected onto a DRR of the 
Alderson phantom. The cross denotes the isocentre, the solid line the symmetrical field 
and the dashed line the asymmetrical field. (b) Absolute dose profiles for the RAPID PDI 
and for the scanning IC PDI for the symmetrical field in (a). (c) (next page) dPDI as 
derived from RAPID and IC PDIs for the symmetrical field in (a), expressed in %. Each 
square has an area of 1 cm2, the IC measurement points being at the centre of the squares. 
The dashed line indicates the field edge, as extracted from the EPID image. The projected 
isocentre is at the centre of the square which has the inverted grey scale. (d) As (c), but 
now for the asymmetrical field displayed in (a). 
(a) (b) 
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figure 2.4(b) are equal to )(yfw 0 . Figure 2.4(b) illustrates that the same shape 
function )(yf0 describes );( wyf well for all w (the SD of the difference between the fit and 
the measured data is < 0.2% for each w, averaged over w it is 0.1%). These results confirm 
the assumptions yielding equation (2.12), which include the cross talk model presented in 
section 2.2.5. The curves )(yfw 0 were applied as );( wyf in subsequent analyses. 
 
2.3.6 The accuracy of PDIs derived from  EPID images 
In figure 2.5(a), a DRR of the Alderson phantom is presented with the outlines of a 
symmetrical and asymmetrical field of 10 × 14 cm2 in the thorax region. The asymmetrical 
field extends 9 cm superiorly (y > 0) of the isocentre and 5 cm inferiorly, and therefore 
covers the y range where the magnitude of the cross talk is largest.The magnitude of the 
portal dose variation inside the field can be judged from figure 2.5(b), where the absolute 
dose profiles along the x- and y-directions as derived with equation (2.8) from the measured 
EPID image are compared with the absolute dose obtained with the scanning IC for the 
symmetrical field. The differences in the absolute doses measured with RAPID and with 
the IC for the     symmetrical field may be appreciated from figure 2.5(c), where the 
difference of the PDI derived from the RAPID image and the PDI measured with the IC 
(hereafter 'difference PDI' or dPDI) is displayed in %. The dPDI values are 0.2 ± 0.4% (1 
SD) over the field area. Note that this difference includes noise in the IC and EPID 
measurements. The dPDI for the asymmetrical field is shown in figure 2.5(d), which 
illustrates that also in this case the agreement over the field is satisfactory: 0.0 ± 0.8%, with 
all deviations < 2%.The validity of equation (2.8) was evaluated for more extreme field 
shapes using a 25 cm thick polystyrene absorber with its centre of mass positioned at the 
2.5(c) 2.5(d) 
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isocentre. In figure 2.6(a), the dPDI of a diagonal multileaf collimator (MLC) field, which 
extended in the y-direction from -9 to +9 cm, is shown. The separation between opposing 
leaves was 10 cm. This particular field tests for the x-shift invariance of the 
correction ))(;( ywyf >< , i.e. the lack of dependency on x expressed by the right-hand 
side of equation (2.5). From figure 2.6(a) we conclude that the cross talk is indeed largely x 
independent, since application of the same ))(;( ywyf ><  for all x yields absolute dose 
differences of –0.1 ± 0.3% over the entire field. Finally, the field shape used to generate the 
dPDI in figure 2.6(b) tests for the validity of the assumption that the cross talk for a field of 
varying width may be derived from that of an equivalent field width expressed by equation  
(2.7). In figure 2.6(b),  the field width runs from w = 18 cm at the top (y = 9 cm) to w = 5 
cm at the bottom (y = -9 cm.) Even for this somewhat extreme case, the accuracy of the 
EPID PDI is -0.6 ± 0.6%, with no deviation larger than 1.5%.  
 
2.4 Discussion 
An algorithm for the generation of absolute portal dose images has been developed and 
applied to images obtained with the RAPID high elbow fluoroscopic EPID for a 25 MV 
photon beam. Images of an anthropomorphic phantom and of field shapes which test the 
assumptions behind the algorithm for extreme cases yield PDIs that agree well with 
absolute portal dose measurements performed with an IC (mean deviation per field ≤ 0.6%, 
1 SD over the field ≤ 0.8%). The maximum observed difference was 1.9% in a PDI pixel 
close to the field edge. 
The PDI algorithm is based on a first order description of the optical cross talk (i.e. 
reflection and re-emission via the fluorescent screen) in the high elbow structure, which is 
applicable because the cross talk is of small magnitude: at worst 6%, in the region furthest 
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Figure 2.6. (a) dPDI for a diagonally shaped field, in %. This figure is similar to figure 
2.5(c), however the squares now cover an area of 1.5 × 1.5 cm2, reflecting the larger 
step between IC measurements for this case. For the bottom row (which would still fit 
inside the field) no IC measurements were available. (b) As (a), but for a triangular field 
shape. 
 
26 
away from the mirror, and on-axis  ≤ 2%. Because the cross talk for the high elbow is to 
first order independent of the x coordinate (parallel to the mirror), it can be accounted for 
by a simple correction, which is derived from 8 portal dose profiles measured along the line 
x=0. However, although the high elbow cross talk is relatively small, it must be corrected 
for in high accuracy dosimetric applications. For example, if we apply S20,20 instead of the 
sensitivity S and set f ≡ 0 in equation (2.8) (thus effectively neglecting cross talk), we 
obtain absolute dose differences of 1.6 ± 1.3 % (1 SD) for the case depicted in figure 2.5(d) 
with extremes of up to 4.4% at the most positive y values. 
The situation is quite different from that of the low elbow SRI-100 system, where the on-
axis cross talk for a 20 × 20 cm2 field is ~ 10% and the cross talk increases towards the 
mirror [99]. The different magnitude and spatial behaviour of the cross talk in the high 
elbow system studied in this paper can be attributed to the larger distance between mirror 
and screen. With the high elbow PDI algorithm described in this paper, a single sensitivity 
array is sufficient for all field shapes, contrary to the algorithm developed for the SRI-100. 
The latter algorithm requires a set of sensitivity arrays for various field sizes, which each 
express both EPID sensitivity and the (small) cross talk contribution that remains after 
deconvolution with a kernel that was derived from on-axis measurements [99].  
Since the actual photon detector of the system is a CCD, the RAPID response has a short 
and long term stability which equals that of the SRI-100 EPID [38]. The current data on the 
stability imply that the frequency of a calibration of the system for in vivo dosimetry can be 
as low as once a year. 
The simplified electronics of the RAPID yields advantages for both low and high elbow 
systems. For the SRI-100 EPIDs investigated at our institute, it was found that the 
measured signal is nonlinear in the amount of light incident on a CCD pixel [99]. This 
phenomenon could be largely attributed to the nonlinearity of the complex camera and 
sampling electronics. For the RAPID, deviations from linearity of pixel value with signal 
intensity per frame (i.e. frame integration time) are negligible.  
The use of the low elbow version of the RAPID for in vivo dosimetry is currently 
investigated, based on the algorithms developed for the SRI-100 EPID. In the future, we 
will also investigate whether we can apply a cross talk correction algorithm similar to the 
algorithm described in this paper to the low elbow RAPID to account for the spatial 
dependency of the cross talk in that EPID structure. In addition, we are investigating the 
properties of the high elbow  RAPID for a 10 MV beam to expand the possibilities of 
clinical application of PDIs. The 10 MV beam requires a different optimal build-up for the 
IC [101], but little changes are expected in the PDI algorithm presented in this paper. In 
fact, we will attempt to apply the same cross talk distribution functions at both energies. 
At present, we are interfacing the MU signal from the accelerator to the RAPID 
software. This feature, together with the fast image capture and image processing 
capabilities of the system, will enable on-line tracking of the leaf positions during dynamic 
MLC treatments [96] combined with a PDI measurement derived from the composite EPID 
image. With an EPID which can simultaneously check leaf (and block) positions and portal 
dose, deviations between measured and predicted PDIs can be separated into treatment 
machine errors and anatomy deviations with respect to the planning CT scan [69] during 
dynamic treatments. 
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Appendix: The relation between portal dose and fluoroscopic EPID image 
pixel value 
 
We denote the portal dose measured with an IC with build-up ICd in the plane of the FS 
behind a homogeneous absorber of thickness t, with the exit surface at a distance L from the 
FS and for a field shape Ω by );,,,,( ICp dLtyxD Ω . Suppose that a fluoroscopic EPID 
could be constructed which was free of cross talk. Then, for the absorber described above, 
the image pixel value at position (x,y) can always be exactly expressed by 
),();,,,,();,,,,(
)(
),,,,( yxSdLtyxdLtyxD
dD
GLtyxG rICICp
refICp
ΩΦΩΩ




= . (A2.1)  
The measurement situation for the reference response value ( refICp dDG )](/[ ) is 
described in section 2.2.3. The relative screen emission Φ  describes the ratio of the light 
output of a perfectly homogeneous FS to Dp and is implicitly normalized to [Φ]ref ≡ 1 ICd∀  
through refICp dDG )](/[ . The quantity Φ takes into account the differences between the 
FS and the IC as dose detectors which were mentioned in section 2.2.3: it describes the 
relative difference between the IC measurement and the process of energy conversion and 
optical photon transport and escape in the FS. This interpretation of Φ, together with the 
fact that we take the product of Dp and Φ in equation (A2.1) and not a convolution, reflects 
the assumption that the difference in secondary electron transport in the miniphantom-IC 
combination and the FS is negligible on the scale of ~ 0.5 × 0.5 cm2 we are interested in. 
The thickness and composition of the homogeneous FS are assumed to be equal to the 
actual thickness and composition at (x,y)=(0,0).  
Sr(x,y) is the position dependent relative sensitivity (Sr(0,0) ≡ 1) which describes 
variations in the FS layer thickness, the spatial distribution of the phosphor grains as well as 
light distribution effects such as the nearly Lambertian emission profile [99, 143].  
In reality, fluoroscopic EPIDs exhibit optical cross talk due to reflections and scatter inside 
the mechanical structure. If K(x,y;x’,y') is the optical cross talk kernel which takes into 
account the signal contribution of a light emitting point at (x’,y’) to a point at (x,y), then 
equation (A2.1) can be generalized to 
∫



=
FS
ICp
refICp
dLtyxDdydx
dD
GLtyxG );,,,','([''
)(
),,,,( ΩΩ
)]',';,()','();,,,','( yxyxKyxSdLtyx rICΩΦ× . (A2.2) 
  
To simplify matters, we seek an ‘optimal’ IC build-up, ICd
)
, which renders Φ ≈ 1 (to 
within 1%) for clinically relevant t, L and Ω (i.e., the light emitted by the FS is proportional 
to the IC reading). Based on equation (A2.2) we derive a method to arrive at ICd
)
 which 
rests on a number of approximations. 
 For an EPID which renders portal images which can be used in clinical practice, K must 
be a function strongly peaked near (x’,y’)=(x,y). Furthermore, for fluoroscopic EPIDs, the 
low-amplitude tails of K decay slowly [52] because the optical coupling between screen and 
mirror takes place over range which is comparable to the size of the screen (see figure 2.1). 
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Therefore, the on-axis value pixel value ),,,0,0( ΩltG as defined by equation (A2.2), will 
be insensitive to off-axis variations in the spatial distribution of Dp. For this reason, and 
because the contribution of scatter to Dp is relatively small (< 10%) for clinically relevant t, 
L and Ω values at a FS-isocentre distance of 50 cm [99], we approximate Dp 
by ),,();,,,0,0( Ω∆Ω yxdLtDD ICpp = , for fields Ω that enclose the (x,y)-origin. The first 
‘effective transmission’ term takes into account the on-axis change in primary transmission 
with t and Ω as well as the change in photon spectrum. The second or ‘spatial’ term 
);,,,0,0(/);,,,,(),,( ICrefrefpICrefrefp dLtDdLtyxDyx ΩΩΩ∆ ≡  
is the relative dose in the detector plane with respect to the beam-axis, and depends 
explicitly on Ω, e.g. due to the fact that ∆ ≈ 0 for (x,y) outside Ω.  
As t, L, and Ω vary, Φ  can only change because of changes in the incident photon 
spectrum (which includes the spectrum of photon incidence directions). The change in 
beam hardness, relative to the ref situation, as t,  L or Ω are varied with respect to their ref 
value, will be to first order independent of (x,y) [98]. An additional argument to use this 
approximation is that, just like for Dp, the integral in equation (A2.2) is insensitive to off-
axis variations of Φ. We therefore rewrite Φ  as  
);,(),,();,();,,,0,0();,,,,( ICcICICIC dyxLtdyxdLtdLtyx ψΩΦψΩΦΩΦ ≡=  
Using the separation of variables described above, we arrive at  
)();,,(
)();,,,0,0(
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LtG
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refICpICp 





=    (A2.3) 
with the definition  
∫= FS IC yxKyxSdyxyxdydxI ),;0,0(),();,(),,()( ψΩ∆Ω . 
Constancy of the left hand side of equation (A2.3) with varying t, L  for a fixed Ω 
implies constancy of Φc at that Ω. As a result, changes in the incident MeV photon 
spectrum with varying t and L have negligible impact on Φc. If a build-up ICd
)
 exists for 
which this can be achieved for a clinically relevant range of Ω, spectral changes obviously 
have negligible impact on Φc and so we can write in good approximation 
),,(1);,,( ΩΩΦ LtdLt ICc ∀≡
)
.  
Since the method described by Pasma et al [99] to derive ICd
)
 is based on the 
minimization of variations in the left hand side of equation (A2.3), they implicitly assumed 
a separation of the variables (x,y) and (t,L). If, for instance, the convolution of the kernel 
with variations in the spatial distribution of DpΦ  with t leads to significant (~ 1%) on-axis 
changes in G with t, a suitable ICd
)
 can not be found with their method. Also note that, for 
the high elbow EPID studied in this paper, the approximations leading to equation (A2.3) 
are expected to hold better than for low elbow systems due to the small on-axis cross talk in 
the high elbow. 
Substitution of Φc ≡ 1 into equation (A2.3) yields equation (2.2), where the fact was used 
that the explicit reference to t, L, Ω and ICd
)
 can be dropped from the equation for constant 
Φc. The effective sensitivity S in equation (2.2) is defined by ),();,(),( yxSdyxyxS rIC
)
ψ≡ . 
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Abstract 
 
Purpose: Following the ICRU-50 recommendations, geometrical uncertainties in tumor 
position during radiotherapy treatments are generally included in the treatment planning by 
adding a margin to the clinical target volume (CTV) to yield the planning target volume 
(PTV). We have developed a method for automatic calculation of this margin.  
Methods and materials: Geometrical uncertainties of a specific patient group can normally 
be characterized by the standard deviation of the distribution of systematic deviations in the 
patient group (Σ) and by the average standard deviation of the distribution of random 
deviations (σ). The CTV of a patient to be planned can be represented in a 3D matrix in the 
treatment room coordinate system with voxel values one inside and zero outside the CTV. 
Convolution of this matrix with the appropriate probability distributions for translations and 
rotations yields a matrix with coverage probabilities (CPs) which is defined as the 
probability for each point to be covered by the CTV. The PTV can then be chosen as a 
volume corresponding to a certain iso-probability level. Separate calculations are performed 
for systematic and random deviations. Iso-probability volumes are selected in such a way 
that a high percentage of the CTV volume (on average > 99%) receives a high dose (> 
95%). The consequences of systematic deviations on the dose distribution in the CTV can 
be estimated by calculation of dose histograms of the CP matrix for systematic deviations, 
resulting in a so-called dose probability histogram (DPH). A DPH represents the average 
dose volume histogram for all systematic deviations in the patient group. The consequences 
of random deviations can be calculated by convolution of the dose distribution with the 
probability distributions for random deviations. Using the convolved dose matrix in the 
DPH-calculation yields full information about the influence of geometrical uncertainties on 
the dose in the CTV.  
Results: The model is demonstrated to be fast and accurate for a prostate, cervix, and lung 
cancer case. A CTV-to-PTV margin size which ensures at least 95% dose to (on average) 
99% of the CTV, appears to be equal to about 2Σ+0.7σ for three all cases. Because 
rotational deviations are included the resulting margins can be anisotropic, as shown for the 
prostate cancer case. Conclusion: A method has been developed for calculation of CTV-to-
PTV margins based on the assumption that the CTV should be adequately irradiated with a 
high probability. 
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3.1 Introduction 
Geometrical uncertainties in radiotherapy treatments cause differences between intended 
and actually delivered dose distribution in the clinical target volume (CTV), as defined by 
the ICRU [62]. The uncertainties primarily consist of external set-up deviations and internal 
organ movement. Both deviations consist of a systematic component, i.e. the same for each 
fraction of the treatment, as well as a random component, i.e. varying from day to day. The 
size of the patient set-up deviations can be assessed by comparison of images acquired 
during the treatment (with megavoltage portal films or electronic portal imaging devices) 
with those of the intended treatment (simulator radiographs or digitally reconstructed 
radiographs generated by the planning system). By imaging several patients of a specific 
patient group regularly, the typical size of the systematic and the random positioning 
deviations for that group can be determined [15, 35], which may indirectly lead to 
improved set-up techniques and/or equipment. In principle, systematic deviations of an 
individual patient can be estimated during the first few fractions and couch corrections can 
be applied for subsequent irradiations [13, 17, 144]. This so-called "off-line protocol" 
reduces systematic deviations while random deviations remain unchanged. Both systematic 
and random set-up deviations can be reduced to negligible values if on-line corrections are 
applied [91, 130]. In this case, the patient position is verified at each fraction using a small 
number of monitor units. If necessary, the couch position is adjusted before the remaining 
dose is given. At the moment however, on-line correction procedures are too time consum-
ing to be routinely used in clinical practice. 
Internal organ motion is the movement of an organ relative to the bony structures. For 
instance, the prostate can move due to variations in bladder- and rectum filling. These 
movements can not be assessed directly by portal imaging since the tumor is generally not 
visible. By implantation of radio-opaque markers in or near the CTV the internal organ 
motion can be visualized which enables on-line positioning corrections [10, 36]. In other 
clinical studies repeated CT-scans have been acquired to get an indication of internal 
prostate movements [54, 109]. Intra-fraction movement of the tumor will add to the random 
deviation. Due to breathing and cardiac motion a tumor in thorax or abdomen can vary 
significantly in position in a matter of seconds [110]. Complex techniques like real-time 
couch movement, respiration gated irradiation or breathing control might limit the conse-
quences of this variation [70, 88, 141]. 
Whatever is done to minimize the geometrical uncertainties, to some extent inaccuracies 
are unavoidable. Once the typical values for a specific group of patients are known they 
should be included in the treatment planning for individual patients from that group. Patient 
set-up deviations not only affect the dose in the tumor region, but in neighboring, possibly 
critical, organs as well. For random deviations, the effect of this deviation can be simulated 
by a convolution of the dose distributions with the distribution of movements in three 
dimensions. Several groups have implemented this for translational deviations [61, 111]. 
Systematic deviations are more of a problem since they are a priori not known for a specific 
patient and only the distribution of systematic deviations for the patient group can be 
determined. The effect of systematic deviations on the dose distribution is more significant 
than that of random deviations, hence relatively small systematic deviations should not be 
ignored. One possible way to deal with systematic deviations has been proposed by Goitein 
[46]. He suggested three parallel planning calculations, one with nominal set-up deviations 
and the others with extreme values, and allow only those plans for which all three dose 
distributions are acceptable in terms of tumor coverage and critical organ sparing. Recently 
this idea has been further developed by Mageras and colleagues, especially to include 
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internal organ motion in radiotherapy planning [80]. Killoran and colleagues simulate 
systematic and random uncertainties simultaneously by multiple Monte Carlo simulations 
which result in multiple dose volume histograms (DVHs) that are used for evaluation of the 
treatment plan [66]. 
The above techniques operate directly on the CTV and are more sophisticated than the 
conventional approach as proposed by the ICRU [62], i.e. using a planning target volume 
(PTV) which is defined as the CTV plus margins for all geometrical uncertainties. 
However, the practical application of the concept of PTV is not always clear. First of all, it 
is rather cumbersome to manually draw margins in three dimensions around an irregularly 
shaped tumor volume [128]. Therefore several groups have developed algorithms for 
automatic margin calculation, either multiple 2D [7] or fully 3D [18, 131]. Furthermore, the 
geometrical uncertainties can originate from rotations as well as translations. Rotational 
deviations will yield anisotropic margins, i.e. the size of the margin will vary depending on 
the position with respect to the axis of rotation. None of the aforementioned algorithms 
have incorporated this. Finally the exact margin size necessary to ascertain adequate 
coverage of the CTV depends on the kind of deviation (systematic or random) and on the 
dose distribution. How this must be taken into account has up till now not been specified. 
We have developed a model that calculates the CTV-to-PTV margins step by step, based 
on clinically measured CTV position deviations and on the requirement that the dose 
distribution delivered to the CTV will satisfy the ICRU recommendations for dose 
homogeneity with a high probability. Internal organ motion as well as external set-up 
deviations, translations as well as rotations, and systematic as well as random deviations are 
included in the model. Once the dose distribution has been planned around the resulting 
PTV, the same algorithms can be used to calculate the influence of all geometrical 
uncertainties on the dose in the CTV and hence to verify the planned dose distribution. The 
use of the model will be demonstrated for a prostate, cervix, and lung cancer planning. 
 
3.2 Methods and materials 
3.2.1 Parameters required 
Since the geometrical uncertainties of an individual patient which is to be planned are not 
known, measured data of a group of similar patients must be used. Clinical studies 
performed in our department and elsewhere have shown that translational deviations in 
patient positioning of a specific group can be approximated by normal distributions of 
systematic and random deviations in the three main directions, e.g. [15, 35]. For each 
patient in the study the average set-up deviation and the standard deviation (SD) of the 
distribution around that average is determined. The random variation σ characterizing a 
certain patient group is then defined as the SD of the day-to-day set-up positions, averaged 
over all patients in the group. The systematic variation Σ is defined as the SD of the 
distribution of average set-up deviations per patient in the group of patients. The overall 
mean deviation M is the average value over all fractions and all patients. If the reference 
set-up (during simulation) can be considered as a sample from the random distribution, M 
will be close to zero and Σ will be close to σ. Rotational deviations around the three main 
axes can in principle be described similarly. The study of internal organ motion can yield 
random and systematic deviations for translations and rotations as well. Hence a set of 
twelve (x/y/z * rot/trans * int/ext) standard deviations Σ and σ and six rotation axes are 
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necessary to describe all geometrical uncertainties of a specific patient group. These values 
are the input parameters of our method and do not only depend on the tumor sites, but also 
on set-up techniques and treatment protocols (and possibly even on more specific variables 
like tumor stage, patient weight, accelerator etc.). 
The parameters are used to calculate margins around a CTV which is initially repre-
sented by a set of input contours as outlined in 2D CT-slices. The contour data points are 
used to determine a 3D volume in a cubic calculation grid in the treatment room (i.e. CT) 
coordinate system. The algorithm has been described before [131] and can be summarized 
as follows. For each slice, intersection points of contour lines with 2D grid lines are 
calculated to fill a 2D matrix with values equal to the fraction of the grid element that is 
enclosed by the contour. The slices are stacked with increasing slice position so that a 3D 
matrix MCTV(x,y,z) is created with values 1 inside the volume and 0 outside the volume (and 
between 0 and 1 at the edge). This matrix is used for subsequent calculations. 
 
3.2.2 Coverage probability calculation using convolutions 
Two separate, equivalent methods have been developed to calculate a matrix with coverage 
probabilities (CPs) which is defined as the probability for each point to be covered by the 
CTV and which will be used for PTV margin determination. They will be designated as the 
convolution method and the Monte Carlo method. The convolution method uses a straight-
forward convolution of the CTV matrix with normal distributions describing the 
geometrical uncertainties. The effect of translational and rotational deviations is calculated 
separately. The normal distribution of mutually independent deviations in translations is 
given by: 
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with sdx, sdy, and sdz the standard deviations of the distributions in the three main direc-
tions. The input matrix MCTV(x,y,z) is convolved numerically with the probability distribu-
tion: 
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with ∆x∆y∆z the voxel size. In the output matrix MCP(x,y,z) the original contents of the 
voxels is spread out according to the distribution of translations. The value in each voxel of 
this "coverage probability" matrix represents the probability of the voxel being covered by 
the CTV. 
Inclusion of rotational positioning deviations is cumbersome in the orthogonal 
coordinate system. To be able to handle rotations around axes in the three main directions, 
an input matrix MCTV(x,y,z) is transformed to cylindrical coordinates MCTV(r,θ,a) using 
bilinear interpolations, where a is x, y or z for rotations about x-, y-, or z-axis respectively. 
The center of the new matrix (r = 0) is taken to be at the (user-defined) position of the 
rotation axis. A one-dimensional distribution matrix N(θ) is defined similar to N(x,y,z) and 
the convolution is performed: 
  ϑ∆θθθθ ∑
θ
 -N a,r,M  = a,r,M CTV
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with ∆θ the bin size. Subsequently the output matrix MCP(r,θ,a) is transformed back to 
orthogonal coordinates MCP(x,y,z). The transformation to a different coordinate system and 
back, on a discrete grid, will already smooth the CTV matrix, even without convolutions. 
To limit this effect, the pixel size in the cylindrical coordinate system is kept four times 
smaller than in the original. To minimize the number of cylindrical matrix elements and 
keep the element size approximately equal for all values of r, the number of angles θ 
increases with r, i.e. the (r,θ)-calculation grid is not rectangular but rather triangular in 
shape. 
In case more than one rotational deviation is present, the above procedure is performed 
again using the output matrix of the first calculation as input for the second, etc. The order 
is arbitrary for distributions that are mutually independent and for the small rotational 
deviations (< 10°) that are usual in patient set-up and organ movement (as will be justified 
later on, see figure 3.4). In case both rotational and translational deviations must be consid-
ered, the rotations should be performed first. 
 
3.2.3 Coverage probability calculation using a Monte Carlo approach 
The Monte Carlo method simulates the fractionated radiotherapy treatment more directly by 
sampling the translations tx, ty, tz and rotations rx, ry, rz from their respective distributions. 
Subsequently all points in the CTV matrix (x,y,z) are moved to a new position (x',y',z') 
according to: 
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where xr,y = (x-Rx,y), xr,z = (x-Rx,z), etc. the coordinates of the matrix point with respect to the 
x-, y-, and z-axes of rotation, respectively (Ry,x,Rz,x), (Rx,y,Rz,y), (Rx,z,Ry,z). The input value at 
point (x,y,z) can be assigned to the eight grid points nearest to (x',y',z') using trilinear 
interpolations or assigned completely to the one nearest point which is faster but less 
accurate. Hence a new matrix Mn(x,y,z) is calculated with n being the sample number. The 
procedure is repeated many times (> 1000) and the resulting matrices Mn(x,y,z) are 
averaged over the number of samples to yield the final result MCP(x,y,z). 
A difference between Monte Carlo and convolution method is the way in which 
rotational deviations are incorporated. The Monte Carlo method handles all rotations at 
once. The voxel displacement resulting from each rotation is calculated assuming the same 
starting position for all rotations, i.e. the input voxel position for the second rotation is not 
the output from the first. The computation of translations is similar for both methods; all 
three directions are handled simultaneously. Comparison of the methods will give an 
indication of their accuracy. 
 
3.2.4 Interpretation of coverage probability  
As mentioned before, the elements in the CP matrix MCP (of which the values vary from 0 
to 1) represent the probability of a fixed point in space to be actually covered by the CTV. 
For sufficiently large volumes (larger in diameter than about 2 SD of the distribution of 
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deviations), the CP value of a certain voxel also represents the probability that the volume 
border lies outside that voxel; i.e. if a point is covered by some part of the CTV, the CTV 
border must lie outside of that point (or exactly on it). Iso-coverage probability volumes are 
therefore logical candidates to define the PTV. Considering translational deviations in one 
dimension and given a selected coverage probability CPs smaller than 0.5, the probability 
(Po) that any point of the CTV volume is outside the PTV will then be equal to 2 CPs. For 
translations in more dimensions and for rotations the relationship between CPs or the 
margin size and Po becomes less straightforward. A special case may however serve as an 
estimate for the general case. 
That special case is a spherical CTV with an isotropic margin m to represent the PTV. 
The probability Po that any point of a CTV with normally distributed translational 
deviations sd in all three dimensions will be outside the PTV can be calculated analytically: 
dr e r  
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             (3.5)  
with r being equal to √(x2 + y2 + z2). The integral can be solved using partial integration. 
For deviations in two dimensions a similar expression can be derived. In figure 3.1 Po is 
displayed as a function of the margin in units of sd, for the one-, two-, and three-
dimensional case. The coverage probability values CPs that should be selected to obtain a 
margin m(sd) are displayed along the upper horizontal axis. The relation between CPs and 
m(sd) is normally independent of CTV shape as long as the volume is sufficiently large (> 2 
sd, as indicated before). For 3D translational deviations, the probability of the CTV being 
partly outside the PTV is considerably higher than for 1D deviations. For instance, a PTV 
margin of 1 sd (or CPs = 16%) has a Po-value of 32% for deviations in one dimension as 
opposed to 80% when deviations in all three dimensions are considered. However, not only 
the probability of CTV miss but also the extent of that miss is important. Even for large Po-
values, the fraction of the CTV outside the PTV is small and the dosimetrical consequences 
are limited.  
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Figure 3.1 Theoretical curves 
for a spherical CTV with 
variations in translations with 
standard deviations sd. 
Rotational variations are zero. 
Indicated is the probability 
that the CTV is partly outside 
the PTV (Po) for variations in 
one, two, and three 
dimensions with varying 
CTV-to-PTV margin size in 
units of sd. The corresponding 
selected iso-probability values 
(CPs) are indicated on the 
upper horizontal axis. 
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3.2.5 Influence of systematic deviations on the CTV dose: dose probability 
histograms 
To investigate the effect of the geometrical uncertainties on the dose distribution in the 
CTV, different approaches for systematic and random deviations are required. Systematic 
geometrical misses will cause underdosage of the same part of the CTV for every fraction 
of the treatment, whereas random deviations will cause underdosage in different parts of the 
CTV for each fraction. For systematic deviations, the CP matrix can be used to estimate the 
influence of systematic deviations on the DVH of the CTV. A normal cumulative DVH is 
constructed by summation of all CTV voxels that receive more than a certain dose, for all 
dose values D: 
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with D'( r ) the dose value at position r , ∆V the voxel volume, and MCTV( r ) the previously 
defined CTV matrix. r  ∈ CTV and r ∈ R3 are those positions which are member of the 
CTV and the whole 3D space, respectively. At the time of planning the systematical devi-
ations in CTV position are unknown for a specific patient but the probability of the CTV 
being systematically at a different position is determined by the systematic variations Σ of 
translations and rotations for the patient group. The average DVH, taking all systematic 
deviations of the CTV position with respect to the dose distribution into account, can then 
be determined to be:  
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with t
r
being a transformation (translations and rotations), N( t
r
) the probability for a 
certain transformation t
r
 (see Eq. 3.1), and )(CTVtM v  the transformed CTV. In the last step 
of the derivation Eq. 3.2 is used. Hence instead of counting voxels receiving a dose ≥ D, as 
for a normal DVH, the average of the DVH for all systematic deviations of the CTV is 
obtained by summation of the coverage probability values for each dose ≥ D. Therefore the 
results of those calculations will be denoted as dose probability histograms (DPHs). It 
should be emphasized that the CP matrix MCP in Eq. 3.7 is calculated using the systematic 
variations Σ. A dose histogram of a CP matrix for random (day-to-day) variations of one 
patient has no physical meaning since DVHs of different fractions should not be added; 
information about the position of the dose, which is essential when adding dose distribu-
tions of different days, is lost in a DVH. 
In figure 3.2 a clinical example of DPH calculations is shown. For an arbitrary prostate 
cancer patient planned according to the ICRU dose specification rules (i.e. block margins 
are such that the 95% isodose volume encloses the PTV), DPHs of CTV have been 
calculated for six different 3D translational variations Σ. Naturally, the probability of CTV 
underdosage increases with increasing variations. Since the ICRU suggested a maximal 
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tumor underdosage of 5% [62], an additional dashed line is drawn to indicate the 95% dose. 
The DPH curves for the CTV now immediately indicate that the 95% isodose will enclose 
on average a large part of the CTV (> about 99%) as long as the CTV-PTV margin is at 
least 2Σ. This implies a high probability of the 95% isodose enclosing the whole of the 
PTV. For smaller margins there will be an increasing probability of underdosage of the 
CTV. The DPH as an average of the DVHs for all systematic deviations seems therefore a 
reliable tool to determine the margin size required to cover for these deviations for a 
specific treatment plan. Also indicated in figure 3.2 are similar curves for variation in 
rectum position. The same variations are assumed without any change in rectum shape. As 
expected, the maximum dose of the DPH increases as the variations increase; the 
probability that the rectum will be part of the higher dose regions will be higher. At the 
same time however, the lower dose volumes decrease with increasing variations. This is 
due to the fact that for isotropic movements in all directions, the probability of the rectum 
moving toward the higher dose regions is lower than for moving away from them. 
 
3.2.6 Influence of random deviations on the CTV dose  
The random deviations displace the CTV with respect to the dose distribution differently 
for each fraction of the treatment. This can be simulated by convolution of the dose 
distribution matrix with the probability distributions, as has been described before [14, 61, 
111, 132]. The same algorithms as for the CP calculations can be applied. If the input file in 
Eq. 3.2 (MCTV) is a dose distribution instead of the CTV, the output will be a dose 
distribution which is spread out locally as a result of random deviations. This distribution is 
the best estimate of the actually delivered distribution during the radiotherapy treatment. In 
general the higher iso-dose regions will decrease in size, while the lower iso-dose regions 
will increase. The extent of shrinkage of the 95% iso-dose volumes should give an 
indication for the size of the required margin [14]. If only the random set-up deviations are 
considered, one calculation will be sufficient to determine its effect on CTV and critical 
organs simultaneously. If the internal random deviations of the critical organs are different 
for different organs, separate convolutions of the combined distributions of random set-up 
and organ movement should be performed with the local dose matrix surrounding each 
organ. Compared to CP calculations, dose modifications are more accurate because 
gradients in dose matrices are considerably flatter than those in CTV matrices. 
 
3.2.7 PTV margin determination 
The goal of a PTV is to create a volume around which the 95% dose can be planned so that 
the CTV is adequately irradiated, which can be verified using DPHs (see next section). In 
principle one might find the correct PTV by trial and error but CP calculations can also be 
used to calculate a good PTV to start with. Because of the different effect of the systematic 
and random deviations on the CTV dose (Σ and σ cannot be added), the PTV is calculated 
in two steps. 
For systematic geometrical uncertainties a high irradiation probability is obtained by 
choosing the margin according to a low iso-probability volume. From figure 3.2 a margin 
equal to about 2Σ would seem reasonable and from the upper horizontal axis in figure 3.1 
can be deduced that this corresponds to iso-probability curves of about 2.5%. Hence the 
first step in the PTV calculation (PTV1) is the determination of the 2.5% iso-probability 
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volume of the CTV (i.e. the volume bounded by voxels having a CP equal to 2.5%), using 
the systematic variations Σ as input to the model. From figure 3.1 this implies that for a 
spherically symmetric situation and deviations in all directions, there still is at least a 28% 
chance of the a part of the CTV is outside PTV1 for all fractions. In other words, there is 
maximally a 72% probability of complete enclosure of the CTV by the PTV1 during the 
radiotherapy treatment. However, the DPH curves of the example in figure 3.2 indicate that 
the 95% isodose will enclose the CTV in practically all cases. The internal and external 
deviations can be handled simultaneously by adding the respective standard deviations in 
quadrature. 
To cover for the remaining random deviations only a moderate increase in the margin 
will be necessary. The total random variation equals the quadratic sum of in- and external 
random variations. The procedure is similar to that for the systematic deviations, this time 
using PTV1 instead of the CTV as input volume. The difference is that random deviations 
do not affect the dose distribution in the tumor as much as systematic deviations. Therefore 
the margins can be smaller and the selected iso-probability volume can be higher. Bel et al. 
studied the dosimetric consequences of random translational variations σ for their prostate 
patients and concluded that a 0.7σ margin would be sufficient to keep the minimal CTV 
dose above 95% [14]. Based on those results we considered the 25% iso-probability volume 
appropriate for random deviations. This means that PTV1 will be partly outside the PTV in 
over 90% of the fractions (see figure 3.1). Once this final margin is added to PTV1, the 
calculation of the PTV is complete. Naturally, the choice of the iso-probability volume for 
either PTV1 or PTV margins is to some extent arbitrary and can be varied according to the 
individual preferences of the clinician. Eventually it should be based on quantitative models 
for the tumor control probability. 
 
Figure 3.2 Example of dose probability histograms for six different systematic variations 
in translation (Σ) for a prostate case planned to conform to ICRU recommendations with a 
1.5 cm CTV-to-PTV margin. With increasing variation in CTV position there will be a 
higher probability of underdosage. The rectum will on average also receive less dose as 
the variations increase, although the maximum dose increases. On the right the CTV 
curves near the 95% dose are magnified. 
dose (%)
vo
lu
m
e 
* C
P
 (%
)
0 20 40 60 80 100
0
20
40
60
80
100
CTV
rectum
DPHs for different 3D translational variations Σ
CTV-to-PTV margin: 1.5 cm
variation (cm)
0.0
0.5
0.75
1.0
1.25
1.5
2.0
100
80 1009590
80
60
CTV
85
 40
3.2.8 PTV margin verification 
Normally, the patient will be planned with certain block margins around the PTV to 
account for the penumbra of the beam. The concepts described can be applied to evaluate 
and judge the effect of geometrical uncertainties on the dose distribution in the CTV. 
Firstly, to calculate the expected dose distribution actually delivered during the treatment 
series, the dose matrix is convolved with the distribution of random deviations. The 95% 
isodose volume will shrink but should still enclose the PTV1 volume. Secondly the 
systematic deviations are used to determine the DPH of the CTV (and possibly critical 
organs), using the dose modified for random deviations. This DPH indicates whether the 
dose distribution is adequate to irradiate the CTV, given the systematic ánd random 
deviations. If the patient has been planned correctly, the average CTV volume receiving > 
95% dose must be high (e.g. > 99%). In case the probability of underdosage is too high, the 
95% isodose volume is too tight around the CTV and either the PTV margin or the block 
margin is too small. The plan can be recalculated using lower iso-probability contours as 
PTV margin or larger block margins. In case the DPH is practically equal to the original 
DVH (i.e. systematic deviations have no influence on the dose in the CTV), the PTV 
margins might be too large and the plan should be recalculated using higher iso-probability 
values as PTV margins (or smaller block margins). In this iterative manner the size of the 
block-to-CTV margins is directly optimized for irradiation of a specific CTV and DPHs of 
CTV instead of DVHs of PTV are used to evaluate the planning. 
 
3.2.9 Hardware 
The method has been implemented using the C programming language on a HP 9000/712 
(100 MHz) workstation. It runs as a separate application next to the CadPlan planning 
system1 and hence uses CadPlan contour and dose files as input. The results are written 
back to CadPlan files for visualization and further planning. At the moment, the voxel sizes 
in the calculations are equal to those used in the planning system, which vary in practice 
from about 2 mm for CT pixel size to maximally 10 mm for the slice distances. The dose 
matrices normally have a resolution of 2.5 or 5 mm. Geometrical uncertainties smaller than 
about 1 mm (1 SD) are consequently not reflected in the calculations. 
 
3.3 Results 
3.3.1 Accuracy of the methods 
To get an indication of the accuracy of the convolution and Monte Carlo method, results of 
the two methods are compared for a schematic example. Figure 3.3a depicts a 2D 
geometrical object which represents a target volume. The simulated random translational 
variations are different in horizontal and vertical direction and the coverage probabilities 
are calculated for both methods. The number of runs in the Monte Carlo method was 1500. 
The iso-probability contours of the different methods coincide well, only the 1% iso-
probability curves deviate slightly. In figure 3.3b an additional variation in rotation is 
simulated. As expected, the area within the higher probability curves decreases while that in 
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the lower increases. Due to the rotations the distance from one curve to the next becomes 
anisotropic. Near the upper right part of the object the lower iso-probability curves actually 
shrink compared to the curves in figure 3.3a; because of the rotations there is a lower 
probability that voxels in that area are enclosed by the object. The differences between the 
two methods become slightly larger, especially near the low probability curves. This is 
attributed to the limited number of runs of the Monte Carlo method which yields poor 
statistics in those regions. 
The largest differences between the two CP calculation methods are expected for 
coverage probability calculations with large rotational deviations. Hence an exaggerated 
(and unrealistic) variation in rotations around the three orthogonal axes through a point in 
the lower left and cranial corner of the input matrix is calculated for a lung tumor CTV in 
the upper thorax. Figure 3.4 shows the 5% iso-probability curves for both methods in a 
transversal, sagittal, and frontal slice near the center of the CTV. The two contours do not 
overlap in all areas but the differences are small: maximally 2 mm (1 CT pixel) while the 
margin is on average 2 cm. In slices near the edges of the volume the maximum differences 
that are found are 4 mm which is adequate considering the irregularity of the Monte Carlo 
contours. The difference between the two 5% iso-probability volumes is 4 cc (1%). In 
clinical practice rotational deviations of extreme values are rare and the occurrence of more 
than one deviation simultaneously is unlikely. Consequently, this close agreement may 
serve as assurance that the calculation of rotational deviations is reliable for both methods. 
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Figure 3.3 Comparison of convolution and Monte Carlo method. The schematic 2D 
CTV is the object outlined by the thick solid contour, the pixel size is 2 by 2 mm. A) 
A horizontal 12 mm (1 SD) and vertical 8 mm variation in translation has been 
simulated. The 1, 5, 20, 50, 70, 95, and 99% iso-probability curves of both methods 
are shown; the thin black lines represent the result of the Monte Carlo method (1500 
runs), the thick grey dashes the convolution method. B) A 5 degrees (1 SD) variation 
in rotation is added. The rotation axis is at the lower left corner of the figure (-12, -12 
cm). The iso-probability curves of the two methods still coincide well. 
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Although Eq. 3.5 was derived for a spherically symmetric case, the results are a 
reasonable approximation for more general clinical situations. For translational deviations, 
computer simulations for a prostate CTV indicate that, even if the margins become 
anisotropic, the deviations from the values in figure 3.1 are small (< 5%). A restriction is 
that the CTV volume should be devoid of sharp edges, which is usually satisfied. Another 
limitation is that rotational deviations are not included in the calculations, hence Eq. 3.5 
underestimates the Po-value if rotations are present.  
 
3.3.2 Clinical examples 
In three clinical examples the stepwise PTV calculation and the verification procedure will 
be illustrated. The values for the geometrical uncertainties are taken from literature or have 
been measured in our institute. In all cases it is assumed that the application of an off-line 
protocol (as mentioned in the introduction) halves the systematic translational set-up 
deviations [13]. The values used are summarized in Table 3.1. All calculations are done 
with the convolution method and all rotation axes are through the center of the CTV unless 
specifically stated otherwise. CT slice distances are 5 mm and CT pixel size are about 2 x 2 
mm. The grid size of the dose matrices is in all cases 2.5 mm in the plane of the CT slices 
and equal to the CT slice distance in the direction perpendicular to the CT planes. All three 
patients were planned with multi-leaf collimators. Block margins were such that the 95% 
isodose closely fitted the PTV and the dose homogeneity in the PTV satisfied the ICRU 50 
recommendations (i.e. dose variation of maximally 95% - 107%). 
 
Figure 3.4 Comparison of the two methods for an extreme case of rotational 
deviations. A lung CTV (thick black lines) has been modified with rotational 
deviations of 10, 8, and 6 degrees (1 SD) around the three major axes in a point about 
8 cm left, cranial, and below the CTV center. The 5% iso-probability curves for the 
convolution (thick grey dashes) and Monte Carlo method (thin black lines) are 
displayed in a transversal (a), sagittal (b), and frontal cut (c) through the CTV. 
Although the two methods handle the effect of rotational deviations differently, the 
results are quite similar. 
cr
an
io
-c
au
da
l (
cm
)
ventro-dorsal (cm)
b) sagittal slice
-8 0 8
lateral (cm)
cr
an
io
-c
au
da
l (
cm
) c) frontal slice
-8 0 8
a) transversal slice
ve
nt
ro
-d
or
sa
l (
cm
)
-8 0 8
lateral (cm)
8
0
-8
 43
3.3.3 Prostate cancer case 
Due to variations in rectum 
and bladder filling, the range 
of the internal prostate 
movements is considerable. 
The values that are used in 
our calculations have been 
estimated from several 
studies available in the 
literature [10, 36, 54]. The 
lateral rotation axis was 
taken to be near the apex of 
the prostate as suggested by 
van Herk et al. [54]. The 
values for external set-up 
deviations are taken from 
routine portal imaging data 
of 228 patients treated at our 
clinic. The final PTV is 
constructed in several steps 
as shown in transversal and 
sagittal slices through the 
tumor (figure 3.5). The CTV 
has been outlined manually 
by a radiation oncologist. 
This volume is expanded 
with a margin to cover all 
systematic deviations; a CP 
matrix is calculated using 
the quadratically summed 
internal and external 
systematic variations (Table 
3.1). PTV1 is taken to be the 
volume enclosed by the 
2.5% iso-probability 
contours. To get the final PTV a subsequent margin is added to PTV1 from the calculated 
25% iso-probability volume with the quadratically summed random variations as input for 
the CP calculations. The random deviations add only an extra 1 - 2 mm (which is close to 
the pixel size). In total, the margin around the CTV varies from minimally 6 in the caudal to 
maximally 13 mm in the cranial region of the PTV. The anisotropy is due to the significant 
rotation around the apex of the prostate.  
The interpretation of the contours in the two-dimensional slices is sometimes misleading 
due to the 3D aspect of the margins; they may appear too large in one slice due to the 
influence of a differently shaped tumor contour in the next slice as, is especially apparent in 
the (cranial) transversal slice. This effect is also visible in the cervix and lung cancer case 
that follow. 
variation translation  
(mm, 1 SD) 
rotation  
(degrees, 1 SD) /axis 
direction LR CC AP LR CC AP 
Prostate 
σext  2.0 2.0 2.0 1 1 1 
Σext  1.2 1.2 1.4 1 1 1 
σint  1 2 2 4* 2 1 
Σint 1 2 2 4* 2 1 
Cervix 
σext  3.5 4.0 3.5 3 1.5 2 
Σext  2.0 2.5 2.0 2 1 1 
σint 1 1 1 1 1 1 
Σint 1 1 1 1 1 1 
Lung 
σext  3.0 3.0 3.0 2 2 2 
Σext  2.0 2.0 2.0 1 1 1 
σint 4 5 5 2 2 2 
Σint 2 3 3 1 1 1 
Table 3.1 Overview of geometrical uncertainties used as 
input for the model for three different tumor sites. 
Systematical (Σ) and random (σ) variations are indicated 
for translations as well as rotations and internal organ 
movement (int) as well as external set-up deviations (ext). 
All rotation axes are assumed to be at the center of the 
CTV except for those indicated by * which are assumed to 
be at the caudal apex of the CTV. 
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A three-field technique was applied to plan the patient. To verify the dose distribution in 
CTV, rectum, and bladder, DVHs have been calculated for each volume and are shown in 
figure 3.6. Subsequently, the dose distributions around the volumes of interest have been 
convolved with the distributions of random deviations. For the CTV the values are directly 
obtained from Table 3.1, for bladder and rectum the internal random motion was estimated 
to be equal to that of the prostate without the rotation. Bladder and rectum volumes were 
assumed to be constant. Resulting DVHs show that the effect of random deviations on the 
CTV dose is negligible, whereas the bladder and rectum high dose volumes are somewhat 
reduced. Finally, the DPHs for the systematic deviations have been determined using the 
dose distributions modified for random uncertainties. Standard deviations are taken from 
Table 3.1 similar to the random deviations. The DPH of the CTV is different from the 
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Figure 3.5 Prostate planning example of the stepwise PTV calculation in a cranial 
transversal slice (a), an isocentric slice (b), a caudal slice (c), and a sagittal reconstruction 
(d). The geometrical uncertainties are from Table 3.1. The CTV (grey curve) is extended 
with a margin to cover for the systematic deviations by selection of the 2.5% iso-
probability volume of the CP matrix (PTV1, dashed curve). The final PTV (white curve) 
results from the 25% iso-probability volume of the CP matrix of random deviations 
applied to the PTV1. Especially in the sagittal slice the influence of the rotations around 
the apex is clear; the PTV margin in the caudal part is significantly smaller than that in the 
cranial part of the prostate. The critical organs (bladder and rectum) are depicted by the 
thin black curves. 
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original DVH but the DPH-curve does not quite intersect the 95% dose line, i.e. the 
probability of underdosage of the CTV is negligible. The DPHs for the critical organs do 
not deviate from the DVHs.  
 
3.3.4 Cervix cancer case 
Compared to prostate cancer patients, external set-up deviations play a major role in the 
planning of (post-operative) gynecological cancer patients. Positioning accuracies of cervix 
cancer patients are also determined by studies in our own institute, one of which is 
described by Creutzberg et al. [35]. Also in contrast with the prostate case, the internal 
organ movement is expected to be relatively small considering the involved anatomy. In 
figure 3.7 four slices through the initially drawn CTV are depicted. The PTV1 margins due 
to systematic deviations are calculated similar to the prostate case and vary from 6 to 9 mm. 
They are mainly caused by the external deviations. The addition of a margin for random 
deviations completes the PTV calculation. The final CTV-to-PTV margin is then about 1 
cm. An additional feature of margin calculation using coverage probabilities is the 
smoothness of the PTV surface. This especially manifests itself in the sagittal view in figure 
3.7d; the inconsistencies in the CTV delineation disappear in the PTV.  
The patient was planned in prone position with a three field technique. The relatively 
large random positioning deviations are solely responsible for the random deviations. 
DVHs and DPHs for CTV, small bowel, and rectum have been calculated similar to the 
prostate case. The results are shown in figure 3.8. The effect of the random uncertainties on 
Figure 3.6 DVHs and DPHs for the prostate cancer patient in figure 3.5. The 
original DVHs of CTV, bladder and rectum are indicated by the thin black lines. 
DVHs for the dose distributions adjusted for random deviations are represented by 
the dashed grey curves. The effect of random deviations on the CTV dose is 
negligible, whereas the bladder and rectum high dose volumes decrease. The DPHs 
(dotted curves) for the systematic deviations have been determined using the dose 
distributions modified for random uncertainties. There is only a noticeable effect on 
the CTV but the curve does not intersect the 95% dose line (dashed) so the 
probability of underdosage of the CTV is negligible. 
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the rectum and small bowel is again a noticeable reduction of the high dose volume. The 
original DVH of the CTV indicates a less homogeneous dose distribution than for the 
prostate case. It is however hardly influenced by the systematic or random deviations and 
the final DPH proves that adequate margins have been applied. 
 
3.3.5 Lung cancer case 
A last example is a 3-field lung booster plan designed to spare the left lung (figure 3.9). 
Due to breathing and cardiac motion there is considerable internal tumor movement the 
magnitude of which has been estimated from previously published values [110]. Values for 
external set-up deviations are based on the preliminary results of a lung cancer patient 
positioning study recently conducted in our own institute. The manually outlined CTV is 
expanded with a 6 - 9 mm margin to cover internal and external systematic deviations. The 
random deviations require an additional 3 - 5 mm margin for the final PTV and the total 
margin becomes 10 - 13 mm. 
Variations in position of the lungs and the spinal cord are assumed to consist only of set-
up deviations. In the DVHs of CTV and right lung the random-deviation-adjusted dose 
Figure 3.7 Example of the PTV calculation for a cervix cancer plan. The geometrical 
uncertainties are from Table 3.1. The same procedure and line styles as for the prostate 
case (figure 3.5) are used except for the small bowel that is depicted instead of the 
bladder. Three transversal (a,b,c) and a sagittal slice (d) through the PTV are shown. The 
overall CTV-to-PTV margin becomes about 1 cm. 
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distributions display similar differences with the original as the cervix cancer case (figure 
3.10). However, the spinal cord is an exception. Since the beams in the three field plan are 
positioned (too) close to the spinal cord, there is a strong dose gradient just next to it 
causing an increase of spinal cord dose in the random-deviation-adjusted plan. To a lesser 
degree the same holds for the left lung. The DPHs for the critical organs are again 
practically equal to the DVHs, except for the spinal cord; due to the position of the beams 
the systematic movements of the spinal cord cause a (slight) increase in average spinal cord 
volume receiving high dose. The DPH of the CTV is different from the DVHs but the high 
probability of sufficient dose homogeneity indicates that the PTV and block margins were 
adequate. 
 
3.3.6 Computer performance 
The calculation speed depends on the selected method and input. The margin and DPH 
calculations normally take about 1-2 minutes with the convolution method. Generally the 
Monte Carlo method is about three to six times slower since a large number (> 1000) of 
samples have to be taken to obtain sufficient accuracy in the low probability regions. 
Therefore the Monte-Carlo method is only used for verification in case of questionable 
results. For both methods the computation time increases linearly with the size of the input 
and convolution matrices. Since the dose matrices are currently fixed to the standard 
CadPlan format (160 x 112 x number of slices), dose modifications are slower. (In principle 
only that part of the dose matrix that surrounds the volume of interest needs to be included 
in the calculations). Besides, almost all elements of the dose matrix are non-zero whereas 
volume matrices contain a substantial part of zero elements that are ignored in the calcula-
tions. The normal time required for dose modifications with the convolution method varies 
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Figure 3.8 Dose distribution verification for the gynecological cancer patient in figure 
3.7. DVHs and DPHs for CTV, small bowel, and rectum have been calculated similar to 
the prostate case of figure 3.6. The effect of the random uncertainties on the rectum and 
small bowel (dashed grey curve) is again a significant reduction of the high dose volume 
compared to the original DVH (thin black curve). The DPH curves (dotted) indicate that 
the CTV is hardly influenced by the systematic or random deviations. 
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from two (without rotations) to about ten minutes which is a fraction of the time needed for 
volumetric dose calculations. Hence the method is sufficiently fast to be used in the 
iterative planning process. 
 
3.4 Discussion 
3.4.1 Margin calculations 
The methods proposed in this paper will be particularly useful for designing PTV margins 
in case of new conformal therapy studies. Based on knowledge (or intelligent guesses) of a 
set of standard deviations describing all possible geometrical uncertainties of the CTV 
position, the CP values will give an indication where the CTV of an individual patient will 
be positioned over the course of treatment. However, repeated calculations within a specific 
patient group will normally yield equal margins for all patients independent of the shape of 
the CTV. For normally distributed deviations and in absence of significant rotational 
deviations, our choice of iso-probability volumes, which is based on the assumption that on 
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Figure 3.9 Example of the PTV calculation for a lung cancer plan. The geometrical 
uncertainties are from Table 3.1. The same procedure and line styles as for the prostate 
case are used (figure 3.5). Two transversal (a,b), a sagittal (c), and a frontal cut (d) 
through the PTV are shown. The overall CTV-to-PTV margin becomes about 10-13 mm. 
The critical organs are the two lungs and the spinal cord. 
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average a high percentage of the CTV volume (> 99%) should receive a high dose (> 95%), 
yields margins of about 2Σ + 0.7σ. Consequently, the margins might also be applied 
directly to the CTV by straightforward CTV expansion algorithms [7, 18, 131], without 
having to perform the CP calculations each time. 
One difference between rigid margin addition and the CP method might reveal itself at 
sharp edges. If no smoothing is performed, the former method will normally closely follow 
all irregularities in the CTV surface so all random deviations in the delineation of the CTV 
will be present in the PTV as well. The latter method will in itself tend to smooth the 
surface and can yield a slightly smaller PTV due to rounding of the corners as has been 
shown in figure 3.3 and figure 3.7d. Another difference will occur at small volumes or near 
small extensions of a volume. For volumes with diameters less than about 2 SD of the 
distribution of deviations, a CP value will no longer represent the probability that the 
volume will be partly outside of it. The actual probability will be larger. Therefore, 
choosing an iso-probability volume as new PTV will yield too small margins. Rigid margin 
addition is insensitive to the size of the input volume. 
In clinical practice one might prefer a tighter CTV-to-PTV margin near a dose-limiting 
structure. In the model described in this paper, nearby critical organs are currently ignored 
in the PTV calculation. However, a critical organ might also be represented by a 3D volume 
matrix which can then be used to modify the CTV-to-PTV margins locally, as has been 
described in a previous paper about straightforward margin calculation [131]. The dose 
probability histograms can of course still be used and the influence of the local margin 
changes on the average dose volume histogram can immediately be visualized. 
The described method assumes that all probability distributions of translations and 
rotations are mutually independent and of a gaussian nature. The mutual independence is 
however not always an accurate description of reality; for example, for internal prostate 
Figure 3.10 DPHs and DVHs of a plan which spares the left lung for the lung cancer 
patient from figure 3.9. The effect of the random uncertainties (dashed grey curve) on 
the CTV and right lung is similar to the prostate and cervix case. However, for spinal 
cord and left lung the effect of random deviations is a slight increase in the high dose 
volume. The DPH curves (dotted) indicate that the dose distribution in the CTV is 
influenced by the systematic deviations but the 95% isodose is still adequately placed 
around the PTV. 
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movement a relation between rotations and translations has been found [54]. This might 
more easily be incorporated in the Monte Carlo method than in the convolution method. 
Instead of sampling from normal distributions, translations and rotations should be 
simultaneously obtained from a data base of prostate movements for a large group of 
patients [80]. This "brute force" method will require a large data base and many samples 
and will therefore be time consuming. The gaussian nature of the distributions has been 
verified repeatedly by studies on set-up position verification. At present too few studies 
have been performed to establish whether this is the case for internal organ movement as 
well or if differently shaped probability distributions might be more appropriate. The 
algorithm does however not depend on the type of probability distribution. Instead of using 
normal distributions for the convolutions, other distributions can be implemented as well. 
The output of the calculations will still be a 3D matrix with coverage probabilities which 
will still represent the probability that the CTV lies partly outside the corresponding voxel. 
Hence the same methods can be applied to obtain the PTV margins. 
 
3.4.2 Dose modifications 
Dose modifications that account for random deviations cause a shift of high dose to the 
lower dose regions. Consequently, the critical organs that receive a high dose in the original 
plan, like the rectum and bladder in the clinical examples, will receive less dose in the 
modified plan. Furthermore, from figure 3.2 is clear that the average DVH curve for 
systematic deviations (i.e. the DPH) can also be lower than the original, although the effect 
is limited for the clinical examples. This implies that the standard DVHs of the planning CT 
slightly overestimate the dose in those organs. For the critical organs that receive relatively 
low doses in the planning CT situation, the reverse is true. In the example for the lung 
cancer patient the organs that have specially been spared (i.e. the spinal cord and the left 
lung) will on average receive a somewhat higher dose due to the geometrical uncertainties. 
A consequence of the application running outside the planning system is that dose 
inhomogeneity corrections are not included when calculating the dose distribution corrected 
for random deviations. The effect might be less significant for calculations in the pelvic 
area but the accuracy of planning in the thorax or neck region will probably be affected. A 
further simplification of the model is that the position of the beam with respect to the 
direction of the deviations is of no consequence. In reality the change in dose of a volume 
moving in the direction of the beam is determined by the inverse square law and the slope 
of the depth-dose curve, which is not incorporated in the algorithm. The errors will be 
relatively small [14], but, ideally, dose modifications should be performed for each beam 
separately which would be a time consuming procedure. In a multiple beam plan the errors 
are less prominent. Nonetheless, the effect of the set-up deviations might be slightly over 
estimated.  
The application can also be utilized for a check of the delivered dose after the irradiation 
series have been completed. Once all fractions have been delivered and portal imaging has 
been applied, systematic and random set-up deviations can be calculated and used as input 
to the application to evaluate the actually delivered dose distribution. Thus it can be 
assessed whether the treatment has been performed correctly and if complications or a 
different local control probability might be expected. The same procedure can also be 
applied before the end of the treatment series to verify the situation at that moment and 
possibly alter the course of the treatment, e.g. change the PTV margin [144]. Even the 
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actual set-up deviations for every fraction might be entered separately and the conse-
quences of the treatment on the dose can be computed more precisely. 
 
3.4.3 Dose probability histograms 
The concept of DPH is especially useful to determine whether the calculated dose 
distribution guarantees adequate CTV irradiation despite systematical uncertainties. Since 
the dose has been planned conform the CTV, every variation in CTV position will 
deteriorate the dose distribution in the CTV. Hence the spread in DVH curves due to 
systematic deviations will be reflected in the average curve. The mean DVH will therefore 
directly indicate the probability of CTV underdosage and hence the goodness of the plan in 
this respect. For critical organs however, positioning deviation in one direction might 
improve the DVH, movement in the opposite direction worsen the DVH, and the average 
will be equal to the original. Hence instead of the average DVH for all systematical 
deviations, the spread of the DVH curves would be more interesting [66,80]. This cannot 
directly be calculated using DPHs but it is possible to extend the critical organ with a 
margin for systematical deviations so that an indication of possible dose values in the organ 
is obtained. This might for instance deteriorate the lung plan because extension of the spinal 
cord volume might yield a significant probability of higher spinal cord dose than indicated 
in figure 3.10.  
At first sight, there appears to be a discrepancy between figure 3.1 and the DPH 
calculations in this paper. Figure 3.1 predicts that our choice of the 2.5% iso-probability 
contour as PTV will for deviations in 3D result in the CTV being partly outside the PTV in 
at least 28% of all patients. The average DVHs (or DPHs) in the clinical examples indicate 
however that the probability of underdosage of the CTV (dose < 95%) is at most about a 
few percent. This is because the extent of CTV volume outside the PTV is small. Using a 
formula similar to Eq. 3.5, it can be calculated that the average distance that the CTV 
border will exceed the PTV border will be about 0.5 Σ for those 28% of patients. Since 
clinical Σ-values range from about 2 to 4 mm, a 1 to 2 mm thick slice of the CTV will be 
systematically outside the PTV for those patients. This is about equal to the size of one CT 
pixel and since the 95% isodose volume does normally not enclose the PTV exactly, the 
probability of underdosage is significantly smaller than the probability of the CTV being 
outside the PTV.  
Since the tightness of the 95% isodose around the PTV will be dependent on the 
treatment technique used (and on the beam characteristics), the required PTV margins to 
guarantee a high probability of sufficient dose in the CTV despite systematical deviations 
will be technique dependent as well. For instance, for conformal techniques slightly larger 
PTVs are required than for conventional techniques using rectangular fields to obtain the 
same DPHs. The same holds for the margin for random deviations. If that margin is based 
on the shrinkage of the 95% isodose, this will also be technique dependent. For patients 
groups with standard treatment techniques, the PTV and block margins can be optimized 
using the DPHs of the dose distribution modified for random deviations. Once the margins 
are standardized, the iteration process to obtain optimal PTV margins will be superfluous 
for each patient separately. 
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3.5 Conclusion 
A model has been developed which allows for the inclusion of geometrical uncertainties in 
the radiotherapy planning process. Required parameters are a set of twelve standard 
deviations describing the various uncertainties. The model calculates PTV margins based 
on the requirement that on average a large part of the CTV (> 99%) is irradiated with a high 
dose (> 95%). The size of adequate margins appears to be approximately equal to 2Σ+0.7σ. 
Since rotational deviations are included, the margins can well be anisotropic. Once the 
patient is planned, the influence of the systematical deviations on the dose distribution in 
the CTV is determined by the average DVH for all systematic deviations, using so-called 
dose probability histograms. The influence of random deviations is determined by 
convolution of the dose distribution with the probability functions. In an iterative process of 
planning and verification of the CTV coverage, the CTV-to-PTV and block margins can be 
optimized for each patient separately. For standard planning techniques of specific patient 
groups, the margins can be standardized and the iterations omitted. 
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Abstract 
 
Purpose:  To determine the magnitude of the errors made in (i) the setup of patients with 
lung cancer on the simulator relative to their intended setup with respect to the planned 
treatment beams and (ii) in the setup of these patients on the treatment unit. To investigate 
how the systematic component of the latter errors can be reduced with an off-line decision 
protocol for setup corrections. 
Methods and Materials: For 39 patients with CT planning, digitally reconstructed 
radiographs (DRRs) were calculated for anterior-posterior and lateral beams. 
Retrospectively, the position of the visible anatomy relative to the planned isocenter was 
compared with the corresponding position on the digitized simulator radiographs using 
contour match software. The setup accuracy at the treatment unit relative to the simulator 
setup was measured for 40 patients for at least 5 fractions per patient in two orthogonal 
beams with the aid of an Electronic Portal Imaging Device (EPID). Setup corrections were 
applied, based on an off-line decision protocol, with parameters derived from knowledge of 
the random setup errors in the studied patient group.  
Results: The standard deviations (SD) of the simulator setup errors relative to the CT 
planning setup in the lateral, longitudinal and anterior-posterior directions were 4.0, 2.8 and 
2.5 mm, respectively. The SD of rotations around the anterior-posterior axis was 1.6° and 
around the left-right axis 1.3°. The setup error at the treatment unit had a small random 
component in all three directions (1 SD =  2 mm). The systematic components were larger, 
particularly in the longitudinal direction (1 SD =  3.6 mm), but were reduced with the 
decision protocol to 1 SD < 2 mm with, on average, 0.6 setup correction per patient.  
Conclusion: Setup errors at the simulator, which become systematic errors if the simulation 
defines the reference setup, were comparable to the systematic setup errors at the treatment 
unit in case no off-line protocol would have been applied. Hence, the omission of a separate 
simulation step can reduce systematic errors as efficiently as the application of an off-line 
correction protocol during treatment. The random errors were sufficiently small to make an 
off-line protocol feasible.  
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4.1 Introduction 
 
Despite a dose of 65 Gy, the local complete remission rate in patients with non-small cell 
lung cancer (NSCLC) is only around 20% [34]. Unless the irradiated volumes are 
decreased, radiation dose escalation can result in unacceptable pulmonary and esophageal 
toxicity, particularly when concurrent chemo-radiotherapy is used [29]. Volume reduction 
may sometimes be achieved by omitting elective nodal irradiation [51, 108] but also by 
enabling the use of small planning margins. Such small margins would also reduce toxity at 
currently standard dose levels. In this paper, we investigate the setup inaccuracies of lung 
cancer patients and discuss the impact on planning margins. 
Treatment planning in accordance with the recommendations of the ICRU 50 report 
requires the definition of a clinical target volume (CTV), which must encompass the gross 
tumor and subclinical disease and possibly involved lymph nodes. The CTV must be 
expanded to a planning target volume (PTV) by some geometrical margin. This margin 
must guarantee adequate coverage of the CTV during treatment and should therefore be 
based on knowledge of target movement with respect to the treatment fields, and machine 
accuracy (e.g. reproducibility of the block positions). However, the ICRU 50 report does 
not give a clear recommendation on how the CTV-to-PTV margin should be chosen.  
Stroom et al. [125] have derived a general calculation method based on the dose 
coverage probability of the CTV to derive a 3D margin from known setup errors and 
internal organ movements, which may have any probability density function. They found 
that a clear distinction must be made between systematic and random errors, where a 
systematic error is the average setup error of the target volume over all fractions for a 
certain patient and the random errors are the inter-fraction variations.  For gaussian error 
distributions, with a standard deviation (SD) Σ for the systematic errors and σ for the 
average random error, a CTV-to-PTV margin of σΣ 7.02 +  seemed appropriate to 
guarantee that, on average, 99% of the CTV receives at least 95% of the prescribed dose (if 
the 95% isodose contour encompasses the PTV in the treatment planning). Their 
calculations incorporated the presence of small rotations (1 SD ~ 1°). A very similar result 
was found by Van Herk et al. [55], who did an analytical calculation for the simplified 
situation of a spherical target volume in an ideally conformal homogeneous dose. Both 
these results confirm the intuitive notion that systematic errors are more important than 
random errors in establishing planning margins.  
Most setup studies in lung cancer patients are 2D [40, 112, 124, 145] or do not properly 
separate and quantify setup errors in terms of random and systematic components [20, 48, 
113]. These studies usually pertain to small (< 20) numbers of patients [40, 48, 112, 113, 
124]. In addition, none of these studies takes into account the setup errors that are made on 
the simulator (which have been shown to be of importance for other tumor sites [12, 76]). 
Lastly, the impact of a 3D off-line correction protocol on the systematic errors during 
treatment has not yet been studied in this patient group. As stressed above, accurate 
knowledge of both the systematic and the random setup inaccuracies (and how they can be 
reduced) is a prerequisite for calculation of optimal planning margins. Therefore, we 
measured the magnitude of both simulator and treatment systematic setup errors as well as 
random treatment setup errors in 3D in 40 lung cancer patients. In addition we report on the 
reduction of systematic treatment errors through an off-line setup verification protocol.  
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Geographical tumor misses are caused both by external setup errors and by internal 
movement of the target volume [40, 110]. In this study we focus on the external setup 
errors for a group of lung cancer patients with CT planning, consisting of 
(1) The errors made by using simulator films as definition of the reference setup [12, 76]. 
The position of the patient anatomy in the reference setup (during which the treatment 
isocenter is marked on the patient and reference images are obtained) relative to the 
isocenter should be in agreement with the corresponding position in the CT treatment plan. 
However, in many institutions (including, until recently, our own) it is customary to mark 
the final beam setup at the simulator, after the planning has been performed. The definition 
of the final isocenter is based on visual inspection, and therefore may deviate from the 
intended CT plan isocenter. This simulator setup error results in a systematic error in the 
patient treatment. For prostate [12] and head and neck [76] irradiation, it was found that the 
simulator setup errors are comparable to systematic setup errors at the treatment unit. In 
these two cases, bony structures relevant to patient setup can be clearly identified, 
somewhat in contrast to the thorax region. Therefore, we expect that the simulator setup 
errors for lung cancer patients will be at least equal to, or larger than, systematic treatment 
unit setup errors. The simulator setup errors are however not well appreciated in the 
literature on setup accuracy of these patients. In fact, of the 7 setup studies we refer to 
above [20, 40, 48, 112, 113, 124, 145], 6 defined explicitly which type of setup reference 
image was used. Out of these 6 studies, 5 used simulator images based on a classical 
simulation [40, 48, 112, 113, 124] (i.e., without registering with the digitally reconstructed 
radiographs (DRRs)) and one study [20] applied both simulator films and DRRs.  
(2) The setup errors at the treatment unit relative to the reference setup, which have a 
systematic and a random component. The systematic component may be reduced with 
portal imaging and setup corrections based on an off-line decision protocol [13, 116]. We 
have investigated both components and report the results of an off-line decision protocol. 
 
4.2 Methods and Materials 
4.2.1 Description of setup errors 
We adopt the definitions introduced by Bijhold et al. [22] for systematic and random errors. 
The systematic setup error of a patient is the setup error averaged over all dose fractions. 
The group mean of this error is denoted by µ and the SD by Σ (i.e., the inter-patient mean 
setup variation). The random error of a patient is the standard deviation (SD) of the setup 
error from fraction to fraction (i.e., the inter-fraction variation). An appropriate average is 
taken to obtain the average random error for the patient population, denoted by σ. A 
specific type of setup error (e.g. a translation in a certain direction) is characterized by the 
set (µ, Σ, σ ). Details on their calculation can be found in the Appendix. Note that if the 
lasers and light-field are proper indicators of the isocenter in both the reference situation 
(simulator or CT scan) and the treatment setup, µ should be close to zero, but Σ may still 
deviate significantly from zero due to interpatient variations (e.g. due to setup errors and 
patient movement during the CT scan or simulation, skin mobility and changes in body 
weight). 
For measurement of the setup errors, we adopt the fixed coordinate system 
recommended by the International Electrotechnical Commission (IEC 61217). In this 
system, the Y axis coincides with the rotation axis of the gantry, the Z axis is perpendicular 
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to the floor and the X axis is perpendicular to both previous axes. For our study, the (X,Y,Z) 
directions coincide with respectively the lateral (LR), longitudinal and anterior-posterior 
(AP) directions. The setup errors for direction D (D = X, Y, or Z) are summarized by (µD, 
ΣD, σD). In a similar way rotations are reported, but now indicated by AP and LR for 
rotation axes Z and X respectively.  
Treatment setup errors measured relative to a reference image (in our study, a simulator 
radiograph) have been denoted by superscript T and setup errors in the definition of that 
reference have superscript R.  Measurements on the treatment setup error for patients which 
were subject to an off-line correction protocol  were used to obtain the setup errors that 
would have been found if no protocol had been applied, as described in the Appendix. The 
quantities that result from this calculation are embellished with a tilde symbol (e.g. Σ~ ). 
 
4.2.2 Anatomical structures and template matching 
In a previous paper [112], we performed a detailed analysis of the intra-fraction movement 
Figure 4.1 Screen shot of the RAPID template match. On the left is a DRR, on the right 
the corresponding simulator film. The contours (which were delineated on the right 
image and matched on the left) represent the thoracic wall and trachea. On the left, the 
cross indicates the actually planned isocenter, on the right the simulated isocenter. For 
both images, the square outlines a 10 × 10 cm2 symmetrical field. As seen from the 
position of the anatomical contours on the simulator image with respect to the 10 × 10 
cm2 field outline, the simulated treatment field is shifted laterally by approximately 1 
cm with respect to the planned position on the left. 
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of anatomical structures visible in AP portal images. Multiple portal images per treatment 
fraction were obtained, contoured, and matched with the first portal image of the 
corresponding fraction. Relevant structures that exhibited little motion were the thoracic 
wall and the trachea. For the thoracic wall, the average SD of intra-fraction movement in 
the X and Y directions was 0.8 respectively 0.6 mm and for the trachea 0.8 and 1.7 mm 
respectively. These SDs includes manual delineation and template matching errors, which 
are probably the origin of the relatively large SD for the trachea in the Y direction. If the 
two structures were matched simultaneously, the SD of the intra-fraction movement in both 
directions was 0.5 mm. We therefore used this structure combination in all the template 
matches referred to in this paper. 
For lateral fields, we matched the vertebrae, sternum and occasionally the trachea. We 
expected the intra-fraction motion of these structures to be negligible, and a pilot study was 
performed to verify that expectation (see next section). 
Fig. 4.1 shows a picture of the template match screen of the applied software of the 
RAPID Electronic Portal Imaging Device (EPID) described below. The contours are 
manually delineated on the reference image (right panel) and can be “picked up” and 
shifted over the image in the left panel using the mouse. In principle, the contours can also 
be rotated around a user-defined point, but the users were instructed to use this option with 
caution and only if they could not reach a satisfactory result without it.  
 
4.2.3 Intra-fraction movement in the Z direction as observed in lateral beams 
As mentioned, in a previous study we performed an analysis of intra-fraction movement in 
the longitudinal and lateral directions for AP treatment fields [112]. This analysis was 
performed with movie-loop images obtained with a BeamViewPLUS EPID (Siemens).  A 
simultaneous analysis of the setup errors in the AP fields showed that the random inter-
fraction errors were relatively small (1 SD = 2-3 mm). For the lateral fields it was hard to 
obtain movie-loop images with relevant structures, because the fields were usually too 
small. Therefore, we studied the intra-fractional movement of structures in the Z direction 
on the basis of inter-fraction variations. 
We selected the vertebrae, trachea and sternum as structures for which we expected little 
motion due to breathing and heartbeat. Next, we obtained images of large rectangular 
lateral fields with a (Philips) SRI-100 EPID in 8 patients and studied the setup error in the Z 
direction using a (simultaneous) template match of the mentioned structures. The large 
portal imaging fields (PIFs) were necessary to capture these structures in the image. The 
exposure per PIF was 10 monitor units (MU) with a 10 MV beam at 200 MU/min. No more 
than 10 fractions per patient were imaged to keep the dose to healthy tissue at a level that 
was considered acceptable by the radiation oncologists. The PIF was taken into account 
during treatment planning and dose-volume histograms were generated with the maximally 
acceptable PIF dose. The mean PIF exposure time of 1.8 sec corresponds to about a third of 
the average breathing cycle period [70]. Therefore, if the mentioned anatomical structures 
exhibit motion with breathing, the measured random (day-to-day) setup error, TZσ , presents 
an upper limit on the magnitude of these motions since it also includes random setup errors.  
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4.2.4 Simulator setup errors 
Simulator setup errors were evaluated for 39 patients with NSCLC.  Frontal and lateral 
laser lines at the CT scanner were marked with ink lines (21 patients) or tattoos (18 
patients), as well as a longitudinal lead strip which was clearly visible in the CT scan. The 
patients were scanned (and treated) in the supine position with no fixation devices, except 
for an armrest at the top of the table in which the upper arms were positioned and a feet 
rest. The CT slice thickness and spacing were 5 mm. The CT data were transferred to the 
(Varian-DoseTek) CadPlan treatment planning system (TPS) to construct a 3D isocentric 
plan.  
The resultant treatment portals were simulated and the radiation oncologist judged the 
accuracy of field placement on the basis of the simulator films, beam's-eye-view (BEV) 
plots and standard CT scout topograms (which suffer from incorrect beam divergence in the 
transversal plane and no divergence in the superior-inferior direction). No DRRs were used 
during the simulation, since the aim of our study was to investigate the accuracy of our 
routine simulation procedure, which did not involve the use of DRRs. At the start of 
simulation, each patient was positioned according to the CT markings using the simulator 
lasers. Next, a (pre-calculated) table translation was executed in agreement with the 
position of the definitive isocenter of the treatment plan. The radiographs obtained in this 
situation often led to additional table adjustments indicated by the clinician based on visual 
comparison with the BEV plots. Once the setup was judged satisfactory, the final isocenter 
position was marked on the patient using skin tattoos and long laser lines, and reference 
setup radiographs were obtained at gantry angles 0° and 90° or 270° (N.B. These angles 
may differ from the treatment beam angles). 
Retrospectively, at the same gantry angles, DRRs were constructed from the 3D planning 
data. They were generated with in-house developed software, which had the benefit of a 
higher spatial resolution than the DRRs from the TPS. It was verified that the TPS DRRs 
coincided geometrically with the DRRs used in our analysis (difference < 0.5 mm). The 
setup difference between DRR and simulator film was measured using the anatomy and 
template match software described above (Fig. 4.1). These simulator setup errors were 
analyzed by calculating the mean error and standard deviation per translation direction and 
rotation axis (yielding, respectively, the systematic errors ( RLR
R
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R
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R
X µµµµµ ,,,, ) and 
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R
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R
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R
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R
X ΣΣΣΣΣ in the terms explained above). 
For 16 patients, the delineation of contours in AP and lateral digitized simulator films 
and the template matching procedure with the corresponding DRR was performed by two 
observers. We estimated the SD of the analysis error for a single observer, SDobs, from the 
SD of the differences between the two observers (which equals 2 × SDobs). 
 
4.2.5 3D setup analysis at the treatment unit and off-line correction protocol 
The setup errors at the treatment unit were studied in 40 patients who were irradiated with 
at least 20 fractions, of which at least 5 fractions were imaged and analyzed within the 
context of the correction protocol described below. When this setup study began, the 
awareness of the potentially large simulator setup errors was limited and so digitized 
simulator films were used as reference images, in agreement with our routine portal 
imaging practice at that time. Mainly due to logistic reasons, this group was not identical to 
the group studied for simulator setup errors, but did include 19 patients from that group. 10 
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MV PIF images were obtained with a fluoroscopic, CCD camera-based EPID developed in 
our hospital. With this RAPID (Rotterdam Advanced Portal Imaging Device) system, 
images of good quality can be obtained with only a few MU of exposure [26]. If the 
treatment field gantry angles did not deviate more than 20° from 0, 90 or 270°, the same 
angle would be used to obtain an enlarged PIF for setup verification. Within these 20° 
intervals, the anatomical structures that were identified to have negligible intra-fraction 
motion in the (exact) AP/PA or lateral portal images can still be considered stable 
structures. In addition, these structures can be easily identified in images in this gantry 
angle interval. The procedure also allowed for the generation of a 'double exposure' image 
in the RAPID software, an example of which is given in Fig. 4.2. If an appropriate gantry 
angle was not available, an extra (AP or lateral) beam direction for the PIF was added to the 
treatment plan. The exposure per PIF was 6 MU, the minimal dose at the clinically applied 
doserate for the MM50 Racetrack Microtron (Scanditronix Medical AB) at which this study 
was performed. 2 PIFs (with approximately orthogonal gantry angles) were given per 
imaged fraction. PIF images were template matched with the corresponding simulator films 
using the RAPID software (Fig. 4.1) and the previously mentioned anatomical structures. 
An off-line (shrinking action-level) correction protocol, such as described by Bel et al. 
[17] for prostate cancer patients, was applied to reduce the systematic setup error. In short, 
the protocol tests the length of the average 3D setup error vector against an action level. In 
the first part of the protocol, the average vector at a certain fraction is calculated over all 
imaged fractions obtained up to and including that fraction (say nmeas fractions) whereas the 
Figure 4.2 Overlay of an anterior treatment field on a corresponding 6 MU PIF 
image. Clearly, very few anatomical details may be discerned in the treatment field 
(although the primary tumor is visible in this specific case) and the PIF image is 
necessary to render important structures visible. 
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action level at that fraction becomes measn/α ; α is a suitably selected 'initial' action-level 
which depends on the (known) random setup errors [13]. If the vector length exceeds the 
action level, a setup correction is performed in all subsequent fractions and the procedure is 
repeated with nmeas reset to 1. This process continues until nmeas   = Nmax subsequent 
measurements have been obtained without the need for a correction, after which the first 
phase of the protocol is finished. In the second phase of the protocol we applied a weekly 
check measurement which was included in a running average of the last Nmax measurements 
and tested against the fixed action level max/ Nfinal αα = [17]. If a correction is necessary 
in this second phase, the protocol is completely restarted. Effectively, the protocol should 
reduce the systematic 3D error vector length to below finalα in nearly all patients [13].  
If random errors are large compared to systematic errors, the off-line protocol is no 
longer practical: a large initial action level must be selected to prevent frequent corrections 
due to the random errors, and so a large number of images must be acquired to reach a 
certain finalα . In a previous study [112], we found that the systematic setup errors 
T
XΣ  and 
T
YΣ  as well as the random setup errors TXσ and TYσ were 2-3 mm for a group of lung cancer 
patients with a setup technique identical to the group studied in this paper. Assuming the 
setup in the Z direction to be equally precise (confirmed by results presented in this paper), 
we found from Monte Carlo simulations similar to those described by Bel et al. [13] that for 
a correction protocol with α = 8 mm,  Nmax = 3 ( =finalα  4.6 mm) applied to a 25 fraction 
treatment, with weekly check measurements, the average number of corrections per patient 
is approximately 1, with on average 9 imaged fractions. Such a correction protocol should 
typically halve TΣ for each direction. The required average PIF dose to healthy tissue 
would be close to 1 Gy, which was considered acceptable (note that about half of the PIF 
dose is delivered with intervals of about 7 days).  
Individual patients may, of course, have significantly larger random errors than the 
population mean, which manifests itself through multiple (inaccurate) corrections. To 
prevent invalid use of the off-line protocol, we accepted no more than 2 corrections per 
patient. If a third correction was necessary, the clinician was informed and the origin of the 
large random error was investigated 
If the protocol generated a setup correction, in subsequent sessions the patient was first 
positioned using the isocenter demarcation applied at the simulator. Next, the table was 
translated by the technicians according to the values indicated by the protocol software. No 
new demarcation was applied, since in our experience this may lead to confusion, 
especially if multiple corrections are required. We measured that the accuracy of the table 
shift readout is better than 0.1 ± 0.3 mm, the effect of which we neglected in subsequent 
analyses. 
 
4.3 Results 
4.3.1 Intra-fraction movement in the Z direction 
For the 8 patients in the pilot study, the random setup error in the Z-direction, as measured 
from the position of sternum, vertebrae and trachea, was TZσ  = 2.2 mm. This random error 
is as small as the random errors in the X-and Y-direction in a similar patient group [112], 
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which we obtained with structures that were proven to exhibit little intra-fraction 
movement. It is also equal to the random setup error we obtained for over 700 prostate 
cancer patients ( TZσ = 2.0 mm) at the same treatment unit [17, 73]. The latter patient group 
can be positioned very accurately and exhibits no indication for intra-fraction movement. In 
summary, our data confirm that the selected anatomical structures reveal negligible intra-
fraction motion and may thus be used for accurate setup verification. 
 
4.3.2 Simulator setup errors 
We analyzed the results for the patient group which had CT lasers marked with ink 
respectively with tattoos separately and investigated differences between the population 
means and standard deviations with the T-test and F-test. At the p = 0.05 level, no 
significant difference was found for any translation direction or rotation axis. This result 
reflects the fact that, although the tattoos are slightly better visible than the ink demarcation 
at the time of simulation, the procedures described above to arrive at the final setup at the 
simulator were identical in both groups. We therefore combined the data from both groups 
to improve statistics (Table 4.1). 
 For each translation direction, the probability density function for simulator setup errors 
was found to be consistent with a normal distribution in a Shapiro-Wilk W-test (p > 0.05). 
The values of all means (µ R) are consistent with 0 within the statistical error (p > 0.05), 
which indicates that there is no overall error in the definition of the coordinate system in the 
TPS relative to that on the simulator, nor in the delineation of the contours in the 
radiographs. However, large simulation setup errors do occur, ranging up to nearly 1 cm for 
all 3 directions.  
The rotations around the AP axis could possibly lead to erroneously derived values of the 
setup error in the Y direction for the lateral fields, but since we only scored setup errors in 
the Z direction in the lateral portals, this did not influence our analysis. Similarly, the 
(smaller) rotations found in the lateral portals will, to some extent, project as translations in 
the Y direction in the AP fields. However, a graph of these rotations versus the Y setup 
errors actually found in the AP fields indicated no trend, which was confirmed by the 
negligible linear correlation coefficient of 0.01 (p > 0.95). 
An interesting relation was found between the gender of the patients and the magnitude 
of simulator setup errors in the AP images. For the 13 female patients, RXΣ = 5.3 mm while 
for the 26 male patients RXΣ = 3.2 mm. A two-sided F-test yielded p = 0.03, indicating that 
this difference is statistically significant. A similar significant result was established for the 
rotations around the AP axis: for the female patients we measured RAPΣ = 2.2° in contrast to 
R
APΣ = 1.2° for the men (p = 0.01). For the Y and Z translations and the rotations around the 
LR axis no significant differences were observed.  
The inter-observer variation SDobs was approximately 1 mm for each translation 
direction and approximately 0.5° for both rotation axes. One could subtract SDobs 
quadratically from Σ R, to correct for the dispersion introduced by observer errors, which 
would reduce the tabulated values by no more than 10%. However, an even smaller 
correction is appropriate since the inter-observer dispersion in delineation of structures in 
the reference image contributes to both Σ R and SDobs, and this dispersion should be 
maintained in ΣR since it represents a true systematic error for setup verification at the 
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treatment unit [22] and therefore must be included in margin calculations. For this reason 
we omitted a correction for inter-observer variations on the values presented in Table 4.1.  
 
Table 4.1. Mean (µ) and SD (Σ) of the simulator setup errors for 39 patients. The entry 
Max indicates the absolute value of the most extreme deviation. 
 
 X (mm) Y (mm) Z (mm) AP (°) RL (°) 
µ R 0.4 0.6 0.3 0.5 0.4 
Σ R 4.0 2.8 2.5 1.6 1.3 
Max 9 8 8 5 4 
 
 
4.3.3 3D setup analysis at the treatment unit 
Of the 41 patients entered into the study, one had to be excluded from the off-line protocol 
because of a large random error in the Y-direction ( TYσ = 6.1 mm), which led to multiple 
corrections without significant improvement in the setup accuracy. This patient had trouble 
with keeping a constant position, specifically of the arms and upper body, due to pain 
complaints associated with previous surgery. For the other 40 patients, no irregularities 
were observed.  
On average, about 8 fractions per patient needed to be imaged and 600 portal images 
were analyzed. The average number of required setup corrections per patient was 0.6. Only 
one patient required 2 setup corrections. These numbers are close to the results of the 
numerical simulation described in the methods section. The measured setup errors are 
summarized in Table 4.2. We find random errors of about 2 mm, whereas the systematic 
errors that would have occurred if no correction protocol had been applied are somewhat 
larger. As expected, the off-line correction protocol roughly halves the systematic errors 
and reduces the length of the systematic error vector to below 4.6 mm for all patients 
whereas without the protocol the distribution tail would have extended beyond 1 cm (Fig. 
4.3). 
 
Table 4.2 Setup errors at the treatment unit for 40 patients.  The correction protocol 
influences only the systematic errors in the translation directions, not the random errors. 
 
 X (mm) Y (mm) Z (mm) AP(°) RL (°) 
   No protocol Tµ~  1.6 0.0 -0.7 0.0 -0.4 
 TΣ~  3.2 3.6   1.7 1.1   1.0 
 Tσ  2.0 2.1   1.8 1.0   1.0 
With protocol µ T 0.9 0.0 -0.5   
 TΣ  1.3 1.6   0.9   
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The observed systematic errors before correction are anisotropically distributed, i.e. the 
systematic error TZΣ
~ is about half the value of TXΣ
~ and TYΣ
~ . An F-test confirms the 
significance of this difference (p < 0.01). The random error is also smallest in the Z-
direction, although here the difference with X and Y is not statistically significant. The 
small setup errors in the Z-direction may be rooted in the fact that the isocenter-table 
distance is used as the final indicator for setup in that direction and not the position of the 
patient tattoos with respect to the laser lines. The smallness of TZΣ and TZσ confirms our 
conclusion on the stability of the anatomical structures selected for template matching for 
the lateral beams. 
The value of Tσ in Table 4.2 is a population average of measured patient specific 
random error SDs Tiσ , as defined in the Appendix.  Suppose that the true random error SD 
(which we could measure if we had an infinite number of setups) is 2 mm in each patient 
(close to the mean values given in Table 4.2). In that case, the inter-patient variation on the 
measured value of Tiσ  would be purely due to the finite statistics of the 7-8 measured 
setups and the SD of this variation would be  ~ 0.6 mm [123]. The measured SDs of the 
inter-patient variation in Tiσ are 0.8, 0.9 and 0.6 mm for the X, Y and Z directions 
respectively. These values are close to the value of 0.6 mm derived above, indicating that 
Figure 4.3 Cumulative distribution of the length of the systematic displacement vector 
for 40 patients treated with an off-line correction protocol (solid line). The dashed line 
indicates the distribution if this protocol had not been applied. 
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the inter-patient variation in Tiσ is small. The slightly larger spread of random errors for the 
X and Y direction may be related to an inter-patient variation in the physical ability or 
experienced (dis-) comfort when holding the cross bar above their head. Despite this 
spread, the number of corrections was not dramatically larger for the 5 patients with the 
largest random errors in the X-Y -plane ( 2,
2
, YiXi σσ + ): 0.8 correction per patient versus 
0.6 on average. 
Similar to the setup at the simulator, at the treatment unit female patients (14 in the 
studied group) seemed to be positioned less accurately than male patients (26 patients): they 
required, on average, 0.9 corrections whereas for the male patients 0.4 corrections were 
sufficient. Investigating this difference in setup correction frequency, we found that it 
originates in larger values of the systematic error before correction, TS~ , in the Y direction 
for the female patients (see appendix for a formal definition of TS~ ). A Kolmogorov-
Smirnov test on | TS~ | in that direction confirms a significant difference between genders (p 
< 0.01) as is illustrated in Fig. 4.4 (an F-test on TYΣ
~ is not valid, since the distribution for 
the men is inconsistent with a normal distribution according to the Shapiro-Wilk test). For 
the other systematic errors, no significant difference in distribution between the men and 
women was observed. The random errors showed no difference in distribution between 
male and female patients either. 
 
Figure 4.4 Cumulative distribution of | TS~ | in the longitudinal direction, for male and 
female patients. 
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4.3.4 Relation between simulator and treatment unit systematic setup errors 
If patient i has a simulation to mark the final field setup based on CT planning, then the 
actual systematic setup error during treatment with respect to the CT plan ( iS ) is the sum 
of the simulator setup error ( RiS ) and the mean treatment setup error with respect to the 
simulator setup ( TiS
~ in case no setup corrections are performed during treatment; see 
Appendix). To calculate the SD of the actual systematic setup error from the SDs for the 
two types of errors given in Tables 4.1 and 4.2 ( RiS  respectively 
T
iS
~ ), we must establish to 
what extent they are correlated, i.e. do large positioning inaccuracies at the simulator lead 
to large systematic positioning inaccuracies at the treatment unit ? This requires a group of 
patients for which RiS  and 
T
iS
~ have been measured separately. 
The overlap of the patient group studied for simulator setup errors (39 patients) and the 
group studied for treatment setup errors (40 patients) consisted of 19 patients. In this group, 
we searched for linear correlations between TS~ and RS and between their magnitudes | TS~ | 
and | RS | . There were no significant correlations for any of the directions (X,Y,Z). In fact, 
the covariance cov( TS~ , RS ) was less than 0.4 for all 3 directions. Therefore, these two 
types of setup errors appear to be uncorrelated. From the Appendix and the numbers in 
Tables 4.1 and 4.2, we find that the impact of the small covariances on the SD of the total 
systematic setup errors is negligible. In the specified group of 19 patients we may calculate 
the actual systematic setup error exactly as Ti
R
i SS
~
+ and find that the SDs of these actual 
errors are ( XΣ
~ , YΣ
~ , ZΣ
~ ) = (5,4,3) mm. These values are consistent with the numbers for 
TΣ~ and RΣ  in Tables 4.1 and 4.2 and cov( TS~ , SR ) = 0, again confirming that  the two 
types of setup errors are uncorrelated.  
In the same 19 patients, both RS  and TS~ have a distribution consistent with a normal 
distribution. An F-test on TΣ~ versus RΣ  indicated no significant difference for any of the 
3 directions.  Hence, we conclude that the setup error at the simulator with respect to the 
setup at the CT scanner is distributed similar to the systematic setup error at the treatment 
unit with respect to the simulation setup. 
 
4.4 Discussion 
 
The purpose of investigating the possible displacements of a target volume during treatment 
relative to the planned situation, is to define appropriate planning margins as well as to 
identify efficient methods to ensure or even reduce those margins. These margins should 
account for both internal target volume displacements and external setup errors. 
The internal displacement for thoracic tumors is mainly due to breathing and cardiac 
activity. An estimate of the internal tumor displacements can be obtained from Ekberg et al. 
[40], who studied tumor mobility in all 3 directions in 20 patients with the aid of 
fluoroscopy. They found that, for tumor locations spread over left and right lung and all 
lobes, the average SD of the tumor displacement in the X, Y and Z directions was 
respectively 1.4, 2.6 and 1.3 mm during normal respiration. However, Ross et al.[110] 
described how the extent of motion measured with ultra-fast CT was found to be strongly 
dependent on the proximity to the heart/aorta or diaphragm. In fact, they describe a 
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displacement due to respiration of the order of 1 cm for lower lobe lesions. Indeed, Ekberg 
et al. also observed large variations in motion amplitude, ranging up to 12 mm. Apart from 
these large variations in amplitude and frequency with tumor location, the probability 
distribution function of these motions strongly deviates from a gaussian distribution [78]. 
Therefore, the SD of these displacements is a poor representation of the distribution 
function and it is not clear whether in such a case the expression for margins given in the 
Introduction ( σΣ 7.02 +=M  which was derived for gaussian distributions [125]) can be 
applied. In addition, in this expression systematic and random displacements are separated, 
but this separation is not trivial in the case of internal movements. Particularly the 
systematic errors introduced by internal movement during the CT scan are not 
straightforward to describe since these movements occur on time scales of the order of the 
slice scan times of a CT scanner [8]. 
A margin calculation scheme that fully copes with internal organ motion and the 
associated problems sketched above, is beyond the scope of this paper. We therefore restrict 
our discussion to external setup errors. Hence, the margins derived below only reflect the 
impact of various treatment protocols on external setup accuracy. Their validity in clinical 
practice is strictly limited to volumes that are known to exhibit negligible internal motion, 
for instance tumors associated with the chest wall [110] or mediastinal lymphnodes. Note 
that due to our definition of matching anatomy, external setup accuracy in this discussion 
means accuracy of isocenter placement with respect to the chest wall and vertebrae.  
In Table 4.3 we give the calculated margins in the X, Y and Z directions for 5 simulation 
and setup verification methods, based on the numbers we have found for the setup errors 
(Tables 4.1 and 4.2). In all 5 cases, we assumed that the patients had a CT based treatment 
plan. Margins were calculated following the methods described by Stroom et al. [125]: 
TM σΣ 7.02 += , where Σ is defined below for each method. From the first to the last case, 
the external setup accuracy increases.  In order of increasing external setup accuracy, the 5 
methods are:  
1.  The beam setup according to the treatment plan is demarcated at the simulator using 
BEV plots and planograms (as in the simulator setup study described in this paper) after 
which treatment takes place without a correction protocol. We have quadratically added 
the systematic simulation and treatment setup errors to arrive at the actual systematic 
setup error: 22 )~()( TR ΣΣΣ +=  (see previous section).  
2.  As case (1), but now the 3D off-line setup correction protocol described in this paper is 
applied with digitized simulator films as reference images, and so 
22 )()( TR ΣΣΣ += . 
3. After the CT scan and treatment planning, no separate simulation is performed. The 
simulator step may be omitted e.g. by marking a temporary isocenter directly at the time 
of scanning. Setup to the final isocenter (from the 3D plan) may be achieved by 
performing a fixed table shift relative to the temporary isocenter during treatment or by 
making the temporary isocenter the definitive isocenter by using asymmetric fields. In 
this case, TΣΣ ~= . 
4.  As case (3), but now including the effect of the off-line protocol with DRRs as reference 
images ( TΣΣ = ). We currently apply this protocol for lung cancer patients using high 
quality DRRs generated with CT-Simulator software (Picker AcQSim) for a CT slice 
distance of 2.5 mm. 
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5. As (4), but with an on-line instead of an off-line correction protocol.  For the residual 
errors of the on-line correction protocol, we have adopted values from van der Steene et 
al. [124] who measured such errors in 16 patients in the AP plane for an action level of 
2 mm per direction. We adopted the values of the systematic and random residual errors 
from Table 4.3 in their paper for Σ and Tσ , and assumed that the residual errors in the 
X direction are also applicable to the Z direction. 
 
Table 4.3 CTV-PTV extension margins M in mm for external setup variations only. 
Margins were calculated from the expression M = 2Σ + 0.7σ for the 3 setup directions 
(X,Y,Z). For a detailed description, see the discussion section. 
 
Simulation/verification method MX  MY  MZ 
1: reference = sim film, no off-line protocol 7 12 11 
2: reference = sim film, with off-line protocol 7 10 8 
3: reference = CT scan, no off-line protocol 5 8 9 
4: reference = CT scan, with off-line protocol 4 4 5 
5: reference = CT scan, with on-line protocol 3 3 3 
 
 
Table 4.3 shows that, for the group of lung cancer patients we studied, the large systematic 
simulator setup errors require large (~ 1 cm) CTV-PTV margins in each of the 3 setup 
directions (method 1). Although the application of an off-line correction protocol based on 
simulator images reduces these margins slightly (method 2), a similar result can be obtained 
by just skipping the separate simulator step and not using any correction protocol during 
treatment (method 3). The applied shrinking action-level off-line protocol efficiently 
reduces systematic errors and hence margins, only if DRRs are used as reference images 
(method 4, compare with method 2). It should be noted that the margins calculated for 
method 4 are still appropriate in case of a separate simulation step to mark the 
(approximate) isocenter position, as long as the off-line setup verification protocol is 
performed based on DRRs. 
The 5th method represents what would happen if one would switch to an on-line protocol 
(imaging and possibly correcting during every fraction), based on DRRs. The margin 
reduction relative to an off-line protocol of ~ 1-2 mm in each direction must be balanced 
against the higher workload. Apart from the significant imaging and analysis workload, 
Van der Steene et al. [124] reported a correction frequency of 85% of the setups (however, 
their patient group seemed to suffer from larger systematic and random errors than 
presented in this paper). In addition, they could use the treatment portals to judge patient 
setup, which is impossible in the case of small thoracic fields (Fig. 4.2). When applying a 
3D on-line protocol for a treatment with small fields, a large number of PIFs must be 
acquired to render the anatomy visible (minimally the number of fractions × 2). To keep the 
PIF dose to uninvolved tissue below ~ 1 Gy for a 30 fraction regime, images must be 
obtained with an exposure < 2 MU. If one also wishes to obtain check images to verify the 
corrections, the exposure must be even smaller: ~ 1 MU if 50% of the portals require a 
setup correction. This is near the limit of what may be achieved with video based EPIDs 
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[124], and it poses a challenge to scanning liquid-filled ionization chamber systems [53] 
since the required read-out time at doserates ≥  200MU/min would be ≤ 0.3 sec. But apart 
from the PIF dose, note again that the margins given in Table 4.3 are only for external setup 
variations. Once the external systematic setup errors are down to < 2 mm (1 SD), like in 
method (4), these errors will no longer be accuracy limiting in most cases due to possibly 
large systematic errors related to internal organ movement [8] and tumor delineation 
inaccuracies [114]. If the latter two error sources are not well controlled, it is debatable 
whether the high degree of external setup precision that can be achieved with on-line setup 
corrections is relevant to treatment planning margins.   
An unexpected result of our study was that systematic setup errors were significantly 
larger for women than for men, both at the simulator and treatment unit. However, this 
difference occurred for the lateral direction during simulation and in the cranial-caudal 
direction during treatment. The larger systematic errors in the cranial-caudal direction could 
be a result of the fact that the frontal tattoos on female patients cannot always be put exactly 
at the isocenter position in which case "direction tattoos" (which are placed on the laser 
lines, but at a small known distance from the isocenter) are used and the best longitudinal 
position is estimated from both lateral tattoos and the frontal tattoo during treatment. The 
reason behind the larger errors in the lateral direction during simulation for women is 
hitherto unexplained. Nevertheless, the benefit of omitting the simulator step together with 
the application of an off-line correction protocol based on DRRs is that such differences 
between gender would not influence the margins: the simulator setup error would vanish in 
all patients, while the off-line protocol ensures the treatment error is controlled. Indeed, we 
found no difference in the distribution of systematic treatment setup errors between men 
and women once the protocol was applied and so the distribution function given in Fig. 4.3 
holds for both women and men. This approach fails if a patient has a much larger random 
error than the population mean, which we observed in one patient. For such a case, a 
transition to an on-line correction protocol could be considered if margin control is 
essential. 
 
4.5 Conclusions 
 
We have investigated the systematic and random external setup errors during the irradiation 
of lung cancer patients. The magnitude of the systematic errors at the simulator and the 
treatment unit is comparable if no protocol is used to reduce the latter errors (Tables 4.1 and 
4.2), indicating that reduction of the former is no less important than reduction of the latter. 
Therefore, an off-line treatment correction protocol based on simulator films becomes 
inefficient (compare methods 2 and 3 in Table 4.3). This leads to an unnecessary loss of 
accuracy, since although no immobilization device was used, the random errors are 
sufficiently small  (~ 2 mm) to reduce the systematic treatment errors significantly with an 
off-line protocol (Table 4.2). Such a protocol should therefore be based on DRRs, unless 
the simulation procedure is changed to better represent the planned treatment setup [76]. 
We have currently adopted the approach to mark the definitive isocenter directly after the 
CT scan on a Picker CT-Simulator, after which the (asymmetrical) treatment fields are 
planned while maintaining that isocenter. Thus, the simulation step and its associated errors 
are omitted altogether. 
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Appendix: Calculation of systematic and random errors 
 
Consider a group of Np patients with Nf,i imaged treatment fractions for patient i. The 
measured setup error during treatment (indicated by T) for patient i in fraction j is εijT. In 
case of no setup corrections, the systematic error (i.e. the mean displacement.) of patient i is 
estimated by ∑
=
−
=
ifN
j
T
ijif
T
i NS
,
1
1
, ε . The population mean setup error is calculated as 
∑
=
−
=
pN
i
T
ip
T SN
1
1µ . 
If one or more corrections took place, a time-weighed average of the systematic errors 
from correction to correction is obtained.  Suppose that patient i has Nc (≥ 1) setup 
corrections, detected in fractions f1, f2, ..., cNf (i.e., correction c, detected in fraction fc, will 
be applied from fraction fc+1 onwards). Hereafter, we omit subscription of the fractions f 
with patient index i to improve readability. Let the last measured fraction be fl. If we define 
f0 = 0 and 1+cNf = fl, then we calculate the systematic error for patient i by  
∑ +
=
−
−
−=
1
1 ,1
1 )(c
N
c
T
icccl
T
i SfffS        (A4.1a) 
where 
 ∑
−
∈<
−
=
],
1
,,
1 cc ffj
T
ijcm
T
ic NS ε                        (A4.1b) 
is the estimated systematic error after correction c-1 has taken place but before correction c 
is applied and Nm,c is the number of measurements in the corresponding fraction interval (in 
general, 1, −−< cccm ffN  since not all fractions are measured). 
Systematic errors that would have occurred if no corrections had been applied were 
calculated in accordance with Bel et al. [17]: if, prior to measurement j, n corrections c 
have been detected with magnitudes δc , the "uncorrected" setup error Tijε~ is calculated from 
n
T
ij
T
ij δεε −=~ , with ∑
=
=
n
c
cn
1
δδ . 
Similar to the definition of TiS , we define the systematic error of patient i for 
the”uncorrected” setup by ∑
=
−
=
ifN
j
T
ijif
T
i NS
,
1
1
,
~~ ε (note that in this case no time-weighed 
average is necessary, because if no setup corrections would have taken place, each 
measurement has an equal weight) and ∑
=
−
=
pN
i
T
ip
T SN
1
1 ~~µ . 
The calculation of Tijε
~ enables us to derive the random (inter-fraction) positioning error 
from data obtained with a correction protocol. We assume that the random errors are not 
affected by the corrections, which is reasonable since the corrections are applied as table 
shifts after the patient is positioned using skin marks. The random errors introduced by 
setting up on the skin marks and performing the template match do not depend on the table 
shift. Inaccuracies in the table shift are neglected, as motivated in the Methods section. We 
may then estimate the random error for patient i, σiT, from  
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The population random error, σT, was calculated from 
2
1
1
21 )( 
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
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−
pN
i
T
ip
T N σσ  [123].  
The population systematic error without a correction protocol is defined as the SD of the 
patient systematic errors if no correction had been applied:  
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Due to the rather limited number of observed fractions per patient (≤ 10), this estimator is 
slightly biased and will lead to an overestimation of the systematic errors due to the 
presence of random errors. With a little algebra, it can be derived that an unbiased estimator 
of the variance of the systematic errors is  
∑
=
−−
−Σ=Σ pN
i
T
iifp
T
bias
T NN
1
21
,
122 )()~()~( σ         (A4.4) 
and this expression was used to calculate TΣ~ . In a similar fashion, TΣ was calculated as 
the SD of the systematic errors after correction ( TiS ). Since each 
T
iS is a weighed mean 
(Eq. A4.1a), the correction term for random errors is slightly more complicated, but 
performing the algebra it can be shown that the correction in Eq. (A4.4) is still a good 
approximation and we applied this same expression (note however, that this term is small). 
The error εijT derived from a portal image measures the setup error relative to the 
reference image. It is this error which is usually reported in papers on positioning accuracy. 
However, for patients with CT planning we should measure errors with respect to the 
planning CT scan. This is the case if the reference image is a DRR. When the reference is a 
simulator film, then the systematic errors are underestimated. In this case, the actual setup 
error is the sum of εijT and the error in the reference setup for patient i, SiR, i.e. the setup 
error during simulation.  If we adopt the above definitions for µ and Σ with T replaced by R 
and σ R ≡ 0 (since we use one reference image per treatment portal) then the actual (µ, Σ, σ) 
are given by ( TR µµ + , ),cov(2)()( 22 RTRT SS++ ΣΣ , Rσ ) where the 
covariance ),cov( RT SS  accounts for potential interdependencies of ST and SR. 
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Abstract  
 
Purpose: In a recent study, large systematic setup errors were detected in patients with lung 
cancer when a conventional simulation procedure was used to define and mark the 
treatment isocenter. In the present study, we describe a procedure to omit the session at a 
conventional simulator to remove simulation errors entirely. Isocenter definition and 
verification was performed at a CT-simulator and digitally reconstructed radiographs 
(DRRs) were used for setup verification and correction at the treatment unit. 
Methods and Materials: A CT-simulation protocol was developed, in which radio-opaque 
markers were used to verify the coincidence of the isocenter marked on the patients’ skin 
with the isocenter defined in the planning CT-scan. This protocol was evaluated for twenty 
patients. Subsequently, electronic portal images were acquired at the treatment unit. The 
three-dimensional (3D) setup error was established from a template match of the 
appropriate anatomy visible in two orthogonal beams with the corresponding anatomy in 
DRRs. An off-line setup correction protocol was applied to reduce systematic setup errors.  
Results: For all patients, the skin marks defined the planning CT-scan isocenter to within ± 
1.5 mm in each of the three main directions. Random setup errors at the treatment unit were 
1.8, 2.0, and 1.9 mm (1 SD) for the lateral (x), the superior-inferior (y), and the anterior-
posterior (z) directions, respectively. With the use of the correction protocol, the systematic 
errors for x, y and z were 1.5, 1.5 and 1.3 mm (1 SD).  
Conclusions: As the distributions of treatment setup errors measured against DRRs 
obtained in our CT-simulation were equal to previously obtained distributions measured 
against simulator films, conventional simulation can be omitted and DRRs are well-suited 
for setup verification. By adopting our CT-simulation procedure the large systematic 
simulation setup errors, that remain hidden if a conventional simulation is performed, can 
be avoided.  
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5.1 Introduction 
 
The local tumor control achieved with external beam radiotherapy (RT) for unresectable 
non-small cell lung cancer (NSCLC) patients still remains poor, with a complete 
pathological response achieved in only 20% of the patients treated to 65Gy [33]. Data from 
patients treated with 3D conformal radiotherapy suggest that a dose of at least 84Gy may be 
required in order to increase the probability of local control to over 50% [81]. Higher 
radiation doses may increase the risk of radiation pneumonitis and the aim of this present 
study was to evaluate steps to reduce the Clinical Target Volume to Planning Target 
Volume (CTV-to-PTV) planning margins for lung cancer patients, in order to reduce the 
irradiation of healthy lung tissue.  
Nowadays, fast treatment planning systems (TPS) enable the generation of 3D treatment 
plans. In order to ensure dose delivery according to the plan, Electronic Portal Imaging 
Devices (EPID) are used to verify the patient setup [24, 27, 28, 72, 105, 112, 127]. With the 
use of an off-line setup correction protocol, the systematic and random setup inaccuracies 
of lung cancer patients relative to the reference setup (as defined by simulator films) are 
within 2 mm, 1 Standard Deviation (1 SD) [28, 112]. However, de Boer et al. [28] showed 
that large deviations (up to 1 cm) may occur between simulator films and digitally 
reconstructed radiographs (DRRs) for these same patients. Therefore, the setup at the 
simulator (where skin marks for treatment setup were placed and corresponding reference 
setup films were obtained) deviated significantly from the setup prescribed by the treatment 
plan. For a group of 39 lung cancer patients, the standard deviations of these simulator 
setup errors were 4.0 mm, 2.8 mm and 2.5 mm for the three orthogonal directions. 
Consequently, if marks placed during simulation are used during treatment setup, the 
simulator setup errors will cause large systematic (i.e., recurring each fraction) setup errors 
relative to the intended treatment plan [28]. These errors will persist if treatment setup 
verification and correction is based on simulator films, which is regular clinical practice. 
Similar findings, though smaller in magnitude, were found for prostate cancer patients [12]. 
In a previous study [28], we analyzed the effect of an off-line setup correction protocol 
on the setup accuracy in lung cancer patients. That study was performed using simulator 
films as reference images because (i) high quality DRRs were not available on a routine 
basis, (ii) our CT scanner did not allow for easy virtual simulation and most importantly 
(iii) the awareness of the size of simulator setup errors grew during the course of the study. 
Since then, an advanced CT-simulator has become available, which provides excellent 
DRRs and allows for isocenter definition and demarcation directly after the planning CT 
has been obtained. Therefore, omission of a conventional simulation session became 
feasible and simulator setup errors could potentially be eradicated. In the present work, we 
study a method to achieve that goal, consisting of the following steps: 
1. A CT-simulator procedure was developed to ensure accurate geometrical alignment of 
the planning CT-scan coordinate system with tattoos placed on the patients’ skin 
during the same CT session. The CT and treatment planning procedures ensured that 
the same tattoos could be used for setup at the treatment unit, and so no conventional 
simulation session was necessary.  
2. At the treatment unit, setup verification and correction was based entirely on DRRs 
generated from the planning CT-scan. 
If the systematic and random setup errors thus obtained at the treatment unit are as small as 
when measured against simulation films, this would imply that conventional simulation is 
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unnecessary in lung cancer patients and consequently that simulation setup errors, an 
important source of systematic setup errors in these patients, can be avoided. 
 
5.2  Materials and methods 
5.2.1 Patients 
Twenty patients participated in the evaluation of our procedure. Of these, sixteen had non-
small cell lung cancer (NSCLC), three had small cell lung cancer (SCLC), and one patient 
had a primary carcinoma of the esophagus. All patients were irradiated with a 3-field, 
coplanar isocentric technique. A total dose of 50-70 Gy was delivered in 20 to 35 fractions. 
Treatments were performed at a Scanditronix MM50 Racetrack Microtron. At both the CT-
simulator and treatment unit, patients were immobilized in the supine treatment position 
using an arm base rest device (Sinmed BV, The Netherlands) and knee and foot brace 
devices.  
 
5.2.2  Protocol for acquisition of the planning CT-scan, and definition and 
verification of the isocenter at the CT-simulator 
Acquisition of the planning CT-scan and subsequent treatment isocenter definition and 
verification were performed at a Picker CT-simulator (PQ5000 system). The patient was 
positioned and immobilized as during treatment (see above). First, using the lateral and 
anterior lasers, lines were drawn on the patients’ skin. These lines were used for visual 
inspection of the patient setup on the couch throughout the procedures at the CT-simulator. 
An anterior topogram was then made to establish the longitudinal scan area, followed by 
acquisition of the planning CT scan. Spiral CT-scanning was used with a table speed of 2 
mm/sec and a revolution time of 1 sec. Next, while the patient remained on the scanner 
couch, transversal slices were reconstructed with a thickness of 3 mm, the distance between 
reconstructed slices was 2.5 mm (slice index = 2.5 mm). The radiation oncologist defined 
the treatment isocenter in the planning CT scan using the Picker virtual simulation software 
by selecting a position in the clinical target volume (CTV) close to its expected center of 
mass, followed by a movement of the couch and the top laser such that the treatment 
isocenter was defined by the laser lines. Using these laser lines, the isocenter was 
demarcated on the patients’ skin with ink markings.  
Subsequently, as a final check of the coincidence of the isocenter definition on the 
patients’ skin (to be used for setup of the patient at the treatment unit) with the isocenter as 
defined in the planning scan (the basis for the design of the treatment plan), the following 
procedure was performed. A 1 mm diameter radio-opaque marker was put on the two 
lateral and the anterior ink markings. Three CT slices were then obtained, one at the level 
of the markers, and one on both sides, at a distance of 2.5 mm from the central slice. Next, 
the CT-simulator software was used to verify that the isocenter cross-hairs, as defined by 
the radiation oncologist in the previously acquired planning CT-scan (see above), did 
indeed agree with the positions of the radio-opaque markers in the central verification slice. 
Moreover, the central slice in the planning CT-scan was visually compared with the CT-
slice containing the markers. Finally, tattoos were placed on the patients’ skin at the 
positions of the ink markings/radio-opaque markers for a definitive demarcation of the 
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isocenter. The overall procedure at the CT-simulator required approximately twenty 
minutes. 
During subsequent treatment planning, the CTV was delineated and it was found that its 
center of mass was in general close to the isocenter defined above. Furthermore, this 
isocenter was always located within the CTV volume and could in all cases be maintained 
for treatment. 
 
5.2.3 The reference for setup verification and correction 
For each patient, two portals were used for setup verification. The first beam had an angle 
of incidence that deviated not more than ± 15º from the vertical direction, the other beam 
not more than ± 15º from the horizontal direction. In previous studies [28, 112] we 
identified anatomical structures that (i) exhibited negligible intra-fraction movement when 
projected in a transmission image (1 SD  = 0.5 mm, including delineation errors) and (ii) 
could be delineated with small inter-observer variation (1 SD < 1 mm). In the present study 
we used these structures for setup definition. For the anterior portal we took the 
combination of the projections of the thoracic wall and the trachea. In the lateral field, the 
ventral side of the spine vertebrae, the sternum and sometimes the trachea were used (Fig. 
5.1). 
The portals to be used for setup verification were selected at the TPS (Cadplan, Varian-
Dosetek, Finland). In order to include the above-mentioned anatomical structures, 
verification portals were always larger than the corresponding, overlapping treatment fields. 
Moreover, the nearly orthogonal beam arrangement as described above could not always be 
realized using only the treatment beam directions. In those cases, setup verification required 
an extra, dedicated portal with a different angle of incidence.  
The definitions of the established verification fields were electronically sent to the CT-
simulator software for generation of DRRs with a resolution of 0.5 x 0.5 mm2 at isocenter 
Figure 5.1 Examples of the used anterior (left panel) and lateral (right panel) DRRs. 
The white lines are the stable anatomical structures used as reference for setup 
verification (section 5.2.3). 
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distance. The spatial resolution of the planning CT-scans used for calculation of DRRs was 
0.94 x 0.94 x 2.5mm3. The DRRs were loaded into the EPID software (next section) and the 
selected anatomical structures were manually delineated according to delineation 
prescriptions (i.e. example images with marked reference structures) presented by this 
software. 
 
5.2.4 Patient setup verification and correction 
The patient setup during treatment was verified using a CCD-camera based EPID 
(Theraview-NT, manufactured by Cablon Medical, The Netherlands). This system has been 
described in detail elsewhere [26, 28, 90]. 
At the treatment unit, image acquisition with the EPID, image analysis, establishment of the 
appropriate setup corrections, and execution of patient setup corrections were performed by 
the technicians, using an unambiguous protocol integrated in the EPID software. 
Prior to the image analysis by a technician, the field edge of an acquired portal image 
was automatically extracted and matched with the prescribed field as defined in the 
planning system, in order to define a common co-ordinate system (this match also 
constituted an independent verification of the delivered treatment field shape). Then, the 
anatomical structures as delineated in the corresponding DRR (previous section) were 
mapped onto the EPID image and shifted with the mouse to establish the optimal match 
Figure 5.2 Overview of the match screen. The patient setup accuracy is shown here in 
terms of deviations between the AP portal image (left image) and the corresponding 
reference DRR (right image). 
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(template matching; Fig. 5.2). To improve the match, the technicians were allowed to also 
rotate the mapped reference structures around the isocenter, but were instructed to use this 
option with caution and only if they could not reach a satisfactory result without it.  
Image analysis was performed after completion of the daily treatment fraction, i.e. off-
line. The established anatomy translations in the two orthogonal verification portals of a 
patient determined the 3-dimensional (3D) patient setup error for that day. This setup error 
was used to drive a 3D shrinking action-level protocol [13, 17, 27, 28] to decide on the 
setup correction to be applied in the remaining treatment fractions. This protocol, which is 
integrated in the EPID software, aims at a reduction of systematic setup errors. The applied 
protocol had an initial action level α = 8 mm and 3 subsequent measurements in the first 
stage (Nmax = 3). The final 3D systematic error obtained with this protocol should be 
smaller than α / √Nmax = 4.6 mm. Details can be found in [28]. 
For easy and safe execution of setup corrections, the required couch translations as 
calculated by the EPID software were expressed in the treatment unit co-ordinate system. 
This software option is available for any treatment unit.  
For each treatment fraction, the patient was first positioned such that the laser lines 
coincided with the tattoos on the patients’ skin, as placed at the CT-simulator (section 
5.2.2). Then, the required 3D setup correction was performed by shifting the treatment 
couch accordingly, followed by irradiation. We verified that these corrections could be 
performed accurately (1 SD < 0.5 mm), and with negligible increases in treatment time 
[28]. 
For each patient, a separate treatment plan was made to estimate the extra dose delivery 
due to the use of enlarged or additional portals for setup verification (section 5.2.3). The 
verification portals were acquired with 6 MU, which was the minimum allowed exposure at 
the treatment unit at the clinical doserate. The additional dose delivery due to application of 
the verification portals in 10 fractions was calculated, as this was estimated to be the 
numbers of fractions required to complete a lung setup protocol [28]. Typically, the extra-
added dose in 10 fractions was about 1 Gy at isocenter level. The corresponding dose 
distribution was added to the cumulative planned dose distribution, and dose-volume-
histograms of this summed distribution were evaluated by the radiation oncologist. 
 
5.3 Results  
 
The observed setup variations are summarized in Table 5.1. All setup errors were obtained 
from matching EPID images with the corresponding DRRs. For each patient, the magnitude 
of the random setup errors was characterized by the SD of the day-to-day (i.e. interfraction) 
variations in the setup errors. The average SD of the population was calculated as described 
in [28] to yield σ, which is a representative measure of the random setup errors. The values 
of σ thus found were 1.8, 2.0, and 1.9 mm for the lateral (x), the superior-inferior (y) and 
the anterior-posterior (z) directions, respectively. Furthermore, for each patient the 
systematic setup error was calculated as the mean of the fraction-specific setup errors 
observed in that patient over the course of treatment. The distribution of systematic setup 
errors in the patient group was summarized through µ, which is the mean of the systematic 
errors, and Σ, defined as the SD of those same systematic errors. After application of the 
correction protocol, we found that µ ≤  0.6 mm for each of the three directions whereas Σ 
was only 1.5, 1.5 and 1.3 mm in the x, y and z directions respectively. The average number 
of setup corrections per patient was 0.8.  
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Using previously described methods [28], we calculated that the systematic errors Σ that 
would have been measured if no setup corrections had been applied, were 2.5, 3.4 and 2.4 
mm (1 SD) in the x, y and z directions respectively while the mean systematic error µ 
remained < 1 mm in each direction. These relatively small systematic errors obtainable 
without setup corrections are consistent with our observations at the CT simulator: for all 
patients in this study, the radio-opaque markers used during CT-simulation to verify the 
accuracy of the isocenter demarcation on the patients’ skin, corresponded to within ± 1.5 
mm with the isocenter in the planning CT-scan as defined by the radiation oncologist. The 
last two columns in Table 5.1 show that the observed rotational setup variations were small. 
These values are independent of the application of the protocol, as no attempt was made to 
correct for rotations. 
 
Table 5.1 Patient setup errors observed at the treatment unit. The x-, y-, and z-axes 
correspond to the lateral, the superior-inferior, and the anterior-posterior directions. AP 
refers to rotations around the anterior-posterior axis, and RL to rotations around the lateral 
axis. The applied correction protocol only influences the systematic errors in the x-, y- and 
z-directions, not the random errors, nor the rotations.  
 
 X (mm) Y (mm) Z (mm) AP(°) RL (°) 
   No protocol Tµ~  -0.3 0.0 -0.9 0.2 0.1 
 TΣ~  2.5 3.4 2.4 0.9 0.6 
 Tσ  1.8 2.0 1.9 1.3 1.0 
With protocol µ T 0.0 -0.6 -0.3   
 TΣ  1.5 1.5 1.3   
 
 
5.4 Discussion 
 
We previously studied the setup of 40 lung cancer patients, using digitized simulator films 
as reference images instead of DRRs [28]. In that simulator-film-based study, the final 
isocenter demarcation on the patients’ skin was performed at the conventional simulator, 
using standard CT scout topograms and beam’s-eye-view (BEV) plots, as derived from the 
planning CT-scan and the treatment plan. The random setup errors (σ) thus obtained were 
2.0, 2.1, and 1.8 mm (1SD). The systematic setup deviations (Σ) obtained with the 
application of the correction protocol were 1.3, 1.6, and 0.9 mm, and they would have been 
3.2, 3.6 and 1.7 mm (1SD) if no protocol had been applied. These results are consistent 
with the numbers in Table 5.1, which were measured relative to DRRs. Particularly the 
random setup errors are almost identical, and the small differences between the values of Σ 
are statistically insignificant (p > 0.05, F-test). This close correspondence is an important 
result, because no patients from the previous study were included in the current study. We 
therefore conclude that (1) setup errors may be measured equally accurate relative to DRRs 
as to simulator films and (2) the isocenter definition procedure at the CT scanner is accurate 
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(otherwise, larger systematic errors would be expected). Therefore, the simulator setup 
errors can be avoided entirely and DRRs constructed as described in section 5.2 can (and 
should) replace simulator films as reference images. This way, the setup accuracy as 
perceived at the treatment unit will correspond to the true setup accuracy (apart from 
observer related errors).  
Stroom et al. [125] have derived that the required (CTV-to-PTV) planning margin M to 
account for geometrical uncertainties may be calculated with 
 
   M = 2Σ + 0.7σ              (5.1)
     
with Σ the overall standard deviation describing all systematic uncertainties, and σ the  
standard deviation describing all day-to-day variations in the treatment geometry. In case 
there are different independent sources i of geometrical uncertainties, each described by 
separate standard deviations Σi and σi, the overall standard deviations Σ and σ, used for 
calculation of the margin M with equation (5.1) are 
   ∑∑ σ=σΣ=Σ
ii
ii )()(
22
    and               (5.2) 
Generally, Σ and σ have contributions from patient setup inaccuracies and from 
uncertainties in the internal anatomy (organ motion) of the patients. 
Both for simulator films and DRRs, the Σ for setup at the treatment unit should be 
included in the calculation of the overall Σ (equation (5.2)). For setup verification based on 
simulator films, the standard deviations describing the simulator setup errors, denoted as 
ΣR, should also be included in Σ. The ΣR-values found by de Boer et al. [28], ΣR = (4.0, 2.8, 
2.5) mm for the (x,y,z) directions, are substantially larger than the treatment setup Σ that are 
obtained with a setup verification and correction protocol (Table 5.1). In equation (5.2), 
standard deviatons Σi, are quadratically added. Therefore, with the procedure applied in that 
study for reference definition with simulator films, the contribution of setup errors to the 
margin M would be dominated by the ΣR. With the use of DRRs as described in the current 
paper, the ΣR are zero. 
To describe the internal displacement of thoracic tumors due to breathing and cardiac 
activity in terms of margins is a complex subject, beyond the scope of this paper. Although 
intrafraction excursions of tumors may range up to 2 cm, particularly when located close to 
the heart and aorta or diaphragm [110], in many cases the displacements are much smaller. 
For instance, Ekberg et al. [40] studied tumor mobility with the aid of fluoroscopy in a 
group of 20 patients with tumor locations spread over left and right lung and all 3 lobes and 
found that the average SD of the tumor displacement in the (x,y,z) directions was 
respectively 1.4, 2.6 and 1.3 mm during normal respiration. Recently, these results were 
confirmed in a 3D study of markers implanted in or near lung tumors [115]. These markers 
were imaged using a fluoroscopic real-time tumor tracking system. A time analysis of 
marker movements in 20 patients revealed major displacements of up to 2 cm in the cranial-
caudal (z) direction for lower lobe tumors not attached to rigid structures, but significantly 
smaller movements (typical amplitudes 1-3 mm) for the other (x,y) directions as well as for 
the z-direction when attached to a rigid structure such as the chest wall. When heartbeat 
was separated from breathing motion by Fourier analysis, amplitudes of 1-2 mm (max. 4 
mm) at frequencies > 1 Hz were found. The systematic errors introduced by internal motion 
will in general be smaller than the amplitudes given above, as these amplitudes describe the 
maximum systematic errors that could occur. Furthermore, due to the finite revolution time 
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of a typical CT scanner of ~ 1 sec the high frequency heartbeat motions are partly averaged 
out. Therefore, for many tumors the systematic simulator setup errors, with the SD values 
of 3-4 mm mentioned above (yielding extremes of 1 cm in each direction) are relatively 
large compared to the systematic errors induced by internal motion, particularly when 
considered in 3D. Consequently, techniques to reduce internal motions are only effective if 
simulator setup errors can be removed.  
Nevertheless, for lung tumors, internal organ motion must of course be taken into 
account when defining the PTV. To avoid the problem of translating internal motion to 
margins in a practical way, we have investigated the use of multiple “slow” planning CT-
scans (CT revolution period 4 seconds) for lung cancer patients to construct a composite 
target volume that should account for the respiratory and cardiac motions [71, 121]. 
Assuming that with this technique internal motion effects are indeed largely accounted for, 
we have below estimated how the treatment volumes of the ten patients in the study of 
Lagerwaard et al. [71] would increase with the use of simulator films as the reference for 
setup verification instead of DRRs. To account for subclinical disease and setup 
uncertainty, the composite target volumes were automatically extended [125, 131] with a 
3D margin. The margin component related with subclinical disease was assumed to be 5 
mm. The contribution of setup uncertainties was calculated with equation (5.1) as described 
above. It follows that, for planning margin calculations, the Σ values with application of the 
setup correction protocol (Table 5.1) are the most important data. As can be seen from the 
last row in this Table, these standard deviations are all small. Therefore, using the data 
mentioned in Table 5.1, the margins related to setup uncertainties are 4, 5, and 4 mm, for 
the x, y and z-axis, respectively. In case setup verification for these patients would have 
been based on simulator films, acquired with the procedure described in de Boer et al. [28], 
the simulator setup errors become the predominant factor, yielding margins of 10, 8 and 7 
mm, respectively. For the ten patients in the study described by Lagerwaard et al. [71], 
setup verification based on simulator films instead of DRRs would have resulted in an 
average increase in the PTV of 54.4 % ± 9.8 % (1SD).  
 
5.5 Conclusions 
 
We have developed and applied a procedure to obtain reproducible and accurate setups of 
lung cancer patients at the treatment unit, thereby reducing the contribution of setup 
uncertainties to required planning margins. Systematic setup errors were reduced in a two-
step approach. First, acquisition of the planning CT-scan and definition and verification of 
the isocenter were performed at a CT-simulator, thereby removing the conventional 
separate simulation procedure. As a result, the (systematic) errors between the intended 
setup defined by the treatment plan and the setup obtained at the simulator were removed. 
Second, portal images were acquired with an EPID, and an off-line correction protocol was 
used to reduce the systematic setup errors. Setup verification was based on anatomical 
reference structures in DRRs. The standard deviations Σ, describing the remaining 
systematic uncertainties in the setup were only 1.3-1.5 mm for the three main directions. 
Day-to-day variations in the patient setup were approximately 2 mm (1 SD). These values 
were identical to previous setup measurements performed relative to simulator films, 
indicating that DRRs obtained with commercially available software can replace simulator 
films in setup evaluation. Consequently, conventional simulation is not required for setup 
 82
definition or verification in lung cancer patients and should therefore be omitted to avoid 
systematic simulation errors. 
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Abstract 
 
Purpose:  The evaluation of a new off-line patient setup correction protocol which 
minimizes the required number of portal images, and a comparison with currently applied 
protocols.  
Methods and Materials: We compared two types of off-line protocols: (i) the widely 
applied shrinking action level (SAL) protocol, in which the setup error, averaged over the 
measured treatment fractions is compared with a threshold that decreases with the number 
of measurements to decide if a correction is necessary and (ii) a new ‘no action level’ 
(NAL) protocol, which simply calculates the mean setup error over a fixed number of 
fractions, and always corrects for it. The performance of the protocols was evaluated by 
applying them to (i) a database of measured setup errors from 600 prostate patients (with on 
average 10 imaged fractions/patient) and  (ii) Monte Carlo generated setup error 
distributions for various values of the population systematic and random errors. 
Results: The NAL protocol achieved a significantly higher accuracy than the SAL protocol 
for a similar workload in terms of image acquisition and analysis, as well as in setup 
corrections. The SAL protocol required approximately 3 times more images than the NAL 
protocol to obtain the same reduction of systematic errors. Application of the NAL protocol 
to measured setup errors confirmed its efficacy in systematic error reduction in a real 
patient population. 
Conclusion: The NAL protocol performed much more efficiently than the SAL protocol for 
both actually measured and Monte Carlo simulated setup data. The resulting decrease in 
required portal images does not only reduce workload, but also dose to healthy tissue if 
dedicated large fields are required for portal imaging (double exposure). 
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6.1 Introduction 
 
Information on the setup of the patient anatomy with respect to the treatment beams as 
derived from portal images may be used in a variety of ways to improve the accuracy of 
that setup [116]. Whatever approach is adopted, it is important to distinguish between 
systematic (occurring each fraction) and random (different for each fraction) patient setup 
errors [22]. In fact, detailed calculations based on dose coverage of the clinical target 
volume (CTV) show that if the standard deviations (SD) of the systematic errors (SD = Σ) 
and of the random errors (SD = σ) are known, then the margin M to expand the CTV to a 
safe (in terms of low probability of underdosage) planning target volume may be expressed 
by M = 2Σ + 0.7σ [125]. This expression for M confirms that planning margins can be 
reduced predominantly through reduction of systematic errors. 
 In this paper, we concentrate on patient setup verification protocols that aim at reducing 
the systematic errors. These ‘off-line’ verification protocols (OVPs) take into account 
measurements of the previous and current fractions, and generate a decision (to correct or 
not, and if so, by how much) for the setup of subsequent fractions [116]. The OVP is only 
efficient if the number of measurements required for a sufficiently accurate estimate of the 
systematic error is significantly smaller than the total number of treatment fractions. The 
off-line approach excludes the possibility to correct for the daily random setup errors. The 
latter can only be achieved through an ‘on-line’ protocol: in each fraction, an image is 
obtained with a few accelerator monitor units exposure and analysis is performed 
immediately after image acquisition. If necessary, a correction is directly applied before the 
remaining fraction dose is delivered [91, 124, 130]. 
Traditionally, off-line setup corrections are based on images obtained in a single (often 
first-day) fraction (see e.g. [20, 49, 113, 120, 133, 134]). These images are sometimes only 
judged by eye without clearly defined quantitative criteria for corrective actions [20, 113, 
133], and both the decision criteria as well as the scheme of follow-up measurements vary 
appreciably from clinic to clinic. A more rational and well-defined approach was 
introduced by Bel et al. [13], who proposed the ‘shrinking action level’ (SAL) protocol. To 
date, the SAL protocol is the only OVP based on quantitative measurements which has 
been consistently applied for large patient groups in various hospitals [13, 17, 28, 103, 138, 
139]. This OVP has also been used in our clinic for pelvic, thoracic and head-and-neck 
treatments, in over 2000 patients. Clinical introduction of EPIDs together with the SAL 
protocol has been essential in transferring the routine decision making process on patient 
setup correction from radiation oncologists to technologists. Thereby, accurate positioning 
verification and correction became available to a large patient population.  However, 
although the application of the SAL protocol is well accepted in our clinic, we have also ran 
into a number of limitations. We found that the SAL OVP required quite a large number of 
imaged fractions  (typically 10 per patient [17, 28]) to reduce the systematic dispersion Σ by 
50%. While this result is consistent with numerical simulations, it is much larger than one 
would expect from the finally reached accuracy and the magnitude of the random setup 
errors (σ  ≈ Σ). The large workload thus generated by the SAL OVP has inhibited routine 
application of the protocol on most of our accelerators. In addition, particularly due to the 
growing application of conformal treatment techniques, portal images must often be 
acquired with dedicated portal imaging fields (PIFs, usually larger than the treatment fields 
and sometimes at different gantry angles) to render useful anatomy visible. Such fields 
imply additional dose to healthy tissue, and it is therefore essential to keep the number of 
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acquired images as small as possible. In our high dose conformal treatments, the cumulative 
dose of the  PIFs is taken into account in the treatment planning to verify that for organs at 
risk the tolerance dose is not exceeded. Because of the above reasons, we started 
investigating an OVP which requires as few portal images as possible to reach a specified 
final distribution of systematic errors, and which preferably reaches such a distribution for a 
fixed number of exposures per patient so that the dose to non-target volumes is fully 
predictable (this is not the case for the SAL protocol). 
The problems with the SAL protocol largely arise from the use of action levels. Such 
action levels introduce a sub-population of patients who do not get a correction, i.e. patients 
for which the estimate of the systematic error is sufficiently small. This would be 
considered an advantage in case correction of the patient setup would significantly 
contribute to the overall workload introduced by the OVP [13]. However, for treatment 
couches with accurate digital read-out or even remote software control, such corrections 
can be accurately executed within seconds and the workload is largely determined by the 
number of images to be acquired and analyzed. In fact, already in the prostate patient setup 
study of Bel et al. [17] it was reported that in two institutions who applied setup corrections 
by table translation (i.e., the Dr. Bernard Verbeeten Institute in Tilburg and our hospital) 
the execution of the setup corrections hardly prolonged treatment time. An alternative 
approach to executing setup corrections was proposed by Yan et al. [145, 146], who used a 
multileaf collimator (MLC) to correct for systematic setup errors. Although this procedure 
involved reshaping the MLC via an MLC preparation system and subsequent data transfer 
to the accelerator, this method assures no increase in daily workload at the accelerator. 
Therefore, the alternative OVP we propose applies no action level (NAL), i.e. every 
patient has one setup correction and for each patient, the same number of images is used to 
estimate the systematic setup error. In this paper, we compare NAL and SAL protocols with 
respect to both the achieved patient setup accuracy and implied workload.  
 
6.2 Methods and Materials 
6.2.1 Definition of relevant quantities 
All definitions below are described more precisely in the Appendix. In this section we only 
briefly introduce the most relevant quantities and terms. 
For a patient p and for treatment fraction f ∈ F={1, 2, ..., Nf } the set-up deviation with 
respect to the reference set-up (usually defined by simulator films or digitally reconstructed 
radiographs) along a certain direction is fpx , . We can now write fppfp Sx ,, ∆+=  
where pS  is the systematic error and fp,∆ the random (fraction-to-fraction) error for patient 
p. The effective systematic error Ffpp xS >=< ,eff, , (the brackets indicate an average over 
the fractions, see Appendix) differs slightly from pS  because of the random setup errors 
and the finite number of fractions Nf.  The random error of p is characterized by pσ , which 
is the SD over f of fp,∆ [123].  
If the applied setup corrections are fpc , , the actual setup deviations become 
fpfpfp cxx ,,
act
, += . Since the corrections fpc ,  are known for each patient, we can obtain 
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the deviations without correction ( fpx , ) directly from the measured deviations  (
act
, fpx ) 
apart from inaccuracies in the performed corrections and measurement inaccuracies. Below 
and in the Appendix we argue why these errors are small, but general expressions including 
all terms are given in the Appendix. 
Bijhold et al. [22] introduced the use of the symbols Σ and σ  to denote SDs of 
respectively systematic and random deviations, and we adopt their convention. We describe 
the setup characteristics of a patient population P through the mean systematic error µ , the 
systematic dispersion Σ and the mean random error rσ , defined by  
PprpPPp
SS 2,)(SD, σσΣµ ===           (6.1), 
where the subscript P indicates that these quantities are calculated over the patient 
population. 
In practice, the dispersion of systematic errors is slightly larger than the dispersion 
defined in Eq. (6.1) due to random setup errors, and the effective systematic dispersion 
becomes 
122
eff,eff )(SD
−+== frpP NS σΣΣ            (6.2). 
Usually, fN ≥ 30, so ΣΣ ≈eff . In the Appendix, we give complete analytical expressions 
for these dispersions if the NAL protocol (defined below) is applied. 
In agreement with our clinical experience [17, 28], we will assume that 0=µ , i.e. there 
is no net discrepancy between the intended treatment setups and the actual setups. Although 
OVPs will also reduce µ  if non-zero [13], a mean discrepancy is the result of a systematic 
procedure error in the radiotherapy treatment chain and should be resolved independent of 
the OVP. In contrast, the systematic and random setup errors may always occur, even in 
case of a perfect mutual alignment of diagnostic scanners, simulator and accelerator and 
therefore require portal imaging to correct for. 
The definitions given above pertain to any direction. Specific directions (X1, X2, X3) will 
be indicated by subscripts 1, 2 or 3. 
 
6.2.2 Setup correction procedure 
To properly predict the results of an OVP, it is important to describe how setup corrections 
are performed. In our clinic, in each fraction the patient is initially positioned according to 
the tattoos and marked laser lines established in the treatment preparation phase. Next, if a 
setup correction is required, a table shift is performed using the digital read-out of the 
treatment couch. If multiple corrections are detected, as is possible with the SAL protocol, 
the last correction is added to the sum of the previous corrections to give the net correction 
with respect to the initial setup. In this setup procedure, no new lines or tattoos are applied, 
which greatly reduces the potential for errors due to misinterpretation of patient marks. 
Furthermore, this procedure allows for retrospective calculation of setup errors that would 
have been obtained without setup corrections (see Definition of relevant quantities), since 
the accuracy with which the patient is initially positioned using tattoos is independent of 
whether a correction is subsequently applied or not.  The precision of such a retrospective 
calculation is therefore only limited by the accuracy with which the prescribed couch shifts 
were performed, as will be discussed below.  
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6.2.3 Verification protocols 
6.2.3.1 The shrinking action level (SAL) protocol 
The properties of the SAL protocol were investigated in detail, yet in only one dimension, 
by Bel et al. [13] using Monte Carlo simulations. A 3D version of the SAL protocol was 
applied in a multi-center study on the impact of this OVP on the setup accuracy of prostate 
cancer patients [17]. The protocol in its originally proposed form has two parameters, the 
initial action level α  (mm) and the maximum number of subsequent measurements without 
a correction, maxN . From measurement N = 1 onwards, the setup error is averaged over the 
last N measurements for each measured direction, yielding a mean error vector NV  of length 
Nd . This length is tested against the action level NN /αα = . The decreasing action 
level Nα  reflects the increasing accuracy with which the systematic error is measured by 
Nd . If NNd α> , a setup correction equal to NV−  is applied in the following treatment 
fractions and the protocol is restarted completely with N set to 1. If, for maxN subsequent 
measurements, the condition NNd α≤ applies, the protocol has finished. We denote the 
number of imaged fractions per patient, averaged over the entire patient population, by 
measN . For any SAL protocol that significantly reduces systematic errors (i.e., yields 
corrections for most patients), measN  is appreciably larger than maxN . 
The procedure described above is sometimes referred to as the first stage of the protocol 
[17] to contrast it with a second stage. The second stage is aimed at detecting errors which 
grow with time during the course of treatment and various sites have adopted different 
second stage protocols [17, 138]. In this paper we will only deal with the first stage of the 
protocol.  
Due to the iterative nature of the SAL protocol, its results and workload cannot be 
predicted analytically but only through numerical simulations [13]. Such simulations 
require a priori knowledge of the distributions of systematic and random errors. As 
described above, the protocol allows for multiple correction detections per patient. A 
frequent occurence of multiple corrections points at an inefficient estimation of the 
systematic errors and inappropriate SAL parameters.  
 
6.2.3.2 The no action level (NAL) protocol  
The NAL protocol we propose here is very simple to conceive. It has only one parameter, 
which is the (fixed) number of fractions to be measured per patient ( mN , << fN ). The 
average setup vector over the first mN fractions ( mNV ) is determined, and a setup correction 
equal to -
mNV is applied in all subsequent fractions, irrespective of its length mNd . Since 
the averaged error is the unbiased estimator of the true systematic error with minimal 
variance [123] it is the optimal setup correction based on mN  measurements for a single 
patient. (In the discussion section, the impact of damping of the setup correction vectors 
based on population statistics, is described.) 
In the Appendix we show that, if the random errors are isotropically distributed 
( rir σσ ≡, , i = 1, 2, 3), then, for  fN >> mN  the NAL protocol yields a cumulative 
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probability distribution of the mean 3D setup error over all fN  treatment fractions, fNd , 
given by 
)erf(1)exp(2)(
2
12
2
1
NALeff, xxxxdP fN −+−=> π
Σ ,  with
m
r
N
σΣ ≈NAL,eff    (6.3). 
NALeff,Σ  is the SD of the effective systematic errors in the NAL protocol. 
Therefore, the final distribution of systematic errors is basically independent of the initial 
distribution of systematic errors, and determined only by the SD of the random errors and 
the number of measurements mN  per patient from which the systematic error of a patient is 
estimated. The expression for NALeff,Σ  in Eq. (6.3) is intuitively plausible since it equals 
the random measurement error on the estimate of the systematic error. 
The NAL protocol requires that each patient is corrected, since we apply no action level. 
Hence, its application requires a treatment table with which such corrections can be 
executed sufficiently accurate and which is preferably actively controlled from the 
accelerator record and verify system. With such an auto setup system, the potential 
reduction in workload of the SAL protocol due to the fact that not all patients are corrected 
vanishes. On our Scanditronix MM50 accelerator, we are already performing setup 
corrections in this manner (taking only a few seconds per patient) and treatment machines 
from various manufacturers offer this possibility.  
To take into account the finite accuracy of the treatment couch and setup measurements, 
one could modify the NAL protocol by not performing corrections below a certain 
threshold, say 1 mm. Such a criterion would usually be met along a single coordinate axis 
only. For the other axes, a correction would still be applied. We will briefly discuss the 
(small) impact of a correction threshold. Note that for the NAL protocol, mNN =meas .  
 
6.2.4 Retrospective application to measured setup data for 600 prostate cancer 
patients 
During 4 years, we obtained setup data for a group of 720 prostate cancer patients. The 3D 
setup error vector was measured in each imaged fraction using one AP beam and two lateral 
beams. All these patients were treated with a 3D SAL protocol with either (α, Nmax) = (9 
mm, 4) or (8 mm, 3).  After the first stage of the protocol was completed, a second stage 
based on weekly checks was started: measurements were obtained once a week and a mean 
setup error vector 
maxNV over the last Nmax measurements (including measurements of the 
first stage if necessary) was calculated.  The length of 
maxNV was tested against the fixed 
action level max/ Nα ; if larger, a correction - maxNV  was performed in subsequent 
fractions while the protocol was completely restarted. The combined first and second stages 
resulted in on average 9.5 imaged fractions per patient, which were distributed over the 
entire treatment period of about 7 weeks. Nmax was either 3 or 4, and the number of weeks 
during which the second stage was applicable at least 6, but images were not always 
obtained during the last week. As a result, minimally 8 fractions should have been imaged, 
also for patients without a setup correction. Therefore, we selected patients with at least 8 
imaged fractions, yielding a total of 600 patients with on average 10.1 imaged fractions per 
patient. With the methods described above, we calculated the setup errors that would have 
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occurred if no protocol had been applied and so derived the population setup distribution 
given in Table 6.1.  
The above-described database of patient setup errors without correction protocol has 
been used for retrospective application of various 3D SAL (first stage) and NAL protocols. 
After each simulation, the systematic errors were calculated based on the assumptions that 
(1) the measurements used for the OVP are obtained in the first subsequent fractions and 
(2) each patient is treated in 30 fractions.  For instance, for the mN = 3 NAL protocol, the 
mean setup error of the first 3 measurements is weighed by 3/30 whereas the mean error of 
subsequent measurements after the NAL correction (on average 7 per patient) is weighed 
by 27/30. Hence, the effective systematic error per patient ( eff,pS ) is estimated from the 
imaged fractions by taking into account the treatment time before and after correction. 
Based on Table 6.1 and Eq. (6.3), we estimate that a NAL protocol with mN = 3 would 
reduce the initial systematic errors by ~ 50% and we selected this protocol as a baseline for 
comparison.  
 
Table 6.1 Set-up deviation parameters (mm) in case no setup corrections would have been 
applied, for a group of 600 prostate cancer patients. Σ was derived from effΣ  using Eq. 
(6.2) with measNN f = = 10.1. 
 X (lateral) Y (Sup-Inf) Z (Ant-Post) 
µ 0.6 1.0 0.4 
Σ  2.2 2.2 2.5 
rσ  2.1 1.8 2.0 
 
 
6.2.5 Monte Carlo simulations 
Studies of  OVPs that use actually measured patient setup data, as described in the previous 
section, include the inter-patient variation of the random error, time trends, and possible 
covariance terms between various variables. However, such simulations require large input 
databases of a few hundred patients to properly represent all this information, and these are 
often not available. An additional problem is that in general not all fractions are measured 
(e.g. for the prostate patients described above,  ~30% was covered) which renders the 
database useless for the simulation of certain SAL protocols (specifically for large values of 
Nmax or small values of α which would generate many multiple corrections). Hence, to fully 
assess the effects of SAL OVPs, we have performed Monte Carlo simulations. 
We developed a 3D Monte Carlo (MC) simulation program with a graphical user 
interface using IDL software (Research Systems Inc). Input to the program is, for each 
direction: the population parameters (µ , rσ , Σ ), the SD of the correction inaccuracy 
( tableσ ) and a threshold for correction: a detected deviation below the threshold will not be 
corrected. Further input consists of selection of the type of OVP (which includes SAL and 
NAL), the OVP parameters, whether it will be followed by a second stage and if so, 
definition of that second stage, the number of treatment fractions per patient fN  and the 
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number of patients per simulation (104 in all following results). For each fraction, the setup 
is simulated, irrespective of whether the OVP prescribes that it should be imaged or not, so 
that the proper statistics can be calculated. In the results presented below, we have only 
simulated the first stage of the SAL OVP. In the simulations, the covariance between the 
stochastic variables is assumed to be 0, i.e. the covariance matrix is diagonal.  
 
6.2.6 Overall verification of Monte Carlo simulations 
Although we checked many details of our MC simulations in 1, 2 and 3D, we present here 
only an overall comparison with previously published results. Bel et al. [17] performed 3D 
simulations for setup inaccuracies measured in 3 different institutions. We took the input 
for our simulations from their Tables 1 and 2 and confined ourselves to simulating the first 
stage of the protocol. The three SAL protocols involved have parameters (α, maxN ) =(6,2), 
(9,4) and (10,4) for patient populations described by  ( Σ , rσ ) = (2,2), (3,2) and (3, 2.5) 
respectively. The outcomes of our simulations were compared to the data in Table 3 in [17]. 
Apart from these verifications for the SAL protocol, we verified the MC simulations for the 
NAL protocol described in the next section with the analytical expressions given above and 
in the Appendix. 
 
6.2.7 Final setup accuracy and workload of NAL and SAL protocols 
In a NAL protocol, for each patient the number of imaged fractions equals the protocol 
parameter mN .  Per value of mN , we have determined the SAL parameter combinations 
(α, maxN ) which yield, on average, an identical imaging and analysis workload as the 
corresponding NAL protocol: mNN =meas . This investigation was performed using the 
previously described MC simulations. We then selected those parameter combinations 
which yield a minimal SALeff,Σ : the SD of the effective systematic errors ( eff,pS ) after the 
SAL protocol was applied (the definition is analogous to the definition of NALeff,Σ  in the 
Appendix). In this way, we determined the optimal SAL protocol (in the sense of minimal 
systematic dispersion) for a given portal imaging workload Nmeas. A SAL protocol was 
considered clinically acceptable if the fraction of patients with 3 or more detected 
corrections (F3+) did not exceed 10%. We posed this constraint since (i) if F3+ is large, the 
value of α is too small, yielding inaccurate corrections largely based on random errors [13] 
and (ii) a large fraction of multiple corrections is clinically unacceptable: 3 or more 
corrections tends to indicate a large random setup error, possibly due to a faulty setup 
demarcation (skin marks) for a particular patient; patients with more than 2 corrections are 
therefore re-simulated in our hospital. Nevertheless, although SAL protocols that generate 
F3+ > 10% may be clinically unacceptable, we will also give "optimal" results that may be 
obtained with such unconstrained SAL protocols.  
The above described simulations were performed for a patient population with 
rσΣ = (close to what is measured in most populations [17, 28, 103, 138, 139], see also 
Table 6.1), µ = 0 and tableσ = 0 in each direction. For each patient, 30 treatment fractions 
were simulated. The optimized SAL protocols were also applied to a simulated population 
with rσΣ 2=  to study the sensitivity to population parameters. 
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6.2.8 Time behavior of systematic setup errors in NAL and SAL protocols 
To gain insight in how NAL and SAL protocols reduce systematic errors from fraction to 
fraction, we used MC simulations to calculate the dispersion of systematic errors at each 
fraction. Since in a simulation we know the true systematic errors pS as well as the applied 
setup corrections fpc , , we can simply obtain the true systematic error for each fraction as 
fppfp cSS ,, +≡ (as 01, =pc for any off-line protocol, it follows that pp SS ≡1, ). This 
allows the calculation of the systematic dispersion over the patient population per fraction: 
)(SD , fpPf S≡Σ . The decrease of fΣ  with fraction number f reflects how systematic 
errors are reduced with time by an OVP. 
 
6.2.9 Correction inaccuracies 
We have found that setup corrections by treatment couch shifts can be performed with a 
high accuracy: 1 SD = tableσ = 0.3 mm for the couch of our Scanditronix Racetrack 
Microtron [28]. Van den Heuvel et al. [58] described a Siemens ZIV digital read-out couch 
with remote control which could be positioned with a precision of 1 mm. For a remotely 
controlled Siemens ZXT table, an accuracy of 0.6 mm (1 SD) in each direction was found 
[16]. Even if the table accuracy is worse, since the inaccuracies in the table shifts are 
random, they are not very important to the final systematic errors (see Appendix). 
However, for the SAL protocol, repositioning inaccuracies may become of importance to 
the workload since they may generate new corrections.  
We have simulated the effect of inaccuracies in the application of corrections by adding 
in each direction a component that is sampled for each fraction from a normal distribution 
with SD = rσ . Although this is a (too) large value for errors on corrections performed by 
table translations (typically rσ  ≥ 2 mm, whereas tableσ < 1 mm), it will help identify 
potential problems due to (random) errors in applied patient setup corrections. 
 
6.3 Results 
6.3.1 Retrospective application to measured setup data  
The cumulative distribution of fNd  (the length of the 3D setup error averaged over all 
fractions) if no corrections had been applied (i.e., 2 3,,eff
2
2,,eff
2
1,,eff pppfN SSSd ++= ) is 
given in Fig. 6.1. The tail extends to 1 cm and the fraction of patients with mean 3D errors 
> 5 mm is 27%, very close to the numbers reported in a multi-center study of a similar 
population [17]. The corresponding distribution for the NAL protocol with mN = 3 is also 
depicted in Fig. 6.1. Obviously, the NAL protocol is very effective in reducing the 
systematic errors: with only 3 measurements per patient, a value of fNd > 5 mm would 
occur in 2% of the patients, which is an upper limit as we point out below.  
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Additionally, Fig. 6.1 shows the predicted analytical cumulative distribution based on 
Eq. (6.3). To properly compare the analytical distribution with results based on 10 
measured fractions per patient, we have added a term to NALeff,Σ  which takes into account 
that, although we properly weigh the measured data with time, we have on average only 7 
measurements available after the correction. This is only a sample of the 27 setups that 
would normally occur in a 30 fraction regime. Hence, the measured 2 NALeff,Σ  is increased 
on average by ~ 7/2rσ with respect to the true 
2
NALeff,Σ  given in Eq. (A6.4) in the 
Appendix. With this small correction, the resulting analytical distribution in Fig. 6.1 agrees 
well with the distribution based on measured patient data. 
 A number of conclusions may be drawn from this agreement. First, it confirms the 
derivation in the Appendix that the population mean random error, rσ  (Table 6.1), is 
sufficient for analytical calculation of the distribution of the final systematic errors in the 
NAL protocol, despite considerable inter-patient variation in pσ  (ranging from 0.4 to 5 
mm for each direction in the studied population). Second, the analytical curve does not take 
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Figure 6.1 The cumulative distribution of the 3D systematic setup errors fNd , 
obtained by retrospective application of the NAL OVP with mN = 3 to measured 
setup data of 600 prostate cancer patients, and the corresponding distribution in case of 
no OVP. Curves marked "theory" were calculated with the analytical expressions 
given in the Appendix. 
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into account explicitly the possible transient effects in the systematic setup error of the 
patient [17, 41, 49, 145]. If such time trends do occur they will increase the values of rσ  in 
Table 6.1 (which is the dominant factor in NALeff,Σ ) with respect to the true random 
dispersion, but it has been shown that such an increase is very small particularly for 
prostate patients  [17]. We observe from Fig. 6.1 that for the studied patient group, the 
(potential) influence of time trends on the retrospectively derived cumulative distribution 
does not introduce significant deviations with respect to our analytical prediction.  From 
these observations, we conclude that in the studied (large) patient population, the NAL 
procedure without a second stage is already sufficient to reduce systematic errors 
significantly and this reduction is well described by analytical expressions. On that basis, 
we may calculate the true distribution of the effective systematic displacements as would 
have been measured in 30 fractions (Eq. (6.3) with NALeff,Σ from Eq. (A6.4)) to arrive at 
the leftmost curve in Fig. 6.1. The impact of the fact that a sample of 10 fractions has been 
obtained in the measured data is non-negligible (in fact, the fraction of patients with fNd > 
5 mm in this 'true' distribution is < 1%), hence we have continued with MC simulations of 
all treatment fractions.  
 
6.3.2 Overall verification of Monte Carlo simulations 
Bel et al. [17] quote the number of mean 3D deviations (i.e., fNd ) > 5 mm, the average 
number of measurements per patient (i.e., measN ) and the average number of detected 
corrections per patient for the first stage of 3 SAL OVPs simulated in 3D. For all 3 
protocols, we found identical results with our simulations to within the accuracy with which 
they present their results in Table 3. Particularly the fraction of patients with fNd > 5 mm 
after the first stage of the SAL OVP is sensitive to all aspects of the simulation and these 
coincide to within 0.1%. The simulation fluctuations on this number are of the order of 
0.1% for 104 simulated patients, hence our results are consistent with the previously 
published results. 
The agreement between the MC simulation and the analytical expression for 
NALeff,Σ derived in the Appendix can be judged from Fig. 6.2. The mean absolute deviation 
between analytical prediction and simulation is 0.3%, on average, which equals ~ 10-3 rσ . 
In Fig. 6.3 we give an analytically predicted and simulated cumulative distribution for a 
NAL protocol with mN = 3 (see next section). The agreement between the two distributions 
is within 0.4%, consistent with the statistical fluctuations of ~ 0.2% (1 SD). 
 
6.3.3 Final setup accuracy and workload of SAL and NAL protocols 
The optimal (i.e., minimising SALeff,Σ ) SAL parameters per workload value measN are 
given in Table 6.2. In Fig. 6.2, the corresponding values of SALeff,Σ  are plotted together 
with the values of NALeff,Σ for an identical workload. All values are expressed in rσ  so 
that the results are independent of the specific value of rσ . Obviously, for a given 
workload, the final systematic errors obtained with the NAL protocol are significantly 
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smaller than for the SAL protocol. For instance, if one aims at halving the effective 
systematic dispersion in each direction, a NAL protocol with measNN m = = 3 will suffice, 
whereas for SAL one requires nearly 3 times as many measurements ( measN = 8-9). Both 
NAL and SAL curves become flat and even turn upwards again for large values of measN . 
This is because in case of 'late' corrections (after a significant number of fractions have 
already been given without a correction) the pre-correction systematic errors start to 
dominate the effective systematic dispersion (see Eq. (A6.4)). 
The optimised SAL protocols of Fig. 6.2 and Table 6.2 were constrained by F3+ ≤ 0.1. 
Our simulations showed that, if one includes protocols with F3+ > 0.1, the reduction of 
Σeff,SAL with respect to the constrained protocols of Table 6.2 is on average 6% (maximally 
~ 10%), which is clinically negligible, whereas the average value of F3+ increases to 0.25. 
Moreover, we found that the outcome of such protocols in terms of workload is extremely 
sensitive to the pre-correction distribution of set-up errors and will thus be hard to predict in 
practice. Therefore, the SAL protocols used to construct Fig. 6.2 represent optimal 
protocols not only in terms of final accuracy but also regarding multiple correction 
detection and robustness.  
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Figure 6.2 The effective systematic dispersion after application of the NAL and 
optimal SAL OVPs, both denoted by OVPeff,Σ , as a function of the mean number of 
imaged fractions per patient measN , expressed in the SD of the random setup errors 
rσ . The results were obtained with Monte Carlo (MC) simulations, but for the NAL 
OVP the analytical result is also depicted (solid line).  
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Table 6.2 3D SAL protocol parameters (α, maxN ) that yield a minimal SALeff,Σ  for a given 
average number of imaged fractions per patient, measN . These results were obtained for a 
population with Σ = rσ . The initial action levels α are expressed in rσ . The fraction of 
patients with at least one setup correction is denoted by F1+.  
 
Nmeas 2 3 4 5 6 7 8 9 10 
rσα /  2.3 3.1 3.7 3.1 3.6 4.0 3.5 3.8 4.3 
Nmax 1 2 3 3 4 5 5 6 7 
F1+  0.5 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 
 
 
We investigated the impact of setting a correction threshold of 1 mm in the NAL 
protocol (i.e. corrections < 1 mm are not executed) and found a negligible impact on 
NALeff,Σ  for Σ = rσ = 2 mm. The number of corrected patients was reduced by only a few 
% (because the setup was unaltered only if the correction was less than 1 mm in each 
direction). 
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Figure 6.3 The cumulative distribution of the 3D systematic setup errors fNd , 
obtained from MC simulations (with population characteristics from Table 6.1) for the 
NAL and optimal SAL OVP for measN = 3: (α, maxN ) = (6.2, 2). For the NAL OVP, the 
analytical result is also given (solid line). 
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If we apply the NAL and SAL protocols used in Fig. 6.2 to a population with rσΣ 2= , 
the values of NALeff,Σ and SALeff,Σ  are practically unaltered (deviations of a few %), 
consistent with published results [13]. However, while Nmeas for the NAL OVP remains the 
same by definition, for the SAL protocols Nmeas increases by approximately 1 
fraction/patient for all tabulated SAL parameter combinations. Moreover, the fraction of 
corrected patients increases to 90% in all cases, approaching the 100% correction 
percentage of the NAL protocol. 
We have applied the NAL and optimal SAL OVP with measN = 3 of Table 6.2 to a 
simulated population described by the parameters given in Table 6.1, assuming 30 
treatment fractions. For the SAL protocol, this implies (α, maxN ) = (6.2, 2), very close to 
the (α, maxN ) = (6.0, 2) for which clinical results obtained in a group of prostate cancer 
patients have been published [17]. The resultant cumulative distributions of 3D systematic 
setup errors are given in Fig. 6.3. As expected from the above results, the actual value of 
measN for the SAL protocol becomes 3.3 instead of 3 due to the fact that Σ is slightly larger 
than rσ  for each direction (Table 6.1).  Again, the gain in final accuracy by application of 
the NAL instead of the SAL OVP is evident.  
 
6.3.4 Time behaviour of SAL and NAL protocols  
For both the NAL mN = 3 protocol and the optimal SAL protocol with measN = 3 from 
Table 6.2, the systematic dispersion fΣ for the first 15 treatment fractions is given in Fig. 
6.4. As expected for the NAL protocol, fΣ  is constant up to f = mN , drops sharply in the 
next fraction and then remains constant at the value NALΣ  given in the Appendix. The SAL 
protocol yields a different picture. Although some patients are corrected already after 1 
fraction (f = 1), the effect on fΣ  for the second fraction is zero. In the Appendix, we show 
that setup corrections equal to the setup error measured in one single fraction have no 
impact on the post-correction distribution of systematic errors if the pre-correction 
distribution of systematic and random errors is identical. This result holds irrespective of 
the action level applied or the dimension of the setup error vector tested, which is 
confirmed in Fig. 6.4.  
After the second fraction, a gradual decay of fΣ follows for the SAL protocol but it 
remains significantly larger than the corresponding value of the NAL protocol; after the 3rd 
fraction hardly any reduction is seen, which can be understood from the fact that maxN = 2.  
In Fig. 6.4 we also show fΣ for the optimised SAL protocol with measN = 8. This SAL 
protocol approximately reaches SALeff,Σ ≈ NALeff,Σ for the NAL protocol with measN = 3 
(Fig. 6.2). The decay of fΣ is slow compared to that of the NAL protocol, from which the 
increased number of required measurements to reach the same final accuracy can be 
understood. 
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6.3.5 Systematic setup errors in the SAL protocol for corrected and uncorrected 
patients 
A significant fraction of the patients is not corrected in a SAL protocol (1- F1+, Table 6.2), 
which was considered one of its attractive features [13]. Although one may argue that these 
patients already have acceptable final systematic errors, the information obtained in the 
maxN measurements is not applied to improve their setup accuracy, resulting in larger 
effective systematic dispersions than for the corrected patients. In Fig. 6.5 we show 
SALeff,Σ as in Fig. 6.2 but now separated into the subgroups of patients who did not get a 
correction and patients who did. Obviously, the setup accuracy in the uncorrected group is 
worse than in the corrected group, particularly with increasing overall accuracy. Since the 
fraction of corrected setups hardly increases with increasing measN  (Table 6.2) the gain in 
accuracy obtained with a larger number of measurements as presented in Fig. 6.2 may be 
attributed to increasingly accurate corrections for larger measN . This is also reflected by the 
stronger decrease of SALeff,Σ with measN  for corrected than for uncorrected setups. 
6.3.6 Correction inaccuracies 
The inclusion of large random errors in the couch translations had a negligible impact on 
the final systematic errors of the NAL protocols, which follows from Eq. (A6.3) in the 
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Figure 6.4 The SD of the systematic errors in fraction f, fΣ  (expressed in rσ ) as 
obtained from MC simulations (with )1 rσΣ = , for three OVPs.   
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Appendix. The number of measurements per patient measN remained of course unaltered, 
whereas NALeff,Σ was increased by less than 6% for maxN  ≤ 5.  
For the SAL protocols with (α, maxN ) from Table 6.2, we again found that the final 
systematic dispersion is hardly affected by correction errors: SALeff,Σ increased on average 
by 3%, ranging up to 8%, consistent with published results for a 1D protocol [13]. 
However, measN and hence the workload increased by 22 ± 7% (the fluctuation is over the 
(α, maxN ) parameter sets of Table 6.2). This is reflected by the fraction of triple and higher 
correction detections, which increased from F3+ < 10% to 21 ± 6%. Therefore, the optimal 
SAL protocols tend to become clinically unacceptable for large inaccuracies in the applied 
table translations.  
  
6.4 Discussion 
 
Based on our clinical experience that the workload introduced by OVPs is mainly related to 
the average number of images required per patient and not so much by the fraction of 
patients with setup corrections, we have proposed the NAL protocol and compared it with 
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Figure 6.5 The effective systematic dispersions in the SAL protocol, SALeff,Σ  
(expressed in rσ ) for the optimal SAL protocols of Table 6.2. The values labeled "all 
patients" (squares) are identical to those in Fig. 2, but here they are separated into the 
values of the subgroups of patients with (triangles) and without (diamonds) setup 
correction. 
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the much applied SAL protocol. The presented results clearly indicate that the NAL 
protocol reaches a target final distribution of systematic errors with much less workload 
than the SAL protocol (Fig. 6.2 and 6.3). 
 The three main causes for the relatively high SAL workload are: 
(1) A correction based on N  measurements will yield a post-correction dispersion of 
systematic errors Nr /σ≈ (Appendix). Since N is fixed for each patient in the NAL 
protocol ( measNN = ), the systematic dispersion for this OVP meas/ Nrσ≈ . For the SAL 
protocols listed in Table 6.2, MC simulations showed that for patients who had their last 
setup correction based on N measurements, again the post-correction systematic dispersion 
Nr /σ≈ . For this OVP, NNN ≥> maxmeas , and therefore the overall systematic 
dispersion will always be larger than meas/ Nrσ , even in the subgroup of corrected 
patients. Moreover, the inaccuracy of setup corrections based on too few measurements are 
the major cause of the multiple corrections and associated workload of the SAL OVP. For 
example, MC simulations of the protocol in Table 6.2 with measN = 4 showed that, of the 
patients who had a first setup correction based on 1 measurement, 68% required additional 
corrections. For patients who had a first setup correction based on 3 measurements, only 
11% had additional corrections. 
(2) The SAL protocol is completely restarted after a correction, and all measured pre-
correction information is discarded. Since the magnitude of the performed corrections is 
known, there is little support for this approach if corrections can be performed accurately 
through table translations.  
(3) A large fraction of patients is not corrected, as a result of the action level. Hence a 
significant amount of the measured information is not applied for setup improvement 
yielding less than optimal results (Fig. 6.5). 
 The first cause described above may be slightly alleviated through a correction damping 
scheme [45, 117]. With the aid of a priori information on the distribution of systematic and 
random errors in the population, one may calculate a damping factor which yields an 
improved (i.e. the maximum likelihood) estimate of the true systematic error for a patient 
[45]. However, corrections for systematic errors based on only one or two measurements, 
as occur in a SAL protocol, can never be quite accurate and hence only small improvements 
from damping have been reported. In a 1D simulation study of the SAL protocol with 
damping, the number of corrections per patient decreased by only 0.1 without any clinically 
significant improvement in post-correction setup accuracy [45]. In another study, such a 
protocol was retrospectively applied to setup data obtained from tangential breast fields and 
similarly small effects were observed [103]. Because these studies were 1D, we repeated 
the simulations in 3D with an optimal damping scheme [45]. For the SAL protocols of 
Table 6.2, we found that, on average Nmeas decreased by 8%, and the systematic dispersion 
by only 1%. For none of the protocols a clear benefit was found. Although damping will 
slightly reduce the number of measurements in SAL protocols for patients with large 
random errors, the other two causes for the relatively high workload of the SAL protocol 
pointed out above remain.  
An additional problem with SAL protocols is the requirement that knowledge of rσ  must 
be accurate since deviating values may rapidly increase workload or decrease final 
accuracy [13, 130]. We found a similar workload effect for variations in Σ , specifically for 
the fraction of corrected patients, which is considered of importance for SAL protocols. In 
contrast, the workload of the NAL OVP is completely predictable and its final accuracy for 
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a given number of measurements better than for the SAL protocol, even if rσ  is poorly 
known. 
A psychological advantage of the SAL protocol is that large measured setup errors may 
be corrected directly after the first measured fraction. As is shown analytically in the 
Appendix, such corrections are not useful when Σ  is comparable to rσ , even if very large 
action levels are applied to this first measurement (see also Fig. 6.4). Of course, one is 
tempted to correct specifically large setup errors detected at the first fraction. However, 
especially for a highly significant error (outside the range one would expect for a given 
population), its origin should be investigated before a correction is applied. Nevertheless, if 
one wishes to correct immediately for very large setup errors (which can be useful if Σ is 
significantly larger than rσ ), the NAL protocol can be modified by introducing one (large) 
action level in the first fraction. If the setup error is smaller than this level, the NAL 
protocol runs unaltered. Otherwise, a correction (preferably with damping [45], because the 
correction is based on a single measurement) is performed for the next fractions and the 
standard NAL protocol continues by performing setup measurements for the remaining 
mN -1 fractions. Next, the applied setup correction is subtracted from the last mN -1 
measurements before averaging all mN  measurements to arrive at an improved estimate of 
the systematic setup error. The corresponding improved setup correction is applied from 
fraction  mN +1 onwards. This approach allows for immediately correcting particularly 
large initial setup errors without increasing the workload of the NAL protocol. 
 Finally, a discussion on off-line setup corrections is incomplete without addressing 
transitions in the systematic setup errors with time. Both the NAL and SAL protocol focus 
on removing initial (large) systematic setup errors, and do not take into account possible 
time dependent effects in these errors. Their use is therefore limited to patient populations 
which do not exhibit large setup shifts over time. The published studies on transient effects 
in systematic setup errors of prostate patients have focussed on gradual systematic shifts of 
the patient with time, the so-called time trends and in fact are limited to linear time trends 
[17, 41, 49, 145]. For a linear time trend, the model of patient setup errors described in 
Methods and Materials should be extended with a shift linear in time. For each patient p, 
this shift has a certain slope ps  expressed in mm/fraction, and so at fraction f the setup 
error becomes fpppfp fsSx ,, ∆+×+= . In some studies, this slope was estimated by 
applying a least squares fit, after which the significance of the estimated slope (i.e., does it 
differ significantly from 0) can be tested with a Student's t-test [123].  
However, if the estimated slope for each of the three setup directions is tested separately 
at the p = 0.05 significance level, the significance level for finding any linear trend in a 
patient is actually 1-(1-p)3 = 0.14. This result implies that, for a patient population without 
any trends, the applied statistical test would yield a significant trend (p < 0.05 in any 
direction) in on average 14% of the patients. Hence, patients with seemingly significant 
trends will  be detected regularly with such a test. For instance, in the study by El-Gayed et 
al. [41], 3 out of 10 patients showed a significant trend at p < 0.05 in a single direction, 
which  implies 3 significant detections in 30 (10 patients × 3 directions per patient) series of 
setup errors. If one supposes that no time trends occur  (the true slope ps = 0 for each 
patient), we can calculate from the binomial probability distribution [123] with N = 30, 
p=0.05, the probability of detecting 3 or more significant trends in 30 such series. The 
result is 10%, which implies that this is not a rare event. Therefore, [41] does not provide 
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unambiguous evidence on the frequent occurrence of time trends, although one particularly 
significant trend was observed (p < 10-5). In a similar analysis, Hanley et al. [49] detected 
significant linear trends in 10 cases, when studying 50 patients (i.e., 150 series of setup 
data). With the calculation method described above, we find that the probability of 
detecting 10 or more significant trends in 150 setup series in which no trends actually 
occurred is 17%. This relatively large probability, and the fact that all the p-values in [49] 
were ≥ 0.02, indicate that the statistical evidence for time trends in their population is 
limited. In the multi-center study of Bel et al. [17], a frequent occurrence of time trends is 
described in the Appendix. Their Table A1 shows that in more than 50% of the patients, 
significant trends (p < 0.05) were observed in each of the three participating institutions. 
However, despite this regular occurrence of time trends the expected number of images and 
setup corrections for this patient group were consistent with simulations that did not 
incorporate such time trends. In addition, the SD of the interpatient variation of the 
estimated ps values was presented in [17]: for each patient, a slope ps  was estimated from 
a linear regression fit, and the SD of these slopes was calculated. The SDs thus derived 
were on average about 0.08 mm/fraction. To assess the meaning of this value, we have 
calculated the value that would be expected for this SD if the true ps = 0 for all patients, i.e. 
for a population without time trends. Then, each estimated slope will still differ slightly 
from zero, due to the random setup fluctuations and the finite number of measurements 
available per patient. Using the magnitude of the random errors ( rσ ) and the number and 
distribution in time of the measurements described in [17], we can estimate the SD of these 
estimated slopes from the linear regression equations [123] and arrive at a value of 
approximately 0.08 mm/fraction. Because this statistical lower limit on the SD of the 
estimated slopes is so close to the SDs actually derived in [17], the simultaneous frequent 
detection of significant (i.e. relatively large) time trends in the same patient group is hard to 
understand. Therefore, the results in [17] on time trends seem to be non-conclusive.  
An off-line protocol suited to take into account time dependent effects is the adaptive 
treatment therapy (ART) [145, 146]. Apart from correcting systematic setup errors, ART 
adapts treatment plan margins once the setup errors have been estimated with sufficient 
confidence. On average, the procedure involves 6 imaged fractions, ranging up to 9 [146]. 
Follow up imaging is required to properly monitor time trends. Hence ART requires more 
imaging workload than the NAL protocol (next to the workload generated by repetitive 
treatment plan optimization and implementation at the accelerator), at the gain of patient 
specific treatment optimization.  Limited data on time trends have yet been obtained with 
this protocol. In a retrospective study [145], time trends were detected in particular in pelvis 
patients. Since the latter patients also suffered from large random and systematic setup 
errors, the relative importance of these trends is not clear.  In a prospective ART study 
[146], a linear time trend was detected in a single patient while in two other patients trends 
were detected but these seemed to alternate. Since no significance levels nor magnitudes 
were given for these trends, their impact on setup accuracy within the context of a NAL or 
SAL protocol is difficult to assess. 
In summary, the results discussed above describe evidence of linear time trends, but do 
not provide a clear picture of the true incidence and magnitudes of such trends. Regarding 
our own measurements, we previously stated that the agreement between the predicted 
results for the NAL protocol and the retrospective application to measured patient setup 
data (which include weekly measurements obtained over the full treatment period) is 
satisfactory without taking into account time trends explicitly in our prediction (Fig. 6.1).  
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Because of this result, and the fact that the correction of time trends is not well possible 
with either the SAL or NAL protocols, we considered a detailed analysis on time trends 
beyond the scope of this paper. Nevertheless, because time trends are expected to occur in 
some patients, we have started investigations on an extension of the NAL protocol which 
involves an effective use of follow up measurements for time trend detection.  
 
6.5 Conclusions 
 
If off-line setup corrections are performed through treatment couch translations, the fraction 
of patients that must be corrected when applying an OVP is not important to the workload. 
Hence, the number of fractions to be imaged and analyzed to reach a specified reduction of 
systematic errors becomes the discriminating factor between OVPs. The NAL protocol we 
have proposed significantly decreases this number of fractions with respect to the much 
applied SAL protocol, while not compromising on the reduction of systematic errors. In 
addition, the workload for the NAL OVP is independent of fluctuations in population 
parameters and the distribution of the final systematic errors obtained can be derived 
analytically from knowledge of the random errors. These properties also render the NAL 
protocol highly suitable for setup verification with large dedicated portal imaging fields, 
since it both minimizes dose to healthy tissue and renders that dose completely predictable.  
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Appendix: Analytical derivation of the systematic dispersion in the NAL 
protocol 
 
We first consider a population P of patients p that were treated in fN  fractions f without 
setup corrections. The patient setup errors may then be written as fppfp Sx ,, ∆+=  
where pS  is the systematic setup error for patient p and fp,∆ the random error in 
fraction },...,1{ fNFf =∈ . The effective systematic error is defined as the actual 
systematic error for a given treatment, i.e. the mean over the treatment fractions F: 
∑
=
−
≡>=<
fN
f fpfFfpp
xNxS
1 ,
1
,eff, . Its value deviates from pS due to the random 
deviations fp,∆ and the finite number of fractions fN .  
Suppose that we want to calculate the SD of eff,pS  over the patient population P, which 
we denote by )(SD eff,eff pP S≡Σ . Using the definition of the SD, we can write 
)()( eff,
22
eff,
2
eff pPpP SESE −=Σ , where EP denotes the statistical expectation value (i.e. the 
population mean [123]) over the population P. However, we cannot calculate such 
expectation values directly, since as mentioned above, eff,pS  not only depends on patient 
properties but also on the particular treatment. We therefore use the statistical concept of 
sample means [123]: we calculate the expectation value of any function of fpx , , as the 
mean of its sampling distribution. We must then define the possible samples of { fpx , } for 
a single patient, since in practice only one sample of fN fractions exists.  
If we could treat the same patient p repeatedly under identical circumstances we would 
obtain various realizations γ of the treatment and corresponding samples γ}{ , fpx (each 
consisting of fN values). The distribution of the random fraction-to-fraction fluctuations of 
fpx ,  is determined by the properties of p, i.e. the underlying probability density function is 
the same for each sample. Then, a function })({ , fpp xΦ (e.g., eff,pp S=Φ ) will have a 
different value γΦ p for each sample γ}{ , fpx , hence we refer to the values of such functions 
for a particular treatment as effective values. The fluctuation of γΦ p  from sample to sample 
(and hence the sampling distribution of pΦ ) is completely defined by p.  The mean of γΦ p  
over all samples Γγ ∈  is denoted by )( pE ΦΓ , and only depends on p. Below, the 
expectation value of an effective value pΦ over the patient population domain, )( pPE Φ , is 
calculated from 
))(()( pPpP EEE ΦΦ Γ≡         (A6.1). 
We can now precisely describe the properties of the systematic and random errors.  We 
define the mean systematic error by µ=)( pP SE  and its SD by Σ=)(SD pP S . The 
random errors satisfy fE fp ∀= 0)( ,∆Γ  and we assume that they are independent: 
2
',',, )( pfffpfpE σδ∆∆Γ =  with ', ffδ  the Kronecker delta function. Note that each patient 
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can have a different SD of random errors, pσ , so we do not assume a homogeneous patient 
population.  
Using the above definitions, we now calculate effΣ since its derivation is illustrative for 
a more complex derivation below.  
Using ∑
=
−+=
fN
f fpfpp
NSS
1 ,
1
eff, ∆ , we immediately find the mean of eff,pS : 
µ∆ΓΓ ==+== ∑
=
− )())(()())(()( ,1
1
eff,eff, pPfp
fN
f PfpPpPpP
SEEENSESEESE .  
Its second moment becomes 
)),(())((2)()(
1 1' ',,
2
1 ,
122
eff ∑ ∑∑
= =
−
=
− ++=
fN
f
fN
f fpfpPf
fN
f fpPPfpPp,P
EENESENSESE ∆∆∆ ΓΓ
= )()( 212 pPfpP ENSE σ
−+ . Using 222 )( µΣ −= pP SE , we finally obtain 
2122
eff rfN σΣΣ −+=   where )( 22 pPr E σσ ≡ is the population-averaged variance of the 
random errors. We have thus formalized the expressions given in Eq. (6.1) and (6.2) in the 
text. 
If we measure the setup errors fpx ,  in portal images, we introduce additional 
inaccuracies. Systematic inaccuracies pε  stem from errors in the definition of reference 
setup [12, 28, 76] (including errors in the definition of the structures used in image 
registration) and systematic errors that may occur during image registration [22]. We 
characterize them by 2ref
2 )(,0)( Σεε == pPpP SDE . The image registration process will also 
introduce random measurement inaccuracies fp,ω  and we assume that 0)( , =fpE ωΓ  (no 
net registration error) and 2 reg,',',, )( pfffpfpE σδωωΓ = (random registration errors are 
uncorrelated, and their magnitude can be patient dependent). With these definitions, the 
measured setup error in the case of no setup corrections becomes fppfp
m
fp xx ,,, ωε ++= .  
In the NAL protocol, we derive a single setup correction cp based on mN  measurements: 
∑
=
−=
mN
f m
m
fpp Nxc 1 , / , which is applied from fraction mN + 1 onwards. The setup 
corrections are executed with a finite accuracy. Throughout this paper, we have assumed 
that corrections are performed with treatment table shifts and so the magnitude of the 
correction errors, fp,τ , is patient independent: 
2
table',',, )( σδττΓ fffpfpE = . Furthermore, 
we assume that the net error of the table shifts is zero: 0)( , =fpE τΓ . The actual 
corrections become fppfp cc ,, τ+= with 0, =fpc  for f ≤ Nm. With this definition of fpc , , 
we can write the measured setup error in case of the NAL protocol as 
fpfppfp
m
fp cxx ,,,, +++= ωε . The corresponding actual setup errors are 
fpfpfp cxx ,,
act
, += . This leads to an effective systematic setup error for the NAL protocol, 
Sp,eff,NAL, and corresponding expectation value: 
µ
f
m
pPFfpp N
N
SExS =>=< )(, NAL,eff,
act
,NALeff,,           (A6.2). 
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Hence, the mean effective systematic error is reduced by a factor fm NN / through the 
NAL protocol. 
The SD of the effective systematic setup errors in the NAL protocol ( NALeff,Σ ) can now 
be calculated from the definition of Sp,eff,NAL in Eq.(A6.2), analogous to the calculation of 
effΣ  given above. Performing the algebra we obtain, after re-arranging terms, 
fmm
r
f
r
N
r
N
r
N
r
N
r
2
table
2
reg2
ref
2
2
3
2
222
NALeff, )1()1()1(
σσΣσσΣΣ −+



+−+−+



+=     (A6.3)
  
where fm NNr /= , and )(
2
reg,
2
reg pPE σσ = , i.e. the mean registration variance. The first 
term in brackets in equation (A6.3) is the systematic variance without corrections ( 2effΣ ) 
we derived above. Obviously, if one waits with correcting until the treatment is over, r = 1 
and 2eff
2
NALeff, ΣΣ = . The second term is the residual systematic dispersion due to the 
inaccuracy of the estimate of Sp because of random setup errors. The third term and fourth 
term stem from respectively the measurement and table translation inaccuracies.  
We now simplify Eq. (A6.3), by observing that errors in the reference definition should 
and can be reduced to a minimum in the pre-treatment phase [76, 122, 134] and we may 
neglect them. Furthermore, in general the random image registration error ≤regσ  1 mm 
[17, 49, 124, 130] while ≥rσ 2 mm and rσΣ ≥  [17, 22, 28, 103, 130, 138], so that the 
impact of regσ  on NALeff,Σ  is also small. Finally, the SD of table translation errors can be 
very small [16, 28, 58] and the fN/1  multiplier in Eq. (A6.3) further reduces this error. 
We therefore neglect the registration and correction errors terms, and only retain the patient 
setup errors to arrive at 
m
r
f
r
N
r
N
r
2
3
2
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NALeff, )1(
σσΣΣ −+



+=          (A6.4). 
The expression in Eq. (A6.4) for NALeff,Σ  was used in the calculation of the curve for the 
NAL protocol in Fig. 6.2.  
In the case of setup corrections, we can define the systematic error of patient p in 
fraction f: fppfp cSS ,, +=  (here, we again neglect the random correction errors fp,τ  in 
fpc , ). In the text, we study the time behavior of the systematic errors by calculating 
)(SD , fpPf S=Σ .  For the NAL protocol, it is easy to see that NAL/ ΣσΣ ≡= mrf N  
for mNf > . With this expression, we can rewrite Eq. (A6.4) as 
2
NAL
32
eff
22
NALeff, )1( ΣΣΣ rr −+=          (A6.5). 
Note that for some parameter choices, 2NAL
2
NALeff, ΣΣ < , i.e. the dispersion of the effective 
systematic errors over the entire treatment can be (slightly) smaller than the dispersion of 
the actual systematic errors after correction. However, for typical fractionation schemes 
with fN  ≥ 30 and NAL protocols with mN < 5,  (A6.5) can be approximated by 
NALNALeff, ΣΣ ≈ . 
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Cumulative distribution of the 3D systematic setup error in the NAL protocol 
 
The expression (A6.3) for NALeff,Σ  can be applied to each direction i of patient translation 
to yield NAL,ieff,Σ . If we assume that the setup and measurement errors have normal 
distributions, so will Sp,eff,NAL,,i. Hence, the cumulative probability distribution of the length 
fNd of the 3D systematic error vector, 
T
epeppfN SSSV ),,( 3,NALff,,2,NALff,,1,NALeff,,≡ , is 
given by 
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Σπκ  
We now assume that the NAL protocol results in isotropic effective systematic 
dispersions: ii ∀≡ isoNAL,eff, ΣΣ . In Eq. (A6.4) and below, we show that this condition is 
approximately fulfilled if the random setup errors are isotropic: ir,i ∀≡ isoσσ . Under this 
commonly occurring condition (e.g. Table 6.1), we can use spherical coordinates to cast 
equation (A6.6) into 
2
2
iso/0
2
0
2)(
r
d
fN erdrddP
−
∞
∑
∫=> π           (A6.7) 
which leads to 
)(erf12)(
2
12
iso
2
rerrdP
r
N f −+=>
−
π
Σ          (A6.8) 
where "erf" represents the standard error function. Eq. (A6.8) implies that 2iso )/( ΣfNd  
has a 2χ  probability distribution with 3 degrees of freedom [123]. This result can be 
understood from the normality of each of the components of the systematic error vector. 
The analytical prediction in Eq. (A6.8) is also quite accurate for anisotropic setup 
deviations. In Fig. 6.6 we show the result of MC simulations for setup distributions with 
50% anisotropy in the initial systematic and random errors: 
)3,2,1()5.01(5.0 iso, =+≡= iiiri σσΣ  and compare it with the result of Eq. (A6.8) with 
∑
=
=
3
1
2
,NALeff,iso 3
1
i i
ΣΣ .  The difference in the cumulative distributions between the MC 
simulation and analytical approximation is everywhere less than 2% (2-3 SD of the 
statistical noise on the simulated data) and on average only 0.2%. Therefore, even for 
significant anisotropy, expression (A6.8) yields an accurate estimate of the final cumulative 
distribution of the 3D systematic errors. 
 
 
 107
Net effect of setup corrections based on a single measurement 
 
Below we show that a setup correction based on a single (e.g. first-day)  measurement has 
no impact on the distribution of systematic setup errors if the systematic and random setup 
errors have similar distributions. For clarity, we treat the 1D case explicitly, but the proof 
can be easily extended to higher dimensions, as will be shown. We will drop some of the 
subscripts of previously introduced variables if they are not strictly necessary.  
Let the probability density function (PDF) of the systematic setup errors S be )(Sps and 
of the random setup errors ∆  be )(∆rp .  We assume that the systematic and random errors 
have an identical PDF and that this PDF is an even function: 
)()()( xpxpxp rs ≡= , )()( xpxp −= , ∫∞
∞−
= 1)( dxxp        (A6.9). 
A setup correction based on a single measurement of the actual setup error, ∆+= SX , 
would in general depend on the magnitude of X . In fact, for action level α , if α>|| X , 
we would apply a setup correction equal to X− (assuming we don't use a priori information 
about the population distributions [45] resulting in a post-correction systematic error of 
∆− , otherwise the systematic error remains S.  We now derive the PDF )(Sp ′′ of the post-
correction systematic errors S ′ . 
The probability that the post-correction systematic error is in the infinitesimal interval 
( S ′ , SdS ′+′ ) is SdSp ′′′ )( . This probability consists of two contributing probabilities. 
The first contribution is from uncorrected patients for which, as pointed out above, SS =′ . 
Hence, the corresponding probability uncorp′  equals the probability that the systematic error 
before correction is in the interval ( S ′ , SdS ′+′ ) times the probability that the total setup 
error is not corrected for, given this systematic error. Hence, 
∆∆α∆
α∆
dpSdSpSSSPSdSpSdSp
S
ss )()()|||()()(
||
runcor ∫
<+′
′′=′=<+′′=′′′        (A6.10),  
where the standard notation for the conditional probability )|( BAP denotes the 
probability that A occurs given B. The second contribution to p′ comes from patients 
whose setup was corrected. For these patients, ∆−=′S . Therefore, the corresponding 
probability corp′  equals the probability that the random setup error is in the interval 
( S ′− , SdS ′−′− ) times the probability that the total setup error is not corrected for: 
∫
>′−
′′
−=′−=>+′′−=′′′
α
∆α∆
||
cor )()()|||()()(
SS
srr dSSpSdSpSSPSdSpSdSp   (A6.11). 
Eqs. (A6.10) and (A6.11) hold in general, irrespective of the PDFs. If we now apply the 
PDF properties in Eq. (A6.9), we obtain 
)()()()()()()(
||||
coruncor SpdxxpdxxpSpSpSpSp
SxSx
′=







+′=′′+′′=′′ ∫∫
>′−<′+ αα
   (A6.12), 
i.e. the PDFs of the post-correction systematic errors is identical to the initial PDF. Hence, 
the distribution of the systematic errors is unaffected by the corrections, irrespective of the 
magnitude of the action level α .  
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We sketch the extension of the proof to multiple dimensions. For a single measurement 
in an Ν -dimensional space, the error vector becomes 
),...,(),...,( 111 ΝΝΝ ∆∆ ++= SSXX . The PDFs of the systematic and random setup errors 
are ),...,( 1 ΝSSps  respectively ),...,( 1 Ν∆∆rp . As before, these PDFs are assumed to be 
identical: ),...,(),...,(),...,( 111 ΝΝΝ xxpxxpxxp rs ≡= . We concentrate on the PDF of the 
systematic error along a single axis, for which we arbitrarily select the first axis. We define 
its PDF by  
∫
−
≡
1
...),...,,()( 22111
Ν
ΝΝ
R
dSdSSSSpSp       (A6.13), 
where the integration is over the entire range of ),...,( 2 ΝSS . Furthermore, we assume that 
the PDF is an even function along this axis, ),...,(),...,( 11 ΝΝ xxpxxp −= . Next, we 
extend the criterion for setup corrections, α>X  for 1 dimension, to Ν dimensions. We 
consider two generally applied types of criteria. The first type is a combined test on the 
components of the error vector and the criterion for correction is αΝ >)||,...,||( 1 XXf  
where f is a function of Ν variables. For instance, in the SAL protocol one 
applies 221 ... ΝXXf ++= to evaluate the first measurement. The second type tests 
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Figure 6.6 Cumulative distributions of the 3D systematic setup errors fNd , for a 
patient population with an anisotropic distribution of systematic and random setup 
errors. The SDs of the initial setup errors are indicated in the figure. The result from a 
MC simulation of the NAL OVP (closed circles) is given together with the analytical 
approximation from the Appendix (solid line). 
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individual vector components: the correction criterion is iiX α>||  for any ],...,1[ Ν∈i , 
e.g. test if the setup error measured in a single fraction exceeds 5 mm in any direction. For 
both types of criteria, we can express the PDF )( 11 Sp ′′  of the post-correction systematic 
error along the first axis, 1S ′ , analogous to Eq.  (A6.10) and (A6.11). Because these criteria 
only depend on the absolute values of the setup errors, we obtain 
)()( 1111 SpSp ′=′′          (A6.14). 
Because the first axis was arbitrarily chosen, Eq. (A6.14) implies that the PDF of 
systematic setup errors is unaltered by the corrections for any direction along which the 
PDF is an even function.  
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Abstract 
 
Purpose: Off-line patient setup correction protocols based on electronic portal images are 
an effective tool to reduce systematic patient setup errors. Recently, we have introduced the 
No Action Level (NAL) protocol which establishes a significant error reduction at a very 
small workload. However, this protocol did not include an explicit verification of the 
applied setup corrections. Systematic mistakes in the execution of setup corrections (e.g. a 
setup correction is always executed in the +X direction whereas a correction in the –X 
direction was prescribed) may introduce large systematic setup errors (irrespective of the 
setup protocol) and may seriously impair treatment outcome. We have therefore extended 
the NAL protocol with a correction verification (COVER) stage, solely aimed at detecting 
such mistakes.  
Methods and Materials: In short, COVER tests the magnitude of the post-correction setup 
error in each relevant direction. If these residue errors are below the acceptance threshold T, 
no more EPI are required and the protocol has finished. If not, the origin of this result 
should be investigated; if no obvious mistakes are present, the procedure is repeated for one 
more treatment fraction. If the residue setup errors are confirmed to be larger than T, the 
entire protocol is restarted. Using both Monte Carlo simulations and analytical calculations, 
we performed a risk analysis and evaluated the workload for various choices of T.   
Results: A threshold T = 3× rσ , where rσ  is the mean standard deviation of the random 
setup errors, ensured that (1) COVER introduces only a small additional workload (1.05 
measurement per patient, while the absolute minimum is 1.0) and (2) serious correction 
mistakes are detected with high probability. Even if setup corrections are wrongly applied 
in each patient (worst case scenario), COVER ensures that the final distribution of 
systematic errors is not wider than the pre-correction distribution of systematic errors; for 
realistic frequencies of correction mistakes (<< 1 per patient) this distribution becomes 
much more narrow.  
Conclusion: The combination of NAL and COVER provides a highly efficient as well as 
safe method to reduce systematic setup errors.  
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7.1 Introduction 
 
Due to the increasing complexity of radiotherapy techniques, the use of electronic portal 
images (EPIs) for verification of both geometrical and dosimetrical aspects of external 
beam radiotherapy treatment is a rapidly expanding field of research [72]. EPIs present 
simultaneous information on both patient anatomy and exit dose distributions during 
treatment in digital format. Therefore, electronic portal imaging devices (EPIDs) have been 
applied to various quality assurance related topics, ranging from verification of basic Linac 
properties such as beam output [38] and light field congruence [77] to dosimetric 
verification of dynamically delivered fluence distributions [95, 97], compensator design 
and verification [44, 101] and patient transit dosimetry [100]. The flat panel a-Si EPIDs 
now commercially available may improve image quality over conventional devices at 
significantly lower exposures per image [6], even allowing for acquisition of CT scans at 
the treatment unit [64]. Despite the active development of these promising techniques, the 
basic application of EPIDs in patient setup verification is only slowly growing, despite 
routine use in a number of centers [17, 28, 56, 75, 146]. Recently, AAPM Task Group 58 
presented a report providing basic clinical and physics information aimed at lowering the 
barrier for clinical EPID use [56]. Part of this barrier is the workload generated by EPI-
based setup correction protocols (SCPs) in relation to their benefits. To facilitate use of 
SCPs in our clinic, we have developed a low workload SCP which is highly effective in 
reducing systematic setup errors [24]. To promote clinical use of this SCP, we have added a 
verification stage to determine if setup corrections are properly executed. The design of an 
efficient verification stage, and its effect in combination with an SCP, is the topic of this 
paper. 
Many approaches to verify and correct patient setup based on EPID images have been 
proposed. They can be separated into “off-line” and “on-line” SCPs [56, 116]. This 
classification refers to the moment at which setup corrections are performed. For off-line 
SCPs [13, 24, 145] the information from EPIs obtained in a certain treatment fraction is not 
applied to improve the setup of that fraction but, if necessary, a setup correction is 
performed in subsequent fractions. In contrast, on-line SCPs [91] require that EPIs are 
obtained in each fraction with a small percentage of the fraction dose, followed by image 
analysis and setup correction before the remaining fraction dose is delivered. The result of 
these two SCP types can be related to the division of setup inaccuracies into “systematic” 
and “random” errors [22]. The systematic setup error of a patient is the difference between 
the mean setup during treatment and the intended setup defined by the treatment plan. A 
random error is an incidental error specific to the setup at a certain treatment fraction, 
which is present in addition to the systematic error. It follows that off-line SCPs correct for 
systematic errors: the setup corrections do not take into account the random errors in the 
fractions in which they are applied. Off-line SCPs therefore aim at estimating the 
systematic error from a limited set of EPI measurements by filtering out the effect of 
random errors. In contrast, on-line SCPs may correct both systematic and random setup 
errors, at the cost of daily imaging and the need to perform accurate image analysis and 
setup corrections under time pressure.  
To determine how random and systematic setup errors impact the dose distribution, 
Stroom et al. [125] analyzed the geometrical margin between the clinical target volume 
(CTV) [62] and planning target volume (PTV) in a statistical approach. They found that, if 
the standard deviation (SD) of the systematic setup errors in a patient population is denoted 
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by Σ and the SD of random errors by σ, a margin of 2Σ + 0.7σ yields an average coverage 
of 99% of the CTV with at least 95% of the prescribed dose for patients in that population. 
Hence, the reduction of systematic errors established by off-line SCPs is an efficient 
method to reduce the required planning margins. In addition, a much smaller number of 
fractions need to be imaged and analyzed in off-line than in on-line SCPs [24, 56]. 
Therefore, although on-line SCPs are useful in some cases, off-line SCPs are an obvious 
choice if workload is critical. 
Because off-line SCPs may still introduce considerable workload when applied in many 
patients, we investigated the efficiency of off-line corrections in previous work [24]. The 
most widely applied SCP to date is the shrinking action-level (SAL) protocol [13], 
developed and clinically tested in a multi-site collaboration in the Netherlands [17]. In our 
institute, the setup of over two thousand patients has been verified and corrected using this 
protocol [17, 24, 27, 28, 93]. We found that careful EPI analysis is the major contributing 
factor to the SCP workload per patient, not the acquisition of the images or the execution of 
setup corrections [17, 24]. This is largely due to the fact that 3D setup evaluation requires 
multiple images per fraction to be analyzed whereas setup corrections can be executed 
rapidly and even automatically by treatment couch translations after the regular patient 
setup procedure [16, 130]. Hereafter, we will refer to all workload related to EPI acquisition 
and analysis as EPI workload.  
Because clinical implementations of the SAL SCP required analysis of a considerable 
amount of EPIs per patient (for instance, ~ 20-30/patient for prostate treatments) [24], we 
developed a new SCP to use EPI information more efficiently. This “no action-level” (or 
NAL) SCP enables the same reduction of systematic setup errors as the SAL SCP with 
approximately 3 times less images [24] and a corresponding reduction in EPI workload. 
This is achieved by establishing sufficiently accurate setup corrections very early in 
treatment for each patient [24]. Apart from a reduction in workload, the small number of 
imaged fractions required by NAL has the advantage that if dedicated fields (e.g. as in 
double exposures) are necessary for setup verification [27, 28], the cumulative dose to 
healthy tissue from such fields can be kept minimal. Furthermore, for the NAL SCP this 
dose is fully predictable a priori, in contrast to the SAL SCP [13].  
Prior to implementation of the NAL SCP in our clinic, we developed the procedure 
described in this paper to detect errors in the execution of the required setup corrections. If 
a systematic mistake (recurring each fraction) is made in the execution of setup corrections 
(for instance because a number is copied with the wrong sign onto a form) the resulting 
systematic setup error may increase considerably, with possibly dramatic consequences. 
Even though quality assurance procedures should guarantee a small incidence of such 
mistakes, they may still occur and the potentially large impact on treatment outcome 
warrants a correction verification stage. At present, little attention has been given to explicit 
correction verification and particularly to the effect of systematically wrongly applied 
corrections. In contrast, the effect of random inaccuracies in the setup corrections has been 
studied [13, 24, 49] but the impact of such inaccuracies can be shown to be small [24]. We 
have therefore developed a correction verification stage to detect systematic mistakes in the 
execution of setup corrections. This stage consists of a test on the measured post-correction 
setup error. Because false detections of mistakes will incur most of the workload if 
corrections are properly executed, the test should have a high sensitivity to severe 
correction mistakes while maintaining a small false detection rate. Although the proposed 
verification stage is designed with the NAL SCP in mind, it can in principle be applied to 
any off-line SCP. 
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7.2 Methods and Materials 
7.2.1 Descriptive model of setup errors and setup corrections  
We will adopt the description of setup errors established in previous work. Below we give a 
short overview of the relevant quantities; details on how we measure and derive these 
quantities can be found elsewhere [17, 24, 28]. Because of the relevance to the procedures 
developed in this paper, we will pay some attention to the distribution of random setup 
errors in the patient population.  
Consider a patient p who is treated in fractions f ∈ F ={1, 2, ..., Nf }. The setup error with 
respect to the reference setup along axis x  is fpx , . We describe the setup errors by 
fppfp Sx ,, ∆+=  where pS  is defined as the systematic error (the recurring component) 
and fp,∆ the random error (fluctuating from fraction to fraction) for patient p. Because the 
number of treatment fractions is finite, we define the effective systematic error [24] as the 
actual mean error over the treatment fractions:  
∑
=
−
≡>=<
fN
f fpfFfpp
xNxS
1 ,
1
,eff, .           (7 .1) 
Hence, eff,pS tends to pS  if Nf  becomes large. The random errors fp,∆  of patient p are 
characterized by their SD, denoted by pσ  (note that pσ  may be different in each patient.)  
Bijhold et al. [22] introduced the use of the symbols Σ and σ  to denote SDs of 
respectively systematic and random deviations measured in a patient population and we 
adopt their convention. The probability density functions of setup errors occurring in a 
patient population P can then be approximately described by the mean systematic error µ , 
the systematic dispersion Σ and the mean random dispersion rσ , defined by  
PprpPPp
SS 2,)(SD, σσΣµ ===            (7.2) 
where BA is the mean of quantity A calculated over domain B and )(SD AB the 
corresponding standard deviation. The expression for rσ  yields a mean random error 
magnitude, useful if the inter-patient variation in the values of pσ  is small [17, 28]. 
However, non-negligible inter-patient variation in pσ  does occur and for our purpose we 
require a more detailed description of random errors. We assume that the probability 
distribution of pσ  in the patient population is normal, a choice validated in the Appendix. 
Consequently, the distribution is determined by the mean value of pσ  and its SD, denoted 
by respectively mpσ  and pδσ . In the Appendix, we describe how we obtain these values 
from measured patient data. Although the normal distribution allows for a positive 
probability for the nonsensical values pσ < 0, the parameters obtained in the Appendix 
ensure that this probability is negligible. For such a distribution, rσ  approaches 
22
pmp δσσ +  (Eq. (7.2)) if calculated for a sufficiently large data-set. Despite this detailed 
description of pσ , for theoretical purposes an analysis for a population without inter-
 115
patient variation in random errors ( pδσ = 0) is often useful. Such a hypothetical patient 
population will be referred to as iso-random population. 
Based on the above, the dispersion of the effective systematic errors if no setup 
corrections have been applied can be derived [28]  
122
eff,eff )(SD
−+== frpP NS σΣΣ .             (7.3) 
In many studies Σ was found to be comparable to rσ , [17, 22, 24, 27, 28, 49, 75, 93, 125, 
130] so that for treatments consisting of more than 10 dose fractions, ΣΣ ≈eff .  
An off-line setup SCP will generate setup corrections })({ ',, fpfp xc for fraction f based 
on measured setup deviations }{ ', fpx in previous fractions f’ < f. To take into account 
errors in the execution of setup corrections, we write fpfpfp cc ,
SCP
,, τ+= where 
SCP
, fpc is the 
correction as calculated by the SCP, and fp,τ  is the inaccuracy in the execution of this 
correction. The setup deviations that occur when a SCP is applied ( SCP, fpx ) can now be 
described in terms of the setup deviations fpx ,  that would have occurred without setup 
corrections:  
fpfpfp cxx ,,
SCP
, +=                     (7.4) 
The above definitions apply to each relevant setup direction. We assume that there is no 
correlation between the setup errors in different directions. An extended description of 
measured and actual setup errors, explicitly taking into account image registration 
inaccuracies and random inaccuracies in the execution of setup corrections, was given 
elsewhere [24].  
 The way setup corrections are executed is essential to the current analysis.  We assume 
the method clinically applied in our hospital, which can be summarized as follows. In each 
fraction the patient is initially positioned according to the skin tattoos or other demarcations 
established in the treatment preparation phase. Next, if a setup correction is required, a 
couch shift is performed either manually using the digital read-out of the treatment couch or 
automatically from the Linac couch-control software [130]. This way, the accuracy with 
which patients are positioned initially is the same as if no setup corrections would be 
applied. Therefore, the setup correction can be regarded as an additive operation, which has 
an accuracy which depends on the treatment couch precision and not on the patient specific 
setup. If only random inaccuracies in the execution of treatment couch shifts occur, 
fp,τ can be characterized by the SD of these inaccuracies, hereafter referred to as couchσ .  
 
7.2.2 The no action level (NAL) setup correction protocol 
The NAL protocol represents the simplest form of off-line SCP. We will describe this 
protocol below in some detail, as its application is the motivation behind our correction 
verification procedure. We will therefore evaluate the effect of the latter procedure in 
combination with the NAL SCP.  
As described in the Introduction, an off-line SCP must filter out the effect of random 
errors to estimate the systematic error and generate a correction for subsequent fractions.  
The obvious method is to average measured setup errors, and the NAL SCP implements 
this method in a straightforward way. For each patient, setup errors are measured during the 
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first mN  fractions, mN being a fixed number typically < 5 [24]. The average setup error 
over the first mN fractions is determined, and a setup correction equal to minus this error is 
applied in all subsequent fractions ( mNf > ), irrespective of its magnitude (see comment 
below). The protocol is then finished, and thus the number of imaged fractions per patient 
always equals mN . In terms introduced in the previous section, the NAL SCP is described 
by 0SCP, =fpc for mNf ≤ and 
NALSCP
, pfp cc =  for mNf > where  
pp
N
f fpmp
N
f fpmp
SNSxNc mm δ∆ +−≡−−=−= ∑∑
=
−
=
−
1 ,
1
1 ,
1NAL .         (7.5) 
As a result, the residue systematic error after correction equals pδ , and the SD of these 
errors over the patient population P equals [24]  
mr N/NALres, σΣ = .                (7.6) 
Equation (7.6) expresses a fundamental property of off-line SCPs: the initial systematic 
setup error is replaced by the inaccuracy in the estimate of that systematic error, [45] in this 
case due to random setup errors in the fractions of measurement.    
To calculate the net effect of the protocol, both pre-correction and post-correction setups 
must be taken into account. When the NAL SCP is applied, the dispersion of the effective 
systematic errors (Eq. (7.1)) becomes 
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+=             (7.7) 
where fm NNr /= [24]. As discussed below, a clinically realistic value is 1.0≈r , in 
which case NALeff,Σ tends to the expression for the post-correction dispersion of Eq. (7.6).  
From Monte Carlo simulations, analytical calculations and retrospective application to 
large databases of measured patient setup data [24, 27], we found that the dispersions given 
by Eq. (7.6) and (7.7) are quite small compared to those obtained with the SAL SCP with a 
similar average number of imaged fractions per patient. The reasons behind this relative 
inefficiency of the SAL SCP have been treated elsewhere [24]. Here we only state that the 
NAL SCP can reduce systematic setup errors with typically 3 times less measurements per 
patient than the SAL SCP. Appropriate values of mN  are typically in the range 2-4 [24, 
27]. Hence EPI analysis workload as well as dose to healthy tissue in dedicated setup 
verification fields can be reduced accordingly.    
Equations (7.5-7) hold if setup corrections are executed properly. If a recurrent error is 
made in the execution of the setup corrections, the obtained result will usually be worse. 
Therefore, a separate correction verification stage was developed, described in the next 
section. 
 
7.2.3  The correction verification (COVER) procedure 
Hereafter, we will refer to the average number of fractions that must be imaged per patient 
as the required number of measurements or measN . We assume that the number of EPIs that 
must be acquired and analyzed per imaged fraction is fixed, and hence the EPI workload 
will be proportional to measN . If correction verification (hereafter, COVER) is applied after 
the NAL protocol, measN  will be at least 1+mN , irrespective of the details of such a 
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verification. We aim to develop a COVER procedure which increases this minimum 
imaging workload by as little as possible but will still detect ‘significant’ correction errors 
with a high probability. We will focus on detection of systematic (recurrent) errors in the 
execution of corrections since random correction errors have a small impact on the final 
systematic setup errors [24]. Hereafter, recurrent errors in the execution of corrections are 
referred to as correction mistakes. The applied COVER approach may be summarized as 
follows. 
In the first fraction in which the setup correction generated by the SCP is applied, the 
setup error is measured. Our strategy is that treatment may continue without further 
verification if this setup error is sufficiently small. To decide if the correction is acceptable, 
the setup error in this first post-correction measurement is subjected to a test, hereafter 
referred to as Test 1. Test 1 must alert the operators with a high probability if an actual 
correction mistake occurred, so that its origin can be identified and corrected for in 
subsequent fractions. If Test 1 indicates the presence of a mistake, but no specific cause can 
be identified, the setup error is measured again in the next fraction (the same setup 
correction is still applied). The setup error measured in this fraction is tested again (Test 2) 
to verify if the result of Test 1 reproduces in this fraction. If so, the SCP is restarted; 
otherwise the setup correction is accepted and will be applied in next fractions without 
further verification.  
If Test 1 does not detect an actual correction mistake, we will refer to such an event as a 
"Type II error" in accordance with hypothesis testing conventions [123]. Because Test 1 is 
based on a single measurement, a small frequency of Type II errors implies it will generate 
some false alerts or "Type I errors". Hence, Test 2 must discriminate between a true 
mistake or a Type I error in Test 1.  
 
7.2.3.1  First verification measurement 
If, for a patient p, the first correction verification measurement is applied in fraction 1ν  
(referring to ‘verification 1’; generally  11 += mNv ),  the setup error in that fraction  
( cor1,νpx )  may be expressed as 
1,1,1,1,
cor
1, vppppppp cSx τδ∆∆ νννν ++=++= .             (7.8) 
The second equality follows from the expression 1,
NAL
1, vppp cc τν += , where 1,ντ p  is the 
error in the executed correction (section 7.2.1), combined with Eq. (7.5). Therefore, cor1,νpx  is 
the sum of  (1) the random setup error 1,ν∆ p  in fraction 1ν , (2) the correction execution 
error 1,ντ p  in that fraction and (3) the average random setup error pδ in the mN  fractions 
that determine NALpc . In case the correction execution errors would be limited to random 
inaccuracies in treatment couch shifts, the SD describing the dispersion in cor1,νpx becomes 
2
couch
21
1, )1( σσσ ν ++=
−
pmp N .             (7.9) 
 To verify if the correction was properly executed, we test if the measured value of cor1,νpx  
is likely given the above SD.  As zero hypothesis 0H  we assume that no correction mistake 
occurred. Test 1 is defined by 
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Accept 0H  if Tx νp <||
cor
1, .            (7.10) 
where T is a threshold for acceptance. Test 1 must be applied to each setup direction 
separately and therefore in principle 3 different values of T may be involved. In this paper, 
we will assume T is constant for the patient population (for a patient specific choice of T, 
see Discussion). The main topic of this paper is to find an appropriate expression for T in 
the population averaged SD of the random errors.  
If 0H  is not accepted by Test 1, it is not definitely rejected either because Tx νp >
cor
1, may 
occur due to random setup errors. Therefore, if the acceptance condition expressed in Eq. 
(7.10) is not fulfilled, an alert for a possible correction mistake is given to the operators by 
the COVER protocol software. In the next section we will develop the actions required in 
case of such an alert. 
 
7.2.3.2 Second verification measurement and completion of COVER  
If Test 1 generates an alert, the operators will search for a potential correction mistake (for 
specific actions, see section 7.4). If an actual mistake is involved, it will in general be 
identified and solved, i.e. it will not recur in subsequent fractions. EPIs are then obtained 
for the first next fraction to verify if the correction is indeed executed properly, and 
therefore Test 1 will be re-applied to the setup errors measured in these EPIs.  
However, operators may also fail to find the cause of an alert. In this case, we can 
perform another verification measurement in the next fraction 112 +=νν and apply another 
test (Test 2) to accept or definitely reject 0H . To specify this test, we first summarize the 
possible reasons of alerts without traceable causes: 
(1) A Type I error occurred ( 0H  was not accepted while true) due to random setup 
errors. 
(2) A random correction error other than a couch translation inaccuracy occurred. For 
example, a setup correction of –4 mm is required in a specific direction, but the operator 
executes a +4 mm couch shift. This may be an incidental error, not recurring in subsequent 
fractions. The magnitude and behavior of this type of error is hard to predict, but formally it 
may be regarded a Type I error because it does not involve a systematic correction mistake. 
In principle, such errors can be eliminated if treatment couch shifts are executed via the 
treatment unit control software [130].  
(3) A systematic correction mistake is actually present, but its origin is not obvious. 
If the SCP was properly introduced and tested, the incidence of correction mistakes 
should be very small. The subset of mistakes that are detected in Test 1 but subsequently 
can not be solved will be even smaller. Nevertheless, reason (3) should lead to an alert 
generated by Test 2, particularly if a large correction mistake is involved. Based on these 
considerations, we choose Test 2 to be similar to Test 1: 
Reject 0H if Tx νp >||
cor
2,             (7.11) 
where cor 2,νpx  is the setup error measured in fraction 2ν . Hence, to definitely reject 0H , Test 
2 requires that the result of Test 1 is reproduced. If more than one setup direction is 
involved, Test 2 is restricted to those setup directions for which 0H  was not accepted in 
Test 1. If 0H  is accepted in Test 2 for all involved setup directions, COVER has ended and 
no more verification measurements are required. However, if 0H  is rejected for any 
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direction, the presence of a correction mistake has been confirmed. Since the origin of this 
mistake is unknown, we propose a restart of the entire procedure, including off-line SCP. 
Such a restart is reasonable because if, after careful searching, no origin of a correction 
mistake was found, no actual mistake may be present.  Instead, the prescribed setup 
correction itself may be inaccurate, not because of the regular random setup inaccuracies 
(Eq.(7.5)) but due to an actual mistake in either the setup or the setup error measurement 
that occurred during one or more of the pre-correction setups. If this mistake is not 
reproduced in fractions 1ν  and 2ν , both Test 1 and 2 may reject 0H  despite correct 
execution of the prescribed correction. In this sense, COVER also tests for pre-correction 
setup and image analysis mistakes. In addition, a small but unavoidable fraction of the 
protocol restarts will be due to random setup errors leading to Type I errors in both Tests 1 
and 2 (see next section). 
In Fig. 7.1, we depict the combination of off-line SCP and COVER in a flowchart. The 
off-line SCP has been left unspecified in this chart. The only constraint on the SCP is that it 
 f = 0, C = 0
Y
N
Off-line SCP
Determine C
f:= f+Nm, T1 = 0
Correct C;
T1 = 0
T1 = 1
N
f:=f+1
Apply C
Measure xf
v1 = f
v2 = f
Test 1:
  H0 ?
T1 = 0 ?
Cause
identified ?
N
Finished
Y
Y
N
 C = 0
Y
Test 2:
H0 ?
Figure 7.1 Flowchart of the off-line setup correction protocol (SCP) and the correction 
verification (COVER) stage. Treatment fractions are numbered by f, the setup error 
measured in that fraction is xf, and the setup correction generated by the SCP is C. The 
fraction to which Test 1 respectively Test 2 are applied are indicated by v1 respectively 
v2 and T1 is a help variable which indicates if Test 1 is to be applied (if T1 = 0). Test 1 
and Test 2 verify whether hypothesis 0H (setup correction correctly executed) can be 
accepted. Further details are in the text. 
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should generate a unique setup correction after Nm fractions, but in principle Nm may be 
different for each patient. Below, we study COVER together with the NAL protocol and the 
full procedure will be referred to as NAL+COVER. 
 
7.2.4 Verification of NAL+COVER with Monte Carlo simulations 
In order to assess the performance of the COVER stage, we must revert to Monte Carlo 
(MC) simulations. Although the incidence of Type I errors may be evaluated analytically in 
some cases (Appendix), the impact of COVER in the presence of correction mistakes can 
only be properly evaluated using MC simulations. We have therefore extended the MC 
software originally designed for investigation of off-line SCPs [24] with the possibility to 
introduce correction mistakes and to verify correction executions with the described 
COVER procedure. Below, we describe the input of these simulations and the method of 
simulation. 
The population setup accuracy is defined by the distribution parameters 
( µ , Σ , mpσ , pδσ ) that would hold if no setup corrections are applied (section 7.2.1). The 
random inaccuracies in table couch translations are specified by couchσ . Optionally, the 
population distribution of linear time trends [17, 49], i.e. gradual shifts in the patient setup, 
can be specified through the SD of the average shift/fraction. The default distribution 
parameters for our simulations were obtained from a setup study we performed for a 
prostate patient population of 600 patients [24]. The setup of all patients was verified with a 
SAL SCP, and the setup errors that would have occurred without SCP were derived using 
Eq. (7.4).  The resultant systematic errors were nearly isotropically distributed and so we 
applied the mean of the values measured in the 3 setup directions to each direction in our 
simulations. Furthermore, the magnitude of the mean systematic error µ was ≤ 1 mm in 
each direction. Averaged over the 3 directions, µ = 0.7 mm, which was used for each 
direction. The measured distributions of random errors were also isotropic, reflected in 
nearly direction independent values of rσ [24]. In the Appendix, we describe how mpσ  and 
pδσ , which determine the random error distribution in this population, were estimated 
from the measured distribution of pσ .  We did not include linear time trends into our 
simulations, as we have shown that their net effect on the distribution of setup errors was 
negligible in this population [24]. In Table 7.1, the values for the distribution parameters 
used in the simulations are given. We will refer to the patient population characterized by 
these parameters as the clinical population as opposed to iso-random populations (section 
7.2.1).  
In the MC simulations, setup errors fppfp Sx ,, ∆+=  are generated for each patient p 
and fraction f in each setup direction. First, pS  and pσ  are drawn from normal 
distributions, respectively ),( ΣµΝ and ),( pmp δσσΝ  ( ),( baΝ denotes the normal 
distribution function with mean = a and SD = b) for each patient. Next, fp,∆  is drawn from 
),0( pσΝ  for each fraction and the values fppfp Sx ,, ∆+=  are processed by the off-line 
SCP to generate setup corrections SCP, fpc for subsequent fractions ("off-line SCP" block in 
Fig. 7.1). For those fractions in which an actual setup error is applied, the random couch 
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translation error fp,τ  is drawn from a normal distribution ),0( couchσΝ after which the 
simulated setup error SCP, fpx  is calculated according to Eq. (7.4) ("Apply C" block in Fig. 
7.1). This process is sufficient to simulate the impact of off-line SCPs on setup error 
distributions [17, 24] . In this paper, we simulated the NAL SCP with mN = 3 imaged 
fractions per patient, because this protocol ensures an acceptable distribution of systematic 
errors ( NALeff,Σ = 1 mm) for the clinical population discussed above [24]. Furthermore, a 
recent analysis of the improvement of tumor control probabilities in prostate patients after 
off-line setup corrections confirmed that a NAL SCP with mN = 3 is a sensible choice for 
populations with σΣ ≈  [4]. 
 
Table 7.1 Setup error distribution parameters (mm) for our clinical population of 600 
prostate cancer patients, if no setup corrections are applied. These parameters were applied 
in each of the three setup directions (isotropic distribution of errors) in the MC simulations. 
 
µ  Σ  mpσ  pδσ  couchσ  
0.7 2.3 1.9 0.4 0.5 
 
 
We have extended the MC simulation with the possibility of correction mistakes 
occurring in a sub-population of the patients. The fraction of patients with correction 
mistakes is defined by the mistake incidence ε, which can be selected between 0 and 1. For 
this sub-population, a correction mistake is introduced from the first fraction in which 
0|| SCP, >fpc  (the "Apply C" block in Fig. 7.1). The type of simulated mistakes can be 
specified.  We investigated 3 types, which are listed in Table 7.2 together with 
corresponding expressions for fpc , .  All three types may occur if the numerical values of a 
setup correction generated by software have to be copied manually. Furthermore, mistake 
types M2 and M3 can occur if the definition of axes (X,Y,Z) in the off-line SCP software is 
different from operator interpretation of those axes, or from their actual orientation due to a 
software configuration error (section 7.2.5).  
If the COVER stage is simulated, the acceptance threshold T must be entered. If 0H  is 
rejected in Test 1 while a mistake was actually simulated, the user can select if the cause of 
this mistake is identified and corrected by the (simulated) operators or not. If so, the "Cause 
Identified" test in Fig.7.1 always yields "Yes" and the mistake is not present in subsequent 
fractions; if not, the mistake will reoccur unless it is detected ( 0H  rejected) in Test 2. In the 
latter case, the protocol restarts completely (Fig. 7.1), but correction mistakes will no longer 
be simulated in subsequently executed setup corrections (i.e., correction mistakes are only 
simulated the first time the SCP generates a setup correction).  
 For each MC run, a treatment of 30 fractions per patient was simulated in at least 10000 
patients. For small ε, the evaluation of the effects introduced by correction mistakes may 
suffer from statistical noise. The following method was used to decrease such noise. If the 
asymptotic value (number of patients → ∞) of a quantity Q for a specific value of ε is 
)(εQ , some Q satisfy )1()0()1()( QQQ εεε +−= . This way, MC results obtained with 
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10000 or more patients for )0(Q and )1(Q  can be used to obtain )(εQ  for small ε with 
negligible statistical noise. An example of such a Q is the cumulative distribution of 3D 
systematic errors described below. 
 
Table 7.2 Correction mistakes introduced in the MC simulations. In this table, the 
subscripts p and f of the corrections c have been dropped. Instead, the corrections have been 
subscripted with the direction in which they are applied. SCPc is the correction prescribed 
by the correction protocol, whereas c  is the applied correction (apart from an additional  
random correction error). 
 
Type Description Applied corrections 
M1 Fixed offset of  Ω mm in X direction 
SCP
SCP
SCP
ZZ
YY
XX
cc
cc
cc
=
=
+= Ω
 
M2 Sign of correction in X and Z directions reversed 
SCP
SCP
SCP
ZZ
YY
XX
cc
cc
cc
−=
=
−=
 
M3 Cyclic mutation of corrections in X,Y,Z directions 
SCP
SCP
SCP
XZ
ZY
YX
cc
cc
cc
=
=
=
 
 
7.2.5 Strategy to establish the acceptance threshold T 
A Type I error during Test 1 will be referred to as a "partial" Type I error, since 0H  may 
still be accepted in Test 2. However, if a subsequent Type I error occurs during Test 2 the 
entire protocol will be restarted unnecessarily. Such a repetition of Type I errors will be 
referred to as a "complete" Type I error. Because both partial and complete Type I errors 
lead to increased workload while decreasing setup accuracy, their frequency should be as 
small as possible. The frequencies of Type I and Type II errors ( If  respectively IIf ) are 
defined as the probability that such errors occur in an arbitrary patient and are calculated as 
the number of Type I (II) errors divided by the number of patients. It is obvious that If  
will decrease with increasing T. The sensitivity to correction mistakes (1- IIf ) will also 
decrease with increasing T. COVER should therefore simultaneously reduce frequencies 
If  and IIf  to acceptable levels. We determined an appropriate value of T in four steps: 
Type I error frequencies were studied in a population in which no correction mistakes 
occur (ε = 0) for a range of T. Because, as argued previously and in point 3 below, the 
incidence of correction mistakes is expected to be << 1, these frequencies and ensuing 
workload are representative of what is expected in reality.  In the Appendix, we derive 
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closed form expressions for If  and the resulting workload associated with COVER if ε = 
0. 
The influence of the threshold T on the frequency of Type II errors was studied in a 
population with mistake incidence ε = 1 using MC simulations. For each patient with a 
Type II error, the correction mistake will be present in all subsequent treatment fractions. 
Using MC simulations, we could determine IIf  sorted according to the magnitude of the 
systematic errors they introduce. However, to evaluate the net result of all Type II errors, 
we evaluated the cumulative distribution of systematic 3D displacements in the patient 
population [17]. The 3D systematic displacement of patient p is defined by 
2/12
,eff,
2
,eff,
2
,eff, )( ZpYpXpN SSSd f ++= , where the displacement vector components can be 
obtained from Eq. (7.1). The following criterion for the cumulative distribution of 
fNd was 
applied to select appropriate thresholds T:  
If the NAL protocol is applied to the clinical population (Table 7.1) and correction mistakes 
occur in each patient (ε = 1), the fraction of patients with 
fNd > 5 mm  (hereafter 5>p ) 
after application of the COVER stage should be no larger than the corresponding fraction in 
case no setup corrections would have been applied. This constraint should be satisfied for 
each of the three mistake types in Table 7.2.   
 The value of 5>p  is chosen because it measures the quality of the systematic error 
distribution in a population of patients [17, 24]. If the above criterion holds for ε = 1, it will 
hold for any ε < 1 if systematic errors are indeed reduced by correct application of the SCP. 
Therefore, a COVER procedure that satisfies this criterion ensures that the application of 
setup corrections will result in a distribution of systematic setup errors equal to or better 
than that obtained without setup corrections. Because our criterion is very conservative 
(based on 100% incidence of correction mistakes), it is not clear a priori whether it can be 
met for a small value of If  (step 1 above). 
For a threshold T that meets the above criterion, the setup accuracy obtained with 
NAL+COVER for a realistic value of ε was evaluated. To estimate the expected magnitude 
of ε in a clinical situation, we evaluated correction mistakes detected in over 2000 patients 
treated with a SAL SCP in our hospital. Two instances were identified, both of type M2. 
These mistakes were due to wrong input to the off-line SCP program, i.e. operator errors. 
They were detected because the SAL SCP yielded increasingly large setup corrections after 
multiple iterations of the protocol (see Discussion). Although our current software design 
precludes this specific mistake to occur, software or machine configuration errors may 
always lead to similar mistakes. Based on the above, the value of ε measured in our 
institute is about 0.001. On the one hand, this is a lower limit because we can not be sure 
that each mistake was properly identified. On the other hand, because one origin of M2 
mistakes has been removed by a different software implementation, the current value of ε 
may be smaller. As a conservative estimate of the time averaged value of ε in a situation 
where insufficient attention is given to the appropriate execution of setup corrections, we 
chose ε = 0.05. The robustness of the workload and mistake detection efficiency of COVER 
against deviations between the assumed magnitudes of random setup errors (on which the 
value of T will be based) and the actual magnitudes was determined.  
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7.3 Results 
7.3.1 The increase of systematic errors due to correction mistakes 
In Figure 7.2, we display cumulative distributions of the systematic displacements in 3D, 
fNd  (section 7.2.5) as obtained from MC simulations using the parameters in Table 7.1 
(i.e., for the clinical population). If no setup corrections are performed, 5>p  is 24%, 
consistent with earlier results obtained in prostate patients [17, 24]. If the NAL protocol 
with 3 measurements per patient is applied and no correction mistakes occur ( 0=ε ) this 
fraction is reduced to 0%. The corresponding value of effΣ is 1.0 mm in each setup 
direction. In contrast, if a correction mistake of type M3 occurs in all patients ( 1=ε ) and 
no correction verification is applied, the resultant cumulative distribution displayed in Fig. 
7.2 is clearly worse than in case of no setup corrections; 5>p  has doubled to 47% and the 
distribution tail is extended. The corresponding SD of systematic errors is effΣ = 3.3 mm 
(in each of the 3 directions). Of course, the persistence of a situation with 1=ε would 
Figure 7.2 Cumulative distributions of the 3D systematic patient displacements, fNd , 
after 30 treatment fractions for the prostate patient population ('clinical population') 
described in the text, without any setup corrections (solid curve) and after application of 
the NAL protocol with 3 measurements per patient (long dash). The effect of M3 type 
correction mistakes in all patients and in 5% of the patients in case no COVER stage is 
applied is illustrated by the solid curve with squares and the short-dashed curve, 
respectively. 
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require that a systematic procedural error (e.g. in software configuration) goes unnoticed 
during SCP commissioning together with a lack of quality assurance on SCP results.  Such 
a situation should not occur if SCPs are conscientiously applied, but this case does 
emphasize the importance of COVER (see also Discussion). 
The distribution obtained for the NAL protocol for a mistake incidence ε = 0.05 is also 
depicted in Fig. 7.2. Obviously, the overall shape of the cumulative distribution remains the 
same, but the tail is raised. In fact, this distribution is simply the weighed mean of the 
curves with ε = 0 (weight 0.95) and ε = 1 (weight 0.05) (section 7.2.4). In this case, 5>p = 
2.5% and the tail of the distribution extends up to 1 cm. 
 
7.3.2 Type I errors and EPI workload in NAL+COVER 
The frequency of Type I errors was studied in a simulated population with no correction 
mistakes ( 0=ε ). First, we studied iso-random populations ( mpδσ = 0, section 7.2.1) 
for mpσ =1.5, 2.0, 2.5 and 3.0 mm while couchσ  = 0.5 mm (note that for iso-random 
populations, rσ  in Eq. (7.2) equals mpσ ). Both MC simulations and evaluations of the 
closed form expressions given in the Appendix were performed. Frequencies of partial and 
complete Type I errors (section 7.2.5) are shown in Fig. 7.3a and b, respectively. The 
required number of measurements per patient ( measN ) for the complete NAL+COVER 
procedure is given in Fig. 7.3c. Obviously, there is good agreement between the MC 
simulated and analytical results, which confirms proper implementation of the 
NAL+COVER procedure in our MC software. From the derivation in the Appendix we 
obtain that the Type I error frequencies in Fig. 7.3 are independent of the initial distribution 
of systematic errors, a result we confirmed by MC simulations for various values of Σ . 
Therefore, we conclude that knowledge of the random setup errors in the patient population 
is sufficient to predict the workload from the NAL+COVER procedure.  
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Figure 7.3 (a) Frequency of partial Type I errors (false alert in Test 1) as a function of the 
acceptance threshold T of the COVER stage following a NAL protocol with Nm = 3. Results 
obtained from MC simulations (closed circles) and analytical expressions (solid curves) for 
iso-random populations with mpσ = 1.5, 2.0, 2.5 and 3.0 mm (curves are labeled with 
mpσ value) and couchσ = 0.5 mm. The dashed line gives the MC result for the clinical 
population. (b) As (a), but now for complete Type I errors (false alert in Test 1 and 2). (c) As 
(a) and (b), depicting the number of EPI measurements per patient ( measN ). Because the 
minimum number of measurements is 4 (3 for NAL and 1 for COVER) irrespective of T, the 
vertical axis starts at this value. (d) Same as (a), but now the frequencies in (a) are plotted as 
a function of T/ rσ , which equals T/ mpσ for iso-random populations. The MC results for such 
populations are indicated by closed symbols. The dashed line gives the MC result for the 
clinical population. The solid line was obtained analytically for couchσ  = 0. 
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We also performed MC simulations for the clinical population (dashed lines in Fig. 7.3), 
in which mpr σσ ≈ = 1.9 mm (Table 7.1). The results slightly deviate from the iso-random 
population with mpσ = 2.0 mm, particularly the slope of the curves becomes less steep due 
to the presence of a distribution of pσ values. Nevertheless, these differences are small and 
unimportant in clinical practice. Note that for iso-random populations with 0couch =σ , the 
curves in Fig. 7.3 would scale in mpσ  (Appendix), i.e. if mpT σ/ is chosen as variable for 
the horizontal axis, all curves collapse into one. Since couchσ = 0.5 mm makes a relatively 
small contribution to the SDs that determine the shape of those curves (see e.g. Eq.(7.9)), 
this is to a high degree also the case for the results in Fig. 7.3. For instance, in Fig. 7.3d the 
MC results of Fig. 7.3a are redisplayed as a function of mpT σ/ , together with the 
analytical prediction for couchσ = 0. Obviously, a single curve is sufficient to determine the 
behavior for any of the studied mpσ  values. Again, the results for the clinical population 
differ little from the iso-random population with mpσ = 2.0 mm. 
Because partial Type I errors alert operators to a possible correction mistake while such a 
mistake is in fact not present, a high frequency of such errors will unnecessarily lead to a 
significant increase in workload. Therefore, the frequency of partial Type I errors should be 
small, say < 5%. Such a small frequency will also stimulate a high level of operator 
alertness to real correction mistakes. Then, for a practical protocol in the clinical 
population, T should be approximately 6 mm or larger and in general T should be at least 3 
× rσ (Fig. 7.3a and d). For such T, the frequency of restarts of the protocol due to complete 
Type I errors is ≤ 0.002 (Fig. 7.3b), implicating that in less than 1 in 500 patients the 
protocol will be unnecessarily restarted. Hence, Test 2 sufficiently filters the partial Type I 
errors. For T = 3 × rσ , measN  will not exceed 4.05 (Fig. 7.3c) in a population without 
correction mistakes, only slightly more than the minimum value of 4; the EPI workload 
from the COVER stage would thus be very small (1.05 additional measurement per 
patient). In the next section, we will verify if the choice T = 3 × rσ  is suited for the 
detection of significant correction mistakes. 
 
7.3.3 Detection of correction mistakes 
To assess the performance of COVER in detection of real setup correction mistakes, the 
NAL+COVER procedure was simulated for the clinical population and for all three types of 
mistake listed in Table 7.2. For a specific mistake type, the corresponding correction 
mistake was simulated in each patient ( 1=ε ). Furthermore, if COVER detected a real 
mistake in a given patient, the simulation continued on the assumption that the cause would 
be identified and the mistake eradicated for that patient. Mistake M1 was applied with a 
value Ω = 5 mm, which would constitute a severe mistake, particularly if it would occur in 
each patient. In Fig. 7.4, we show the resulting values of 5>p  as a function of acceptance 
threshold T for each mistake type. Obviously, 5>p  is quite independent of the mistake 
types investigated here. Based on Fig. 7.4, criterion (2) formulated in section 7.2.5 for 5>p , 
combined with 5>p  = 24% without setup corrections (section 7.3.1), yields T ≈ 6.5 mm as 
an appropriate acceptance threshold. This value meets the requirements for the maximum 
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Type I error frequency, T ≥ 3 × rσ  (previous section). Due to reasons of robustness pointed 
out in the next section, we choose T  = 3 × rσ = 5.8 mm in the results presented hereafter. 
Fig. 7.5 displays the simulated cumulative distributions of fNd obtained for 100% 
correction mistake incidence for the three mistake types as compared to treatment without 
setup verification and correction. For NAL without COVER, the M1 mistakes enhance the 
shoulder of the cumulative distribution while M2 and M3 mistakes strongly enhance the tail 
(long-dash curves in Fig. 7.5a-5c). As expected, application of NAL+COVER with T  = 3 
× rσ  and 100% mistake eradication after an alert by Test 1 of COVER, forces the 
cumulative distributions of fNd to be similar or even better than the distribution obtained 
without setup corrections (short-dash curve with closed squares in Fig. 7.5a-5c). 
The short-dash curves with open squares in Fig. 7.5a-5c are the cumulative distributions 
of fNd obtained if only 50% of the correction mistakes that yield an alert in Test 1 are 
eradicated (the mistake incidence was kept at 1=ε ). In this situation, both the shoulder and 
the tail of the cumulative distribution are still strongly reduced relative to no COVER stage. 
Even for this extreme case (only 1 out of 2 detected correction mistakes are solved while 
mistakes occur for each patient), the criterion 5>p  < 24% is still met for all three mistake 
types, demonstrating the robustness of the procedure against variations in the fraction of 
solved mistakes. This robustness stems from the fact that large mistakes that are not solved 
after Test 1 will often be confirmed by Test 2 and subsequently eradicated because of the 
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Figure 7.4 Probability that the 3D systematic patient displacement fNd  > 5 mm, in 
case of 100% correction mistake incidence (for each of the three types of correction 
mistakes in Table 7.2). Obtained from MC simulations for the case that alerts raised by 
Test 1 always resulted in correction mistake identification and eradication. 
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complete restart of the protocol (Fig. 7.1).  
Fig. 7.5d shows the effect of the COVER stage in case of the more realistic, but still 
large mistake incidence 05.0=ε  (based on simulations in which each detected mistake is 
eradicated). As can be seen by comparing the curves for NAL with 0=ε  and NAL with 
05.0=ε  in Fig. 7.2, only the tail of the cumulative distribution is significantly influenced 
by correction mistakes at the latter incidence level.  Hence, the cumulative distributions for 
05.0=ε  are shown for fNd > 4 mm. For each of the mistake types, COVER reduces 5>p  
from 2-3% to 1%. Moreover, COVER ensures that the fraction of patients with fNd > 1 cm 
becomes totally negligible. The workload for 05.0=ε due to COVER is less than 1.08 
measurement per patient, independent on the mistake type, which is close to what was 
obtained for 0=ε  (section 7.3.2). 
 
7.3.4 Robustness to uncertainties in the setup distribution parameters of a 
patient population 
Based on the above, we conclude that for T = 3 × rσ , the requirements of section 7.2.5 are 
met, at a workload which is very close to the minimum of 1 extra measurement per patient. 
In this section we investigate the effect on the workload, the number of protocol restarts 
and the detection efficiency of correction mistakes, if the measured parameters describing 
the setup distribution of the patient population is not entirely accurate, e.g. when derived 
from a limited patient data set.  
As demonstrated in the Appendix, for 1<<ε  the Type I error frequencies and workload 
of COVER depend solely on the distribution of the random setup errors. For an iso-random 
population, the accuracy with which the measured value of rσ  from Eq. (7.2) approximates 
the actual value can be calculated from the chi-square distribution [123]. In our institute, it 
has become standard to base the setup error distribution parameters on groups of at least 30 
patients with at least 5 imaged fractions per patient. For setup studies with 5 fractions 
imaged in 30 patients, the measured value of rσ  will be between rσ87.0 and rσ13.1  in 
95% of the studies. Therefore, if we would perform such a setup study in the clinical 
population of Table 7.1, and subsequently apply the rule T = 3× rσ , the derived T value 
would typically range between 5.1 and 6.6 mm instead of its optimal value of 5.8 mm. To 
study the workload and number of protocol restarts for this range of T-values we performed 
MC simulations for the clinical population and 0=ε . The value of T was varied over the 
above range, and kept independent of setup direction. These simulations were similar to 
those presented in section 7.3.2, but now the number of patients per MC run was increased 
to 30000 to precisely determine the restart rate due to complete Type I errors over the T-
range of interest. Note that, because in practice the inaccuracy in the measured value of rσ  
will differ per direction, the net effect of the inaccuracies in the estimate of T will in general 
be smaller than presented below; instead of the isotropic variations studied here (i.e., T was 
under-or over estimated by equal amounts in all 3 directions), the effects of inaccuracies for 
different directions will partly compensate each other. 
 Fig. 7.6 shows that, for the range of threshold values of importance, measN does not 
exceed 4.14; hence the COVER workload is no more than 1.14 measurement/patient. The 
fraction of patients with an unnecessary protocol restart is below 1% over this same range, 
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which we consider acceptably small. The robustness of the detection efficiency of 
correction mistakes against variation in T can be directly derived from Fig. 7.4. For a 100% 
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Figure 7.5 Cumulative distributions of the 3D systematic patient displacements fNd , 
from MC simulations; (a) The solid thick curve is the distribution obtained without setup 
corrections. The long dash curve is obtained if setup corrections are established with the 
NAL protocol, but wrongly executed with Type M1 mistakes (Table 7.2) for all patients 
( 1=ε ) while no COVER stage was applied. The short dash curve with closed squares is 
obtained if COVER with T = 3 rσ is applied and each correction mistake detected in Test 
1 of COVER is eradicated. The short dash curve with open squares is the result of the 
same COVER procedure, but now for the case that only 50 % of such detected mistakes 
are immediately identified and eradicated. (b) and (c) are as (a), but obtained for M2 
respectively M3 mistake types. (d) Tails of the cumulative distributions for COVER and 
no COVER stage if the correction mistake incidence is 5% ( 05.0=ε ) for each of the 
three mistake types. These distributions were obtained under the assumption that each 
mistake indicated by COVER in Test 1 is eradicated.
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incidence of the three mistake types studied, the COVER stage establishes that the 
criterion 5>p  < 24% is satisfied for the range of threshold values of interest, although just 
so for the largest values (T  = 6.6 mm).  
We conclude that the threshold T of the COVER stage can be determined on the basis of 
a setup study of the limited size described above. One could further reduce the number of 
patients if the number of setup measurements per patients is increased, but such an 
approach is only useful if the inter-patient variation pδσ  is small. 
7.4 Discussion 
 
We have described a correction verification procedure (designated COVER) to detect large 
mistakes in the execution of setup corrections at a small additional workload per patient. 
The criteria for the selection of the parameter T in the COVER procedure (formulated in 
section 7.2.5) were chosen conservatively. In particular, the requirement that the cumulative 
distribution of systematic displacements should not worsen due to correction mistakes for 
the very unlikely situation that each patient suffers from such a mistake ( 1=ε ), constrains 
the acceptance threshold T. An argument for choosing conservative criteria is that we have 
incomplete knowledge of the mistakes that may occur, and only a limited sample of 
possibilities can be studied. Nevertheless, we could reconcile these criteria with a workload 
due to the COVER stage that is very close to the minimal workload of 1 additional 
measurement per patient.  
The final result of the combined NAL+COVER procedure is partly determined by the 
type of correction mistakes that occur, but most importantly by their incidence. From Fig. 
7.5d, we see that the benefit of COVER for the relatively large incidence of 05.0=ε  lies 
mainly in reducing the tail of the distribution of systematic displacements. Although the 
height of this tail is already small without COVER (few %), COVER precludes large 
systematic displacements (> 1 cm).  This result can be quite relevant to individual patients 
if treatment planning margins are based on the expected small systematic displacements 
after setup correction (see the tightness of the 0=ε  distribution in Fig. 7.2). An equally 
important property of the COVER stage is that it will alert operators frequently in case of 
an error in the SCP procedure itself. For instance, a software configuration error may 
generate mistakes in the generated setup correction in each patient. As a result, the mistake 
incidence would make a jump transition from 0≈ε  to 1=ε , and the workload and alert 
frequency of Test 1 in COVER would strongly increase. If, for example, a software error 
would lead to M2 type mistakes (Table 7.2), then for the clinical population, the frequency 
of operator alerts would increase from 4% to 46%. Such an increase would undoubtedly be 
noticed and hence an 1=ε  situation will be detected rapidly. 
The acceptance threshold of the COVER protocol is based on a priori knowledge of the 
setup error distributions of the patient population. Alternatively, T could be made patient 
specific if the random setup errors measured during the Nm pre-correction fractions are 
taken into account.  However, for the 2 to 4 pre-correction measurements available in a 
typical NAL protocol [24], the accuracy of the measured value of pσ  is small. In fact, for 
Nm = 3, the measured value would be related to the true value through the chi-square 
distribution with 2 degrees of freedom [123]. As a result, the 95% confidence interval for 
the actual value of pσ would range from 0.5 to 6.3 times the measured value in any given 
patient. Hence it is not possible to develop an appropriate test (small Type I and Type II 
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error frequency, low workload) without use of a priori knowledge of the random setup 
errors, a result we confirmed by replacing the global geometrical test of Eq. (7.10) by a 
Student's t test [123] in our MC simulations. We found that, with the latter test, sufficient 
mistake detection efficiency could only be obtained at large Type I error frequencies [25].  
The NAL+COVER protocol aims at providing a low workload solution to off-line setup 
corrections. For our prostate population, the NAL+COVER procedure would require < 4.1 
measurements/patient to achieve the final systematic displacement distribution of the NAL 
0=ε  curve in Fig. 7.2. Because the NAL SCP was proposed as a low EPI analysis 
workload alternative to the SAL protocol [24], we should compare the workload of 
NAL+COVER to that of the SAL protocol.   
First, the workload of the COVER stage is not only determined by the number of 
required measurements, but also by the time required to falsify partial Type I errors (section 
7.2). We take the following actions to determine the nature of a possible error detected by 
COVER. In case of a setup correction, our EPID software automatically prints a form 
containing all relevant data so copying by hand cannot be the source of error. However, the 
corrections are performed manually by a technologist. Although a second technologist 
always inspects this correction, we first consider if the detected error is likely due to a 
manual execution error, e.g. in reading the numbers from the form. If not, we check if the 
data on the correction form used are identical to those presented by the EPID software. 
When the form is correct, the patient data input, i.e. the quality of the reference setup 
Figure 7.6 EPI workload (right vertical axis) and % protocol restarts (left vertical axis) 
in the clinical population for a range of acceptance thresholds T. This range reflects the 
expected statistical uncertainty in rσ  (hence in T = 3 rσ ) when obtained from a limited 
setup study. 
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images, the treatment plan data, the contours used in matching and the selected SCP, are 
verified. If no peculiarities are found, the search ends and the second verification 
measurement will be performed in the next fraction. The workload introduced by the above 
actions is small compared to the entire EPI workload, not only because each action requires 
little operator time but more importantly because they are necessary in less than 5% of the 
patients and generate further actions in an even much smaller group (section 7.3.2). 
Second, we compared the EPI workload of the NAL and SAL SCPs. We used methods 
described elsewhere [24] to determine SAL protocol parameters which yield a cumulative 
distribution comparable to that achieved with the NAL+COVER procedure (i.e. effΣ = 1 
mm). The optimal parameters are those that achieve such a distribution with a minimum 
value of measN . The optimal SAL parameters thus found were (α , maxN ) = (7.5 mm, 6), 
requiring measN = 9.5. Other SAL protocol parameters that achieved the specified 
cumulative distribution with less frequent multiple corrections (hence clinically more 
acceptable [24]), required measN ≥ 11. We also determined the minimum value of effΣ  that 
can be achieved with a SAL protocol of the same EPI workload as the described 
NAL+COVER protocol, i.e. measN = 4. We found that for this workload, the SAL SCP 
could not reduce effΣ  below 1.6 mm. In summary, the NAL+COVER protocol remains 
markedly more efficient than the SAL protocol, with the additional benefit that the 
reduction of systematic errors is realized early in treatment with a single setup correction.  
Third, we must evaluate how the SAL SCP treats correction mistakes because this is the 
reason behind COVER. If a setup correction is generated by the SAL protocol, the SCP 
restarts, and additional setup corrections may follow [13]. In practice, such multiple setup 
corrections are added together to provide the net correction [17]. For the clinical population 
described in this paper, patients with a setup correction had multiple corrections in over 
20% of the cases. This rate of multiple corrections is expected for the SAL protocol [17] 
and therefore operators are not prompted to search for a possible correction mistake. 
Multiple setup corrections in themselves increase the risk of correction mistakes, because 
the numerical values of the setup correction change over time.  More importantly, a large 
correction mistake will also lead to multiple setup corrections indistinguishable from 
'standard' setup corrections. As a result, whether the SAL protocol corrects such mistakes is 
dependent on the origin of the mistake. To illustrate this, we distinguish between software 
and operator mistakes.  
Operator mistakes may be dealt with effectively by the SAL SCP in some cases. For 
instance, if a prescribed setup correction is copied wrongly onto a form, which is 
subsequently used to execute the correction manually, the SAL SCP may detect this 
mistake through a large residue setup error and will generate a new correction. Because the 
SCP can not distinguish between actual setup errors and correction mistakes, the net 
correction will be calculated as if the previous correction was executed correctly. It can be 
shown that two additional setup corrections are required to eliminate the effect of the 
mistake, if the two subsequent corrections are both executed correctly. A disadvantage of 
this mechanism is that the origin of the mistake is never identified, and alertness to prevent 
mistakes is not raised.  
Software mistakes, on the other hand, may not be corrected but instead amplified by the 
SAL SCP. For example, we mentioned previously the clinical occurrence of an M2 type 
mistake. This was the result of wrong input of the patient orientation to the software at the 
start of treatment. As a result, all corrections generated by the SAL SCP contained the M2 
mistake for that patient. Although the SAL SCP detected the correction mistakes by 
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generating multiple corrections, each of these corrections suffered from the M2 mistake. 
The magnitude of the net setup correction grew to such a large value, that operators 
investigated the cause and solved the problem. However, nothing in the output of the SAL 
SCP indicated correction mistakes. The moment of mistake detection therefore depended 
on human observation. This is particularly worrisome as increasing automation tends to 
make software mistakes more important than human mistakes. Hence, it may be a better 
approach in general to extend SCPs by a COVER stage instead of using the SCP itself as an 
iterative verification tool. 
Although the final setup accuracy obtainable with NAL+COVER is high, actual results 
obtained with any SCP are only as good as the measurement accuracy. For instance, if the 
anatomical structures selected in the portal or reference image are not mutually consistent 
or a systematic patient rotation is present in the reference image, the applied setup 
correction can be inaccurate while post-correction measurements, based on the same 
structures, still indicate a seemingly satisfactory setup.  This problem of systematic 
measurement inaccuracy occurs in all SCPs and solutions must be found in careful image 
analysis procedures. For instance, for all prostate patient setups, we analyze opposed lateral 
fields to reduce as well as visualize the effect of e.g. rotations or patient movement in 
between beams [17]. Systematic measurement inaccuracies may also be detected if two 
observers perform the anatomy match independently. As indicated in section 7.2.3, COVER 
helps to detect large random measurement inaccuracies. If, for a specific patient, setup error 
measurements are significantly less accurate than in most patients, this will increase both 
the apparent random setup errors as well as the actual post-correction systematic setup 
error. Consequently, it is probable that the apparent setup error in the verification 
measurement exceeds the threshold T. The actions listed above to be performed after 
operator alerts may then help identify the source of the problem. 
We conclude that the NAL+COVER protocol is a safe and highly efficient means to 
reduce systematic setup errors. At present, we clinically evaluate the NAL+COVER 
protocol for prostate patients with the parameters described in this paper.  
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Appendix 
 
A. Derivation of the population distribution of random errors 
 
As described in section 7.2.1, the SDs of the random errors pσ  were assumed to be 
normally distributed among patients with distribution function ),( pmp δσσΝ . The squares 
in Fig. 7.7 show the distribution of pσ  values measured in 600 prostate patients [24]. In 
fact, because the pσ -distributions were similar for each setup direction, they were added 
so that the displayed distribution is based on 3 × 600 values. Because a finite number of 
setup measurements per patient is available ( measN = 10 [24]), each measured value of pσ  
is related to its actual value by the chi-square probability distribution [123]. Hence, the 
measured distribution of pσ values is not normally distributed if the actual distribution is, 
but rather a convolution of the normal distribution and the chi-square distribution. We used 
MC simulations to derive the actual distribution from the measurements as follows. 
3D setup errors were simulated in 10 fractions per patient for 10000 patients, where the 
actual value of pσ  was drawn from ),( pmp δσσΝ  for each patient. This process was 
repeated for a range of parameter values ),( pmp δσσ . Per pair of parameter values, pσ  
values were calculated from the simulated setups and compared to the measured set using 
the Kolmogorov-Smirnov (KS) statistic [104]. The KS statistic expresses the significance 
of a difference between two distribution functions of two sets of measurements (in our case, 
one set is measured pσ , the other set is simulated pσ ). Optimal parameters ),( pmp δσσ  
were sought by minimizing the KS statistic. By considering the significance of this statistic 
for the optimal parameters, the assumption of a normal distribution function for the actual 
pσ can be tested. Note that, for unconstrained parameters ),( pmp δσσ , the probability 
distribution ),( pmp δσσΝ  may assign finite probabilities to values of pσ  < 0. This non-
physical behavior was taken into account by truncating the distribution below pσ = 0 in the 
MC simulations. However, the KS statistic reached a minimum in a region of 
),( pmp δσσ values where the probability of pσ < 0 was completely negligible (see below). 
In Fig. 7.7 we show the frequency distribution of measured pσ  values in 0.25 mm wide 
bins. The 2 SD wide error bars were derived from the available number of measurements 
per bin [123]. The optimal parameters were ),( pmp δσσ = (1.9 mm, 0.4 mm) and these 
values are given in Table 7.1. The corresponding simulated frequency distribution is 
depicted by the dashed line in Fig. 7.7. The visual correspondence of the two distributions 
is confirmed by a large significance level of the KS statistic: p = 0.63. Therefore, a normal 
distribution of actual pσ values is an acceptable assumption; the solid line in Fig. 7.7 
shows the actual normal distribution for the optimal parameters given above. 
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B. Expressions for the Type I error frequency and Nmeas implied by COVER 
 
In this section, we will use the symbols introduced in section 7.2.3. For readability, we will 
drop the patient subscript p, as the analysis below will hold for each patient. We will 
assume that the random setup errors have a normal probability density function equal for 
each patient (iso-random) and that no correction mistakes occur ( 0=ε ). Then, the first 
post-correction verification measurement 11
cor
1 vx τδ∆νν ++=  (Eq.(7.8)) will be normally 
distributed with SD = 1νσ  as given by Eq. (7.9). For a single setup direction, the frequency 
of partial Type I errors, 1D I,pf  will equal the probability )|(|
cor
1 TxP >ν , which can be 
evaluated in terms of the standard error function ("erf"): 




−=>=
1
cor
1I,1D
2
erf1)|(|
v
p
TTxPf
σ
ν .         (A7.1) 
0
0.05
0.1
0.15
0.2
0.25
0.3
0 1 2 3 4 5 6
σp (mm)
Fr
eq
ue
nc
y
Figure 7.7 Distribution of random setup errors pσ in 0.25 mm bins. Squares with 
error bars (2 SD wide) are measured data from the clinical population (600 patients, 10 
measurements per patient), the dashed line is the corresponding MC result for 
distribution parameters ),( pmp δσσ = (1.9 mm, 0.4 mm). The solid line is the 
corresponding actual (normal) distribution of pσ . 
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For k setup directions, and isotropic distributions of setup errors, the partial Type I error 
frequency kD I,pf becomes 

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
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which was used to obtain the solid curves in Fig. 7.3a for k = 3.  
The frequency of complete Type I errors is slightly harder to obtain. For such an error to 
occur, both verification measurements must exceed the acceptance threshold: Tx >|| cor1ν  
and Tx >|| cor2ν . However, the probability )|(|
cor
2 TxP >ν is not independent of 
)|(| cor1 TxP >ν , because 22
cor
2 vx τδ∆νν ++=  contains the same δ -term as cor1νx  (in fact, the 
residue systematic error after correction). We write δνν += 1cor1 Rx  and δνν += 2cor2 Rx , 
where the stochastic quantity 1vR  is independent of 2vR , both being normally distributed 
like ),0( RσΝ  with 2couch2 σσσ += mpR  (section 7.2.3). Because the random setup errors 
are normally distributed, so is δ  with distribution ),0( resΣΝ  where the SD resΣ is given 
by Eq. (7.6) for the NAL protocol. We can now calculate the probability of a complete 
Type I error in one dimension: 
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where )(' xP  is the probability density function of  x. Substitution of the normal 
distributions described above for )(' xP  yields 
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The frequency of complete Type I errors in more than one dimension can be obtained from 
Eq. (A7.2) by substituting Icf  for Ipf . The expression in Eq. (A7.4) was evaluated using 
a modified Romberg method [104] to yield the solid curves in Fig. 7.3b (again for k = 3). 
With the above expressions, we can also evaluate the number of measurements required 
by the NAL+COVER procedure. The minimum number of measurements required to 
complete the procedure equals min1 NN m ≡+ . For a fraction of patients equal to kD I,pf , at 
least one additional measurement must be performed and for a fraction kDI,cf  the protocol 
must be restarted. For the latter group, at least another minN measurements must be 
performed, etc. As a result, the average number of measurements required per patient 
becomes 
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             (A7.5). 
By putting k = 3, the solid curves in Fig. 7.3c were obtained. 
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Abstract 
 
Purpose: To quantify systematic and random patient set-up errors in head and neck 
irradiation and to investigate the impact of an off-line correction protocol on the systematic 
errors. 
Methods and Materials: Electronic portal images were obtained for 31 patients treated for 
primary supraglottic larynx carcinoma who were immobilised using a PVC cast. The 
observed patient set-up errors were input to the shrinking action level (SAL) off-line 
decision protocol and appropriate set-up corrections were applied. To assess the impact of 
the protocol, the positioning accuracy without application of set-up corrections was 
reconstructed. 
Results: The set-up errors obtained without set-up corrections (1 standard deviation (SD) = 
1.5-2 mm for random and systematic errors) were comparable to those reported in other 
studies on similar fixation devices. On average, 6 fractions per patient were imaged and the 
set-up of half the patients was changed due to the decision protocol. Most changes were 
detected during weekly check measurements, not during the first days of treatment. The 
application of the SAL protocol reduced the width of the distribution of systematic errors to 
1 mm (1 SD), as expected from simulations. A retrospective analysis showed that this 
accuracy should be attainable with only 2 measurements per patient using a different off-
line correction protocol, which does not apply action levels. 
Conclusions: Off-line verification protocols can be particularly effective in head and neck 
patients due to the smallness of the random set-up errors. The excellent set-up 
reproducibility that can be achieved with such protocols enables accurate dose delivery in 
conformal treatments. 
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8.1 Introduction 
 
Radiotherapy treatment delivery in head and neck tumors requires a highly accurate and 
reproducible treatment set-up. The steep relation between tumor dose and tumor control 
probability (TCP) frequently observed in this region  [86, 92, 119], together with the large 
value of the 50% tumor control dose [92] implies that the TCP will be very sensitive to 
'cold spots' in the dose distribution and necessitates a good coverage of the entire target 
volume with a prescribed minimum dose [32]. Therefore, the local recurrence rate may be 
quite sensitive to set-up errors, as was pointed out early by Goitein and Busse for 
supraglottic lesions [47]. Similarly, due to the close proximity of sensitive structures (e.g. 
spinal cord, salivary glands) such set-up errors may lead to severe complications [86]. 
Specifically systematic set-up errors (repetitive errors that occur in each treatment fraction) 
may lead to an inhomogeneous dose distribution in the target volume and above tolerance 
doses in the critical normal tissues [55, 125].  
Numerous investigations on the patient set-up accuracy during head and neck irradiation 
have been reported, both using films (e.g. [19, 59, 140]) and electronic portal imaging 
devices (EPIDs) [15, 145, 146]. The latter devices allow for easy repeated imaging and 
image processing, rapid quantitative assessment of treatment set-up errors, and automated 
verification of the field shape [116]. Hence, apart from their application in studies on the 
set-up accuracy for a certain immobilisation technique, EPIDs facilitate accurate set-up 
verification and, if necessary, the application of set-up corrections.  
Although EPID guided set-up corrections based on a quantitative protocol have been 
applied successfully for some treatment sites [17, 28, 91], to date the application of such a 
protocol in the head and neck region has been either speculative [15, 39] or realised only in 
very small patient groups of two to six patients [102, 135, 146]. In an off-line decision 
protocol, the set-up correction for a given treatment fraction is entirely based on set-up 
measurements in previous fractions. Hence, these protocols can only reduce the systematic 
set-up errors [13], not the random day-to-day variations in set-up. As will be discussed 
later, the above mentioned small patient number studies are insufficient to determine the 
distribution of systematic set-up errors with an appreciable accuracy. Therefore, the effect 
of an off-line protocol should be studied in a larger patient group. In this paper, we describe 
the impact of a shrinking action level (SAL) protocol [13] on the set-up accuracy of 31 
patients treated for supraglottic larynx carcinoma. These patients were positioned using a 
commercially available head rest and mask system. Data are presented on both the set-up 
accuracy without application of the SAL protocol  (i.e., the accuracy achieved with the 
fixation device alone) and with set-up corrections (i.e., the improvement achieved with the 
SAL protocol). Based on the obtained results, we also evaluated a new correction protocol 
aimed at the reduction of systematic errors with less portal imaging workload.  
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8.2  Methods and Materials 
8.2.1 Patient group and set-up method 
The study group consisted of 31 patients with a (T1-4) supra-glottic larynx tumor without 
detectable positive lymphnodes in the neck (N0). In the first 23 fractions (nearly opposed 
beams at 70° and 290°), both the elective neck and primary tumor target volumes were 
irradiated to a dose of 46 Gy. Next, the primary target volume was boosted in 12 fractions 
(with beams at 90° and 270°) to a dose of 70 Gy. Details on the CTV definition and 
planning optimisation techniques are found in [37]. The patients were positioned in supine 
position using a commercially available polyurethane head support (Sinmed BV, The 
Netherlands; type CUS/14) with accompanying small base plate (PosifixTM). A transparent 
PVC mask fabricated from a plaster of Paris cast was attached to the base using 2-point 
fixation at both sides of the head (Fig. 8.1). Next, a planning CT scan was performed using 
5-mm slice thickness and a 3D-dose distribution was calculated using the CadPlan (Varian-
Dosetek, Finland) treatment planning system. Subsequently, set-up reference lines and the 
isocentre as defined by the treatment plan was marked on the patient mask on a simulator, 
and films of all portals were obtained for documentation. The films obtained at 270° were 
used as reference images for set-up verification in most patients; the last few patients who 
entered our study were scanned on a Picker CT-simulator and thereby high quality DRRs 
were available as reference images (based on 3 mm thick CT slices).  
Figure 8.1 Illustration of the PVC mask and base plate used in this study. 
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At the treatment unit, patients were positioned using the head support and PVC mask, 
after which the lateral and midline laser beams were aligned on the definitive isocentre 
demarcation on the mask. 
 
8.2.2 Image acquisition and analysis 
Since treatment beams were at slightly oblique angles during the first 23 fractions, and 
treatment fields were usually too small to discern anatomical structures useful in portal 
image analysis, an enlarged specific portal imaging field (PIF) was added [28] at a gantry 
angle of 270°. Patient set-up verification and correction was based entirely on the PIF. 
Given the orientation of the treatment beams, this was considered sufficient for this patient 
group.  
The exposure per PIF was 6 accelerator monitor units (MU), which, at a clinical doserate 
(200 MU/min), was the minimum exposure feasible at the accelerator at which this study 
was performed. No more than 8 fractions were imaged per patient (see section 8.2.3), so the 
cumulative PIF exposure was always less than 0.5 Gy. The contribution of the maximum 
PIF dose to the treatment plan was reviewed by the clinicians to evaluate the impact on the 
critical structures (e.g. parotid- and submandibular glands, spinal cord).  
The images were obtained with the new Theraview-NT EPID (Cablon Medical, the 
Netherlands) [26]. Although mechanically this EPID resembles the previous generation of 
Theraview EPIDs, there are notable changes. For instance, the tube camera was replaced by 
a CCD camera in order to facilitate accurate portal dosimetry. In addition, completely new 
software was developed which features the integration of set-up correction protocols in the 
image analysis process. 
After image acquisition, the field edge of the image is extracted and an automatic 
template match (which allows for variation of scaling in both directions, rotation and 
translation) with a prescribed field definition from the planning system is performed [90]. 
Once this match is completed, the co-ordinate system of the portal image has been 
established. At the same time, this match constitutes an automated independent verification 
of the delivered treatment field shape. From an analysis of long term measurements on the 
reproducibility of these field matches, we have found that the position of the projected 
isocentre within our the EPID images is known with an accuracy of 0.5 mm (1 SD) in any 
direction [90] and so we can measure patient set-up errors with respect to the isocentre with 
a high precision.  
The EPID software allows for delineation of anatomical structures in the reference 
images, which can be projected onto the corresponding portal images and subsequently 
shifted and rotated until a satisfactory match is achieved [28]. The anatomical structures we 
used in this template match are depicted in Fig. 8.2. The white contours were considered 
the most appropriate structures for matching since they are expected to exhibit negligible 
internal movement with respect to the target volume. These represent the spinous process of 
C2, the lower back of the skull, and the posterior aspect of the vertebral bodies (drawn as a 
single continuous line). Sometimes, the outlines of the separate vertebral bodies and the 
lower jaw were used to aid in the matching process. The latter structure was used only to 
detect possible jaw movement, and was not allowed to influence match results.   
Once a template match was accepted by the user, it was automatically input to the 
selected off-line correction protocol (i.e., the SAL protocol described in the next section) 
and the necessary set-up corrections were presented by the EPID software together with a 
review of all relevant data. 
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The reproducibility of the match results was determined from a repetitive analysis of the 
same set of portal images. For 5 patients, 2 fractions were selected and the corresponding 
10 images were matched 5 times, in 5 subsequent runs of 10 images by one of the authors  
(JRvSdK). Because the images of a single patient were always matched by a single 
observer, in most cases the aforementioned author, we consider the thus derived intra-
observer variation as representative of the measurement uncertainty in our study. The 
images were selected to represent the various image qualities and visibility of anatomical 
structures encountered in clinical practice. The interval between match runs was at least 
two hours and the runs were distributed over 2 days.  
 
8.2.3  Set-up correction protocol and corrections 
 To improve the set-up accuracy, in particular to reduce the systematic errors, we applied 
the off-line SAL protocol [13]. From measurement N = 1 onwards, the set-up error is 
averaged over the last N measurements for each measured direction, yielding a mean error 
vector NV  of length Nd . In our study, this vector has two components, the translation 
along the cranio-caudal direction (Y) and the ventro-dorsal direction (Z). The vector-length 
Nd  is tested against the action level for this measurement, NN /αα =  where α  is the 
initial action level. If the vector length exceeds the action level, a set-up correction is 
performed in all subsequent fractions and the procedure is repeated with N  reset to 1. This 
process continues until N = Nmax subsequent measurements have been obtained without the 
Figure 8.2 The anatomical structures used in our portal image analysis, indicated by 
white contours.  
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need for a correction, after which the 'first stage' of the protocol is finished. The first stage 
of the SAL protocol intends to correct initial large systematic set-up errors, and we aimed at 
finishing this stage no later than the second week of treatment. Applicable values of the two 
SAL protocol parameters α  and Nmax were determined from Monte Carlo simulations (see 
section 8.2.5) based on typical patient set-up accuracy values found in literature [15, 59, 
145]. The selected parameters (α , Nmax) = (5 mm, 2) ensured that the maximum remaining 
systematic patient set-up error is approximately 3.5 mm (i.e., max/ Nfinal αα = = 
2mm/5 ) while at the same time the PIF exposure remains below 24 MU (few patients 
would require multiple corrections with these parameters, and so the number of imaged 
fractions rarely exceeds 4 in the first stage).  
The second stage of the protocol is concerned with follow up measurements to assure 
that proper set-up accuracy is maintained throughout the treatment. In this study, second 
stage images were obtained once every two weeks during the first 46 Gy (irradiation 
includes the elective neck) and once a week during the last 24 Gy (irradiation of the 
primary target volume only). The set-up errors derived from these images were included in 
a running average of the set-up error vector over the last Nmax measurements. The length of 
the latter vector was compared with the fixed action level finalα . If a correction was 
necessary during the second phase, the protocol was completely restarted. This procedure is 
identical to the procedure we applied previously to other treatment sites [17, 28]. 
Set-up corrections were performed by first setting up the patient using the original 
isocentre demarcation, after which the treatment couch was shifted according to the set-up 
correction vector, i.e. NV− . We verified that these corrections could be performed 
accurately (1 SD = 0.3 mm, [28]) and with negligible added treatment time. Note that due 
to this procedure, we can assume that the execution of set-up corrections will have no 
influence on the rotation component of the set-up errors, i.e. rotations of patient anatomy 
relative to the intended set-up do not depend on whether a correction is executed or not. 
 
8.2.4 Set-up accuracy analysis 
We adopt the definitions introduced by Bijhold et al. [22] for systematic and random errors. 
The systematic set-up error for a specific patient is the mean set-up error of that patient. 
Formally, if the set-up error in a certain direction during fraction f is fx , and the total 
number of treatment fractions is fN , then the patient's systematic error is 
∑
=
−
=
fN
f ff
xNS
1
1 . Each patient p will have a systematic error, pS . The mean of pS over 
all patients in a given population is denoted by µ whereas its standard deviation (SD) is 
given by Σ .  
In addition to systematic errors, the patient set-up will be different for each treatment 
fraction, due to random set-up errors. The random errors can be characterised by the SD of 
the variations in fx . This SD, which we refer to by pσ for patient p, may be different for 
each patient. To characterise the random errors in a population an appropriate average is 
calculated over the patient group, which is denoted byσ [28].  
Our measured patient set-up data include the effect of a correction protocol. However, 
since we know the magnitude of the applied corrections and we can perform these 
corrections with high accuracy (see previous section) we can obtain the patient set-up data 
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that would have been measured without a set-up protocol. This method has also been 
applied in set-up studies on prostate [17] and lung cancer patients [28]. The data thus 
derived will be referred to as  'initial' and labelled with 'init'. Quantities directly based on 
the measured set-up data (which were obtained with the SAL protocol) will be labelled with 
SAL, e.g. SALΣ . The SDs of the random error will be calculated exclusively from the initial 
data, so that σσσ ≡≡ initSAL . The SD calculated from the initial data represents only the 
true random set-up variations (and of course the accuracy with which they can be 
measured; details are in [24, 28]). The SD of the random errors obtained from data with set-
up corrections, however, represents the true random set-up variations as well as the spread 
introduced by the set-up corrections.  
Note that with the off-line correction protocol we applied, only a subset of 
the fN fractions was imaged and analysed. This has some impact on the calculated value of 
Σ obtained from the measurements, particularly if the number of fractions imaged per 
patient (Nmeas) is small. If no set-up corrections are applied, pS is best estimated by 
∑
=
−
meas
1
1
meas
N
i i
xN  [28], where the summation is over the subset of fractions which have 
been imaged and analysed.  The value of Σ derived from these estimates is always slightly 
overestimated due to the random set-up errors, and the amount of overestimation can be 
easily calculated [28]. We corrected for this bias in our calculation of initΣ . In case of set-
up corrections, the measured value of Σ can also be biased with respect to its true value, 
and this bias depends on the set-up correction specifics, the number of imaged fractions, 
and the relative weights assigned to the available measurements. For simple limiting cases, 
such a bias can be expressed analytically, but in case of the SAL protocol we cannot derive 
such closed form expressions [13]. We therefore estimated the bias in SALΣ  from Monte 
Carlo simulations as described in the next section.  
 
8.2.5 Monte Carlo simulations 
We developed a 3D Monte Carlo simulation program [24] analogous to Bel et al. [13] to 
study the impact of correction protocols on patient set-up error distributions. The program 
simulates the systematic and random set-up errors occurring in a population of patients for 
a specific number of fractions per patient by drawing numbers from appropriate statistical 
distributions (in the current implementation, normal distributions) describing such set-up 
errors. Furthermore, per patient, the decisions that would be generated by an off-line 
verification protocol based on these simulated set-up errors are derived, and the effect of 
the application of the prescribed set-up corrections on subsequent fractions are simulated. 
Details of this process and validation of the results can be found in [13, 17, 24]. Here, we 
describe the program input relevant to the present study. The program requires, for each 
relevant direction, the parameters that describe the patient set-up distribution if no 
corrections are applied ( initµ ,σ , initΣ ) and the SD of the accuracy with which the set-up 
corrections can be executed by treatment couch shifts. The type of off-line verification 
protocol can be selected (e.g. the SAL protocol) together with the protocol parameters (e.g., 
(α , Nmax)). A correction damping scheme (i.e., the magnitude of the set-up corrections is 
reduced according to a priori information on systematic and random errors [45]) can be 
optionally selected. If applicable (as in the case of the SAL protocol), a 'second stage' 
follow-up protocol can be defined (see section 8.2.3). Finally, the number of treatment 
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fractions per patient ( fN ) and the number of patients per simulation must be given. All 
treatment fractions are always simulated, so that the accuracy of the results is only limited 
by the number of patients of the simulation run (104 patients in all simulations, unless 
mentioned otherwise). However, statistics are also calculated for the sample of fractions 
that would have been imaged in clinical practice, i.e. those fractions for which imaging is 
mandatory according to the selected correction protocol. Hence, biases in results based on 
actually measured data can be quantified. 
 
8.2.6 Evaluation of a new off-line protocol  
In previous work [23, 24], we have shown that the reduction of Σ achieved by the first 
stage of the SAL protocol is much lower than expected from the required number of 
measurements per patient. We therefore introduced the  "No Action Level" or NAL 
protocol, which has only one parameter, Nm. Within this protocol, for each patient the first 
Nm fractions are imaged and the systematic error vector is estimated to be the mean of these 
measurements 
mNV . In subsequent fractions a correction equal to mNV− is always applied, 
irrespective of the magnitude of 
mNV (apart from vector components with a magnitude 
below the accuracy with which table corrections can be executed) and the protocol ends. 
Hence, the number of measurements per patient is always Nm. The protocol is based on our 
clinical experience that the application of set-up corrections by couch translations requires 
nearly negligible treatment time [17], whereas the workload introduced by image analysis is 
considerable. 
To verify if clinical application of the NAL protocol would yield satisfactory results, we 
started with a retrospective application to a large database of measured set-up errors in 
prostate patients [23]. The database consisted of 3D set-up data for 600 patients where, on 
average, set-up errors for 10 fractions per patient were available. Next, for each patient, we 
applied both SAL and NAL protocols to the available set-up data  and calculated the effect 
of the corrections that would have been prescribed by these protocols. We found that the 
reduction of systematic set-up errors obtained with any SAL protocol could be achieved 
with significantly less measurements per patient using the NAL protocol. We then 
performed both a theoretical analysis of both types of correction protocols as well as Monte 
Carlo simulations analogous to those described above [24]. We found that, quite 
independent from the exact magnitudes of the initial systematic and random errors, a target 
magnitude of systematic errors (i.e. Σ ) can be achieved with a NAL protocol using 2-3 
times less portal images than a SAL protocol. Apart from the reduced imaging workload, 
this result is of particular importance in patient groups requiring dedicated PIF fields for 
set-up verification (section 8.2.2), as it enables a reduction of the dose given to healthy 
tissue without compromising on set-up accuracy. 
At the time the patient set-up study presented in this paper was performed, we had not 
yet devised the NAL protocol. However, because the NAL protocol allows for a completely 
analytical calculation of the attainable set-up accuracy if the SD of the initial systematic 
errors ( initΣ ) and random set-up errors (σ ) are known, we can reliably establish its 
outcome in retrospect [24]. In fact, the SD of the systematic errors obtained with NAL is 
approximately mN/NAL σΣ = , and hence depends primarily on the magnitude of the 
random set-up errors [24]. In addition, as mentioned above, we have incorporated the NAL 
protocol in our Monte Carlo simulation software (section 8.2.5) so we can verify both 
 147
analytical predictions and simulated results. We have used these tools to evaluate the 
efficacy of a NAL protocol in head and neck patients using the distribution parameters of 
the initial (no correction) set-ups obtained in our SAL protocol study.  
 
8.3 Results 
8.3.1  Match accuracy 
For each of the ten images, the SD of the reproducibility over the 5 matches was 
determined.  For the set-up error measured in the Y direction, these SDs ranged from 0.2 
mm to 0.9 mm, yielding a mean reproducibility over these images of 1 SD = 0.5 mm. For 
the Z direction, the corresponding range of SDs was 0.2 to 0.8 mm, and the mean was again 
0.5 mm. For rotations, the range over the ten images was 0.0° to 0.6°, with a mean SD of 
0.4°.  These small random match inaccuracies (i.e., intra-observer variations) have a 
negligible impact on the derived systematic and random patient set-up errors, as will be 
discussed below. 
 
8.3.2 Measured patient set-up accuracy  
Of the 31 patients we studied, 15 patients had at least one set-up correction (48%). The 
protocol resulted in an average number of imaged and analysed fractions of 6.1 per patient.  
Most corrections were detected during the second stage of the protocol (see below), during 
which the action level is actually constant. Nevertheless, the protocol did reduce the 
systematic errors significantly (Table 8.1). The mean systematic errors ( µ ) were reduced 
to below 0.5 mm, whereas the SD of the systematic errors ( Σ ) was reduced from 
approximately 2 mm to 1 mm in both directions.  The SDs of the random errors  (σ ) were 
approximately 1.5 mm in both directions, indicating that the fixation system ensures 
adequate patient set-up reproducibility. This partly explains why the systematic errors were 
already quite small initially [22], and why only half of the patients had their set-up 
corrected.  
The value of σ given in Table 8.1 is an average of the SDs of random errors measured in 
individual patients ( pσ ).  Since pσ  is slightly different in each patient, we can calculate 
the SD of pσ  in order to quantify the inter-patient variation in the random errors. 
However, the latter SD is partly determined by the sample size: if each patient had a true 
pσ  identical to the σ value given in Table 8.1, the measured pσ 's would not be identical 
due to the finite sample of 6 measurements per patient. The sample size thus presents a 
lower limit on the SD of pσ  measured in a real population, which can be quantified [28, 
123]. In our study, these limits equal 0.5 respectively 0.4 mm for the Y respectively Z 
directions. The measured SD of pσ  is 0.6 mm in both directions. This is close to the lower 
limit, indicating that inter-patient variation in random set-up errors is small in the patient 
group we studied. 
For one patient, a particularly large set-up error of 5 cm was detected during the first 
fraction. The source of this error was traced to the simulation, during which the isocentre 
demarcation had been placed at a wrong position on the patient’s mask. Once this mistake 
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had been corrected, the patient required no more set-up corrections.  The loss of tumor dose 
was calculated and corrected for during the subsequent fractions.  This case illustrates that 
portal imaging can very effectively minimise the possible damage that could ensue from 
incidental huge set-up errors. 
 
Table 8.1 Measured distribution parameters of patient set-up errors in 31 patients. Values 
are given for patient set-ups with and without the application of the corrections generated 
by the SAL protocol described in the text, labelled "SAL" and “init”, respectively.  
 
 
initµ  initΣ  σ  SALµ  SALΣ  
Y (mm)   0.6 1.6 1.6  0.3 1.1 
Z (mm)  -0.5 2.1 1.4 -0.5 1.2 
            θ (°)   0.0 0.5 1.1   
 
The SAL protocol allows for multiple set-up correction detections per patient [13], since 
after an applied correction, the protocol restarts. We found that 10% of the patients had 
multiple corrections detected and applied, comparable to the multiple correction frequency 
observed in applications of the SAL protocol to other treatment sites [17, 28]. In Fig. 8.3, 
the cumulative distributions of the 2D systematic errors  (length of the average set-up error 
vector, where the average is calculated over all treatment fractions) with and without set-up 
corrections according to the SAL protocol are shown. With application of the protocol, all 
Figure 8.3 The cumulative distributions of the 2D systematic errors (i.e., length of the 
2D vector) obtained without and with the SAL or the NAL correction protocols. 
0
20
40
60
80
100
0 2 4 6 8
2D systematic setup error (mm)
N
um
be
r o
f p
at
ie
nt
s 
(%
)  No corrections
 SAL simulated
 SAL measured
 NAL (N = 2) simulated
 149
mean 2D errors are < 3.5 mm, consistent with expectations (section 8.2.3). 
 In Table 8.1, the measured rotation errors in the sagittal plane (θ) are listed. As can be 
seen, the systematic components are small (0.0 ± 0.5° (1 SD)), and will have had only a 
small impact on match results. This result, together with the small value of the (less 
important) random rotations, confirms that rotation errors posed no problem in the studied 
patient group. Note that we did not separate rotations into values measured either with or 
without a correction protocol; they are identical due to the reasons pointed out at the end of 
section 8.2.3.   
If we correct the numbers in Table 8.1 for the finite match accuracy expressed by the 
SDs given in section 8.3.1, the impact is very small. Since the systematic errors are based 
on averages over approximately 6 fractions per patient, the correction of Σ  is minute.  The 
effect on σ  is approximately 5% for both translations and rotations, which we consider 
negligible.  
We analysed the rate of corrections during the 2nd stage of the protocol (see section 
8.2.3) in more detail, since it is the source of a significant workload: without this stage, the 
number of required images per patient is approximately halved.  In Fig. 8.4, we show the 
correction rates in the second stage as the number of measurements in this stage progresses. 
The correction rate for a certain measurement number N2nd in the second stage is defined as 
the probability of detecting the necessity for a set-up correction in that measurement. We 
chose to let N2nd count only the second stage measurements, i.e. not the 'in between' first 
stage measurements due to possible corrections detected in the second stage. We illustrate 
this procedure by considering a patient for which N2nd =1 at fraction 11. A correction is 
detected and applied after which the first stage SAL protocol is restarted. Given an Nmax 
value of 2, and the low probability of multiple corrections, this stage will be finished near 
fraction 13. Next, the second stage protocol starts again and a follow up measurement is 
performed at, say, fraction 19. This now becomes measurement 2 in the second stage (N2nd 
=2). If no correction is detected, the next follow up measurement increases N2nd to 3, etc. 
By not counting the measurements in the short periods of the first stage SAL protocol 
initiated during the second stage, the correction rates thus derived are representative for the 
spread in time of the corrections detected in the second stage. For instance, if the interval 
between 2nd stage measurements is 5 fractions, the x-axis of Fig. 8.4 should be multiplied 
by 5, to obtain the correction rate in time. From Fig. 8.4, we see that the measured 
correction rate decays slowly with time, certainly considering the statistical uncertainty 
expressed by the ± 1 SD error bars in that figure. These uncertainties were estimated as 
follows. If the correction rate at a certain N2nd is r, the expected number of correction 
detections is r × N where N is 31 patients in our study. We assume that the correction rate r 
is equal for each patient; this is a reasonable approximation once the first stage of the 
protocol is completed and if the inter-patient variation in the magnitude of the random set-
up errors is small (see above).  The actual number of corrections observed will then be 
binomially distributed with success probability p = r and N = 31 [123].  For such a 
distribution, the SD on the number of actually observed corrections can be estimated as 
)1(N rr −× , where r is the observed correction rate. 
8.3.3   Comparison with simulation results 
Monte Carlo simulations including both the first and second stage SAL protocol were 
performed assuming a correction accuracy of 0.3 mm (1 SD; see section 8.2.3). The values 
of  ( initµ , initσ , initΣ ) were taken from Table 8.1. The mean imaging frequency during the 
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second stage was measured to be once every 8 fractions (in between the weekly and 
biweekly frequencies described in section 8.2.3) and we used this frequency in our 
simulations.  
The simulations yielded set-up corrections in 49% of the patients, while on average 6.2 
fractions were imaged per patient. These values are very close to the actual values obtained 
in our clinical study (previous section). The fraction of patients with multiple correction 
detections was 16%, consistent with the measured value of 10% to within the noise 
introduced by the group size of 31 patients (this was confirmed by repeating simulations 
with only N = 31 patients instead of N = 104). Final systematic errors ( SALΣ ) were 
calculated both from the simulated fractions that would have been imaged using the set-up 
protocol (superscripted 'imaged' in Table 8.2), as well as from all simulated fractions 
(superscripted  'all', which by definition equals the true value of SALΣ ). As can be seen 
from Table 8.2, differences between the two values are very small, and both are almost 
identical to the measured values. Hence, we do not need to correct our measured values for 
the bias introduced by the finite sample of imaged fractions. In Fig. 8.3, the simulated 
cumulative distribution of the 2D systematic errors in case of application of the SAL 
correction protocol is shown. Again, the simulated and measured distributions correspond 
to within the statistical uncertainties posed by the measured data.  
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Figure 8.4 Frequency of corrections during the second stage of the off-line protocol as 
function of the number of check measurements in that stage. The solid line was obtained 
from simulations, whereas the closed squares were measured. The error bars represent ± 
1 SD estimates of the statistical uncertainty on the measured correction rates. 
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It is of interest that, although no time trends nor transient events in the patient set-ups 
were simulated, the simulations confirm the tendency observed in the clinical data that 
slightly more than 50% of the set-up corrections is detected during the second stage of the 
protocol. This second stage was initially intended to correct for time dependent changes in 
the systematic set-up error [17], but obviously its practical effect is quite different. In fact, 
the simulations show that the rate with which corrections are detected during the second 
stage decays slowly with measurement number (Fig. 8.4), and the simulated rates are fully 
consistent with the measured rates.  Hence, we conclude that the measured second stage 
corrections do not require time dependent changes in the systematic set-up errors. Instead, 
they can be ascribed to the statistical uncertainties in the decision process of the SAL 
protocol. The second stage corrections are inefficient if no time trends are present due to 
their late occurrence in treatment. Nevertheless, they do contribute to a reduction of 
systematic errors: our simulations showed that without the second stage, SALΣ would have 
been approximately 1.5 mm, instead of the 1 mm presently achieved (Table 8.1). 
 
Table 8.2 Patient set-up distribution parameters derived from simulations. The systematic 
variations obtained in Monte Carlo simulations of the SAL protocol were split into values 
that would have been obtained from the "imaged" fractions only, as well as from "all" 
fractions. The systematic variations obtained by application of a NAL protocol with 2 set-
up measurements per patient are given in the last column. The resulting systematic errors 
(from which NALΣ was obtained) were calculated from all simulated fractions per patient. 
 
 imaged
SALΣ  
all
SALΣ  NALΣ  
Y (mm) 1.0 1.1 1.0 
Z (mm) 1.1 1.2 0.9 
 
8.3.4  Evaluation of the NAL protocol  
Based on the approximate expression for the SD of systematic errors achievable with NAL 
( NALΣ ) given in section 8.2.6, we estimated that a NAL protocol with Nm = 2 
measurements per patient should yield similar results to the SAL protocol we actually 
applied. In the last column of Table 8.2, we show that for such a protocol, the remaining 
systematic variations NALΣ  are indeed approximately 1 mm in each set-up direction. In Fig. 
8.3, we give the cumulative distribution we would have obtained for a NAL protocol with 
Nm = 2 (the curve is taken from the Monte Carlo simulation, which is indistinguishable 
from the analytical result).  As expected from the NALΣ values in Table 8.2, this cumulative 
distribution is slightly better than the result obtained with the first and second stage SAL 
protocol combined, while the number of necessary measurements per patient is reduced 
from 6 to 2. This reduction is consistent with the expected reduction in workload discussed 
in section 8.2.6, and is made possible because the SAL protocol is rather inefficient. The 
SAL inefficiency is mainly due to the restart of the first stage of the protocol after each set-
up correction. Set-up information obtained before the restart is lost and so information on 
maximally Nmax measurements is used for any set-up correction. As a result, the value of 
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Σ can not be reduced appreciably below max/ Nσ  by the SAL protocol, even though the 
number of imaged fractions per patient can be much higher than Nmax. For instance, in the 
present study the number of imaged fractions per patient was 6, three times the Nmax value 
of 2. On the other hand, the NAL protocol uses information of each imaged fraction, and 
due to its lack of action levels does not require subsequent iterations.  
 
8.4 Discussion and conclusions 
Our data show that with careful daily positioning using a simple head and neck fixation 
device, random patient set-up errors with an SD of 1.5 mm were obtained, whereas the SD 
of the systematic errors becomes approximately 2 mm for both directions in the sagittal 
plane (Table 8.1). The rotations we measured in this plane were small. Furthermore, 
because such small random set-up variations can be achieved, the systematic errors could 
be approximately halved using an off-line set-up correction protocol. In this section, we 
will first evaluate our ‘baseline’ set-up accuracy, obtained without any set-up corrections, 
by comparison to similar studies (in fact, using portal imaging at the treatment unit and 
comparable fixation devices) in the literature. Next, we will discuss the increase in accuracy 
obtained with set-up corrections and further improvements for the future. 
The published studies on head and neck patient set-up accuracy can be roughly divided 
into two groups, the small patient number studies (N ≈ 10) and the medium to large patient 
number studies (N > 20). Unfortunately, the small patient number studies do not provide 
constraining information on the distribution of the systematic set-up errors. From statistical 
estimation theory, the confidence intervals for the actual value of Σ  can be readily 
obtained from the value measured in a group of N patients [123]. For instance, if a value of 
Σ = 1.5 mm was measured in a group of 10 patients, the 95% confidence interval for the 
actual Σ would be 1.0-2.7 mm, a range covering both quite narrow and relatively broad 
distributions of systematic errors. In contrast, the numbers on the random set-up accuracy 
are usually quite reliable even if N is small, provided there are sufficient measurements per 
patient and the inter-patient variability is limited. We considered the small number studies 
in which the magnitude of both systematic and random errors are clearly reported. These 
were (1) Hunt et al. [59], on the positioning of 6 nasopharynx patients immobilised with a 
customised aquaplast head restraint, (2) Bel et al. [15], investigating the set-up of 10 
patients with parotid gland or tonsillar tumors positioned in individual PVC head casts and 
(3) Yan et al. [145], who obtained set-up data for 12 head and neck patients immobilised in 
thermal plastic masks. For each study, we calculated the confidence interval of Σ and 
found it overlapped with the values of initΣ  listed in Table 8.1. Values of σ were in the 
range 1-2 mm in each study (the average values were Yσ = 1.4 mm, Zσ = 2.0 mm). Again, 
these values were consistent with our results (Table 8.1).   
 We also considered four studies with larger patient numbers. Weltens et al. [140] 
performed a set-up study on 43 head and neck patients positioned in either PVC or 
thermoplastic masks. Irrespective of the fixation device, they found random errors of 
magnitude σ = 2.1 mm in both the Y and Z directions. In their presentation of systematic 
errors, the three set-up directions can not be uniquely distinguished, but their values of 
Σ are approximately 3.5 mm.  These values are significantly larger than the systematic 
errors we obtained and outside the confidence intervals of the small patient number studies 
discussed above. Even larger systematic set-up errors were found by Mitine et al [87], for 
27 head and neck patients immobilised in plastic masks.  They measured Σ = 4.3 and 4.6 
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mm in the Y  respectively Z directions, and much smaller values of the random errors (σ = 
2.5 respectively 2 mm).  They concluded that set-up correction decisions based on a first-
day image is an effective procedure for head and neck patients, because in their case the 
large systematic errors could be found with a relatively high accuracy from such a single 
image. This is obviously not true for patient groups where the systematic errors are 
comparable to the random errors, as is the case in our study was well as some of the 
previously mentioned ones. Finally, Hess et al. [57] performed a study on 95 head and neck 
patients immobilised with individual synthetic casts, and derived deviations between 
simulation and treatment set-up from a verification film of a single treatment fraction. From 
their data we can derive the SD of the overall set-up error, which equals 22 σΣ + . By 
fitting an error function to the closed curve in Fig. 1 in [57] we obtained a value of 3.4 mm 
as a mean for both set-up directions. Again, this number is significantly larger than the 
value of 2.3 mm we calculate from Table 8.1.  
 The above studies pertain to various head and neck tumor sites and treatment 
techniques, and hence to various patient conditions, possible weight loss, etc. In addition, 
several manufacturing materials and methods were applied to construct the fixation devices. 
Nevertheless, the magnitude of systematic errors that were reported in these studies are 
comparable to, or sometimes larger than, the values listed in Table 8.1. The lower limit on 
the spread of systematic errors that can be achieved with conventional mask fixation 
devices therefore seems to be approximately 2 mm (1 SD). 
By applying set-up corrections, however, we could reduce the systematic errors further 
to Σ = 1 mm. Such small systematic errors will be of importance in highly conformal 
treatments. Moreover, the correction protocol ensures that the "tail" of the distribution of 
systematic errors can be controlled (Fig. 8.3), establishing a "guaranteed" accuracy in all 
patients. One extremely large set-up error, resulting from a misjudgement during 
simulation, was quickly detected and corrected for. The timely detection of such events 
requires regular portal imaging in all patients.  
Because portal imaged guided set-up corrections can yield small systematic set-up errors, 
the reference images against which these errors are measured become increasingly 
important. For most patients in the present study digitized simulator films were used. 
However, in our current daily routine the reference is defined by DRRs whenever 
appropriate CT data are available. Various studies have shown that set-up errors at the 
simulator (which become systematic if the simulator defines the reference position) are 
comparable to those at the treatment unit [28, 76]. Hence, optimal set-up accuracy for 
patients with CT planning requires the use of DRRs as reference images.  
 In this study, we applied the SAL protocol for set-up verification and correction, and 
required on average 6 imaged fractions per patient. We found that the reduction of 
systematic errors was partly established during the second stage of the protocol. Originally, 
the second stage was introduced to detect possible transient effects in the patient set-up 
[17], i.e. to verify if the concept of a constant systematic set-up error breaks down in certain 
patients. For instance, weight loss could introduce a time dependent factor in the systematic 
set-up error, and perhaps also in the magnitude of the random errors. In our study, we 
observed a slowly decaying rate of correction during the second stage (Fig. 8.4). Our 
simulations showed that this result can be entirely explained by the limited statistics on 
which correction decisions are based and does not require the presence of transient effects. 
In fact, the corrections for systematic set-up errors during the second stage are partly 
triggered by the noise introduced by the random set-up errors, and as such the effectiveness 
of this second stage is not optimal. Firstly, the relatively late point in time at which the set-
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up corrections are applied (on average, half way the total irradiation period) decrease the 
possible benefit of these corrections. Secondly, whether or not a patient has an actual set-up 
correction becomes somewhat arbitrary.  
It can be shown that, in general, systematic set-up errors can be reduced faster and with 
less imaging workload using the NAL instead of the SAL protocol  [23, 24]. The 
calculations presented in this paper confirm this result for head and neck patients: with 
information from only 2 fractions per patient, we predict a set-up accuracy slightly better 
than actually obtained with the SAL protocol using 6 imaged fractions per patient. The 
main reason for this increased efficiency was given in section 8.3.4. When dedicated PIF 
fields are used for set-up verification, as in our study, an additional benefit of the NAL 
protocol is the significant reduction of dose to healthy tissue without compromising on set-
up accuracy. At present, we are conducting a randomised prospective study to evaluate the 
NAL and SAL protocols in prostate patients, and are studying the necessity of verification 
measurements or other follow up measurements. If the expected reduction in workload is 
confirmed, we will rapidly broaden the application of this protocol to other treatment sites, 
including head and neck cancer patients.  
In conclusion we found that, although not optimally efficient, the SAL off-line protocol 
enabled the reduction and control of systematic set-up errors for head and neck patients 
immobilised with conventional PVC masks. The remaining systematic errors after 
application of this protocol were small (1 SD = 1 mm) and would have been very difficult 
to achieve using only masks. 
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Abstract 
 
Purpose: For cervix cancer patients, treatment fields may extend up to vertebra L1. In 
clinical practice, set-up verification is based on measured displacements of the pelvic rim as 
visible in the caudal part of the treatment fields. The implications of this procedure for the 
positions of bony structures in the cranial part of the fields were investigated. 
Methods and materials: Twelve patients had 4 repeat simulator sessions. Both during 
treatment simulation (the reference) and the repeat sessions anterior radiographs were 
acquired covering the whole treatment field. The films were used to investigate differences 
between the cranial and the caudal part of the treatment field in day-to-day bony anatomy 
displacements. 
Results: Both in the transversal and the longitudinal direction these differences were 
significant (3.5 mm, 1 standard deviation). Indications were found that large differences in 
cranio-caudal direction may be correlated with (non-rigid) internal pelvic rim rotations 
around a lateral axis. In the longitudinal direction, the position of L1 correlated much better 
with the position of vertebra S1 than with the position of the pelvic rim, which is usually 
used for set-up verification. 
Conclusions: Due to the non-rigid bony anatomy of the studied patients, the usual set-up 
verification and correction procedure can result in set-up errors of 10 mm and more for 
structures in the cranial part of the treatment field, even in case of a perfect set-up of the 
pelvic rim. Possibly, other patient set-up and immobilization procedures may result in a 
better day-to-day reproducibility of the 3D bony anatomy shape. (Remaining) differences in 
anatomy position changes between the caudal and cranial field ends may be accounted for 
by using non-uniform CTV-to-PTV planning margins, or by an adapted patient set-up 
verification and correction protocol. 
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9.1 Introduction 
 
Generally, treatment fields applied in radiotherapy account for uncertainties in the daily set-
up of the patient in the treatment beams as well as for internal organ movement e.g. due to 
breathing or variations in rectum or bladder filling [62, 63, 79, 80, 125]. The larger these 
uncertainties are, the bigger the selected treatment fields, and the higher the probability of 
treatment related morbidity. 
Patient set-up verification with Electronic Portal Imaging Devices (EPID) has been 
applied to reduce the uncertainty of the set-up of the bony anatomy of the patient in the 
treatment beams. EPID-images acquired during the first few treatment sessions have been 
used to minimize systematic deviations between the patient set-up during treatment and the 
reference set-up as defined by a simulator film or a digitally reconstructed radiograph 
(DRR) [17, 28]. Both systematic and random set-up errors have been minimized using 
daily-acquired images for on-line set-up verification and correction [91, 130]. Especially 
systematic set-up errors have a major impact on the magnitude of the required planning 
margins [125]. Several studies have been performed to investigate the use of EPIDs for 
detection and correction of internal organ movement, i.e. position variations of internal 
organs relative to the bony anatomy of the patient [3, 10, 36, 69, 129, 136].  
 For subgroups of cervix cancer patients [21, 94] we include the para-aortic nodes in the 
target volume, resulting in field lengths of up to 38 cm at isocentre distance. At the time 
that this study was performed, a Philips SRI-100 EPID was used for set-up verification of 
these patients. The (fixed) focus-to-detector distance of 160 cm resulted in a maximum 
detectable field length in cranial-caudal direction of 19 cm, defined at 100 cm from the 
focus. Therefore, bony structures in the cranial part of the treatment fields were not visible 
in the acquired EPID-images. 
In the present study we have used radiographic films to investigate implications of the 
clinically applied set-up verification, based on the pelvic rim as visible in an EPID-image, 
for the position of the (non-visible) anatomy in the cranial part of the field.  
 
9.2 Methods and materials 
9.2.1 Patients 
Twelve patients with a gynaecological malignancy were included in this study.  All patients 
were treated with postoperative external beam radiotherapy. The Clinical Target Volume 
(CTV) [62] included the primary tumor region, the parametria, the proximal 2/3 of the 
vagina, and the para-aortic, iliacal and obturator lymphnodes. The dose prescription was 
48.6 Gy, delivered in daily fractions of 1.8 Gy. All patients were treated in supine position. 
Long lateral, sagittal and transversal laser lines were marked on the patient. The 
intersection points of these lines were tattooed, together with the caudal field border. In 
case of discrepancy between the skin marks in longitudinal direction, the caudal field 
border tattoo was the decisive parameter for set-up [35].  
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9.2.2 Discrepancies between caudal and cranial anatomy displacements  
To study correlations between day-to-day variations in the bony anatomy position in the 
caudal part of the anterior treatment field with position variations in the cranial part of the 
field, all twelve patients had 4 repeat sessions on the treatment simulator with 1 week 
intervals. In order to always fully capture the complete treatment field, both during 
treatment simulation and during the repeat sessions, two anterior simulator films were 
taken, one including the caudal field border, the other with the cranial border; the time 
interval in between acquisition of the films was typically 1-2 minutes. The isocentre and the 
corresponding transversal and longitudinal cross hairs, and a common part of the bony 
anatomy of the patient of at least 20 cm in cranio-caudal direction were visible on both 
films. In the analyses, the imaged isocentres and cross hairs were used to position the two 
films relative to each other. The common anatomical structures visible in the two films 
were then used to inspect for patient movement on the treatment couch in between 
acquisition of the two simulator films. In that case the films were excluded from the 
analyses. Patient positioning on the simulator table was performed as on the treatment unit, 
using lasers, and lines and tattoos on the patients’ skin (see section 9.2.1).  
All films were digitised using a CCD camera and a frame grabber coupled to a PC. 
Delineation of bony anatomy and registration of delineated structures in the digitised 
reference simulator film and a corresponding repeat film were performed with in-house 
developed software written in AVS (Advanced Visual Systems, Waltham MA). 
Corresponding cranial and caudal films were analysed independently. In-plane rotations 
Figure 9.1 Partial delineation of the pelvic rim in a repeat film for measurement of the 
caudal anatomy translation (δXcaud, δYcaud) in relation to the reference set-up. 
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were small (<1°) and neglected in the analyses.  A description of the applied software is 
given by Stroom et al. [130]. 
For the caudal repeat films, the position of the delineated lateral parts of the pelvic rim 
(see figure 9.1) - which were judged to be appropriate indicators for the (primary) target 
volume position - was compared to the position in the corresponding reference film as 
acquired during treatment simulation.  For the cranial repeat films, delineations of the 
vertebrae L1 and L2 were used to assess position deviations with respect to the reference 
situation during treatment simulation. In the remainder of the paper, the symbols ∆X and 
∆Y refer to differences in deviations from the reference set-up between the cranial and the 
caudal field ends. E.g., ∆X = δXcaud - δXcran, with δXcaud the transversal displacement of the 
pelvic rim in the repeat film relative to its position in the reference film, and  δXcran the shift 
in transversal direction of L1/L2 in the repeat film relative to the reference position (see 
figure 9.2 for a graphical definition of  δXcran, δYcran, δXcaud,δYcaud, ∆X, and ∆Y).  
To assess the inter-observer variation, 80% of all analyses were performed by two 
independent observers. 
 
9.2.3 Pelvic rim out-of-plane rotations around a lateral axis  
It is well known that pelvic patients may have significant internal (i.e. non-rigid) rotations 
of the pelvic rim around a lateral axis. In an anterior film such a rotation may appear as a 
translation in longitudinal direction. In those cases, the rotations may contribute to the 
measured ∆Y. 
The influence of internal pelvic rim rotations around lateral axes on measured ∆Y values 
was (indirectly) studied by also assessing δYcaud displacements using fully delineated pelvic 
rims, instead of partial delineation (figure 9.1). In the absence of the above described out-
of-plane rotations, δYcaud, derived from partially or fully delineated pelvic rims, should be 
equal. Observed differences in  δYcaud between partial and full delineation for the subgroup 
of  repeat set-ups with ∆Y < 4 mm (group I) were compared to δYcaud differences in group 
cranial film
L1
L2 δXcran
δYcran
reference
repeat
caudal film
reference
repeat
δXcaud
δYcaud
pelvic rim
∆X=δXcaud-δXcran
∆Y=δYcaud-δYcran
Figure 9.2 Schematic definition of the quantitites δXcran, δYcran, δXcaud δYcaud, ∆X, and ∆Y. 
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II, defined as ∆Y ≥ 4 mm.  
For the repeat set-ups in group II, the changes with respect to the reference situation in 
the distance between the center of mass of L5 (point III in figure 9.3) and the center of mass 
of the pelvic rim (point IV) were determined. The latter investigations required 
simultaneous analyses of cranial and caudal films. This could not be done with the software 
mentioned above. Therefore, corresponding caudal and cranial films were positioned on a 
light box with the proper overlap (section 9.2.2) and measurements were performed with a 
ruler. 
 Hanley et al. [49] have described techniques to investigate the influence of out-of-plane 
rotations also using lateral fields. 
 
9.2.4  Vertebra S1 as a predictor for the position of L1 
For the studied patient group, the vertebra S1 is always visible in (the upper part of) an 
EPID-image. For the repeat set-ups with translation differences ∆Y of  4 mm or more 
(group II, see above), we investigated whether the center of mass of  S1 (point II in figure 
9.3) was a better predictor for the Y-coordinate of L1 (point I in figure 9.3) than the 
commonly used, partially delineated pelvic rim (see above). These analyses were also based 
on measurements performed with a ruler and films positioned on a light box (previous 
section). 
 
III
I
IV
II
L1
L5
Sacrum
Figure 9.3 The anatomical structures used for the ruler measurements on film. Points I, 
II, and III are the centre of mass of L1, sacrum and L5, respectively. Point IV is situated 
on the horizontal tangential defined by the two acetabuli, centred between the two 
vertical tangentials to the pelvic rim.
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9.3 Results  
9.3.1  Discrepancies between caudal and cranial anatomy displacements   
Of the maximum number of 48 differences ∆X and ∆Y in anatomy translation between the 
caudal and the cranial part of the treatment field that could be determined with the 12x4 
repeat simulator sessions, 2 observations ∆X and ∆Y had to be excluded from the analyses 
because of noticeable patient movement in between acquisition of the cranial and the caudal 
film. For the remaining 46 observations, the obtained translation differences, given in the 
format mean ± 1 standard deviation (SD), were ∆X = - 0.4 ± 3.7 mm  (range –10, +9 mm) 
and ∆Y =  1.0 ± 3.6 mm  (range –5, +15 mm), see Table 9.1.  
A second observer repeated an arbitrary selection of 36 of the 46 analyses. The observed 
mean differences between the first and second observer in δXcran and δYcran, as derived from 
measured displacements of L1/L2, and the standard deviations were 0.3 ± 1.2 mm and 0.1 ± 
1.5 mm, respectively. Differences in observed pelvic rim displacements yielded inter-
observer variations in δXcaud and δYcaud of 0.0 ± 0.8 mm and 0.5 ± 1.2 mm, respectively. 
The inter-observer variations in ∆X and ∆Y were 0.3 ± 1.4 mm and 0.0 ± 1.8 mm, 
respectively, which is consistent with the inter-observer variations given above as found for 
the separate cranial and caudal analyses. 
To correct the translation differences ∆X and ∆Y found by the first observer for inter-
observer variations, the standard deviations describing the variations between observers 1 
and 2 in ∆X (1.4 mm) and ∆Y (1.8 mm) were divided by √2 and then quadratically 
subtracted from the squared standard deviation of observer 1 for ∆X (3.7 mm) and  ∆Y (3.6 
mm), respectively. The corrected values for the standard deviations of ∆X  (3.6 mm) and 
∆Y (3.5 mm) show that observation errors are negligible compared to the found differences 
between the cranial and caudal parts of the anterior treatment field in anatomy position 
variations (Table 9.1).  The observed large standard deviations for ∆X and ∆Y point at a 
non-rigid bony anatomy in our patient group.  
 
Table 9.1 Translation differences. ∆X and ∆Y: mean displacement differences between the 
anatomy in the caudal field end and the anatomy in the cranial field end. The errors are 
standard deviations (1SD). X is the lateral direction, Y the longitudinal direction. 
 
 based on 1 observer corrected for inter- 
observer variation 
∆X (mm) -0.4  ± 3.7 -0.4  ± 3.6 
∆Y (mm) 1.0  ± 3.6  1.0  ± 3.5 
 
9.3.2 Pelvic rim out-of-plane rotations around a lateral axis 
For the groups I (N=36), and II (N=10), with small and large ∆Y, respectively, (section 
9.2.3) the observed differences in δYcaud between partially or fully delineated pelvic rims 
are 0.4 ± 0.7 mm (group I) and 0.7 ± 1.7 mm (group II); the latter standard deviations are 
corrected for inter-observer variations (1 SD = 1.1 mm) in the measured differences in 
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δYcaud related to partial or full delineation of the pelvic rim. Using a two-sided F-test to test 
statistical significance of the difference in the observed standard deviations (0.7 mm versus 
1.7 mm) yielded a p-value of 0.0001. The difference in the observed standard deviations for 
the two groups suggests larger pelvic rim rotations around a left-right axis for group II. This 
is confirmed by the standard deviation of 3.0 mm that was found for the measured distance 
variations between L5 (point III in figure 9.3) and the center of mass of the pelvic rim 
(point IV in figure 9.3) for film pairs belonging to group II.  
 
9.3.3 Vertebra S1 as a predictor for the position of L1 
For repeat set-ups with ∆Y larger than 4 mm (group II), the standard deviation describing 
the variation in the measured distance along the Y-axis between the center of mass of L1 or 
L2 and the center of mass of  S1 was only 1.0 mm. This is much less than the observed 
standard deviation of 3.6 mm (for the groups I and II together, section 9.3.1), describing ∆Y 
variations determined using the pelvic rim instead of S1. This data suggests that S1 is a 
much more accurate predictor for the Y-position of L1 than the pelvic rim.  
 
9.4 Discussion and Conclusions 
 
For subgroups of cervix cancer patients the para-aortic nodes may be included in the target, 
resulting in treatment fields as long as 38 cm (defined at isocentre). Using repeat simulator 
films for twelve of these patients, large discrepancies (standard deviations of 3.6 mm and 
3.5 mm in X- and Y-direction, respectively, and maximum deviations of 10 and 15 mm) 
were observed between displacements of the pelvic rim with respect to the reference 
situation (treatment simulation) and the corresponding displacements of the vertebrae L1 
and L2. These discrepancies are due to 3D bony anatomy shape changes (non-rigid bony 
anatomy), that are projected in the applied long treatment fields. Indications were found 
that the occurrence of the larger discrepancies in the longitudinal direction correlated with 
non-rigid, internal rotation of the pelvic rim around a lateral axis. In clinical practice, the 
usual set-up verification and correction procedure may result in errors of 10 mm or more in 
the position of structures in the cranial end of the treatment field, even in case of a perfect 
(corrected) set-up of the pelvic rim. 
At the time that we performed this study, a Philips SRI-100 EPID was used for set-up 
verification of these patients. Due to the fixed focus-to-detector distance (FDD) of 160 cm, 
the maximum detectable field length in cranial-caudal direction was only 19 cm (defined at 
isocentre distance). Therefore, bony structures in the cranial part of the treatment fields 
were not visible in the acquired EPID-images. In this study we have shown that the vertebra 
S1, which is visible in an anterior image acquired with the SRI-100, is a much better 
predictor for shifts in the Y-direction of bony structures in the non-visible cranial part of the 
treatment field than the pelvic rim. 
Our currently used TheraviewNT EPIDs (manufactured by Theraview Technology by 
Cablon Medical), have an adjustable FDD, resulting in a maximum detectable field length 
of 29 cm for an FDD of 130 cm. However, even if also displacements of structures in the 
cranial part of the fields may be detected, their use in set-up verification and correction may 
be not trivial in case non-rigid bony anatomy changes result in different effective required 
couch translations for cranial and caudal structures. 
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Other patient set-up and immobilization techniques may possibly result in a more 
reproducible 3D bony anatomy than observed in this study. (Remaining) anatomy 
displacement differences between the caudal and cranial field ends, as detected with the 
EPID, may be corrected by couch translations to cancel pelvic rim displacements, 
combined with field shape changes to properly include cranial structures in the treatment 
fields. Alternatively, increased treatment planning margins may be applied around the 
cranial part of the delineated CTV. Further investigations are needed to test or implement 
these, and possibly other strategies, in clinical practice.  
In this study, we investigated implications of the non-rigid bony anatomy of cervix 
cancer patients treated with long fields for set-up correction and verification. Also other 
patients are sometimes treated with very long fields, e.g. patients with Hodgkins disease. 
Detailed investigations for these other patient categories seem warranted. 
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 10 Discussion 
 
Although EPIDs were introduced clinically decades ago [5, 31, 72, 116], how to use them 
effectively is still a topic of research and debate [56, 72]. Apart from the relatively 
widespread use of the SAL set-up correction protocol [13], the general tendency is to 
develop and implement in-house methods for EPID-based set-up and dosimetric treatment 
verification. Furthermore, the formats in which results have been reported and the methods 
used to derive these results from measured data are still far from uniform. As a result, 
comparison of study outcomes is often difficult and sometimes impossible. Perhaps this 
non-uniformity is to be expected for a relatively young field of research. However, the 
current lack of standardisation of EPID-based verification methods is awkward as EPIDs 
serve to assure the quality of radiotherapy treatments, while radiotherapy relies in many 
other aspects on broadly accepted protocols (e.g. as issued by the ICRU).  
One of the main tasks of radiotherapy physics is to ensure that the prescribed dose is 
actually delivered. Although it is now well accepted that mobility of patient anatomy is an 
important issue in dose delivery, emphasis is still on QA in treatment preparation and 
treatment unit performance. The high degree of QA thus achieved in planning systems and 
treatment units is quite misleading if the volume in which dose is delivered is not equally 
well controlled.  
The lack of generally accepted strategies to apply EPIDs routinely is all the more 
surprising if one considers the suitability of EPIDs for QA purposes. In early studies, it was 
already shown that positioning errors could be accurately measured and corrected for with 
EPIDs [116], as confirmed by the generally small values of set-up errors reported in this 
thesis. Similarly, EPIDs based on CCD cameras have been shown capable of accurate 
dosimetry [chapter 2 of this thesis and references therein]. Nevertheless, a recurrent theme 
in meetings on EPI is the low degree of utilisation of EPIDs outside research purposes [56]. 
Below, we discuss some of the reasons for the infrequent use of EPIDs, and how these 
problems relate to the subjects treated in this thesis. 
 
10.1 Are EPIDs hard to use? 
AAPM Radiation Therapy Committee Task Group 58 (TG58) was initiated "to provide 
materials to help the medical physicist and colleagues in the clinical implementation of 
EPIDs in radiation oncology". In their recent publication [56], TG58 quantifies the 
disappointing use of EPIDs in the US and describes the main properties of commercially 
available EPIDs. Furthermore, procedures are described for routine maintenance of EPIDs 
and some clinical applications are discussed. This report is valuable as an introduction to 
new users, and provides guidelines that will assist in clinical EPID introduction. 
Unfortunately, TG58 does not provide much more information than previous EPID reviews 
[31, 116] as to why EPIDs are infrequently used, apart from the often-reported insufficient 
image quality. However, some of the essential reasons behind the lack of clinical EPID use 
are perhaps quite straightforward and will be discussed below. 
There exists a major gap between the software to acquire and analyse EPID images used 
in many published studies and the software commercially available. For example, our initial 
studies on patient set-up and dosimetry using the Philips SRI-100 EPID [2, 38, 52, 99], 
were only possible because of our knowledge of the accompanying software. As this EPID 
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was developed in collaboration with our institute, we could modify the source code when 
necessary. This software-tuning phase, as well as the transfer of knowledge accumulated 
during that phase, is often not sufficienty appreciated by EPID manufacturers. For instance, 
many of the procedures required for routine calibration and maintenance of EPIDs 
described by TG58 are not integrated in EPID software. In addition, the possibility to 
extract relevant patient information from the treatment planning system or treatment unit 
software is not universally available, requiring considerable manual labor to enter new 
patients in the EPID database. Similar limitations exist for importing reference images.  
Another hurdle is the lack of integrated and easily configurable patient set-up 
verification and correction protocols. Here, the user must often fall back on homemade 
software. Such protocol software must combine information measured in EPIs of various 
treatment beams and handle the involved co-ordinate systems properly. Furthermore, the 
possibility to query and review statistics obtained for a group of patients defined by user-
specified criteria is usually lacking. Given these examples of important limitations in 
commercially available software, routine use of EPIDs often implies a high workload and it 
is not surprising that EPIDs are used infrequently or incompletely in many radiotherapy 
centers. 
Finally, the relative success of EPID application in Europe, and certainly in the 
Netherlands, may be partly ascribed to the important role of technologists in the analysis 
and correction of patient set-ups. If the analyses of EPI and subsequent actions have been 
fully protocolized, and radiotherapists have agreed upon these protocols, the actual 
execution can be transferred to the technologists. The technologists in our hospital have, in 
general, found this a stimulating approach, as it helps them to visualize the accuracy of their 
work and to quantify and correct the set-up errors for patients that seem to be hard to 
position. At the same time, radiotherapists are relieved from the burden of tracking the EPI 
results of many patients on various treatment units, although they are informed in case of 
irregularities. 
 
10.2  Will flat panel imagers boost the clinical use of EPIDs? 
Lack of proper image quality is often mentioned as a reason for limited EPID use. 
However, the TG58 report [56] mentions that this observation is in contrast with the 
excellent quality reported in literature. The gap between what is achieved in specialised 
centers and the image quality available to the general user confirms our suggestion that 
both software and hardware of commercially available EPIDs insufficiently transfer the 
knowledge gained by research groups. We find that well-calibrated EPIDs have long been 
capable of providing proper image quality for most practical purposes (see below), but 
perhaps well-calibrated EPIDs are rare. The procedures described in the TG58 report, 
which are largely aimed at establising a working QA program for the EPIDs themselves, 
can help alleviate this problem. Because of promising image quality and recent commercial 
availibility, the attention has currently shifted to flat panel EPIDs (either based on direct or 
indirect radiation detection [5]) and the hope is that they will solve many EPI-related 
problems. However, below we argue that the benefit of flat panel detectors for regular 
portal imaging may be quite limited.  
 We have achieved small set-up errors (Σ ~ 1 mm, σ ~ 1-2 mm) using camera-based 
EPIDs for various treatment sites (this thesis). Furthermore, other groups have obtained 
similar results when using similar set-up protocols [17, 73, 75, 135, 138, 139]. Hence, the 
image quality of EPIDs over the past years has certainly been sufficient for accurate 
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determination of the position of relevant (bony) anatomical landmarks. This is confirmed 
by the small inter- and intra-observer inaccuracies reported in this thesis. As described in 
chapter 2, CCD camera-based EPIDs (CEPIDs) have a track record for precise transit 
dosimetry as CCDs are extremely stable and highly linear detectors [38, 52, 69, 97, 99-
101]. Although the optical cross-talk is much smaller in flat panels than in CEPIDs [5], 
cross-talk in CEPIDs can be accurately corrected for [chapter 2 and references therein].  
Moreover, the glare generated in the fluorescent screen is also present in indirect flat panel 
imagers [82]. Furthermore, frame-transfer CCDs allow for instantaneous complete sensor 
read-out and therefore are highly suited for verification of dynamically delivered IMRT. 
It has been shown in chapters 4, 5, and 8 that EPIs of 10 MU or less, obtained with a 
CEPID with an uncooled CCD camera (chapter 2), allow for accurate set-up verification 
based on anatomical landmarks. Even if dedicated "imaging only" fields (PIFs) are 
required, and the total dose delivered in these fields to uninvolved tissue may not exceed ~ 
1 Gy, this exposure is sufficiently low for off-line correction protocols, particularly in case 
of the NAL protocol (chapters 6 and 7). Using a cooled CCD camera, we have shown that 
exposures can be lowered to such levels that on-line protocols based on PIFs become 
possible [11] (see below).  
EPIDs can also be used for the visualisation of organ position and movement through 
small implanted markers. Marker positions have already been measured using various 
camera-based EPIDs [9, 65, 126, 136, 137]. We have obtained images using a CEPID 
equipped with a sensitive, cooled CCD [11]. Various clinically applied markers, including 
small platinum ones (diameter 0.9 mm, length 3 mm) could be observed at exposures of 2-3 
MU in lateral images. The straightforward image processing applied to these images and 
the less than optimal use of the CCD camera dynamic range implies that we can push 
exposures even lower. The spatial resolution, as expressed by the half-value frequency of 
the normalised MTF [106] was f50 = 0.36 lp/mm, markedly larger than in conventional 
CEPIDs [118]. Equally important, the occurrence of 'hot pixels' due to radiation damage by 
photo-neutrons produced at photon beam energies > 10 MV, was strongly reduced by the 
Peltier cooling of the CCD.  After 8 months of operation on an intensively used Linac 
(radiating most of the time at 23 MV) no hot pixel has yet been observed and the dark 
current pixel-to-pixel variations are still extremely small. This result promises a dramatic 
increase in lifetime compared to non-cooled radiation damaged CCDs, which usually do not 
last much longer than 12 months at beam energies > 15MV. Hence the largest problem of 
CEPIDs (gradual loss of image quality) has been tackled.  
Another benefit of flat panel devices that is often mentioned is their compact design. 
Although this design allows for a more compact state when retracted, the large cross-
section when deployed offers less clearance than camera-based EPIDs when in actual use. 
Furthermore, large fields cannot be imaged with flat panel imagers and asymmetrical fields 
in general require extra caution, because radiation damage to the electronics surrounding 
the actual detector area must be prevented. Given the large financial costs still involved 
with these panels and the uncertainty about their lifetime in clinical environments, the case 
for flat panel EPIDs may not be entirely obvious.  
We conclude that the limited clinical use of conventional EPIDs is mainly due to poor 
calibration and provision of relevant tools by their manufacturers, and therefore not 
inherent to the technical capabilities of these devices. Hence, even if flat panel EPIDs 
become the default choice, their clinical use will be largely limited by the same factors as in 
previous EPID types. In particular, the lack of user-friendly software tools means that local 
efforts are required and quantitative regular use, especially if set-up corrections are 
involved, may still be unattainable in many clinics.  
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10.3 Off-line set-up corrections: is early verification sufficient?  
In this thesis, we described the development of treatment verification and correction at an 
acceptable increase of portal imaging related workload. The focus was on reduction of 
systematic errors, as it was shown in a population statistical approach that such errors 
require larger geometrical planning margins than random set-up errors (chapter 3).  
In contrast to the huge number of set-up studies in which the magnitude of observed set-
up errors is reported for various treatment sites, the number of studies in which patient set-
up is actually corrected on the basis of EPI is still quite limited. In particular, there are only 
a handful of studies in which set-up corrections are based on a more than very crude 
protocol [60, chapter 6].  
For many years, the shrinking action level (SAL) protocol has been the standard for off-
line corrections [13]. In this protocol, the magnitude of the systematic error is estimated as 
the mean of the measured set-up errors and compared to an action level which shrinks as 
the number of measurements increases (in fact as n/α  where α is the initial action level 
(mm) and n is the number of measurements). The shrinking level reflects the increased 
accuracy of the estimate of the systematic error with increasing number of measurements. If 
no correction was necessary during a specific number of measurements (Nmax), the protocol 
has finished. If a set-up correction is required, the protocol starts again and hence requires 
at least Nmax more measurements to finish (see Chapters 4-8 for details). The No Action 
Level (NAL) protocol introduced in chapters 6 and 7 has a different approach. It is based on 
the observation that, since off-line protocols correct for a systematic set-up error, one 
should not correct before this error is known with sufficient accuracy. It is straightforward 
to derive that if set-up corrections are determined from the average set-up error in Nm 
measurements, one achieves mN/residue σΣ = after correction (chapter 6). As the 
distributions of random set-up errors and systematic errors before correction are often 
comparable ( σΣ ≈ , chapters 3-9, and references therein), off-line set-up corrections based 
on a single measurement (Nm = 1, e.g. a check during the first fraction) are ineffective. In 
the NAL protocol, early in the fractionated treatment, each patient is imaged for Nm 
subsequent fractions without any correction and the systematic error is estimated as the 
mean set-up error in those fractions. In the remaining fractions, this error is always 
corrected for by a table shift; there is no action level involved. By the formula given above, 
Nm fully determines the residue systematic errors for the patient population. Due to various 
reasons, discussed in chapters 6 and 7, the NAL approach reduces systematic errors with 
much less measurements than the SAL protocol and a reduction in workload of a factor 3 
can be achieved.   
The NAL protocol may serve as a model for a protocol in which the systematic errors are 
corrected for early in the fractionated treatment. For such protocols, however, systematic 
shifts of patients over the course of treatment (time trends) would not be detected. We will 
therefore address the issue of these time trends at some length. Since the first quantitative 
report on their magnitude [41], it is widely accepted that repeat measurements during the 
entire treatment period are mandatory. We will first discuss available literature on time 
trends, both on bony anatomy as well as on prostate movement. We will also present initial 
results of a prospective study on the efficacy of the NAL protocol in prostate patients, 
which included an analysis of time trends. Finally, we investigate whether a practical 
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protocol could be devised to detect significant trends at an early stage based on a 
statistically valid criterion.  
 
10.3.1 Time trends in published studies 
Time trends in set-up errors have been mainly analysed in terms of 'linear trends': when the 
patient is positioned on external marks, the actual position of the (bony) anatomy shifts by a 
fixed amount relative to the previous treatment fraction. A clear mechanism for such linear 
trends is lacking, and it is important to stress that large trends can never be linear. After all, 
there are physical limits to the amount of mobility of patient anatomy relative to the 
fixation device or skin, particularly when one considers a systematic time dependent shift. 
Linear trends may therefore only serve as a first order description pertaining to small 
effects.  
The first systematic study on time trends was performed by El-Gayed et al. [41], who 
studied two small patient groups (10 prostate and 10 rectal carcinoma patients) and no 
detailed studies have become available since, with the exception of Hanley et al. [49]. As 
discussed in chapter 5, there are reasons to doubt the statistical value of the evidence on 
trends given in these publications. But there are other, non-statistical doubts about the 
importance of the trends reported in these studies. El-Gayed et al. [41] mention that 
progressive displacements with time due to gradual changes in muscle tension would 
predominantly cause non-linear trends, i.e. the fraction-to-fraction displacements would 
decrease in magnitude as treatment progresses. However, these authors subsequently state 
that such non-linear trends were not observed in their study. They propose that the large 
linear trends they did observe (leading to displacements over time of 1 cm) were due to the 
non-randomness of re-inking skin marks. Therefore, their paper, which inspired most 
subsequent trend investigations because of the large magnitude of the reported trends, 
suggests that these trends may in fact not be related to patient posture or anatomical 
variation, but are a consequence of their procedure of re-marking. Contradictory to this 
observation, they maintain that repeated imaging over the course of treatment is necessary 
for proper set-up correction, a thought that has found foothold since.  
In the study of Hanley et al. [49] on set-up accuracy in 50 prostate carcinoma patients, it 
is concluded that the statistically significant trends are clinically insignificant, i.e. the net 
displacements due to significant trends are no larger than 2-3 mm. In a retrospective 
analysis, Yan et al. [145] reported time dependent drifts in 4 out of 27 lung patients and 8 
out of 25 pelvic patients. Unfortunately, the magnitudes of the trends are not mentioned, 
and it is unclear if the Kalman-filter method they applied to determine optimal set-up 
corrections actually tests for statistical significance. As such, this study does not present 
quantitative information on the importance of trends. In a recent study by Alasti et al. [1], 
in which 32-41 fractions per patient were imaged in 23 prostate patients, no evidence for 
time trends was found, but it is not evident how the set-up correction protocol applied by 
these authors influenced that result. 
The set-up studies described in this thesis strongly suggest that time trends are 
unimportant. In the N = 600 prostate patients study (chapter 6), we have shown 
retrospectively that the NAL protocol reduces systematic errors efficiently over the entire 
treatment period. The distribution of systematic errors measured prospectively with the 
SAL protocol followed by weekly verification measurements were consistent with the 
results from Monte Carlo simulations (MC) of set-ups without time trends. This consistency 
with MC includes important observed variables such as detection frequency of corrections, 
 168
distribution of number of corrections per patient and the fraction of patients with 
corrections. In particular, the relatively large frequency of corrections detected during the 
weekly measurements in the so-called second stage of the protocol [17] is reproduced in the 
MC simulations. If we consider the sub-group of 454 prostate patients with SAL parameters 
α = 9 mm, Nmax = 4 [13], both measurements and simulations without time trends show that 
the SAL protocol yields corrections in approximately 30% of the patients, whereas the 
second stage increases this number to 50%. Therefore, frequent and large trends are no pre-
requisite for explaining frequent corrections in the second stage. Instead, MC simulations 
show that such corrections are rather the result of repeated application of the action-level 
test. Nevertheless, the second stage is necessary in combination with SAL, not in particular 
to reduce the effect of trends, but to reduce systematic errors to the commonly accepted 
levels of Σ = 1-1.5 mm which are usually not achieved by SAL alone [17, chapter 6]. 
Similar results regarding the second stage and trends were found for head and neck patients 
(chapter 8). In fact, because possible weight loss in the latter group may incur increased 
mobility within the patient mask, we investigated in detail whether the correction 
frequencies generated in the second stage required time dependent changes in the 
systematic set-up errors. Within the error of measurement, this was not the case (section 
8.3.3). 
 Based on the available publications, we conclude that there are no published population-
based set-up studies for bony anatomy to support the claim that time trends need to be taken 
into account. Rather, there seems to be substantial support for the statement that trends are 
unimportant. Nevertheless, we thought that definitive acceptance of a NAL-like protocol, 
based solely on set-up measurements in the initial part of the fractionated treatment, 
demanded a prospective study to exclude potential adverse effects due to time trends. The 
initial results of such a study are presented below. 
 
10.3.2 A prospective study on NAL and the importance of time trends;  
preliminary results 
We studied 30 prostate cancer patients in the NAL protocol with Nm = 3, according to the 
methods described in chapter 6. A set-up correction was executed if it was larger than 1.5 
mm in the left-right or superior-inferior directions and larger than 1.0 mm in the anterior-
posterior (AP) direction. After correction, the accuracy of the applied correction was 
validated with the COVER procedure described in chapter 7. Once this procedure was 
completed, image analysis was finished for the technologists at the treatment unit, who 
applied the same set-up correction for all subsequent fractions. For the purpose of our 
study, as many fractions as possible were imaged. These images were intended solely for 
post-correction monitoring of the systematic error and were analysed in 'background' with 
no feedback to the treatment unit. In the same period, 55 patients were treated with our 
standard SAL protocol for prostate patients, which includes a second stage of weekly 
verification measurements ([17], chapters 4 and 8). 
 The number of measurements per patient required for the NAL + COVER procedure was 
4.0, for SAL it was 9.6. However, for the NAL patients, set-up data was available for, on 
average, 23 fractions per patient with a good coverage over the entire treatment period. This 
allowed for an accurate determination of residue systematic errors in this group. The 
resultant cumulative distributions of the 3D systematic displacements are given in Fig. 10.1. 
There is no statistically significant difference between the distributions achieved with NAL 
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and SAL, despite the fact that, contrary to NAL, SAL did include weekly verification 
measurements.  
Since no 3D systematic displacement exceeded 4 mm for NAL, this result demonstrates 
that time trends played no role of importance. In fact, NAL reduced the values of Σ from 
1.6-2.2 mm to 1.1 mm in each direction, whereas MC simulations without time trends 
yielded a Σ-value of 1.0 mm in each direction. Given the sample size of 30 patients, MC 
and measured values obviously correspond within statistical uncertainty (p = 0.47). As a 
result, there is no need for time trends to describe the set-up data measured in this study. 
Nevertheless, given the well-sampled set-up data in the NAL patient group, we could 
analyse linear trends independently. The trend magnitude and statistical significance were 
determined with linear regression analysis [41, 49]. Apart from p < 0.05, we required that 
the trend magnitude should lead to a net displacement over 30 post-correction fractions of 
at least 3 mm in order to be clinically significant. In addition, post-correction set-up data 
had to be available over a time period spanning at least 15 daily fractions to identify lasting 
trends. The largest trend thus observed was 0.14 mm/fraction (AP direction), yielding a 
maximum displacement from fraction 5 to 35 of 4 mm. Hence, the increase in the 
systematic error for this particular patient and direction was 2 mm. Note that part of this 
trend may well be due to statistical noise, as the SD of the trend magnitude due to finite 
sampling, even in this well sampled study, is approximately 0.06 mm/fraction. A more 
general statistical analysis was performed, the details of which are beyond the scope of this 
Figure 10.1 The cumulative distribution of the 3D systematic setup errors obtained for 
30 patients treated with NAL (solid line) and 55 patients with SAL (dashed line). The 
distribution obtained if no corrections would have been applied was identical in both 
groups and is given by the solid line with squares. 
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discussion. We only mention here that the distribution of the trend magnitudes over the 
patients is approximately given by 0.0 ± 0.03 (1 SD) mm/fraction (corrected for the 
statistical noise described above), all under the assumption that linear trends did indeed 
occur.  This narrow distribution of trends confirms that trends played no role of importance 
in the studied patient group. 
 
10.3.3 Internal organ motion and time trends 
The studies discussed above pertain to bony anatomy, whereas internal organ motion might 
introduce different trends. The largest and most detailed study presently available 
investigated the position of the prostate and seminal vesicles in 50 patients in prone 
position through multiple CT scans over an 8-9 week period [85]. Trends were not observed 
in the population as a whole, nor where any strong individual trends seen over the entire 
treatment period. These findings are consistent with a similar earlier study on prone 
positioning in prostate patients [127]. In the latter study, a time trend for patients in supine 
position was observed in the sagital plane but this trend was non-linear and its effect 
vanished towards the end of treatment. The trend was associated with a difference in 
laxation procedure between planning and repeat scans. The net displacement ascribed to the 
trends was 1-1.5 mm in the AP and cranial-caudal directions during part of the treatment 
period, quite small compared to the systematic displacements due to prostate movement 
alone (Σ  = 2.5-2.7 mm) in the same group. Hence, at present no indication for important 
trends in prostate position exists. Furthermore, the small observed trends can be 
counteracted with appropriate procedures (e.g. prone positioning). We are not aware of 
similar studies on time trends for other target organs.  
 
10.3.4 Can time trends be detected in time using a statistical criterion? 
Suppose that a treatment site could be found in which trends are an important limiting 
factor to the set-up accuracy achievable with off-line correction protocols. In that case, 
trends should be identified at a sufficiently early stage. Since systematic errors of Σ = 1-1.5 
mm can be achieved on a routine basis with off-line corrections, a systematic error larger 
than 3 mm in a specific direction has become rare. Hence, if systematic set-up errors are 
reduced effectively during the first treatment week, a gradual patient shift of 5 mm over the 
entire treatment period would introduce an unexpectedly large error. As pointed out above, 
such a shift is close to what one would expect to be the maximum trend that can be 
described linearly. If 30 fractions are delivered after the initial set-up correction, the shift 
per fraction is 0.17 mm. This magnitude is much larger than trends actually observed in our 
NAL study (previous section) and its probability of occurrence, based on the SDs given 
there, is entirely negligible. Nevertheless, even such a large shift would be hard to find 
amidst random displacements with a typical SD of σ = 2 mm. We assume that trends will 
be detected by the linear regression method described above [41, 49], i.e. the slope of the 
linear fit to the measured set-up data is tested for statistical significance. If the significance 
level p = 0.05 and set-up errors are measured every day, we derive that approximately 20 
fractions need to be imaged and analysed to detect the 0.17 mm/fraction trend with 50% 
probability. Obviously, this would be a highly inefficient procedure, requiring a vast 
workload to detect trends at a late stage. Furthermore, if so much imaging per patient is 
feasible, on-line corrections, which render time trends unimportant, become the evident 
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choice. Instead, if time trends are sought with weekly imaging  (say once in 5 fractions), the 
spread in time helps to detect trends with fewer measurements. Nevertheless, we then find 
that at least 8 measurements would be required and hence important trends are not likely to 
be detected before fraction 35.  
The required number of measurements derived above holds if first all measurements are 
obtained, and next the significance of a possible trend is established. In practice however, 
one would reassess the significance of a trend with each new measurement. This implies a 
rapid increase of false trend detections for conventional significance levels of about 0.05. 
Suppose that 3 set-up measurements are performed during the first week of treatment and 
that the significance of a time trend is determined on the basis of subsequent weekly 
measurements. The probability of false trend detection increases with each measurement, 
particularly since 3 set-up directions are tested independently. We performed MC set-up 
simulations for patients in which no time trends occurred and who had random set-up errors 
σ = 2 mm in all 3 directions. We assumed that 4 weekly check measurements were 
performed (i.e. approximately up to fraction 25) and a trend was deemed significant as soon 
as a measurement yielded p < 0.05 and a predicted shift over 30 fractions of at least 3 mm. 
Because no trends were simulated, any significant trend was a false detection due to 
statistical uncertainty. Such false detections occurred in 40% of the patients. To reduce this 
unacceptably large false detection rate to 5%, the statistical significance level must be 
lowered to p = 0.005. However, large actual trends of the magnitude discussed above would 
then be detected in only 6% of the cases and even huge trends, causing displacements of 1 
cm, would have a probability of detection of less than 30%. We conclude that no 
satisfactory procedure exists to detect large trends at a suitably early stage without incurring 
a tremendous rate of false positives.    
 
10.3.5 NAL-based set-up corrections: conclusions 
As stressed above, most studies have found no evidence for relevant time trends, even in 
large patient groups. Hence, there are obviously positioning methods that render the 
occurrence of trends rare to non-existent in all studied sites. This implies that the NAL 
protocol can yield a significant workload reduction compared to conventional protocols 
without loss of positioning accuracy, as demonstrated clinically in section 10.3.2. It should 
be appreciated that off-line protocols are aimed at creating an acceptable distribution of 
systematic errors for a patient population. As indicated above, weekly verification 
measurements are not suited for discrimination between time trends and random set-up 
fluctuations. Therefore, only if a huge number of false positive detections are allowed, the 
effect of hypothetical time trends may be reduced. It is questionable if the very infrequent 
or even purely speculative occurrence of an actual trend warrants the large workload 
involved with weekly imaging for all patients. This is particularly true if that workload 
limits the application of set-up corrections to a small group of patients, while the increase 
of accuracy in that small group due to weekly imaging is negligible. One could even argue 
that, in case of dedicated PIFs (chapters 4, 8) where healthy tissue is irradiated only for 
imaging purposes, the lack of a convincing demonstration of trends further precludes 
weekly check measurements and a protocol like NAL is the optimal solution.   
Recently, the effect of NAL set-up corrections was analysed from a radiobiological point 
of view for prostate cancer [4]. It was demonstrated that, for Σ ≥ σ, a NAL protocol with 
Nm = 3 was sufficient to gain most of the benefit in tumor control probability incurred by 
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set-up corrections. The optimal efficiency of such a protocol under similar conditions was 
also derived in chapter 6 on purely geometrical grounds. 
In chapter 7, we developed the COVER procedure as an extension of NAL, in order to 
verify the proper execution of set-up corrections with minimal workload. We think that set-
up corrections will ultimately become fully automated. EPID and accelerator control 
software will be interconnected and all corrections will be performed automatically through 
treatment couch shifts. Consequently, the validation of the correction execution will occur 
primarily in the acceptance phase of the EPID-accelerator-treatment couch interface. In 
principle, this would allow for a NAL protocol with only Nm and not Nm+1 measurements. 
Nevertheless, it is likely that a post-correction image will still be required to satisfy the 
physician, as well as for administrative or legal purposes and so the COVER procedure 
would remain a useful method to detect systematic errors in the procedures used for set-up 
correction. 
The NAL protocol, combined with COVER, is now applied in our clinic to position 
prostate, lung, head-and-neck and gynaecology patients. Furthermore, we are investigating 
the use of NAL for correction of systematic positioning errors rooted in internal organ 
movement (as detected in EPI with markers), since the prevailing importance of decreasing 
systematic errors early in treatment also holds true for internal motion.  
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Samenvatting 
 
For a summary in English, see section 1.5 
 
Dit proefschrift behandelt de theoretische onderbouwing en klinische toepassing van 
efficiënte methoden ter bewaking van de kwaliteit van radiotherapeutische externe bundel 
bestralingen met behulp van 'Electronic Portal Imaging Devices' (EPIDs). Deze methoden 
zijn ontwikkeld vanuit de gedachte dat ze, naast effectief, ook  relatief simpel te 
implementeren moeten zijn en dat de toegevoegde werklast op de bestralingstoestellen klein 
is. Een belangrijke reden achter deze criteria is dat de acceptatie van het gebruik van EPIDs 
in de dagelijkse praktijk op een systematische, geprotocolleerde wijze, sterk achter is 
gebleven bij initiële verwachtingen.  
Met EPIDs worden afbeeldingen gemaakt van de bestralingsbundel waarin de 
doorstraalde patiëntanatomie, zoals geprojecteerd door deze bundel, zichtbaar wordt. Op 
deze manier kunnen positioneringsfouten (afwijkingen ten opzichte van de geplande 
situatie) van de patiënt ten opzichte van de bundel worden gemeten. Daarbij blijkt het 
essentieel te zijn deze fouten te scheiden in systematische fouten (die gedurende iedere 
bestraling van een bepaalde patiënt optreden) en willekeurige of 'random' fouten (die voor 
iedere bestralingssessie ('fractie') van een bepaalde patiënt anders kunnen zijn). Met name 
de reductie van systematische fouten blijkt een efficiënte methode om onderdosering van de 
tumor te voorkomen.  
Door de intensiteiten in de EPID afbeeldingen te analyseren kan ook de bestralingsdosis 
die in de patiënt is afgegeven worden gecontroleerd. Met een toenemende complexiteit van 
de technieken die gebruikt worden om de juiste driedimensionale dosisverdeling in de 
patiënt te verkrijgen wordt een dergelijke controle steeds belangrijker. 
 
Hieronder volgt een beknopt overzicht van hoe bovenstaande onderwerpen in de diverse 
hoofdstukken aan bod komen. 
 
Hoofdstuk 1. Introductie 
De scheiding van positioneringsfouten in systematische en random fouten wordt in detail 
uitgelegd. De beschrijving van de distributie van deze fouten in een populatie van patiënten, 
essentieel voor latere hoofdstukken, wordt toegelicht.  
 
Hoofdstuk 2. Beschrijving van de TNT EPID en dosimetrische toepassingen 
In dit hoofdstuk geven we een technische omschrijving van de EPID die in al het 
beschreven werk is toegepast. Deze EPID is in onze kliniek ontwikkeld, in eerste instantie 
als prototype in het kader van een NKB project, en momenteel in een samenwerking met 
Cablon Medical (Leusden, Nederland). Alhoewel de techniek zich sterk heeft ontwikkeld 
sinds het prototype dat in dit hoofdstuk wordt beschreven, zijn belangrijke elementen (zoals 
het gebruik van een CCD camera als lichtdetector) behouden gebleven. Tevens is de 
beschreven methode om EPID beelden om te rekenen naar 2D transmissiedosisverdelingen 
onveranderd. Deze methode, die kan worden toegepast op basis van een vrij beperkte 
hoeveelheid calibratiemetingen,  is specifiek voor EPID systemen waarin de afstand tussen 
de fluorescerende laag en spiegel (Fig. 1.1) groter is dan in conventionele EPIDs. 
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Hoofdstuk 3. Relatie tussen positioneringsfouten en planningmarges 
In de radiotherapie wordt het tumorvolume dat bestraald moet worden met een bepaalde 
minimum dosis (clinical target volume of CTV) bepaald door de radiotherapeut in 
bijvoorbeeld een CT scan. Echter, door  positioneringsfouten tijdens de bestraling kan dit 
volume verplaatst zijn ten opzichte van de bestralingsbundel waardoor onderdoseringen 
kunnen optreden. Om dit te voorkomen, wordt het CTV meestal uitgebreid met een 
bepaalde marge naar het planning target volume (PTV) en tijdens de computerplanning van 
de bestraling wordt zorg gedragen dat dit uitgebreide volume met de vereiste 
minimumdosis wordt bestraald.  
Hoe groot de uitbreidingsmarge moet zijn als de verdeling van systematische en random 
fouten in een populatie van patiënten bekend is, is het onderwerp van hoofdstuk 3.  Hiertoe 
wordt het zogenaamde 'coverage probability' (CP) model gebruikt, waarin de 
waarschijnlijkheden dat een bundel de tumor juist bedekt worden berekend aan de hand van 
eerdergenoemde verdelingen van de positioneringsfouten. Op deze manier kan worden 
geëvalueerd wat, uitgaande van een bepaalde marge rond het CTV en een gegeven 
dosisverdeling in het zo gecreëerde PTV, de dosisverdeling in het CTV, gewogen over alle 
mogelijke positioneringsvariaties, zal worden.  
Door bepaalde voorschriften op te leggen aan deze gemiddelde dosisverdeling kunnen 
toepasselijke marges worden uitgedrukt in te grootte van de systematische en random 
fouten in de populatie. Daarbij blijkt dat systematische fouten leiden tot zo'n 3 maal grotere 
marges dan random fouten van dezelfde grootte. Het is daarom vooral van belang om 
systematische fouten zoveel mogelijk te beperken, opdat de bestraalde volumina zo klein 
mogelijk kunnen blijven en anderzijds de kans op onderdoseringen kan worden 
geminimaliseerd. Naast een dergelijk marge 'recept' voor een populatie, kan het CP model 
ook worden gebruikt om op individuele basis veilige uitbreidingsmarges af te leiden. 
 
Hoofdstukken 4 en 5: onnauwkeurigheden optredend tijdens het vastleggen van de 
referentiepositionering voor bestraling van longkankerpatiënten en effectiviteit van 
positioneringscorrecties tijdens de bestraling 
In hoofdstuk 4 wordt ingegaan op de nauwkeurigheid waarmee het tijdens de 
computerplanning vastgestelde bestralingsplan wordt vastgelegd tijdens de zogenaamde 
bestralingssimulatie, toegespitst op de situatie voor longkanker patiënten. Tijdens de 
simulatie wordt de bestraling nagebootst en worden markeringen geplaatst op de patiënt of 
op patiënt-fixatiemiddelen om deze situatie vast te leggen en later te reproduceren op het 
bestralingstoestel. Daarbij worden doorlichtingbeelden gemaakt (simulatiefilms) die tijdens 
de bestraling vaak worden gebruikt als referentiebeelden ter vergelijking met EPID 
beelden. Dit betekent dat een positioneringsfout tijdens de simulatie een systematische fout 
is, die tijdens iedere fractie van een gegeven patiënt optreedt, en bovendien met 
simulatiefilms als referentiebeelden niet zal worden opgemerkt. Om deze simulatiefouten te 
kwantificeren werden simulatiefilms vergeleken met digitally reconstructed radiographs 
(DRRs). DRRs zijn doorlichtingbeelden die worden berekend uit de CT data in combinatie 
met het daarop gebaseerde bestralingsplan en geven daarmee per definitie de geplande 
positionering perfect weer.  Door de positie van anatomische structuren in de DRRs te 
vergelijken met die in de corresponderende simulatiefilms konden de simulatiefouten 
worden bepaald.  
Omdat deze fouten groot bleken te zijn en, zoals genoemd, systematisch van aard, wordt 
in hoofdstuk 5 een procedure uitgewerkt waarbij de simulatie wordt overgeslagen en de 
patiëntmarkering benodigd voor de positionering tijdens de bestraling direct op de CT-
scanner plaats vindt. In hoofdstukken 4 en 5 wordt bovendien het effect beschreven van 
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positioneringscorrecties aan de hand van EPID beelden in een zogenaamd 'off-line' 
correctie protocol. Off-line betekent dat positioneringsfouten gemeten in EPID beelden 
tijdens een aantal bestralingssessies worden gebruikt om een correctie voor volgende 
sessies te bepalen. Dientengevolge kunnen hiermee alleen systematische 
positioneringsfouten worden gereduceerd. Uit deze studies blijkt dat de benodigde 
correcties nauwkeurig kunnen worden bepaald op basis van zowel simulatiefilms als DRRs 
als referentiebeelden. Omdat om bovengenoemde redenen de simulatiefilms aanzienlijke 
systematische fouten kunnen bevatten kan de procedure beschreven in hoofdstuk 5 
gecombineerd met correcties gebaseerd op DRRs en EPID beelden worden toegepast om 
systematische fouten effectief te verkleinen. 
 
Hoofdstukken 6 en 7. Een methode om systematische positioneringsfouten nauwkeurig te 
corrigeren met weinig werklast. 
In hoofdstuk 6 beschrijven we een nieuw off-line protocol om systematische fouten te 
reduceren. In dit 'No Action Level' (NAL) protocol wordt eerst de gemiddelde 
positioneringsfout gedurende een klein aantal fracties (bijv. 3) vroeg in de behandeling 
bepaald. Gedurende deze fracties vinden geen correcties plaats, maar in de volgende 
fracties wordt een correctie uitgevoerd ter grootte van de fout bepaald in de eerste fracties. 
Het NAL protocol werd retrospectief toegepast op met EPIDs gemeten positioneringsfouten 
in 600 prostaatkankerpatiënten. Daarnaast werd gebruikt gemaakt van Monte Carlo 
simulaties en analytische afleidingen om het gedrag van het NAL protocol nauwkeurig te 
bestuderen. De conclusie van dit werk is dat met het NAL protocol dezelfde reductie in 
systematische fouten bereikt kan worden als met het meest toegepaste protocol van dit 
moment, het 'shrinking action level' (SAL) protocol, maar met een factor 3 maal minder 
EPID gerelateerde werklast.  
In hoofdstuk 7 wordt dit protocol uitgebreid met een extra meting gericht op het 
verifiëren van de juiste uitvoering van de positioneringscorrectie berekend in het NAL 
protocol (correction verification ofwel COVER). Deze uitbreiding is nuttig omdat in het 
NAL protocol slechts één maal een correctie wordt berekend, waarna niet meer wordt 
afgebeeld. Om te voorkomen dat er een systematische fout wordt gemaakt in de uitvoering 
van deze correctie gedurende alle volgende fracties, werd een methode bedacht om 
significante uitvoeringsfouten met weinig metingen te detecteren. Uit een risicoanalyse 
gebaseerd op Monte Carlo simulaties werd een testcriterium afgeleid voor de 
positioneringsfout gemeten in de eerste fractie waarin de positioneringscorrectie wordt 
uitgevoerd. Met dit criterium hoeft, indien geen systematische fouten worden gemaakt in de 
uitvoering, voor 95% van de patiënten niet verder te worden gemeten, terwijl grote 
systematische afwijkingen toch worden gedetecteerd. Daarmee werd het mogelijk om een 
verificatiestap toe te voegen die de lage werklast van het NAL protocol niet 
noemenswaardig verhoogt. 
 
 
Hoofdstuk 8: Positioneringscorrecties voor hoofd-hals patiënten. 
In hoofdstuk 8 wordt een studie beschreven naar de positioneringsnauwkeurigheid van 
hoofd-hals patiënten, gefixeerd met een conventioneel masker en gecorrigeerd met het SAL 
correctie protocol. Daarnaast wordt de effectiviteit van het NAL protocol voor deze 
patiëntgroep geanalyseerd, en wordt bevestigd dat een factor 3 werklast reductie mogelijk is  
ten opzichte van SAL. Daarbij wordt vastgesteld dat de wekelijkse verificatiemetingen, 
zoals in het algemeen toegepast in combinatie met SAL, in deze patiëntgroep geen ander 
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effect lijken te sorteren dan compensatie van het gebrek aan correcties in het eerste deel van 
het SAL protocol. 
 
Hoofdstuk 9: Positioneringsproblemen als gevolg van een flexibele anatomie 
Het meeste werk op het gebied van positioneringscorrecties is gericht op het uitvoeren van 
correcties door verschuivingen van de behandeltafel (Fig. 1.1). Deze aanpak werkt zolang 
relatieve veranderingen binnen de patiëntanatomie geen rol spelen. Dit is echter niet 
vanzelfsprekend  zodra vervormingen of rotaties van belang worden en dit belang neemt toe 
naarmate de behandelde volumina groter worden. De meeste modellen trachten het effect 
van rotaties in de 2D projecties van EPID beelden te beschrijven aan de hand van een rigide 
patiënt anatomie. De aanname van dergelijke rigiditeit lijkt echter inconsistent met het 
optreden van diezelfde rotaties. Om dit probleem te illustreren wordt in hoofdstuk 9 
onderzocht of positioneringsfouten gemeten aan de hand van benige structuren in het 
caudale deel van grote cervix bestralingsvelden overeenkomen met de simultaan gemeten 
fouten in het craniale deel van het veld. Dit blijkt sterk afhankelijk van de keuze van de 
structuren waarmee deze fouten worden gemeten, en in het algemeen zijn de afwijkingen 
tussen caudaal en craniaal gelegen structuren van dezelfde orde als de positioneringsfouten 
van de caudale structuren. 
 
Hoofdstuk 10: Discussie 
De discussie spitst zich toe op twee onderwerpen. Ten eerste worden enkele redenen achter 
de tegenvallende verspreiding van klinisch gebruik van EPIDs besproken, waarbij tot de 
conclusie wordt gekomen dat niet zozeer de beeldkwaliteit maar eerder de gebrekkige 
software een belangrijke rol speelt. Ten tweede wordt aandacht geschonken aan 
zogenaamde time trends: geleidelijke, systematische verplaatsingen van de patiënt 
gedurende de totale bestralingsperiode. Uit deze discussie wordt geconcludeerd dat er 
weinig concreet gerapporteerd is over time trends en dat de gerapporteerde trends ofwel 
voorkomen kunnen worden ofwel klein zijn. Deze discussie wordt met name toegevoegd 
omdat time trends van belang zijn voor de effectiviteit van het NAL protocol. In dit kader 
worden de resultaten behaald met het NAL protocol bij prostaatpatiënten in een 
prospectieve studie gepresenteerd. 
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Dankwoord 
 
De artikelen zijn geworden tot een proefschrift en dit wordt, zoals gebruikelijk, uitgebracht 
onder één naam. Maar, zoals de lijsten van (co)auteurs bij de diverse hoofdstukken al 
aangeven zijn er vele anderen bij betrokken geweest en dit is het moment minstens een 
aantal daarvan nog eens bij naam te noemen.  
Allereerst copromotor en onderzoeksmotor, Ben Heijmen. Zijn vermogen om dwars door 
alle ruis de zin en onzin van onderzoeksresultaten te doorzien, de tijd die hij altijd nam voor 
langdurige en intensieve discussies (naast de vele prettige gesprekken over de meest 
uiteenlopende onderwerpen buiten het werk), de bereidheid mijn artikelen zeer grondig te 
lezen en van commentaar en verbeteringen te voorzien en zijn voortdurende motivatie tot 
het doen van onderzoek zijn niet alleen van groot belang geweest voor het tot stand komen 
van dit proefschrift, maar vormen ook elementen die het dagelijkse werk tot een plezier 
maken. Ik hoop dan ook dat we nog lange tijd zullen kunnen samenwerken. 
Maar uiteraard ben ik vele anderen dank verschuldigd. Ten eerste de EPID-fysici van het 
eerste uur, Henk Huizenga en Andries Visser, die in mij het vertrouwen stelden en de 
middelen aanreikten om 'van scratch' een nieuwe EPID te ontwikkelen, een project waar 
'RAPID' (zie hoofdstuk 2) het gevolg van was. Daarbij moet ook Boudewijn Swanenburg 
worden genoemd, indertijd directeur van de Stichting Ruimteonderzoek (SRON)-Leiden. 
Dankzij hem kwam ik in contact met de afdeling klinische fysica van de Daniel den Hoed 
Kliniek, een groep waar hij mee had samengewerkt bij de ontwikkeling van de Philips SRI-
100 EPID. Ook zijn latere inbreng in de werkgroep ter ontwikkeling van RAPID was 
bijzonder waardevol. 
 Ten tweede is daar de groep 'MM50 laboranten' die er al snel voor zorgden dat ik me 
thuis voelde in 'de Daniel' dankzij hun collegialiteit en enthousiasme. Hun inzet was altijd 
heel stimulerend. Dankzij Gert, Sandra Quint, Merik, Henri, de Marjoleinen, Petra en nog 
vele anderen werd de toepassing van EPIDs een succes in onze kliniek. De enorme database 
met positioneringsfouten van honderden patiënten, waar ik voor dit proefschrift gebruik van 
kon maken, zou er zonder hen nooit zijn gekomen en al zeker niet van dezelfde kwaliteit 
zijn geweest. 
John van Sörnsen de Koste  was de laborant die samen met mij het NKB project 
uitvoerde waar het meeste werk uit dit proefschrift op gebaseerd is. Uit diverse 
hoofdstukken wordt zijn belangrijke bijdrage duidelijk, en zijn uitputtende analyses van 
duizenden EPID beelden zijn onder insiders legendarisch. Ik heb altijd de neiging gehad 
resultaten, aangeleverd door anderen, niet zomaar over te nemen zonder er zelf goed naar 
gekeken te hebben. Bij John durfde ik dat principe vaak los te laten omdat hij altijd goed 
voorbereid, precies en systematisch werkte, ook als er tijdsdruk was. 
Een andere essentiële groep vormen de programmeurs en automatiseerders. Het  
prototype van RAPID had nooit tijdig in klinisch gebruik genomen kunnen worden zonder 
de inspanningen van Bert van der Leije, die bij het hele ontwikkeltraject betrokken was. Hij 
bouwde eigenhandig en binnen enkele maanden een compleet nieuwe EPID user-interface 
en wist daarmee ook van Visual C++ turbotaal te maken. Gelukkig werkt hij nog steeds 
mee aan de software voor de opvolger van RAPID, het TNT systeem, dat we in 
samenwerking met Cablon Medical ontwikkelen. Op die basis zijn Paul en Jaco erbij 
gekomen, die er niet alleen voor hebben gezorgd dat we het aandurfden de software op een 
volledig nieuwe basis op te zetten maar die ook nieuwe technieken en ideeën inbrachten. 
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Het blijft inspirerend om met dit groepje te werken. Bart, Hafid, Norman (en weer Bert) wil 
ik bedanken voor de snelle ondersteuning bij computerproblemen, en de vrijheid die ze 
lieten om eigen experimenten op de PC te ondernemen. 
 Uiteraard zijn er ook de klinisch fysici (in opleiding) en projectmedewerkers met wie 
het niet alleen prettig omgaan was maar die ook een belangrijke inbreng hebben gehad in 
dit werk. Ten eerste Joep Stroom, met wie ik  vooral tijdens de eerste jaren vaak uitgebreid 
ging lunchen wat leidde tot de meest uiteenlopende gesprekken. Soms leidden die tot slappe 
lachaanvallen, maar ook tot stevige discussies over wat te doen met al die 
onnauwkeurigheden in de radiotherapie, met name over de concepten die hij in hoofdstuk 3 
van dit proefschrift beschrijft. Ook Kasper en Marco (lange tijd kamergenoten), Maarten, 
Sandra Vieira, Lars en Robert hebben altijd voor een aangename sfeer met veel discussie 
over EPIDs en de rest van de wereld gezorgd. Van Marco heb ik een groot aantal nuttige 
IDL routines kunnen overnemen, waar ik op kon bouwen voor het werk in hoofdstuk 2. 
Lars en Robert wil ik ook bedanken voor het grotendeels overnemen van de klinische 
EPID-ondersteuning waardoor ik de ruimte kreeg dit boekje eindelijk af te schrijven.  
Uiteraard was veel van het werk uit dit proefschrift alleen mogelijk dankzij de 
betrokkenheid van radiotherapeuten die het nut van positioneringsverbetering met EPIDs 
nadrukkelijk erkenden. Manouk Olofsen, Carien Creutzberg en Suresh Senan wil ik 
hartelijk danken voor hun actieve betrokkenheid bij diverse studies en bijdrage aan het 
stimuleren van systematisch EPID gebruik. Daarnaast heeft mijn promotor, Peter Levendag, 
regelmatig zijn enthousiasme over het EPID-werk in onze kliniek getoond, evenals over het 
onderzoek in dit boekje. Ik wil hem en de overige leden van de promotiecommissie 
bedanken voor het doornemen van dit proefschrift. Dat geldt ook voor de leden die nog niet 
zijn vermeld: Ben Mijnheer, Pieter Vos, Vincent Grégoire and Phil Evans, thank you very 
much for coming over to Rotterdam to take part in the opposition. 
Ik doe tekort aan veel mensen als ik niet de overige klinisch fysici, klinisch fysisch 
medewerkers, laboranten, artsen, instrumentmakers, electronici, secretaresses, etc., zou 
bedanken, niet alleen voor eventuele bijdragen aan dit boekje (want die zijn er zeker), maar 
ook voor het samen maken van de 'Rotterdamse sfeer' waarin ik het prettig werken vind. 
Maar, er is meer dan collega's. Mijn vader was door zijn nieuwsgierigheid, technische 
inslag en creativiteit een inspiratiebron en ik zal hem op de dag van mijn promotie 
bijzonder missen. Daar staat tegenover dat mijn moeder en twee zussen onvermoeibaar 
belangstelling en vertrouwen tonen in wat ik doe, en ook veel gezelligheid brengen. 
Christophe en Karin bleven trouwe vrienden, ook toen ik steeds minder tijd kreeg om 
uitgebreid dingen te ondernemen. Ook Homme bleef dat tot het laatste moment. Zijn 
afwezigheid zal ik zeker blijven voelen.   
Stephen, Tanya and Julius, thank you for being great friends in the land down under. 
Om Mariëtte hier te bedanken is eigenlijk te simpel. In de periode waarin dit boekje tot 
stand kwam, en waarin ik tevens de opleiding tot klinisch fysicus afrondde, werden ook 
Niels en Veerle geboren. Dankzij Mariëtte draaide alles zonder probleem door, ook op haar 
werk, en daarom weet ik niet zeker wie nu eigenlijk het meeste gedaan heeft voor dit 
proefschrift. Wat ik wel weet is dat Niels en Veerle voor ons beiden een enorme bron van 
energie en plezier zijn, die maken dat het ondanks de drukte toch nooit echt zwaar wordt. 
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